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Summary 
Request from the Norwegian Food Safety Authority (NFSA) 
In September 2013, the Norwegian Food Safety Authority requested VKM to update relevant 
parts of the benefit-risk assessment of fish in the Norwegian diet published by VKM in 2006. 
The background for the request was new knowledge and data on the content of some 
nutrients and contaminants both for wild and farmed fish since 2006. The proportion of 
vegetable ingredients used in farmed fish feed has in recent years increased, and new 
national dietary surveys for adults and children have been conducted. 
The Norwegian Food Safety Authority referred to VKM’s report from 2006, which pointed out 
that the positive impact of fish consumption on public health was especially due to the 
content of polyunsaturated fatty acids and vitamin D in fish. Further, VKM concluded that the 
contaminants that could pose a potential risk to public health through fish consumption 
mainly were methylmercury, dioxins and dioxin-like PCBs (dl-PCBs).  
The request included a reassessment of fish consumption in Norway with focus on specific 
nutrients; n-3 fatty acids (eicosapentaenoic acid (EPA), docosapentaenoic acid (DPA), 
docosahexaenoic acid (DHA)), vitamin D, and the minerals iodine and selenium, and on 
specific contaminants; mercury, dioxins and dl-PCBs. VKM was asked to address the main 
changes in the use of raw materials in farmed fish feed and how these affect the levels of 
nutrients, mercury, dioxins and dl-PCBs and in fish feed. Further, VKM was asked to address 
to what extent levels of nutrients and contaminants in fish have changed since 2006, to 
describe these changes and estimate the human intake of the substances in question on the 
basis of recent dietary data. VKM was also requested to consider the benefits of eating fish 
with regard to the intake of nutrients and the risks associated with the intake of mercury, 
dioxins and dl-PCBs and comment on whether this change the conclusions from the report in 
2006. Additionally, on the basis of updated knowledge, VKM was asked to comment whether 
other substances, like pesticide and residues of veterinary medicinal products, could affect 
the conclusions with regard to the impact on public health. 
The Norwegian Food Safety Authority and the Directorate of Health will use the updated 
assessment as a basis for public recommendations concerning the consumption of fish and 
fish products.  
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How VKM has addressed the request 
The VKM appointed a working group consisting of VKM members and external experts to 
answer the request. Several of the scientific panels of VKM reviewed the report during its 
preparation. The Scientific Steering Committee of VKM has given their final assessment and 
approval of the current report. 
In the current report, VKM has mainly used data from national surveillance and monitoring 
programs for nutrient and contaminant concentrations in fish feed, farmed fish and wild 
caught fish, but occurrence data have also been derived from peer reviewed articles. 
VKM has estimated fish consumption in three population groups (2-year-olds, adults and 
pregnant women). The estimated fish consumption was compared to national dietary 
guidelines. 
To assess health effects of fish consumption, the current estimated fish intakes were also 
compared with assessments done by recognised international bodies and results from 
epidemiological studies addressing possible associations between fish consumption and 
specific health outcomes. Literature searches were done to identify relevant epidemiological 
studies. VKM has not systematically assessed reviews or meta-analyses nor individual studies 
for weight of evidence, but merely summarised the studies retrieved from the literature 
search. It was considered being beyond the scope of this assessment to review individual 
studies included in reviews or meta-analyses. 
Furthermore, based on current fish consumption in the various population groups, intake of 
nutrients and exposure to contaminants from fish were estimated. For benefit 
characterisation of the specific nutrients the estimated nutrient intake was compared with 
national recommendations of nutrients intake and for EPA and DHA a comparison was also 
done with European recommendations. For risk characterization of contaminant exposure 
from fish, VKM used health based guidance values set by international risk assessment 
bodies (WHO, EFSA). 
VKM noted that the request from NFSA was restricted to fish, whereas the VKM report in 
2006 included both fish and other seafood. 
VKM focused on specific nutrients and contaminants as requested by the NFSA. In addition, 
VKM also commented on other substances that could affect the risk assessment, such as 
residues of veterinary medicinal products including residues of antibiotics, new contaminants 
from fish feed like the pesticide endosulfan, polycyclic aromatic hydrocarbons (PAHs), 
mycotoxins, the synthetic antioxidants ethoxyquin, butylhydroksyanisol (BHA) and 
butylhydroksytoluen (BHT), as well as environmental contaminants like brominated flame 
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Background 
In the Norwegian diet fish is important source of well-balanced proteins, and important 
nutrients such as EPA and DHA, vitamin D, iodine and selenium. On the other hand, fish is 
also a source of exposure to chemical contaminants like dioxins, PCBs and mercury. 
Over the last 10 years there has been a great change in raw materials used in fish feeds, 
and in 2013 terrestrial plant proteins and vegetable oils accounted for 70% of the feed. The 
changes in concentrations of nutrients and contaminants in fish feed for farmed Atlantic 
salmon and trout are reflected in changed concentrations and compositions of the same 
nutrients and contaminants in the farmed fish fillet. 
The current national dietary guideline is to eat fish as dinner meals 2-3 times per week for all 
age groups, representing 300-450 g fish per week for adults, including at least 200 g fatty 
fish, such as salmon, trout, mackerel and herring. Fish is also recommended as bread 
spread. Further, a daily supplement of vitamin D to infants from 4 weeks of age is 
recommended, and if this supplement is taken as cod liver oil it will in addition ensure an 
adequate supply of EPA and DHA. 
The present benefit-risk assessment is comprised of three elements, i.e. benefit assessment, 
risk assessment and benefit-risk comparison. This methodology is in accordance with the 
guidance given by EFSA in 2010. 
Fish consumption in Norway and comparison with national dietary guidelines 
VKM has used information about fish consumption from more recent national dietary surveys 
among 2-year-olds (Småbarnskost 2007) and adults at 18-70 years of age (Norkost 3, 
2010/2011), as well as information for pregnant women who answered the Norwegian 
Mother and Child Cohort Study (MoBa2, 2002-2008) food frequency questionnaire. The 
national food consumption survey Ungkost 2000, which covers the age groups 4-, 9-, and 
13-year-old children, was considered too old to be used and it is therefore not known if their 
fish consumption patterns have changed, neither in amount consumed nor type of fish 
consumed. 
Even though there are methodological differences between the dietary surveys used in 2006 
and 2014, the amount of fish consumed appears to be unchanged for all population groups. 
Furthermore, in 2014, lean fish and fatty fish contribute with about 60 and 40 percent, 
respectively, of the total fish consumption, which is similar to 2006.  
Given a portion size of 150 g fish, the average adult eats fish equivalent to 2-3 dinner 
servings per week and the average pregnant woman eats fish equivalent to 1-2 dinner 
servings per week, while the average two-year-old eats fish equivalent to 1-2 dinner servings 
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Fish consumption (expressed as raw fish), mean grams (g) per week in 2-year-olds 
(Småbarnskost 2007, n=1674), adults (Norkost 3, n=1787) and pregnant women (MoBa, 
n=86277)  
Population groups Mean fish consumption g/week  
 Fish,  
total 
Lean fish 
(≤ 5% fat) 
Fatty fish  
(> 5% fat) 
Fish roe and 
liver 
2-year-olds  112 70 35 7 
Adults  364 210 147 7 
Pregnant women 217 126 77 14 
VKM concludes that of the different population groups, only adults (18-70 years of age) with 
an average or higher fish consumption reach the national food based dietary guidelines for 
total fish consumption. Mean total fish consumption and fatty fish consumption in children 
(2-year-olds) and pregnant women, as well as the mean fatty fish consumption in adults are 
lower than recommended. In pregnant women and 2-year-olds, fish consumption is too low 
to meet the food based dietary guidelines. 
Health effects of fish consumption 
VKM is of the opinion that according to epidemiological studies, the net effects of the present 
average fish consumption in Norway for adults including pregnant women is beneficial for 
specific cardiovascular diseases (particularly cardiac mortality, but also with regard to 
ischaemic stroke, non-fatal coronary heart disease events, congestive heart failure and atrial 
fibrillation), as well as for optimal neurodevelopment of foetus and infants. Furthermore, 
VKM is of the opinion that those with fish consumption less than one dinner serving per 
week may miss these beneficial effects. 
The health benefit of fish consumption is reported from 1-2 dinner servings per week and up 
to 3-4 dinner servings per week. For higher fish intake per week, the limited number of 
consumers in epidemiological studies does not allow for drawing firm conclusions about the 
actual balance of risk and benefit. More knowledge is needed to reveal the beneficial 
mechanisms of fish consumption. 
Benefit characterisation of nutrients in fish 
VKM is of the opinion that there has been minor or no changes of the composition and 
concentrations of nutrients in wild caught fish since 2006. 
Due to replacement of fish oil and fish protein with plant proteins and vegetable oils in feed 
for farmed fish, the concentrations in farmed Atlantic salmon with regard to EPA, DPA and 
DHA, and selenium are about 50 and 40% respectively, of the corresponding levels in 2006, 
while the concentration of vitamin D appears unchanged. The level of iodine in farmed 
Atlantic salmon was low in 2006, and is still low compared to lean fish. The level of n-6 fatty 
acids is about 4-fold higher than in 2006. 
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VKM has estimated the contribution from fish to the recommended daily intakes of certain 
nutrients. Fish is the major source of EPA+DPA+DHA, but for vitamin D, iodine and 
selenium, other sources in addition to fish are needed in order to meet the recommendation. 
Fish is not a major dietary source of n-6 fatty acids. The contribution of dietary n-6 fatty 
acids from farmed salmon compared to the overall dietary intake of n-6 fatty acids is low 
(less than 3%). 
VKM concludes that with current average consumption of fish, the contribution of EPA and 
DHA from fish will reach the European recommended intake of EPA+DHA for adults and 2-
year-olds. For pregnant women the average EPA+DHA intake is insufficient to meet the 
European recommendation for this group. However, the average intake of DHA is sufficient 
to meet the national intake recommendation for pregnant women. 
For vitamin D, current average fish consumption contributes approximately 20% of the 
national recommended intakes for adults but less for pregnant women and 2-year-olds. 
Furthermore, with current average fish consumption, low intakes of selenium and iodine 
from fish relative to the national recommended values may be complemented by intake from 
other dietary sources. 
VKM has made various scenarios to foresee how possible changes in fish consumption 
pattern and amounts will affect the contribution from fish to recommended intakes of 
specific important nutrients. According to the scenarios, increasing the consumption of fatty 
fish will increase the intakes particularly of vitamin D, EPA+DPA+DHA, while increasing 
consumption of lean fish will increase the intakes particularly of iodine. Furthermore, VKM 
notes that the choice of fatty fish species, e.g. farmed Atlantic salmon, mackerel and herring 
is also of importance for nutrient intake due to differences in nutrient content. 
Risk characterisation of undesirable substances in fish 
The available concentration data of contaminants in wild fish is not suitable for time-trend 
analyses. A rough comparison of contaminant concentrations between 2006 and 2014 
indicates minor or no changes in concentrations of mercury, dioxins and dl-PCBs in wild fish 
species. However, for dioxins and dl-PCBs, a decreasing environmental time-trend is 
expected to be reflected also in wild fish species. 
Due to replacement of fish oil and fish protein with plant proteins and vegetable oils in 
farmed fish feed, the concentrations of dioxins and dioxin-like PCBs, and mercury have 
changed in farmed Atlantic salmon. VKM concludes that the current concentrations of dioxins 
and dl-PCBs, and mercury in farmed Atlantic salmon are reduced to about 30 and 50%, 
respectively, of the corresponding levels in 2006. 
VKM has estimated the dietary exposure to contaminants from fish based on mean levels in 
different fish species and compared the exposure levels with the relevant health based 
guidance levels, tolerable weekly intakes (TWIs). A tolerable intake is the amount of a 
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substance, or substance group, which can be consumed safely throughout a person's lifetime 
without appreciable risk of adverse health effects. Tolerable intakes incorporate safety 
margins, in order to protect all parts of the population. 
VKM concludes that with the present mean concentration of mercury in fish on the 
Norwegian market and the present fish consumption in Norway, the methylmercury exposure 
from fish is below the tolerable weekly intake (TWI) of 1.3 µg/kg bw/week for more than 
95% of the population of 2-year-olds, adults and pregnant women. This exposure represents 
a negligible risk and is of no concern. 
With the present mean level of dioxins and dl-PCBs in fish on the Norwegian market and 
the present fish consumption in Norway, high fish consumption (the 95th percentile) 
contributes with up to 50%, 19%, 67% of the TWI of 14 pg TEQ/kg bw/week for adults, 
pregnant women and 2-year-olds respectively. Daily consumption of cod liver oil or fish oil 
(which is common in all population groups) in amounts as suggested on the product will in 
addition contribute with 0.8 to 16% of the TWI, depending on the body weight. With the 
present TWI and taking into consideration that fish and fish products are significant sources 
to dioxins and dl-PCBs in the Norwegian diet, VKM concludes that the exposure from fish to 
dioxins and dl-PCBs represents negligible risk and is of no concern. 
VKM is of the opinion that the present exposure to residues of veterinary medicinal 
products including residues of antibiotics in farmed fish in the Norwegian diet is of no 
concern since the levels are very low and often not detectable even with sensitive analytical 
methods.  
For new contaminants in fish feed like the pesticide endosulfan, polyaromatic 
hydrocarbon (PAHs) and mycotoxins, VKM is of the opinion that the concentrations in 
farmed fish in the Norwegian diet are likely not a food safety issue since the concentrations 
are very low and often not detectable even with sensitive analytical methods. 
Regarding the environmental contaminants brominated flame retardants, VKM refers to the 
conclusions in a risk assessment from EFSA in 2011 that the health risk associated with the 
current exposure to these compounds is low. The amount of fluorinated compounds such as 
PFOS and PFOA in the Norwegian diet is much lower than what is tolerable according to an 
EFSA assessment in 2008. 
VKM has made various scenarios to foresee how possible changes in fish consumption 
pattern and amounts will affect the exposure from fish to TWIs of methylmercury, and 
dioxins and dl-PCBs. Fish is the only source for methylmercury exposure from foods, whereas 
exposure to dioxins and dl-PCBs also comes from other foods than fish. Based on these 
scenarios, where only exposure to dioxins and dl-PCBs from fish were taken into 
consideration, VKM is of the opinion that fish consumption in line with the food-based dietary 
guideline of 300-450 g fish, hereof 200 g fatty fish per week, does not lead to exposures to 
dioxins and dl-PCBs or methylmercury from either fatty or lean fish exceeding the respective 
TWIs, and is therefore, from a contaminant exposure perspective, of no concern. 
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However, since there are other food sources in the Norwegian diet that contribute to 
exposure to these contaminants, VKM performed a simple model estimate of weekly intake 
of dioxins and dl-PCBs in adults from various amounts of farmed salmon and other foods. 
Based on this scenario, VKM is of the opinion that there is negligible risk associated with 
eating farmed Atlantic salmon with the present mean concentrations of dioxins and dl-PCBs. 
The TWI is not exceeded when consuming amounts equivalent to 1400 g farmed salmon 
weekly for adults (representing 9 weekly dinner servings). Neither is the TWI exceeded when 
exposures to dioxins and dl-PCBs from other foods and cod liver oil are taken into 
consideration. In comparison, an adult can consume about 800 g mackerel weekly 
(representing 5 weekly dinner servings) with current mean concentration of dioxins and dl-
PCBs without exceeding TWI. From a contaminant exposure perspective consumption of 
farmed salmon is of no concern. This also applies for commercially available wild caught fish 
like mackerel. 
Benefit – risk comparison 
Following a comprehensive assessment of the scientific literature on the positive health 
effects of fish consumption and the contribution from fish to intake of beneficial compounds 
as well as exposure to hazardous contaminants in Norway, VKM concludes that the benefits 
clearly outweighs the negligible risk presented by current levels of contaminants and other 
known undesirable substances in fish. Furthermore, adults including pregnant women with 
fish consumption less than one serving per week may miss the beneficial effects on 
cardiovascular diseases and optimal neurodevelopment in the foetuses and infants. In 
contrast to the conclusion in 2006, VKM concludes that there is no reason for specific dietary 
limitations on fatty fish consumption for pregnant women.  
Uncertainties 
This benefit-risk assessment is composed of several different parts. Various databases are 
used, including data on levels of nutrients and contaminants in fish feed and fish which may 
all contain uncertainties which in turn may influence the overall assessment. Furthermore, 
there may be uncertainties in the estimated fish consumption data retrieved from the dietary 
food surveys and there may be weaknesses in the epidemiological studies about health 
effects of fish consumption. Despite some limitations in assessing the fish consumption and 
the uncertainties related to the estimated intakes of nutrients and exposures to contaminants 
from fish and fish products, VKM concludes that the intake and exposure estimates 
presented in this opinion are within realistic ranges for each study population. VKM 
compared intakes of nutrients with national recommended intake values and exposures to 
contaminants with internationally recognised health based guidance values (tolerable 
intakes). Likewise, the benefits for health associated with fish consumption were also 
evaluated by international bodies, and the uncertainties in these assessments were not 
evaluated by VKM. VKM considers the overall uncertainty in the outcome of the present 
assessment on benefit and risk of fish consumption in Norway to be low.  
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Sammendrag 
Oppdrag fra Mattilsynet 
I september 2013 ba Mattilsynet Vitenskapskomiteen for mattrygghet (VKM) om å oppdatere 
relevante deler av nytte-risikovurderingen av fisk i norsk kosthold utgitt av VKM i 2006. 
Bakgrunnen for oppdraget var ny kunnskap og data om innhold av enkelte næringsstoffer og 
fremmedstoffer både for villfisk og oppdrettsfisk siden 2006. Andelen vegetabilske 
ingredienser som brukes i fôr til oppdrettsfisk har økt i de senere årene og nye nasjonale 
kostholdsundersøkelser for voksne og barn har blitt gjennomført. 
Mattilsynet viste i sitt oppdrag til VKM rapporten fra 2006, som påpekte at den positive 
helseeffekten av å spise fisk spesielt var relatert til fiskens innhold av flerumettede fettsyrer 
og vitamin D. VKM konkluderte den gang med at forurensninger som kan utgjøre en 
potensiell risiko for folkehelsen gjennom konsum av fisk hovedsakelig var metylkvikksølv, 
dioksiner og dioksinlignende PCB. 
Mattilsynets bestilling omfattet en revurdering av fiskekonsumet i Norge med fokus på 
spesifikke næringsstoffer; n-3-fettsyrer (eikosapentaensyre (EPA), dokosapentaensyre (DPA), 
dokosaheksaensyre (DHA)), vitamin D, og mineralene jod og selen, og på bestemte 
forurensninger; kvikksølv, dioksiner og dioksinliknende PCB (dl-PCB). VKM ble bedt om å 
vurdere de viktigste endringene i bruken av råvarer i fôr til oppdrettsfisk, og hvordan disse 
igjen påvirker nivåene av næringsstoffer, kvikksølv, dioksiner og dioksinliknende PCB i 
fiskefôret. Videre ble VKM bedt om å vurdere i hvilken grad nivåene av næringsstoffer og 
forurensninger i fisk har endret seg siden 2006, samt beskrive endringene og beregne inntak 
av de aktuelle stoffene ut i fra nasjonale kostholdsundersøkelser. VKM ble også bedt om å 
vurdere fordelene ved å spise fisk med hensyn til inntak av næringsstoffer opp mot risikoen 
forbundet med inntak av kvikksølv, dioksiner og dioksinliknende PCB og vurdere om dette 
endrer konklusjonene fra rapporten i 2006. I tillegg, på bakgrunn av oppdatert kunnskap, ble 
VKM bedt om å kommentere om andre stoffer, som plantevernmiddel- og medisinrester, kan 
påvirke konklusjonene med hensyn til innvirkning på folkehelsen.  
Mattilsynet og Helsedirektoratet vil bruke den oppdaterte vurderingen som grunnlag for 
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Hvordan VKM har arbeidet med og besvart Mattilsynets bestilling 
VKM nedsatte en arbeidsgruppe som besto både av VKM medlemmer og eksterne eksperter 
for å svare på bestillingen. Underveis i arbeidet hadde flere av VKMs vitenskapelige 
faggrupper rapporten til gjennomsyn og kommentering. VKMs Hovedkomite har i flere møter 
behandlet rapporten og gitt den sin endelige godkjenning. 
VKM har i sin vurdering hovedsakelig brukt forekomsttall både for næringsstoffer og 
miljøgifter i fiskefôr, oppdrettsfisk og villfisk fra nasjonale kontroll- og 
overvåkingsprogrammer, men forekomsttall har også blitt hentet fra fagfellevurderte artikler. 
VKM har estimert fiskekonsumet i tre grupper av befolkningen (2 år gamle barn, voksne og 
gravide kvinner). Det estimerte fiskekonsumet ble så sammenlignet med nasjonale kostråd 
for fiskekonsum. 
For å vurdere helseeffekter av fiskekonsumet, ble dagens estimerte fiskekonsum også 
sammenlignet med resultater fra vurderinger gjort av anerkjente internasjonale 
organisasjoner og resultater fra epidemiologiske studier som har sett på mulige 
sammenhenger mellom fiskekonsum og spesifikke helseutfall. Det ble utført litteratursøk for 
å identifisere relevante epidemiologiske studier. VKM har ikke systematisk vurdert 
oversiktsartikler, metaanalyser eller enkeltstudier med hensyn på vekting av holdepunkter, 
men har oppsummert resultatene fra studiene funnet i litteratursøket. En vurdering av de 
enkelte studiene som inngikk i oversiktsartiklene eller metaanalysene ble ansett å ligge 
utenfor rammen av denne rapporten. 
I tillegg ble inntak av næringsstoffer og eksponering for miljøgifter fra fisk estimert basert på 
dagens fiskekonsum i de ulike befolkningsgruppene. For nyttekarakterisering av de spesifikke 
næringsstoffene ble det estimerte inntaket av næringsstoffer sammenlignet med nasjonale 
anbefalinger for inntak av de respektive stoffene. For summen av EPA og DHA ble det også 
gjort en sammenligning med europeiske anbefalinger for inntak. For risikokarakterisering av 
miljøgifteksponering fra fisk benyttet VKM helsebaserte referanseverdier satt av 
internasjonale risikovurderingsorganer (WHO, EFSA).  
VKM tok til følge at Mattilsynet ønsket en vurdering av fisk, mens VKM rapporten i 2006 
omfattet både fisk og annen sjømat. 
VKM har lagt vekt på de spesifikke næringsstoffene og miljøgiftene som Mattilsynet ba om. I 
tillegg har VKM omtalt andre stoffer som kan ha betydning for vurdering av risiko, slik som 
legemiddelrester, inkludert rester av antibiotika, nye miljøgifter i fiskefôr, som 
plantevernmiddelet endosulfan, polysykliske aromatiske hydrokarboner, mykotoksiner, 
syntetiske antioksidanter som ethoxyquin, butylhydroksyanisol (BHA) og butylhydroksytoluen 
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Bakgrunn 
Fisk en viktig kilde til godt balansert kosthold med hensyn til protein og viktige 
næringsstoffer som EPA og DHA, vitamin D, jod og selen. På den annen side er fisken også 
en kilde til eksponering for miljøgifter som dioksiner, PCB og kvikksølv. 
I løpet av de siste 10 årene har det vært en stor forandring i råvarer som brukes i fiskefôr, 
og i 2013 besto 70 % av fôret av terrestriske planteproteiner og planteoljer. Endringene i 
konsentrasjoner av næringsstoffer og fremmedstoffer i fôr til oppdrettslaks og oppdrettsørret 
gjenspeiles i endret konsentrasjon og sammensetning av de samme næringsstoffene og 
fremmedstoffene i fisken. 
Dagens nasjonale kostråd er å spise fisk til middag 2-3 ganger per uke i alle aldersgrupper. 
Dette representerer 300-450 g fisk per uke for voksne, inkludert minst 200 g fet fisk, som 
laks, ørret, makrell og sild. Fisk er også anbefalt som pålegg. Videre anbefales et daglig 
tilskudd av vitamin D til spedbarn fra fire ukers alder, og hvis dette tillegget er tran, vil det i 
tillegg sikre tilstrekkelig inntak av EPA og DHA. 
Denne nytte-risikovurderingen består av tre deler, dvs. en nyttevurdering, en risikovurdering 
og en sammenligning av nytten og risikoen. Metodikken er i samsvar med veiledning fra 
EFSA (EFSA, 2012). 
Fiskekonsum i Norge sammenlignet med nasjonale kostholdsråd 
VKM har brukt informasjon om fiskekonsum fra nyere nasjonale kostholdsundersøkelser blant 
2-åringer (Småbarnskost 2007) og voksne 18-70 år (Norkost 3, 2010/2011), samt 
informasjon fra gravide kvinner som har besvart matvarefrekvensskjemaet i den norske mor 
og barn-undersøkelsen (MoBa, 2002-2008). Den nasjonale kostholdsundersøkelsen Ungkost 
2000, som omfatter aldersgruppene 4-, 9- og 13-åringer, ble ansett for gammel til å bli 
brukt. Det er derfor ikke kjent om mønsteret i fiskekonsumet har endret seg for disse 
aldersgruppene, verken når det gjelder mengde eller type fisk som konsumeres. 
Selv om det er metodiske forskjeller mellom kostholdsundersøkelsene som ble brukt i 2006 
og 2014, er mengden fisk konsumert stort sett uforandret i de ulike aldersgruppene. 
Fordelingen mellom fet og mager fisk er også stort sett uforandret; ca. 60 % mager og 40 % 
fet fisk av det totale fiskekonsumet. 
Gitt en porsjonsstørrelse på 150 g fisk tilsvarer fiskekonsumet hos en gjennomsnittlig voksen 
2-3 fiskemiddager i uken og hos en gjennomsnittlig gravid kvinne 1-2 fiskemiddager per uke. 
En to-årings fiskekonsum tilsvarer 1-2 middager per uke gitt en porsjonsstørrelse på 75 g. 
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Gjennomsnittlig ukentlig fiskekonsum i gram (g) (uttrykt som rå fisk) hos 2-åringer 
(Småbarnskost 2007, n=1674), voksne (Norkost 3, n=1787) og gravide kvinner (MoBa, 
n=86277)  




(≤ 5 % fett) 
Fet fisk  
(> 5 % fett) 
Fiskerogn og 
fiskelever 
2-åringer  112 70 35 7 
Voksne 364 210 147 7 
Gravide kvinner 217 126 77 14 
VKM konkluderer med at av de ulike befolkningsgrupper, er det kun voksne (18-70 år) med 
et gjennomsnittlig eller høyere konsum av fisk som når de nasjonale matvarebaserte 
kostrådene for total fiskekonsum. Gjennomsnittlig totalt fiskekonsum og konsum av fet fisk 
hos barn (2-åringer) og gravide kvinner, så vel som konsum av fet fisk hos voksne, er lavere 
enn anbefalt. Fiskekonsumet hos gravide kvinner og to-åringer er for lavt til å nå anbefalt 
mengde i forhold til de matvarebaserte kostrådene. 
Helseeffekter av fiskekonsum 
VKM mener at i henhold til epidemiologiske studier er nettoeffekt av det nåværende, 
gjennomsnittlige konsumet av fisk hos norske voksne, inkludert gravide kvinner, gunstig for 
å forebygge spesifikke hjerte-karsykdommer (spesielt dødelighet på grunn av hjertesykdom, 
men også med hensyn til iskemisk hjerneslag, ikke-fatale hendelser av koronar 
hjertesykdom, hjertesvikt og atrieflimmer), samt for optimal utvikling av nervesystemet hos 
foster og spedbarn. Videre mener VKM at de som har fiskekonsum som er lavere enn 
tilsvarende én middagsporsjon per uke vil gå glipp av de gunstige virkningene av 
fiskekonsum på hjerte- og karsykdommer og optimal nevrologisk utvikling hos foster og 
spedbarn. 
Helsefordelene ved fiskespising opptrer fra 1-2 måltider per uke og opp til 3-4 måltider per 
uke. Det kan ikke trekkes sikre slutninger om nytte og risiko av enda høyere fiskekonsum, 
fordi det er for få som spiser mer enn 3-4 måltider per uke i de epidemiologiske studiene. 
Det trengs også mer kunnskap om hvorfor fisk er helsebringende. 
Nyttekarakterisering av næringsstoffer fra fisk 
VKM mener at det har vært liten eller ingen endringer i sammensetning og konsentrasjoner 
av næringsstoffer i villfanget fisk siden 2006 
Fordi fiskeolje og fiskeprotein er erstattet med planteproteiner og planteoljer i fôret til 
oppdrettsfisk, er konsentrasjonene av EPA, DPA og DHA i oppdrettslaks ca. 50 %, og selen 
ca. 40 % av nivåene i 2006, mens konsentrasjonen av vitamin D ser ut til å være uendret. 
Nivået av jod i oppdrettslaks var lavt i 2006, og er fortsatt lavt sammenlignet med mager 
fisk. Nivået av n-6 fettsyrer er omtrent fire ganger høyere enn i 2006. 
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VKM har beregnet bidraget fra fisk til det anbefalte daglige inntaket av bestemte 
næringsstoffer. Fisk er hovedkilden til EPA+DPA+DHA, mens for vitamin D, jod og selen er 
andre kilder i tillegg til fisk nødvendig for å oppnå anbefalt inntak. Fisk er ikke en viktig kilde 
for n-6 fettsyrer. Oppdrettslaks bidrar i liten grad (mindre enn 3 %) til inntak av n-6 fettsyrer 
i forhold til det samlede inntaket av n-6 fettsyrer fra kosten. 
VKM konkluderer at med dagens gjennomsnittlige konsum av fisk er bidraget av EPA og 
DHA fra fisk hos voksne og 2-åringer i tråd med europeiske anbefalte inntak av EPA+DHA. 
For gravide kvinner er det gjennomsnittlige EPA+DHA-inntaket ikke tilstrekkelig til å dekke 
den europeiske anbefalingen for gravide. Imidlertid imøtekommer det gjennomsnittlig 
inntaket av DHA hos gravide kvinner det nasjonalt anbefalte inntak for gravide. 
Dagens gjennomsnittlige konsum av fisk bidrar med ca. 20 % av det nasjonalt anbefalte 
inntaket for vitamin D hos voksne, mens bidraget fra fisken er lavere for gravide kvinner og 
2-åringer. 
Dagens gjennomsnittlige konsum av fisk bidrar i begrenset grad til inntak av selen og jod i 
forhold til nasjonalt anbefalte inntak. Annen mat bidrar til inntak av disse stoffene. 
VKM har laget ulike scenarier for å forutse hvordan eventuelle endringer i mønster av 
fiskekonsum og mengde fisk vil kunne påvirke bidraget fra fisk til anbefalte inntak av 
spesifikke, viktige næringsstoffer. Ifølge scenariene vil økt konsum av fet fisk gi økt inntak 
særlig av vitamin D, EPA+DPA+DHA, mens økt konsum av mager fisk vil gi økt inntak særlig 
av jod. VKM påpeker at valg av type fet fisk også vil ha betydning for næringsinntaket fordi 
ulike fiskeslag, f.eks. oppdrettslaks, makrell og sild, har ulikt næringsinnhold. 
Risikokarakterisering av uønskete forbindelser i fisk 
Tilgjengelige tall for konsentrasjoner av miljøgifter i villfisk er ikke egnet for 
tidstrendanalyser. En grov sammenligning av miljøgiftnivåer i 2006 og 2014 indikerer små 
eller ingen endringer av kvikksølv, dioksiner og dl-PCB i villfisk. Imidlertid viser forekomsten 
av dioksiner og dl-PCB i miljøet en generelt nedadgående tidstrend, og denne nedgangen er 
forventet å bli reflektert også i villfisk. 
Fordi fiskeolje og fiskeprotein i stor grad er erstattet med planteproteiner og planteoljer i 
fiskefôret, er konsentrasjonene av dioksiner og dl-PCB og kvikksølv endret i oppdrettsfisk. 
VKM konkluderer med at dagens konsentrasjoner av dioksiner og dioksinlike PCB og 
kvikksølv i oppdrettslaks er redusert til henholdsvis ca. 30 % og 50 % av nivåene i 2006. 
VKM har beregnet eksponeringen for miljøgifter fra fiskekonsum basert på 
gjennomsnittsnivåer i ulike fiskearter og sammenlignet eksponeringsnivåer med relevante 
helsebaserte referanseverdier, tolerable ukentlige inntak (Tolerable Weekly Intake - TWI). Et 
tolerabelt inntak er den mengden av et stoff, eller stoffgruppe, som kan inntas trygt 
gjennom hele livet uten nevneverdig risiko for uheldige helseeffekter. Tolerable inntak 
innehar sikkerhetsmarginer for å beskytte alle deler av befolkningen. 
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VKM konkluderer med at med dagens gjennomsnittlige nivå av kvikksølv i fisk på det norske 
markedet, og det nåværende fiskekonsumet i Norge, er eksponeringen for metylkvikksølv fra 
fisk under det tolerable ukentlige inntaket på 1,3 mikrogram/kg kroppsvekt/uke for mer enn 
95 % av to-åringer, voksne og gravide kvinner. Denne eksponeringen representerer en 
ubetydelig risiko som ikke fører til bekymring. 
Med dagens gjennomsnittlige nivå av dioksiner og dl-PCB i fisk på det norske markedet, 
og det nåværende fiskekonsumet i Norge, bidrar høyt konsum av fisk (95-persentilen) med 
opp til 50 % hos voksne, 19 % hos gravide og 67 % hos 2-åringer av tolerabelt ukeinntak på 
14 pg TEQ/kg kroppsvekt/uke. Daglig inntak av tran eller fiskeoljer (som er vanlig i alle 
grupper av befolkningen) i mengder som foreslått på produktet, vil i tillegg bidra med 0,8 % 
til 16 % av tolerabelt ukeinntak avhengig av kroppsvekt. Fisk og fiskeprodukter er vesentlige 
kilder til dioksiner og dl-PCB i norsk kosthold. VKM konkluderer likevel med at med gjeldende 
tolerabelt ukeinntak, så representerer dagens eksponering for dioksiner og dl-PCB fra fisk en 
ubetydelig risiko som ikke fører til bekymring. 
VKM mener at den nåværende eksponeringen for legemiddelrester inklusive rester av 
antibiotika i oppdrettsfisk ikke fører til bekymring siden nivåene er svært lave og ofte ikke 
gjenfinnes selv med følsomme analysemetoder. 
For nye miljøgifter i fiskefôr som plantevernmiddelet endosulfan, polyaromatiske 
hydrokarboner (PAH) og soppgifter (mykotoksiner), er VKM av den oppfatning at 
konsentrasjonene i oppdrettsfisk i norsk kosthold trolig ikke utgjør noe mattrygghetsproblem 
siden konsentrasjonene er svært lave og ofte ikke gjenfinnes selv med følsomme 
analysemetoder. 
Når det gjelder miljøgiftene bromerte flammehemmere viser VKM til EFSA, som i 2011 
konkluderte at helserisikoen knyttet til nåværende eksponering for disse stoffene er lav. 
Mengdene perfluorerte forbindelser som PFOS og PFOA i norsk kosthold er mye lavere enn 
det som er tolerabelt i henhold til en risikovurdering fra EFSA i 2008. 
VKM har laget ulike scenarier for å kunne forutse hvordan eventuelle endringer i fiskekonsum 
vil påvirke bidraget fra fisk til det tolerable ukeinntaket for henholdsvis metylkvikksølv, og 
dioksiner og dioksinlike PCB. Fisk er eneste kilde til metylkvikksølveksponering fra mat, mens 
for dioksiner og dioksinlike PCB bidrar annen mat også til eksponeringen. Basert på disse 
scenariene mener VKM at et fiskekonsum blant voksne i tråd med nasjonale matvarebaserte 
kostråd, 300-450 g fisk herav 200 g fet fisk per uke, ikke bidrar med dioksiner og dioksinlike 
PCB eller metylkvikksølv, verken fra fet eller mager fisk, i mengder som overskrider de 
respektive tolerable ukeinntakene. Denne eksponeringen utgjør derfor ingen bekymring fra 
et miljøgifteksponeringsperspektiv. 
Siden flere andre matvarer i det norske kostholdet bidrar til eksponeringen for dioksiner og 
dl-PCB, gjorde VKM et enkelt modellestimat av ukentlig eksponering for dioksiner og 
dioksinlike PCB fra ulike mengder oppdrettslaks og andre matvarer hos voksne. Basert på 
dette scenariet mener VKM at med dagens gjennomsnittlige konsentrasjon av dioksiner og 
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dioksinlike PCB er det ubetydelig risiko forbundet med å spise oppdrettslaks. Det tolerable 
ukeinntaket overskrides ikke selv ved konsum av mengder som tilsvarer 1400 g ukentlig for 
voksne (tilsvarende ni ukentlige middagsporsjoner). Det tolerable ukeinntaket overskrides 
heller ikke når eksponering for dioksiner og dl-PCB fra andre matvarer og tran blir tatt 
hensyn til. Til sammenligning kan en voksen konsumere ca. 800 g makrell i uken (fem 
ukentlige middagsporsjoner) med den nåværende gjennomsnittlige konsentrasjon av 
dioksiner og dioksinlike PCB uten at det tolerable ukeinntaket overskrides. I perspektiv av 
miljøgiftinnholdet kan oppdrettsfisk spises uten bekymring. Det samme gjelder for 
kommersielt tilgjengelig villfisk som makrell. 
Nytte - risiko sammenligning 
Etter en helhetlig vurdering av den vitenskapelige litteraturen om de positive helseeffektene 
av fiskekonsum og bidraget fra fisk til inntak av viktige næringsstoffer samt eksponering for 
farlige miljøgifter i Norge, konkluderer VKM med at fordelene klart oppveier den ubetydelige 
risikoen som dagens nivå av forurensninger og andre kjente fremmedstoffer i fisk 
representerer. Videre er det mulig at voksne inklusive gravide kvinner med fiskekonsum 
mindre enn tilsvarende en ukentlig middagsporsjon, går glipp av gunstige effekter på hjerte-
karsykdommer og optimal utvikling av nervesystemet hos foster og spedbarn. I motsetning 
til konklusjonen i 2006, konkluderer VKM nå med at det ikke er grunn til spesifikke kostråd 
for gravide om begrensninger på konsum av fet fisk. 
Usikkerhet 
Denne nytte-risikovurderingen er sammensatt av flere ulike deler. Forskjellige databaser er 
brukt, inkludert data på nivåene av næringsstoffer og fremmedstoffer i fiskefôr og fisk, og 
alle kan inneholde usikkerheter som igjen kan påvirke den samlede vurderingen. Videre kan 
det være usikkerhet i fiskekonsumet som er estimert ut i fra de nasjonale 
kostholdsundersøkelsene, og det kan være svakheter i epidemiologiske studier om 
helseeffektene av fiskekonsum. Til tross for noen begrensninger i vurderingen av 
fiskekonsum og usikkerhetene knyttet til de estimerte inntakene av næringsstoffer og 
eksponeringene for forurensninger fra fisk og fiskeprodukter, konkluderer VKM at de inntaks- 
og eksponeringsestimatene som presenteres i denne rapporten er realistiske for hver av 
alderspopulasjonene. VKM sammenlignet inntak av næringsstoffer med nasjonale anbefalte 
inntaksverdier og eksponering for forurensninger med internasjonalt anerkjente helsebaserte 
referanseverdier (tolerabelt inntak). Likeledes er helsegevinstene forbundet med konsum av 
fisk også evaluert av internasjonale organer, men usikkerheten i disse vurderingene ble ikke 
vurdert av VKM. VKM anser at den generelle usikkerheten i utfallet av denne nytte-
risikovurderingen av fiskekonsumet i Norge er lav. 
Nøkkelord: VKM, nytte-risikovurdering, fisk, fiskefôr, oppdrettslaks, fiskekonsum, 
helseeffekter, næringsstoffer i fisk, marine n-3 fettsyrer, jod, vitamin D, selen, 
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Abbreviations and glossary 
Abbreviations 
95th perc.  95th percentile 
AA  arachidonic acid 
AAP  American Academy of Pediatrics 
ACS   acute coronary syndrome  
ADI  acceptable daily intake 
AF  atrial fibrillation  
AFSSA/ANSES Agence nationale de sécurité sanitaire de l’alimentation, de l’environnement et 
  du travail/French Agency for Food, Environmental and Occupational Health &  
  Safety 
AI  adequate intake 
ALA  alpha linolenic acid 
ao  among others 
AR  average requirement  
BHA  butylhydroksyanisol 
BHT  butylhydroksytoluen 
BMD  benchmark dose  
BMDL  benchmark dose lower confidence limit 
bw  body weight 
Ca  chemical symbol for calcium 
CEN  European Committee for Standardization 
CHD  coronary heart disease 
CI  confidence interval 
CNS  central nervous system 
CONTAM EFSA Panel on Contaminants in the Food Chain 
COT-  Committee on Toxicity, UK 
CRL  community reference laboratories 
DALY   disability-adjusted life year 
DDD  dichlorodiphenyldichloroethane (breakdown product of DDT) 
DDE  dichlorodiphenyldichloroethylene (breakdown product of DDT)  
DEHP  di-2-ethylhexyl phthalate 
DDT   dichlorodiphenyltrichloroethane (an organochlorine pesticide) 
DHA  docosahexaenoic acid 
DiBP   di-isobutyl phthalate 
dl-PCBs dioxin-like PCBs 
DPA  docosapentaenoic acid 
EER  estimated energy requirement 
EFSA  European Food Safety Authority 
EPA  eicosapentaenoic acid 
EQ  ethoxyquin 
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FFQ  food frequency questionnaire 
HBCD  hexabromocyclododecane 
HBCDD hexabromocyclododecane 
HCH  hexachlorocyclohexane  
HCB  hexachlorobenzene  
HF  heart failure 
Hg  chemical symbol for mercury 
IQ  Intelligence Quotient 
IOM  Institute of Medicine (US) 
JECFA  Joint FAO/WHO Expert Committee on Food Additives 
JMPR  Joint FAO/WHO Meeting on Pesticide Residues 
KBS  Norwegain software system used to calculate dietary intake of nutrients 
kg  kilogram   
LB  lower bound 
LA  linoleic acid 
LCPUFA long chain polyunsaturated fatty acid 
LI  lower intake  
LOD  limit of detection 
LOAEL  Lowest Observable Adverse Effect Level 
LOEL  Lowest Observable Effect Level 
LOQ  limit of quantification 
MI  myocardial infarction  
MJ  mega joule 
ML  maximum level 
MoBa   Norwegian Mother and Child Cohort Study  
MoBa Val MoBa Validation Study 
MOE  margin of exposure 
MRL  maximum residue level 
MRPL  minimum required performance limits 
ng  nanogram  
NRL  national reference laboratories 
ndl-PCBs non-dioxin-like PCBs 
NOAEL  No Observed Adverse Effect Level 
NMKL  Nordisk metodikkomité for næringsmidler (i.e. Nordic Methodological 
   Committee for Food) 
NNR5  Nordic Nutrition Recommendations 5th edition 
NPN  non-protein nitrogen 
P95  95th percentile 
PBDEs  polybrominated diphenyl ethers 
PBPK  physiologically based pharmacokinetic modelling 
PCBs  polychlorinated biphenyls  
PCDDs  polychlorinated dibenzodioxins 
PCDFs  polychlorinated dibenzofurans 
PDI   Psychomotor Development Index 
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pers. comm. personal communication 
PFAS   perfluoroalkylated substance 
PFOS   perfluorooctanosulfonate 
PFOA   perfluorooctanooacid 
PG  propylgallate 
pg  picogram 
PICO   Population Intervention Comparison Outcome 
POPs   persistent organic pollutants 
prep.  preparation  
PTDI   provisional tolerable daily intake 
PTWI  provisional tolerable weekly intake 
PUFA   polyunsaturated fatty acid 
QALY   The quality-adjusted life year  
RCT  randomized control trials 
RR  relative risk 
SCF  Scientific Committee for Food; now replaced by EFSA 
SD  standard deviation 
T2DM  type-2 diabetes mellitus 
TBBPA  tetrabromobisphenol A 
TOR  terms of reference 
TCDD  tetrachlorodibenzo(p)dioxin 
TDI  tolerable daily intake 
TE  toxic equivalent 
TEF  TCDD toxic equivalency factor 
TEQ sum of TCDD toxic equivalents (concentration of each dioxins, furan and  
dl-PCBs multiplied with its corresponding TEF value and then summarised) 
TWI  tolerable weekly intake  
UB  upper bound 
UL  Upper intake levels (se Glossary for definition) 
US  United States 
US ATSDR United States Agency for Toxic Substances and Disease Registry 
VKM  Norwegian Scientific Committee for Food Safety 
VT  venous thromboembolism 
VMP  veterinary medicinal product  
WHO  World Health Organization 
ww  wet weight 
Glossary 
Average requirement (AR) is the daily intake of a specific nutrient estimated to meet the 
requirement in 50% of healthy people in an age- and gender-specific group. 
Acceptable daily intake (ADI) is the amount of an additive or a pesticide residue in food 
that a person can ingest daily throughout life without an appreciable health risk. 
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Benchmark dose (BMD) is a dose or concentration that produces a predetermined change 
in response rate of an adverse effect (called the benchmark response or BMR) compared to 
background. The BMD approach estimates the dose that causes a low but measurable target 
organ effect. 
Body burden is the total amount of a particular chemical present in the body. 
Benchmark dose lower confidence limit (BMDL) is a statistical lower confidence limit 
on the dose producing a predetermed level of change in adverse response compared with 
the response in unexposed individuals. 
 
Cocktail effect is a popular term of combined toxic effect of multiple chemical exposures.  
“Consumers only” is a term that refers to a calculated value based on data from only 
those who reported consumption of the specific food item. 
Disability-adjusted life year (DALY) is a measure of overall disease burden, expressed 
as the number of years lost due to ill-health, disability or early death.  
Frequent consumption is a relative quantification related to a study dependent scale.  
High consumers are defined by the 95th percentile.  
Lower bound values are values below limit of detection (LOD) or limit of quantification 
(LOQ) and are thus set to zero. 
Lower intake (LI) is a limit below which long-term intake are associated with an increased 
risk of developing deficiency symptoms. 
Maximum residue limit (MRL) of a veterinary medicinal product is the maximum 
acceptable concentration of a substance that may be found in a food product obtained from 
an animal that has received a veterinary medicine. The MRL for an active substance is based 
on its pharmacological and toxicological data which are derived from experimental animal 
studies. The EU-Commission approves the MRL values, which are implemented in Norway by 
the Norwegian Food Safety Authority. 
Maximum residue level (MRL) of a pesticide refers to the upper allowed level of residues 
of a particular pesticide that may remain in crops on the market, e.g. in feed or food, based 
on Good Agricultural Practice (GAP). 
Medium bound is when values below limit of detection (LOD) or limit of quantification 
(LOQ) are set to half of the LOD or LOQ. 
n-3 polyunsaturated fatty acids (PUFAs) refer to the fatty acids eicosapentaenoic acid 
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n-3 long-chain polyunsaturated fatty acids (LCPUFAs) refer to the long-chain fatty 
acids EPA, DPA and DHA only (not ALA). 
Polychlorinated biphenyls (PCBs) consist of 209 different congeners, amongst which the 
congeners numbered 121, 153 and 180 are the most commonly analysed for. 
Quality-adjusted life year (QALY) is a measure of disease burden, including both the 
quality and the quantity of life lived.  
The Stockholm Convention on Persistent Organic Pollutants (POPs) is a global treaty 
administered by the United Nations Environment Programme (UNEP) to protect human 
health and the environment from chemicals, and first entered into force in 2004 (Stockholm 
Convention on POPs 2004 http://www.chm.pops.int). The criteria for being included in SC 
are persistence, bioaccumulation, potential for long-range transport and adverse effects.  
Tolerable weekly intake (TWI) is the amount of a substance, or substance group, which 
can be consumed per week safely throughout a person's lifetime without appreciable risk of 
adverse health effects. 
Upper bound is when values below limit of detection (LOD) or limit of quantification (LOQ) 
are set equal to the LOD or LOQ. 
Upper intake levels (UL) are maximum levels of daily chronic intakes judged to be 
unlikely to pose a risk of adverse health effects in humans. 
Withdrawal times for veterinary medicinal products (VMPs) are based on the 
Maximum Residue Limit (MRL) of the active substance and results from analyses of residue 
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Background as provided by the 
Norwegian Food Safety Authority 
Fish and fish products contain substances that are beneficial to health as well as 
contaminants and other unwanted substances. Environmental contaminants are found in 
varying degrees in different types of food, and fish can be one of the sources of these 
substances in our diet. In 2004, the Norwegian Food Safety Authority requested the 
Norwegian Scientific Committee for Food Safety (VKM) to conduct a comprehensive 
assessment of fish and other seafood. The assessment was to take into account both the 
nutritional benefits of fish consumption and the health risks associated with the exposure to 
contaminants and other undesirable substances. 
In 2006, VKM published the report "A comprehensive assessment of fish and seafood in the 
Norwegian diet." The report stated that compared to many other countries, the consumption 
of fish and other types of seafood in Norway was high. Two thirds of the fish consumption 
comprised lean fish and minced fish products, and about one third was fatty fish. While most 
adults ate some fish and other seafood, a high percentage of children and teenagers did not 
eat such food at all. Young women consumed less fish than the general population. 
Since 2006, new knowledge about the content of some nutrients and contaminants in fish 
feed, fish and fish products has become available, both in wild and farmed fish. In recent 
years, the proportion of vegetable ingredients used in fish feed has increased. Moreover, 
results from new national dietary surveys for adults and children are available. In view of the 
increased knowledge, the Norwegian Food Safety Authority requests VKM to update relevant 
parts of the benefit-risk assessment of fish in the Norwegian diet. The Norwegian Food 
Safety Authority and the Norwegian Directorate of Health will use the updated assessment as 
a basis for public recommendations concerning the consumption of fish and fish products. In 
2006, VKM pointed out that the positive impact of fish consumption on public health was 
especially due to the content of polyunsaturated fatty acids and vitamin D in fish. Further, 
VKM concluded that the contaminants which could pose a potential risk to public health 
through fish consumption mainly were methylmercury, dioxins and dioxin-like PCBs. The 
Norwegian Food Safety Authority thus requests VKM to perform a reassessment with focus 
on the following: 
 Nutrients 
o n-3 fatty acids: Eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) 
o Vitamin D 
o Minerals iodine and selenium 
 Contaminants 
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Terms of reference as provided by the 
Norwegian Food Safety Authority 
The Norwegian Food Safety Authority (NFSA) requests an update of the benefit-risk 
assessment: “A comprehensive assessment of fish and other seafood in the Norwegian diet”. 
NFSA asks VKM to base the updated assessment on the new knowledge about fish and fish 
consumption and to specifically address the following issues: 
1. What are the main changes in the use of raw materials in feed, and how are these 
changes reflected in the levels of nutrients, dioxins and dioxin-like PCBs and mercury? 
2. To what extent have levels of nutrients and contaminants in fish changed since 2006? 
Describe this change. 
3. Calculate the intake of these substances on the basis of recent dietary data. 
4. Consider the benefits of eating fish with regard to the intake of nutrients and the risks 
associated with the intake of dioxins, dioxin-like PCBs and mercury. 
5. Does this change the conclusions from the report in 2006? 
6. On the basis of updated knowledge, please comment if other substances, like pesticide 
and drug residues, which are not listed, could affect the conclusions with regard to the 
impact on public health? 
The NFSA will use VKM’s benefit-risk assessment both nationally and internationally. We 
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Assessment 
1 Introduction and definition of terms 
Fish is an integral component of a balanced diet (Norwegian Directorate of Health, 2014; 
Norwegian National Council for Nutrition, 2011) providing an important source of well-
balanced protein, and important nutrients such as long-chain marine n-3 polyunsaturated 
fatty acids (n-3 LCPUFAs), vitamin D, iodine and selenium. There is evidence of beneficial 
effects of fish consumption on specific health outcomes, i.e. cardiovascular disease and 
optimal neurodevelopment, and it is assumed that marine n-3 fatty acids play an important 
role in the health-promoting effects of fish. However, it is also known that certain fish 
species constitute a source of exposure to chemical contaminants like dioxins, PCBs and 
mercury.  
In Norway, fish consumption has traditionally been high, and lean fish has been dominating. 
However, in recent years, the consumption of farmed fish, particularly farmed Atlantic 
salmon, has increased considerably. 
In recent years, concerns about the potential health risks associated with exposure to 
contaminants from food have resulted in strong focus on chemical management and policy 
both nationally and internationally. Stricter controls, use-restrictions and bans (the 
Stockholm Convention; see Glossary) of the most important persistent organic pollutants, 
have resulted in significant decline in concentrations of the most hazardous chemicals, i.e. 
PCBs, dioxins, persistent pesticides and brominated flame retardants, the last 20 years, both 
in the environment and in humans. Fish, as other food, contain both beneficial (i.e. 
nutrients) and potential hazardous compounds like dioxins, dl-PCBs and mercury, and the 
weighing of benefits and risks of food/fish consumption has become a main public health 
issue although the main focus has been on possible risks.  
In 2006, the Norwegian Scientific Committee for Food Safety (VKM) conducted an 
assessment of the nutritional benefits of consuming fish and seafood, compared with the 
health risks associated with the intake of contaminants and other undesirable compounds 
that fish and other seafood may contain. In 2006, VKM concluded: “Consumption of fatty fish 
in particular provides important nutrients such as vitamin D and marine n-3 fatty acids. The 
consumption of fish in general and of marine n-3 fatty acids is important for preventing and 
impeding the development of cardiovascular disease. Marine n-3 fatty acids are important for 
pregnancy and foetal development as well” (VKM, 2006).  
Since 2006 the data bases on both nutrient and contaminant concentrations in both wild and 
farmed fish have been improved substantially and updated information on fish consumption 
in 2-year olds, adults (18-70 years of age) and pregnant women is available from two more 
recent food consumption surveys, Småbarnskost 2007 (Kristiansen et al., 2009) and Norkost 
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3 (Totland et al., 2012) and from the Norwegian Mother and Child Cohort Study (MoBa) 
(Magnus et al., 2006), respectively. Also, large prospective cohort and population studies 
have been conducted since 2006, assessing fish consumption and associations with different 
health outcomes.  
On this basis VKM has been asked by the Norwegian Food Safety Authority (NFSA) to 
conduct an updated comprehensive benefit-risk assessment of fish in the Norwegian diet 
(see Terms of reference from the NFSA). This assessment should also take into consideration 
that feed used in farming of Atlantic salmon and rainbow trout have changed the last 10 
years, resulting in changes in both levels and composition of nutrients and contaminants in 
the farmed fish fillets. With regard to contaminants, the main focus was to be on dioxins, 
dioxin-like PCBs (dl-PCBs) and mercury. However, VKM was also asked to comment if other 
substances, like plant and medicine residues could affect the conclusions with regard to 
impact of fish consumption on public health. 
In this report, the associations between fish consumption and neurodevelopment  and other 
health outcomes related to the central nervous system, cardiovascular disease, cancer, 
type-2 diabetes and metabolic outcomes, and asthma/allergy/atopy, are examined, as well 
as the risks from exposure to the contaminants dioxins, dl-PCBs and methylmercury 
contributed by fish. VKM has also made various scenarios to foresee how possible changes in 
fish consumption pattern and amounts will affect the contribution from fish to recommended 
intakes of specific essential nutrients and tolerable intakes of specific contaminants. The 
contribution to total dioxins and dl-PCBs from sources other than fish is considered only in 
scenarios where a simple model estimate of weekly intake of dioxins and dl-PCBs in adults 
from various amounts of farmed salmon and other food is done.   
VKM has not systematically weighted the evidence from national and international 
comprehensive reports, or graded the results reported in reviews/meta-analyses and 
individual studies, but summarised the results. Single studies from the Nordic region were 
included because they were considered of special relevance. In addition, single studies 
published in 2014 were included in order to cover the most recent information.  
The purpose of this report is to update the comprehensive assessment of fish and other 
seafood in the Norwegian diet from 2006, by addressing the benefits and risks from fish 
consumption, and thus provide a foundation for Norwegian food authorities in preparing 
advice on fish consumption for the Norwegian population. 
Definition of terms: The term “fish” used in this report is defined as finfish (vertebrates), 
whether of marine or freshwater origin, farmed or wild. Marine mammals, shellfish 
(invertebrates), as well as sustainability issues and environmental impacts, although 
important, are considered to be outside the scope of this report since it was not requested in 
the Terms of reference. This is in contrast to the VKM assessment from 2006, which included 
both fish and other seafood. 
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Persistent lipophilic contaminants like PCBs and dioxins will accumulate in fatty tissue and 
biomagnify in the marine food chains. Organic metals, like mercury, will also accumulate in 
the marine food chain, and the concentrations increase with age and size of the individual. 
Thus, it is expected to find the highest concentrations of PCBs and dioxins in fatty tissue, 
such as fillets of mackerel, herring and salmon, and in the liver of e.g. cod, while the highest 
mercury concentrations are found in old individuals of lean fish constituting top of marine 
food chain, such as pike and tuna. Fish is the only dietary source of methylmercury, which 
constitutes about 80-100% of total mercury in fish. For dioxins and PCBs there are several 
important dietary sources in addition to fish and other seafood. VKM uses the reference 
values set by international risk assessment bodies as basis for risk characterization of 
contaminant exposure from fish in the present opinion. 
N-3 polyunsaturated fatty acids (n-3 PUFAs) contain one of the double bonds located at 
three carbon atoms from the methyl end. The main n-3 PUFAs in the diet are alpha-linolenic 
acid (ALA), eicosapentaenoic acid (EPA), docosapentaenoic acid (DPA), and docosahexaenoic 
acid (DHA). EPA, DPA and DHA are usually referred to as n-3 LCPUFAs, i.e. n-3 PUFA with 20 
or more carbon atoms (EFSA, 2010b; EFSA, 2012b). Thus, in this assessment the term n-3 
LCPUFA refers to EPA, DPA and DHA and does not include ALA, which has carbon chain of 18 
atoms. VKM uses mainly the national reference values of nutrients intake for benefit 
characterisation of the specific nutrients intakes from fish. For n-3 LCPUFAs, comparison is 
also done with European recommendations. 
Existing dietary guidelines for fish consumption: It has long been recognized by 
health authorities, both nationally and internationally, that fish consumption and n-3 LCPUFA 
from fish are beneficial to human health. In the report on “Diet, nutrition and chronic 
diseases” from WHO (2003), a regular fish consumption (1-2 servings per week) is 
recommended to protect against coronary heart disease and ischaemic stroke (WHO, 2003). 
Each serving should provide an equivalent of 200-500 mg EPA and DHA. In June 2014, the 
US Food and Drug Administration (FDA) and the US Environmental Protection Agency issued 
an updated draft advice for fish consumption encouraging pregnant women and 
breastfeeding mothers to eat more fish low in mercury (EPA/FDA, 2014). The updated advice 
is in line with the 2010 Dietary guidelines for Americans. 
In 2006, the Norwegian recommendation for fish consumption merely was to eat more fish 
both for dinner and as bread spreads. As a consequence of results presented in the VKM 
opinion on fish from 2006 and the report from the Norwegian National Council for Nutrition, 
“Dietary advice to promote public health and prevent chronic diseases in Norway” 
(Norwegian National Council for Nutrition, 2011),  these recommendations were altered and 
made quantitative by the Norwegian Directorate for Health, which currently recommends fish 
as dinner meal 2-3 times per week for all age groups (Norwegian Directorate of Health, 
2014). Fish is also recommended as bread spread. This recommendation represents totally 
300-450 g fish per week for adults, and less for children. For adults, at least 200 g should be 
fatty fish, such as salmon, trout, mackerel or herring. Six portions of bread spreads 
represents approximately one dinner portion. A clearification is given for young females and 
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pregnant women. They should, over time, avoid eating more than two meals of fatty fish per 
week, including fish like salmon, trout, mackerel and herring. In addition to the general 
recommendation to eat 300-450 g fish per week, the NFSA continuously issues regional 
advice to restrict consumption of fish caught in certain polluted fjords and harbours and fish 
species known to have high concentrations of pollutants (www.matportalen.no).  
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2 Update of reference values for 
selected nutrients and undesirable 
substances 
The majority of health authorities worldwide recommend a regular fish intake in order to 
ensure proper nutrition and health benefits. There are also updated recommendations for 
intake of several key nutrients present in fish, such as the n-3 fatty acids eicosapentaenoic 
acid (EPA) and docosahexaenoic acid (DHA), vitamin D and selenium. After 2006, new 
reports and risk assessments concerning the contaminants (dioxins, mercury) present in fish 
have emerged. 
2.1 Recommendations for selected nutrients contributed from fish 
The FAO/WHO report on the risks and benefits of fish consumption (FAO/WHO, 2011) 
concluded that: "The health attributes of fish are most likely due in large part to 
eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA). Fish, however, contain other 
nutrients (e.g. protein, selenium, iodine, vitamin D, choline and taurine) that may also 
contribute to the health benefits of fish consumption.  
The sections below are based on the Norwegian dietary recommendations (Norwegian 
Directorate of Health, 2014), which are based on the 5th updated version of the Nordic 
Nutrition Recommendations (NNR5, 2012). Other sources include the scientific reports 
“Dietary advice to promote public health and prevent chronic diseases in Norway” 
(Norwegian National Council for Nutrition, 2011), “Evaluation of negative and positive health 
effects of n-3 fatty acids as constituents of food supplement and fortified foods” (VKM, 
2011b) and “Scientific Opinion on Dietary Reference Values for fats, including saturated fatty 
acids, polyunsaturated fatty acids, monounsaturated fatty acids, trans fatty acids, and 
cholesterol” (EFSA, 2010b). 
The Norwegian recommendations for n-6 and n-3 polyunsaturated fatty acids are given as 
energy percent for the two essential fatty acids linoleic acid (LA, 18:2n-6) and alpha-linolenic 
acid (ALA, 18:3n-3) and no recommendation is given for the n-6 to n-3 ratio (Norwegian 
Directorate of Health, 2014). The main focus of this evaluation regarding fatty acids is the 
amount of EPA, DPA and DHA provided from fish and fish oil supplements. 
 N-3 fatty acids eicosapentaenoic acid (EPA) and docosahexaenoic acid 2.1.1
(DHA) 
Eicosapentaenoic acid (EPA), docosapentaenoic acid (DPA) and docosahexaenoic (DHA) are 
important structural components of cell membranes and contribute to various membrane 
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functions such as fluidity, permeability, activity of membrane-bound enzymes and receptors, 
and signal transduction (FAO/WHO, 2011; VKM, 2011b). 
Norway does not give any specific recommendations for dietary intake of EPA, DPA or DHA 
but based on the 5th edition of the Nordic Nutrition Recommendations (NNR5, 2012) the 
Norwegian Directorate of Health now recommends a daily intake of 200 mg DHA for 
pregnant and lactating women (Norwegian Directorate of Health, 2014). 
In 2010, EFSA published a scientific opinion on population reference intakes for the 
European population on fat, including EPA and DHA (EFSA, 2010b). It concluded that with 
respect to cardiovascular diseases, prospective epidemiological and dietary intervention 
studies indicate that oily fish consumption or dietary n-3 long-chain polyunsaturated fatty 
acids supplements (equivalent to a range of 250 to 500 mg of EPA+DHA daily) decrease the 
risk of mortality from coronary heart disease (CHD) and sudden cardiac death. An intake of 
250 mg/day of EPA+DHA appears to be sufficient for primary prevention in healthy subjects. 
Therefore, and taking into account that available data are insufficient to derive an average 
requirement, the Panel proposed to set an Adequate Intake of 250 mg for EPA+DHA for 
adults based on cardiovascular considerations. To this intake 100 to 200 mg of preformed 
DHA (i.e. DHA from fish or supplements) should be added during pregnancy and lactation to 
compensate for oxidative losses of maternal dietary DHA and accumulation of DHA in body 
fat of the foetus or infant. In older infants, DHA intakes at levels of 50 to 100 mg/day have 
been found effective for visual function in the complementary feeding period and are 
considered to be adequate for that period. The EFSA Panel proposed an Adequate Intake of 
100 mg DHA for older infants (older than 6 months of age) and young children below the 
age of 24 months. EFSA states that the currently available evidence does not permit to 
define an age specific quantitative estimate of an adequate dietary intake for EPA and DHA 
for children aged 2 to 18 years. However, dietary advice for children should be consistent 
with advice for the adult population (i.e., 1 to 2 fatty fish meals per week, and for adults 
equivalent to ~250 mg of EPA+DHA per day) (EFSA, 2010b). KM previously concluded that 
based on the reviewed literature, it was not possible to identify clear adverse effects from 
EPA and DHA, which would be a prerequisite  for setting tolerable upper intake levels (VKM, 
2011b). 
 Vitamin D 2.1.2
The role of vitamin D in the development and maintenance of bone is well established, and 
vitamin D has been associated with numerous health outcomes. Vitamin D regulates serum 
calcium and phosphate levels, and may modify immune function, cell proliferation, 
differentiation and apoptosis (Basit, 2013). Current evidence from systematic literature 
reviews indicates that vitamin D intake and status is associated with fractures and falls, 
cardiovascular outcomes, and total mortality (Bjelakovic et al., 2014; Lamberg-Allardt et al., 
2013; Zheng et al., 2013b). 
 
 
VKM Report 2014: 15  39 
Vitamin D is primarily synthesised in the skin on exposure to sunlight, when skin is subjected 
to UV radiation. During winter months in northern European countries, UV radiation is not 
strong enough for vitamin D production and the body has to rely on body stores and dietary 
sources. Vitamin D occurs naturally in foods as vitamin D2 (ergocalciferol) and vitamin D3 
(cholecalciferol). In the 5th edition of the Nordic Nutrition Recommendations (NNR5, 2012), 
and consequently the Norwegian dietary guidelines from 2014, the recommended intake for 
vitamin D was increased from 7.5 μg to 10 μg/day for children above two years and adults, 
and to 20 μg/day for the elderly (75 years or older) (Table 2.1.2-1) (NNR5, 2012; Norwegian 
Directorate of Health, 2014). The reason behind the increased recommendation is new 
scientific data that has emerged after 2004. As in the 4th edition of the Nordic Nutrition 
Recommendations (NNR4, 2004), serum 25-hydroxy-vitamin-D (25OHD) concentrations of 
more than 50 nmol/L was upheld as an indicator of sufficient vitamin D status.  
For people with little or no sun exposure, the recommended intake is now 20 μg/day. This 
can be achieved by taking a daily supplement of 10 μg vitamin D3 in addition to the dietary 
intake, or by choosing foods rich in vitamin D. For the elderly (75 or older), the 
recommended intake can be achieved by selecting foods naturally high in vitamin D and 
vitamin D-enriched foods in combination with a supplement if necessary (NNR5, 2012). 
Taking into consideration that both EFSA and the US Institute of Medicine  (IOM) have 
increased the tolerable upper intake level (UL) for vitamin D (EFSA, 2012c; IOM, 2010) this 
was also applied to the NNR5 (2012). The UL for adults and adolescents (11-17 years) was 
increased from 50 to 100 μg/day. For younger children, UL was set to 50 μg/day and for 
infants (0-12 months) the UL was set at 25 μg/day. The average requirement (AR) and lower 
intake level (LI) for vitamin D were set to 2.5 and 7.5 µg/day, respectively (Table 2.1.2-1). 
Table 2.1.2-1 Vitamin D recommendations in Nordic Nutrition Recommendations, 5th edition (NNR5, 
2012) 












Recommended intake 10b 10 10 20 
Average requirement 7.5 7.5 - - 
Lower intake level 2.5 2.5 - - 
Upper intake level 100c 100c - - 
aFrom 1-2 weeks of age, infants should receive 10 μg vitamin D3 per day as a supplement. 
b10 µg/day also for pregnant and lactating women.  
cEFSA (2012c); IOM (2010) 
- not given any average requirement, lower or upper intake levels. 
 Iodine 2.1.3
Iodine is important for normal functioning of the thyroid gland and production of the 
hormones thyroxine (T4) and triiodinethyroxine (T3). A deficiency of iodine in the diet is 
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associated with enlargement of the thyroid gland (thyroidea), the development of goiter 
resulting in effects such as arrested growth and mental retardation in children, and low 
metabolism, reduced blood pressure and weakness of the muscles in adults. Iodine 
deficiency is considered by WHO to be “the single most important preventable cause of brain 
damage” worldwide (WHO et al., 2007) Insufficient iodine status is not only a problem in 
developing countries, but is a major public health problem in many countries in Europe and 
in Australia, New Zealand and the US (Brantsaeter et al., 2013; Pearce et al., 2013; 
Vanderpump et al., 2011). 
In the Nordic Nutrition Recommendations 5th edition (NNR5), and consequently the 
Norwegian dietary guidelines, no change to the previous recommended intake of iodine was 
applied. The experts evaluating new scientific evidence concluded that there were not new 
data supporting changes (NNR5, 2012). In the 4th edition of the Nordic Nutrition 
Recommendations (NNR4, 2004) the estimated average requirement (AR) was set at 100 
μg/day for both adult men and adult women. The recommended intake was set at 150 
μg/day to include a safety margin for any goitrogenic substances in foods. The lower intake 
level in adults was set at 70 μg/day for both sexes (Table 2.1.3-1). The UL is 600 μg/day. 



















150a 150 90 120 150 
Average 
requirement 
100 100 - - - 
Lower intake 
level  
70 70 - - - 
Upper intake 
level  
600 600 - - - 
aFor pregnant women: 175 μg, and lactating women: 200 µg/day. 
- not given any average requirement, lower or upper intake levels.  
EFSA published a Scientific Opinion on dietary reference values for iodine in May 2014. A 
recommendation for adequate intake (AI) of 150 μg/day is proposed for adults. For infants 
aged seven to 11 months and for children, AIs range between 70 μg/day and 130 μg/day. 
For pregnant women and lactating women, an AI of 200 μg/day is proposed, taking into 
account the additional needs (EFSA, 2014a). 
UNICEF/ ICCIDD/WHO in 2007 increased the recommendation for iodine from 200 to 250 
μg/day for pregnant, which is also their recommendation for lactating women (WHO et al., 
2007). The reason behind this is pregnant women and infants are exceptionally vulnerable to 
deficiency. In the NNR5 and Norwegian dietary recommendations, the recommended iodine 
intake for pregnant and lactating women was kept at 175 and 200 μg/day, respectively.  
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 Selenium 2.1.4
Selenium is an essential trace element that plays an important role as cofactor for enzymes 
involved in protection against oxidative damage and regulation of immune function. 
Selenium is also important in the detoxication of various heavy metals (Alexander, 2015). 
Low selenium status has been associated with increased risk of mortality, poor immune 
function, and cognitive decline, but supplementation is problematic due to the narrow range 
of recommended intake, and selenium supplementation may adversely affect people with 
adequate status (Rayman, 2012).  
The recommended intake of selenium was updated in Nordic Nutrition Recommendations 5th 
edition (NNR5) and the Norwegian dietary guidelines (Norwegian Directorate of Health, 
2014), resulting in an increase from 50 μg/day for men and 40 μg/day for women to 60 
μg/day for men and 50 μg/day for women (Antypa et al., 2012). The recommended intake 
during pregnancy and lactation is increased from 55 to 60 μg/day and the recommended 
intake for children is increased to 25, 30 and 40 μg/day for different age groups based on 
extrapolation from the adult values (Table 2.1.4-1). For adults, the UL is unchanged at 300 
g of selenium per day. 
Table 2.1.4-1 Selenium recommendations in the Nordic Nutrition Recommendations, 5th edition 








(2-5 years)  
µg/day 
Children 





Recommended intake 50a 60 25 30 40 
Average requirement 30 35 - - - 
Lower intake level 20 20 - - - 
Upper intake level 300 300 - - - 
aFor pregnant and lactating women: 60 µg/day. 
- not given any average requirement, lower or upper intake levels. 
2.2 Contaminants and some other undesired substances in fish– 
possible hazards and established tolerable intakes  
Fish can contribute significantly to the dietary exposure to some contaminants, of which the 
most important are methylmercury and the dioxins and dioxin-like PCBs (dl-PCBs). For these 
substances, parts of the population have previously been reported to exceed the tolerable 
intakes.  
A tolerable intake is the amount of a substance, or substance group, which can be consumed 
safely throughout a person's lifetime without appreciable risk of adverse health effects. 
Tolerable intakes are set by large international risk assessment bodies, such as WHO or 
EFSA, and incorporate safety margins, in order to protect all parts of the population, 
including the most vulnerable parts of the population. Tolerable intakes can be set on a 
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daily, weekly or monthly basis, depending on the characteristics of the substance in 
question. Exceedance of tolerable intakes is undesirable and may represent a risk to human 
health if repeated frequently. The purpose of this chapter is to summarise and update recent 
reports/risk assessments of contaminants that are most relevant for fish. VKM uses the 
reference values set by international risk assessment bodies (Table 2.2-1) as basis for risk 
characterization of contaminant exposure from fish in the present opinion.  
Table 2.2-1 Tolerable intakes for some persistent organic pollutants present in fish 
Contaminant Tolerable intake Reference 
Methylmercury 1.3 μg/kg bw/week EFSA (2012a)  
Inorganic mercury 4.0 μg/kg bw/week EFSA (2012a);JECFA (2010)  
Dioxins and dl-PCBs 14 pg TE/kg bw/week SCF (2001) 
Dioxins and dl-PCBs 70 pg TE/kg bw/month  JECFA (2001) 
PCB-6a 10 ng PCB-6/kg bw/dayb VKM (2008) 
PFOS 150 ng/kg bw/day EFSA (2008) 
PFOA 1.5 µg/kg bw/day EFSA (2008) 
aSum of PCB-28, -52, -101, -138, -153, -180  
breference value used by VKM in 2008, not a tolerable intake 
 Mercury 2.2.1
Mercury is released into the environment from both natural and anthropogenic sources. Once 
released, mercury undergoes a series of complex transformations and cycles between 
atmosphere, ocean and land. The three chemical forms of mercury are (i) elemental or 
metallic mercury (Hg0), (ii) inorganic mercury (mercurous (Hg2
2+) and mercuric (Hg2+) 
cations) and (iii) organic mercury. Methylmercury is by far the most common form of organic 
mercury in the food chain, and after oral intake, methylmercury is much more extensively 
and rapidly absorbed than mercuric and mercurous mercury. Seafood is the main dietary 
source of both inorganic mercury and methylmercury exposure (EFSA, 2012a), and the only 
important dietary source of methylmercury. 
2.2.1.1 Methylmercury 
Methylmercury accumulates in the body and crosses the placenta- and blood-brain barriers. 
Total mercury in hair and blood are routinely used as biomarkers of methylmercury 
exposure. Hair contains almost exclusively methylmercury, whereas blood contains both 
inorganic and methylmercury. However, in fish-eating populations the blood methylmercury 
concentration is much larger than the inorganic mercury concentration and therefore serves 
as a good biomarker of methylmercury exposure. 
Unborn children constitute the most vulnerable group for developmental effects of 
methylmercury exposure. EFSA in 2012 reduced the tolerable weekly intake (TWI) for 
methylmercury from 1.6 (set by WHO in 2004) to 1.3 μg/kg bw/week, expressed as mercury, 
based on recent findings of neurodevelopmental effects in prenatally exposed children at 
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slightly lower methylmercury exposure than previously reported (EFSA, 2012a). EFSA 
calculated that mean exposure in Europe (all population groups) is below the TWI, whereas 
95th percentile exposure is in the range of or exceeding the TWI. This was confirmed by 
reported levels in hair and blood in Europe.  
In general, all mercury in other food groups than fish and other seafood is believed to be 
inorganic, and there are no other substantial dietary sources. 
2.2.1.2 Inorganic mercury 
The kidney is sensitive to inorganic mercury toxicity. Inorganic mercury is also toxic to the 
liver, the nervous system and the immune system, and is also a reproductive and 
developmental toxicant. 
EFSA recently established a tolerable intake of inorganic mercury of 4.0 μg/kg bw/week, 
expressed as mercury, based on kidney toxicity (EFSA, 2012a). This was in line with the 
evaluation from the JECFA in 2010 (JECFA, 2010). 
2.2.1.3 Time-trends of mercury exposure in Norway 
Time-trends on human exposure levels in Norway were not available. There are indications 
of increasing levels of mercury in freshwater fish in Norway (Braaten et al., 2014; NIVA, 
2009) and Sweden (Akerblom et al., 2012).  A report from the OSPAR commission in 2009 
on trends and concentrations of selected hazardous substances in sediments and biota 
(OSPAR Commission, 2009) stated that background concentrations of mercury are found in 
fish and shellfish at some stations in Ireland, Scotland, and western Norway. They reported 
that both upward and downward temporal trends in fish and shellfish occur in the North East 
Atlantic, with a grouping of generally upward trends in southern Norway (stations along the 
south-east and-south west coast). 
 Dioxins and polychlorinated biphenyls (PCBs) 2.2.2
Dioxins and PCBs are closely related groups of chlorinated organic compounds and constitute 
a subgroup among the persistent organic pollutants (POPs). They are fat-soluble and 
persistent to degradation, they bioaccumulate and are biomagnified in the environment. 
They are found in the highest concentrations in organisms located high up in the food chain. 
Fat of animal origin, and in particular marine fat, is the major dietary exposure source.  
The term 'dioxins' usually encompasses both the 75 chlorinated dibenzo-p-dioxins (PCDDs) 
and 135 chlorinated dibenzofurans (PCDFs). There are 209 different PCB congeners. The 
chemical properties and toxicological effects of dioxins and PCBs vary according to the 
number and positions of the chlorine atoms on the aromatic rings. 
Of the 209 possible PCB congeners, 12 are included in the group of dioxin-like PCBs (dl-
PCBs) and are evaluated together with the dioxins, since they share mechanism of action 
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with the most toxic dioxins. The rest of the PCBs are referred to as non-dioxin-like PCBs (ndl-
PCBs).  
2.2.2.1 Dioxins and dioxin-like-PCBs 
The toxicity of 17 dioxins and 12 dioxin-like PCBs (dl-PCBs) is related to binding and 
activation of the transcription factor Ah (aryl hydrocarbon) receptor, also known as the TCDD 
or dioxin receptor. These substances have been assigned toxic equivalency factors (TEF) in 
relation to 2,3,7,8-TCDD, which is the most potent dioxin congener and has a TEF of 1. The 
total amount of toxic equivalents (total TEQ) in a sample is calculated by multiplying the 
concentration of each congener with the associated TEF and then adding up the 
contributions from the different congeners. The total TEQ in a sample is an estimate of the 
total dioxin effect, which is a simplified method for making risk assessments of dioxin/PCB-
mixtures. The WHO-TEFs were set in 1998 (WHO1998-TEF) and revised in 2005 (WHO2005-
TEF). 
Abnormal activation of the Ah-receptor may disrupt cell function by altering the transcription 
of vast array of genes whose activities are involved in a number of processes, including 
growth regulation and development. The most significant hazardous effects on health 
resulting from chronic exposure to dioxins and dl-PCBs are impairment of the reproductive 
system, a weakened immune system, impairment of the endocrine system and neurotoxic 
and carcinogenic effects. Dioxins have been classified as carcinogenic to humans (Group 1) 
by IARC (IARC, 1997), but they are not genotoxic (JECFA, 2001; SCF, 2001). The critical 
effect used in risk assessment was reproductive effects in rats that were exposed prenatally. 
Risk assessments performed by SCF and JECFA took into account the large difference in 
biological half-life of TCDD between rats and humans (i.e. about one month versus 7.5 
years), the insufficiency of the toxicological database, and limited knowledge about the 
variation in the biological half-lives in different population groups. The TWI established by 
SCF is 14 pg TEQ/kg bw/week (SCF, 2001). JECFA's assessment is comparable with that of 
SCF, except that JECFA expresses the tolerable intake level on a monthly basis (70 pg 
TEQ/kg bw/month) (JECFA, 2001). 
2.2.2.2 Non-dioxin-like PCBs 
The presence of non-dioxin-like PCBs (ndl-PCBs) has been expressed as the sum of three 
PCB congeners (PCB-138, -153 and -180) or PCB-6 (PCB-28, -52, -101, -138, -153, -180), or 
as PCB-7, which in addition to PCB-6 includes PCB-118 (a dl-PCB). Sometimes the PCB 
concentration has been expressed as total PCBs. PCB-153 is often used as an indicator of 
total PCB or PCB-6, because the correlation between PCB-153 and PCB-6 is high. 
IARC has in 2013 classified PCBs in Group 1, i.e. carcinogenic to humans. According to IARC, 
the carcinogenicity of PCBs cannot be solely attributed to the carcinogenicity of the dioxin-
like PCBs (Lauby-Secretan et al., 2013). In epidemiological studies, the most important 
adverse health effects associated with exposure from food and the environment were related 
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to perinatal PCB exposure and the impairment of reproduction, including delayed 
development of the central nervous system and an impaired function of the immune system. 
According to EFSA (2005), it was not possible to distinguish between the effects resulting 
from dioxins and dl-PCBs and the effects resulting from ndl-PCBs. This is because exposure 
to ndl-PCBs is normally highly correlated with exposure to dioxins and dl-PCBs. Furthermore, 
in many experimental studies the PCB test substance has been contaminated with dioxins. As 
a result, EFSA concluded that it is not possible to establish a tolerable intake level for ndl-
PCBs (EFSA, 2005). 
Neurotoxic effects of ndl-PCBs are well known. The ndl-PCBs act via several different 
mechanisms and not via the AhR. Mechanistic studies indicate that they may affect 
components of the nervous system in several different ways. They alter intracellular signal 
transduction pathways by interfering with intracellular sequestration of calcium and increase 
activation of protein kinase C (PKC). Induction of apoptosis and increased production of 
reactive oxygen species and changes in levels of neurotransmitters such as dopamine and 
acetylcholine have been reported. The latter is suggested to be linked to interference with 
PCB on thyroid hormone levels because cholinergic fibres are particularly sensitive to thyroid 
hormone deficiency. Furthermore, increased release of arachidonic acid has been observed. 
Changes in the PKC signalling pathway and calcium homeostasis as well as reduced 
dopamine levels has been confirmed in animal studies (EFSA, 2005). 
A provisional tolerable intake of 20 ng/kg bw/day for all 209 PCB congeners was proposed at 
the 2nd PCB workshop in Brno (Czech Republic, May 2002) and has been used in France, the 
Netherlands, and Norway (AFSSA, 2007; Baars et al., 2001; VKM, 2008). This corresponds to 
a provisional tolerable daily intake of 10 ng PCB-6/kg bw/day, since half the total intake of 
PCBs consists of PCB-6.  
In 2003, AFSSA adopted a reference dose of 20 ng/kg bw/day for all 209-PCB congeners, 
and a tolerable daily intake of 10 ng PCB-6/kg bw/day, since half the total intake of PCBs 
consists of PCB-6 (AFSSA, 2007). The reference dose was derived from the BMDL (see 
Glossary) from human studies described in the EFSA opinion from 2005. In 2008, VKM used 
10 ng PCB-6/kg bw/day as a reference value in an evaluation of whether the TWI for dioxins 
and dl-PCBs was also protective to ndl-PCBs exposure from the diet, given the relative 
composition of dioxins, dl-PCBs and ndl-PCBs in the food consumed by in Norway. VKM 
concluded that with the combination of dioxins and PCBs in Norwegian food, exposure to 
dioxins below the TWI would also protect against toxicological effects from exposure to ndl-
PCBs (VKM, 2008). 
2.2.2.3 Time-trends of dioxin and PCB exposure in Norway 
Dioxins and PCBs are commonly determined in blood or breast milk, and concentrations are 
generally expressed per unit of fat in the sample, reflecting that these substances are highly 
fat soluble. Since dioxin/PCB concentrations in the body lipids are quite similar, other tissue 
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(e.g. fat tissue or cord blood) can also provide information on contaminant exposure levels in 
humans. 
From 1986 to 2005 the concentration of dioxins and dl-PCBs and ndl-PCBs in breastmilk from 
first time mothers in Norway decreased by approximately 70% (VKM, 2013a).This reflects 
falling environmental levels and therefore falling levels in food, leading to lower dietary 
exposure. A similar decrease has also been reported up to 2007 in men from Northern 
Norway (Nost et al., 2013). More recent time-trend data were not available.  
 Other contaminants  2.2.3
A large number of substances in the group of chlorine-, fluorine or bromine-substituted 
organic compounds can represent a hazard to human health and be present in fish. This 
applies to dioxins, PCBs, campheclor (toxaphene), dichlordiphenyltrichlorethane (DDT) and 
its metabolites (DDD and DDE), chlordane, dieldrine, aldrin, endrin, heptachlor, 
hexachlorbenzene (HCB), chlorinated cyclohexane, brominated flame retardants such as 
polybrominated diphenylethers (PBDEs) and fluorinated compound such as PFOS and PFOA. 
Such substances are found in the highest concentrations in organisms located high up in the 
food chain. Fat of animal origin, and in particular fat of marine origin, can be the major 
exposure source. Most of these compounds are however no longer in use, and since also 
cleaning of industrial emissions has been implemented, the levels in the environment are 
generally declining. 
With fluorinated compounds the situation is different, see below. 
Also organotin substances, which have been used as anti-fouling agents on ships for decades 
until their use was banned, can be present in fish from fjords and harbour areas. However, 
since the main bulk of fish on the market are not caught close to harbours, organotin 
substances are not addressed further in this opinion. 
2.2.3.1 Polybrominated flame retardants  
Polybrominated diphenyl ethers (PBDEs) are to some extent structurally related to ndl-PCBs. 
Three commercial mixtures of PBDEs (penta-, octa- and deca-BDEs) have been used as 
flame retardants, and their composition is reflected in food and environment. These 
substances have in addition potential for long-range atmospheric transport. 
Penta- and octa-BDE, as substances, in mixtures and in products are banned both in EU and 
Norway, and also globally via the POP regulation (the Stockholm Convention). 
Since 2008, it has been prohibited to manufacture, import, export, place on the marked and 
use substances and mixtures containing 0.1% or more of decaBDE in Norway. The regulation 
also applies to products and parts of products containing 0.1% or more of decaBDE. Some 
derogations are given. 
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The European Chemicals Agency (ECHA), in collaboration with the Norwegian Environment 
Agency, has recently proposed a European restriction within the REACH regulation on the 
manufacturing, use and placing on the market of decaBDE. The restriction proposal is on 
public consultation until March 2015 and will also be reviewed by the ECHA Committees for 
Risk Assessment (RAC) and Socio-economic Analysis (SEAC) before any new regulation could 
be adopted.  In parallel with this process, the Norwegian Environment Agency has proposed 
a globally ban on decaBDE via the POP regulation.  
Food is a main PBDE exposure source in humans, however, there are large individual 
differences and dust can be a major source, especially in children. The congeners most 
commonly occurring are BDE-47, BDE-99, BDE-100, BDE-153 and the fully brominated BDE-
209. In Norway, highest mean dietary exposure was seen for BDE-47 (mean 0.97 ng/kg 
bw/day) and BDE-209 (1.5 ng/kg bw/day), and the major dietary sources were fish (BDE-47) 
and dairy products (BDE-209) (Thomsen et al., 2008). In different European countries, EFSA 
estimated in 2011 that the exposure to BDE-47 ranged between 0.29 and 1.91 ng/kg 
bw/day, whereas that of BDE-209 ranged between 0.35 and 2.85 ng/kg bw/day (EFSA, 
2011). 
The concentrations of PBDEs in blood from Norwegians are in the same range as those in 
the rest of Europe, but approximately 10-fold lower than in blood from inhabitants in the 
USA. After a strong increase in concentration of PBDEs in blood during the 90-ties, the levels 
of some PBDEs have been falling the latter years, whereas for other the increase has leveled 
off. 
Effects reported in experimental rats and mice after exposure to different PBDEs include 
induction of liver enzymes, effects on thyroid hormone levels, reproductive effects and 
disturbed neurodevelopment. 
No tolerable intakes for PBDEs have been set by EFSA due to lack of sufficient knowledge 
about their toxicities. However, the margin between concentrations that cause low toxic 
effects in experimental animals and those seen in European populations appear to be large, 
and EFSA concluded that the risk of adverse health effects is low (EFSA, 2011). 
EFSA (2011) also concluded that it was inappropriate to use BMDL to establish a health 
based guidance value, and instead used a margin of exposure (MOE) approach for the health 
risk assessment of hexabromcyclododecanes (HBCDs or HBCDDs). Since elimination 
characteristics of HBCDs in animals and humans differ, the Panel used the body burden as 
starting point for the MOE approach. EFSA (2011) concluded that current dietary exposure to 
HBCDs in the European Union does not raise a health concern. 
2.2.3.2 Fluorinated substances 
Fluorinated substances have been widely used for decades because of their water and oil 
repellent abilities, but they did not gain much attention until approximately ten years ago. 
Although substances in this class are associated with plasma proteins and are not fat-
 
 
VKM Report 2014: 15  48 
soluble, they are persistent and the highest concentrations are found in organisms high up in 
the food chain. Perfluorooctanosulphonate (PFOS) and perfluorooctanoacid (PFOA) are found 
at highest levels in food, and food (particularly seafood) is the most importand source of 
these contaminants. They are found in muscle from all kinds of fish (lean or fatty), but at 
higher levels in liver (Haug et al., 2010). Estimated intakes in Europe and Norway are low 
(PFOS: 0.27 to 5.2 ng/kg bw/day; PFOA 0.08-4.3 ng/kg bw/day). The TDIs set by EFSA in 
2008 (for PFOS 150 ng/kg bw/day and for PFOA 1.5 µg/kg bw/day) are orders of magnitude 
higher than the dietary exposure.  
 Veterinary medicine residues in farmed fish  2.2.4
Sometimes it is necessary to treat farmed fish with veterinary medicinal products (VMPs). 
When farmed fish is medicated, several measures are taken to ensure food safety for the 
consumer.  
 Only authorized veterinarians/aquamedicine biologists can prescribe approved 
veterinary medicinal products. 
 Only therapeutic agents that have been evaluated and approved in accordance with 
the EU regulations can be applied. For each substance and animal group, Maximum 
Residue Limits (MRLs) have been established. 
 Withdrawal times for medicated fish are applied. 
Withdrawal time denotes the time from completion of therapy with a veterinary medicinal 
product (VMP) until slaughtering of the fish can be done, and the purpose is to ensure that 
residual levels of the VMP in the fish are below the legal limit. The Norwegian Medicinal 
Agency is responsible for setting withdrawal times for VMPs holding a Norwegian marketing 
Authorisation. When setting maximum residue levels (MRLs) eventual effects of VMPs on 
future processing of food, and if the VMP has additional use (e.g. as pesticide) which could 
lead to additional exposure for the consumer, is taken into account as outlined in the The 
Norwegian Pharmaceutical Product Compendium (http://www.felleskatalogen.no/medisin-
vet/tilbakeholdelsestider). The veterinarian or aquamedicine biologist initiating the theraphy 
as well as the fish farmer is responsible to ensure that fish is not slaughtered during this 
period. All use of VMPs must be reported to the Norwegian Food Safety Authority (NFSA) by 
the veterinarian/aquamedicine biologist in charge of the use. It is mandatory for the fish 
farmer to submit plans for slaughtering before effectuation. These actions enable the NFSA 
inspector to control that withdrawal times have been complied with at fish slaughtering. The 
fish can be banned from slaughter if the withdrawal times are not being withheld. 
To avoid the presence of residues of VMPs at levels that might cause harm for the 
consumers, acceptable legal residue concentrations in food producing animals have been 
established. According to current EU legislation (EU 37/2010) each substance is assigned a 
maximum residue level (MRL), which is the highest permitted residual concentration of 
legally applied pharmacologically active substances in products (food) intended for human 
consumption. Consumption of food with medicine residues below the MRL should, by a wide 
safety margin, not pose any health risk to the consumer. The MRLs for fish are set for 
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muscle and skin in natural proportions. For more details se the latest report on Monitoring 
program for pharmaceuticals, illegal substances, and contaminants in farmed fish (Hannisdal 
et al. 2014).  
On behalf of the NFSA, the National Institute of Nutrition and Seafood Research (NIFES) 
carry out a continuous surveillance programme on veterinary medicinal products in seafood 
in accordance with EU Directive 96/23/EC. One sample per 100 tons of produced fish has 
been analysed each year since 1998. Samples have been collected by official inspectors from 
the NFSA at the farm, without prior notification to the farmer, and sampling has been done 
after the expiration of the withdrawal period. Additionally, samples representative of the 
farmed fish ready for the market have been collected at the slaughterhouse/processing 
plants.  
According to Hannisdal et al. (2014), banned substances include growth promoters such as 
steroids and stilbenes, and substances listed in Commission Regulation (EU) No 37/2010 
under prohibited substances for which MRLs cannot be established. Prohibited compounds 
considered relevant for aquaculture are chloramphenicol, nitrofurans, and metronidazole. To 
ensure harmonized levels for the control of banned substances, analytical methods used for 
banned compounds should meet minimum required performance limits (MRPLs) set by the 
community reference laboratories (CRLs), national reference laboratories (NRLs) and 
member states of the European Union (Commission Decision 2003/181/EC; Commission 
Decision 2004/25/EC; CRL Guidance Paper 2007). 
During the years 1998-2013, more than 30 000 samples from farmed salmon have been 
analysed. So far (November 2014), no residues of banned substances or medicine residues 
above EU MRLs for VMPs including antibiotics have been detected in any of the samples.  
Antibiotics 
The use of antibiotics in farmed fish in Norway has been low since mid and late 1990 
(NORM/NORM-VET, 2013). In relation to the biomass of farmed fish, there have been 
marginal changes in antibiotics sales during the latest years. The amount of antibiotics sold 
in recent years represents approximately one treatment in 0.5-1% of the fish.  
Effective vaccines against bacterial infections in fish farming were developed in 1990s and 
the implementation of vaccination programmes of fish was established. This resulted in a 
major decrease in the usage of antibiotics in fish farming despite a rapid growth in the 
biomass slaughtered fish (Figure 2.2.4-1). 
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Figure 2.2.4-1 The total sale in tonnes of active ingredients of antibiotics sold in Norway and 
used in Norwegian farmed fish during the years 1981 to 2012, and the concurrent biomass farmed 
fish slaughtered during the same time span. Source: NORM/NORM-VET 2013 (with permission) 
(NORM/NORM-VET, 2013) 
Agents against sea lice 
Infestation caused by sea lice, an ectoparasite of salmonids in salt water, mainly 
Lepeophtheirus salmonis, is at present a challenging health issue in Norwegian aquaculture. 
Sea lice infestation may cause skin lesions and subsequent osmo-regulatory problems, 
thereby subjecting the fish to secondary infections. Resistance to some sea lice agents has 
resulted in increased sales of other agents. Use of veterinary medicinal products for 
treatment of sea lice has been high since 2009.  
An increasing use of flubenzurons has raised concerns over its possible environmental 
dissemination and impacts. In short, sea lice belong to the crustacean group, and 
flubenzurons from aquaculture may be expected to influence other crustacean species near 
the treated fish cages (Samuelsen et al., 2014). Crustaceans, shellfish and wild fish near 
cages receiving treatments may obtain flubenzurons from excess medicated feed pellets or 
from active substances in fish faeces. However, there is a ban to catch wild fish close to 
farming sites, and data show that the risk of exceeding acceptable daily intake (ADI) of 
teflubenzuron (ADI = 0.01 mg/kg bw) from wild fish is neglectable (Samuelsen et al., 2013). 
However, this issue is beyond the scope of this opinion to comment on. 
VMP against sea lice are included in surveillance programme on veterinary medicinal 
products in food in accordance with EU- Directive 96/23/EC, and no residues above the given 
MRL for the various VMPs has been detected (Hannisdal et al., 2014).  
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Other agents  
As in 2006, several disinfectants and cleaning agents are approved for use in the food 
industry including the seafood industry. The risk from exposure to these substances from 
farmed fish is probably limited. 
In aquaculture, prevention and treatment of fungal infections (Saprolegnia spp) are done by 
topical application of fungicides (veterinary medicinal product, VMP) to farmed fish and roe 
(only prevention). The use of the fungicide bronopol (a VMP), for bath treatment of fish has 
been relatively stable in the period 2010-2012, but increased by 30% in 2013.   
Malachite green is no longer allowed for application in aquaculture. The regular surveillance 
programme has not detected malachite green in farmed fish. 
2.3 Summary of reference values for selected nutrients and 
undesirable substances  
The majority of health authorities worldwide recommend a regular fish intake in order to 
ensure proper nutrition and health benefits (Chapter 1).  
Nutrients in fish 
Several updates of recommendations for nutrients present in fish have been published. 
 In 2010 EFSA established recommendations for intake of EPA and DHA 
o Adults: 250 mg/day for primary prevention of coronary heart diseases in 
healthy subjects  
o Pregnant and lactating women: Additional 100 to 200 mg DHA per day was 
recommended  
o Older infants (older than 6 months of age) and young children below the age 
of 24 months, an Adequate Intake of 100 mg DHA was proposed  
o Young children above 2 years: EFSA proposed that dietary advice for should 
be consistent with advice for the adult population (i.e., 1-2 fatty fish meals 
per week or ~125 mg of EPA and DHA per day when adjusted for portion 
size) 
 In 2014, based on the Nordic Nutrition Recommendations 5th edition (2012), the 
Norwegian Directorate of Health revised the Norwegian recommendations. They: 
o established a new recommendation for DHA of 200 mg/day for pregnant and 
lactating women 
o increased the recommended intake of vitamin D from 7.5 μg to 10 μg/day for 
children above 2 years and adults, and to 20 μg/day for the elderly (75 or 
more years of age) 
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o increased the recommended intake of selenium from 50 μg to 60 μg/day for 
men and from 40 μg to 50 μg/day for women  
o kept the recommendations for iodine intake unchanged 
Contaminants in fish 
 The substances mainly addressed in this opinion are methylmercury and dioxins and 
dl-PCBs because they occur in fish at levels that may result in exposure close to 
tolerable intakes. Other contaminants are also present in fish. Several of the 
compounds in the group of chlorine-, fluorine or bromine-substituted organic 
compounds, including dioxins and dl-PCBs, are declining in the environment because 
they are no longer in use.  
 Fish is the only important dietary source of methylmercury. Since the VKM benefit risk 
assessment of fish consumption in 2006, a new tolerable intake for methylmercury 
has been set by EFSA which implicated a reduction from 1.6 to 1.3 μg/kg bw/week, 
expressed as mercury.  
 For dioxins and dl-PCBs, the TWI established by SCF at 14 pg TE/kg bw/week in 2001 
(SCF, 2001) is still valid.  
 For ndl-PCBs, EFSA could not establish a tolerable intake because of difficulties in 
distinguishing effects of ndl-PCBs from those of dl-PCBs (EFSA, 2005). Since exposure 
to ndl-PCBs is normally highly correlated with exposure to dioxins and dl-PCBs, VKM 
concluded in 2008 that with the combination of dioxins and PCBs in Norwegian food, 
exposure to dioxins below the TWI would also protect against toxicological effects 
from exposure to ndl-PCBs (VKM, 2008). 
 For PBDEs and HBCDs, EFSA concluded that the risk of adverse health effects from 
exposure is low (EFSA, 2011), but no tolerable intakes could be set. The margins 
between levels in Europeans and levels excerting toxicity in experimental animals was 
high, indicating low concern. 
 For fluorinated substances, the TDIs set by EFSA in 2008 for PFOS and PFOA are 
orders of magnitude higher than the dietary exposure in Norway.  
Medicine residues in farmed fish 
 When farmed fish is medicated, several measures are taken to ensure food safety for 
the consumer. These include retention times after treatment and large programs to 
control that the maximal residue limits (MRL) for veterinary medicinal products are 
not exceeded in farmed fish. 
 No residues of banned substances or medicine residues above EU maximal residue 
limitsfor veterinary medicinal products have been detected in any of the analysed 
30 000 samples from farmed fish (1998-2013). The residues controlled include e.g. 
antibiotics and agents agains sea lice. 
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The reference values used by VKM as basis for benefit and risk characterization of nutrient 
intake and contaminant exposures from fish in the present opinion are shown in Tables 2.3-1 
and 2.3-1.  
Table 2.3-1 Recommended daily intakes for nutrients used for benefit and risk characterisation 
(Chapter 8) 









2-year- olds ~125a  10 90 25 
Adults ~250b 10 (20)d 150 50 (women) 
60 (men) 
Pregnant women ~250 (+100-200 DHA)b  
200 DHAc 
10 175 60 
aaccording to EFSA (2010b) and adjusted for portion size for children being 50% of an adult portion of 
150 g 
baccording to EFSA (2010b) 
caccording to Norwegian dietary recommendations (Norwegian Directorate of Health, 2014), which 
were based on the Nordic Nutrition Recommendations 5th edition (NNR5, 2012) 
dFor elderly (>74 years), vitamin D is recommended at 20 µg/day  
Table 2.3-2 Tolerable weekly intakes for contaminants used for benefit and risk characterisation 
(Chapter 8) 
Population groups Tolerable weekly intake for contaminants 
 Methylmercurya 
µg/kg bw/week 
Sum dioxins and dl-PCBsb  
pg TEQ/kg bw/week 
2-year-olds 1.3 14 
Adults 1.3 14 
Pregnant women 1.3 14 
aaccording to EFSA (2012a)  
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3 Fish and fish products in the 
Norwegian diet 
Norwegians have traditionally had a relatively high fish and seafood consumption, especially 
in the coastal areas. Fishing and hobby angling contribute to higher fish consumption in 
subgroups of the population. The previous report (VKM, 2006) provided an overview of how 
to assess information about fish consumption and methodological challenges when assessing 
information about fish consumption. In the 2006 report (VKM, 2006), information about fish 
consumption was derived from dietary studies available at the time. These were the Norkost 
1997 (adults), Spedkost 1998-99 (infants 6 months and 1-year-olds), Småbarnskost 1999 (2-
year-olds), and Ungkost 2000 (4-, 9- and 13-year-olds). In addition, data from the 
Norwegian Fish and Game study, a national survey of the consumption frequencies relating 
to specific foods considered to contain potentially high levels of environmental contaminants, 
was included, and also some preliminary results from the Norwegian Mother and Child 
Cohort Study (MoBa) were presented. 
In this report we have used information about fish consumption from newer national dietary 
surveys in 2-year-olds (Småbarnskost 2007) and adults (Norkost 3) as well as information 
about fish consumption reported during the time period 2002-2008 by pregnant women in 
MoBa.  
Data from the national food consumption survey Ungkost 2000, with food consumption data 
for the age groups 4-, 9-, and 13-year-olds were considered too old to be used in this 
opinion. It is not known to which extent the fish consumption patterns have changed, 
neither in amount consumed nor type of fish eaten, in these age groups.  
3.1 Description of food consumption surveys 
The estimated consumptions of fish presented in this opinion are based on data from the 
national food consumption surveys for children (2-year-olds), adults (18-70-years) and from 
the MoBa cohort for pregnant women. The food consumption data from the three studies 
used in this opinion are the most complete and detailed data currently available in Norway.  
However, it should be pointed out that three different methodologies were used in the 
different surveys and thus direct comparisons between the different study populations (2-
year-old children, adults, pregnant women) can be misleading.  
A description of the food consumption surveys and the different methodologies used is given 
below:  
Two-year-olds: Småbarnskost 2007 is part of the national dietary surveillance system. The 
study was conducted by the University of Oslo, and financed by the Norwegian Directorate of 
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Health and the NSFA. Småbarnskost 2007 is based on a semi-quantitative food frequency 
questionnaire (FFQ). Ten questions in the FFQ asked about fish intake. In addition to 
predefined household units, food amounts were also estimated from photographs. The study 
was conducted in 2007, and a total of 1674 2-year-olds participated (participation rate 56%) 
(Kristiansen et al., 2009). 
Adults: Norkost 3 is part of the national dietary surveillance system. The study was 
conducted by the University of Oslo, and financed by the Norwegian Directorate of Health 
and the NSFA. Norkost 3 is based on two 24-hour recalls by telephone at least one month 
apart. Food amounts were presented in household measures or estimated from photographs 
(Totland et al., 2012). The study was conducted in 2010/2011 and 1787 men and women 
aged 18-70 years participated (participation rate 37%). A total of 97 different fish and fish 
containing foods were reported in the two 24-hour recalls. The participants were asked to fill 
in a food propensity questionnaire after having completed the two 24-hour recalls. A total of 
1453 participants filled in the questionnaire. The propensity questionnaire consists of 216 
frequency questions of different foods, drinks, dishes and supplements. Of these, 21 
questions asked about fish consumption and there were three questions about fish- and cod 
liver oil.  
In Småbarnskost 2007 and Norkost 3, the daily intake of nutrients and exposure to 
contaminants of fish and fish products was computed by using food databases in the 
software system (KBS – “kostberegningssystem”) developed at the Institute of Basic Medical 
Sciences, Department of Nutrition, at the University of Oslo. The food databases are mainly 
based on various versions of the official Norwegian food composition table (Rimestad et al., 
2000) and are continuously supplemented with data on new food items.  
Pregnant women (MoBa): The Norwegian Mother and Child Cohort Study (MoBa) is a 
prospective population-based pregnancy cohort study conducted by the Norwegian Institute 
of Public Health (Magnus et al., 2006). Participants were recruited from all over Norway from 
1999 to 2008. The women consented to participation in 40.6% of the pregnancies. The 
cohort now includes 114500 children, 95200 mothers and 75200 fathers. An FFQ was 
developed and validated specifically for this cohort (Brantsaeter et al., 2008; Meltzer et al., 
2008). This FFQ was used from February 2002 and onwards. The current opinion included 
dietary reports from 86277 pregnancies. Thus, estimation of nutrient intakes has been based 
on all 86277 participants, while exposure to contaminants has been based on 83782 
participants because body weights were not reported for 2494. The MoBa FFQ is a semi-
quantitative questionnaire designed to capture information on dietary habits during the first 
4-5 months of pregnancy. Frequencies were converted into food amounts using portion sizes 
for women and FoodCalc (Lauritsen, 2005), and women with improbable energy intakes 
were excluded (1.6%), i.e. energy intake below 4.5 MJ or above 20 MJ. 
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3.2 The consumption of fish and fish products in Norwegian 
dietary surveys 
The fish consumption is presented as raw fish to match the concentration data of nutrients 
and contaminants analysed in raw fish. Details regarding percentages of raw fish content in 
various fish products and type of fish used for each fish product are presented in Appendix I.  
The exception is cod roe and liver pâté, in which concentration data for nutrients and 
contaminants was analysed from the whole product, and not divided into cod roe, cod liver 
and cod liver oil.  
The Norwegian and Latin names for various fish species are listed in Appendix II. 
 Two-year-olds 3.2.1
Table 3.2.1-1 shows the number of consumers and consumption of different fish species and 
fish product categories in the 2-year-olds. Nearly all the 2-year-olds, 98%, reported eating 
fish, but the distribution of which type of fish and amounts of consumption differed widely. 
The 10 questions in the FFQ about fish intake covered fish balls/fish pudding, fish au gratin, 
fish burgers, fish fingers, cod/saithe, trout/salmon, cod roe and liver pate, mackerel in 
tomato-sauce, caviar, and jarred baby food with fish.  
Table 3.2.1-1 Consumption of raw fish in 2-year-olds (Småbarnskost 2007, n=1674) 
Food item Number of 
consumers  









Fish, total  1640  98 16 14 36 
Lean fish (≤5% fat) 1609  96 10 9 24 
Atlantic cod/saithe, fileta  1158  69 2 1 6 
Fish balls, fish puddinga 1243  74 3 2 9 
Fish au gratina  1040  62 1 <1 3 
Fish burgersa  1196  71 3 2 8 
Fish fingersa  940  56 2 1 6 
Jarred baby food w/fisha 68  4 <1 0b <1 
Fatty fish (>5% fat) 1238  74 5 2 16 
Salmon (farmed)  1013  61 1 1 4 
Mackerel in tomato saucea  736  44 3 0b 14 
Fish roe and liver  697  42 1 0b 5 
Cod roe and liver pâté 54  3 <1 0b -c 
Roe (in caviar) 685  41 1 0b 4 
P95 = 95th percentile 
aOnly raw fish content from the different food products are included.  
bMedian is zero due to less than 50% of the participants eating the fish or fish product. 
cLess than 60 consumers 
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The mean consumption of fish per day was 16 g, median consumption was 14 g and high 
(95th percentile) consumption was 36 g of fish per day. Lean fish contributed with 63% of the 
total fish consumption, fatty fish contributed 31% and cod roe and liver contributed 6%. Fish 
products like fish cakes and fish balls/pudding were the foods that contributed most to lean 
fish intake, while mackerel from mackerel in tomato-sauce was the most eaten fatty fish. 
Cod as filet and in fish products was reported eaten by 96% of the participants. Farmed 
salmon was most often reported of the fatty fishes, with 61% consumers. Fish as bread 
spread was frequently reported, and 44% of the participants used mackerel in tomato-sauce 
as bread spread, and also caviar was used by 41% of the participants. Cod roe and liver pate 
was only reported eaten by 54 of the participants. 
Consumption of fish oils and cod liver oil in 2-year-olds 
Mean consumption of fish/cod liver oil was 2 g/day in 2-year-olds, while the 95th percentile 
was 6 g/day (Table 3.2.1-2). A total of 41% of the 2-year-olds were given fish/cod liver oil 
(Table 3.2.1-3). The 2-year-olds that were given fish/cod liver oil as a supplement had a 
significantly higher mean fish intake (18 g/day) than those who were not given such 
supplement (15 g/day). 
Table 3.2.1-2 Consumption of fish oil and cod liver oil in 2-year-olds (Småbarnskost, n=1674) 





Fish oil/cod liver oil 2 6 
P95 = 95th percentile 
Median is not given, but was zero because less than 50% of the participants had consumed fish oil or 
cod liver oil. 
Table 3.2.1-3 Consumption of fish oil and cod liver oil in 2-year-olds in consumers only 
(Småbarnskost 2007, n=689) 
Supplement Number of consumers Consumers only 
  







Fish oil/cod liver oil 689 41 4 5 6 
P95 = 95th percentile 
 Adults 3.2.2
Table 3.2.2-1 presents the mean consumption of the different fish and fish categories for all 
participants and how many of the participants in Norkost 3 that consumed fish and different 
fish categories during the two 24-hour recalls. 
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A total of 97 different fish and fish containing foods were reported in the two 24-hour recalls. 
Only the content of raw fish is presented from the fish products, except for cod roe and liver 
pâté.  
When only two days of food intake are the basis for the fish consumption, persons that have 
eaten fish for dinner on both recall-days will be represented in the 95th percentile. It is 
unlikely that even a high fish consumer eats fish every day for a prolonged time, and 
therefore, the high mean fish consumption among those who reported fish for dinner both of 
the two consumption days represents an overestimate. Also, many participants with no 
registered fish intake during the two 24-hour recalls will usually eat fish. A total of 61% of 
the participants in the two 24-hour recalls had eaten fish, while 97% of the participants had 
reported to eat fish at least once a month in an accompanying questionnaire (Chapter 
3.2.2.1). This leads to a low median intake, and for fish species the median will be zero 
because less than 50% of the participants have eaten the specific fish during the two 24-
hour recalls. VKM has therefore not included the median for the adult population in the 
tables, but the median for total fish consumption is cited in the text.  
Table 3.2.2-1  Consumption of raw fish in adults (Norkost 3, n=1787)  







Fish, total  1095 61 52 201 
Lean fish (≤5% fat) 577 32 30 162 
Saithe 69 4 3 <1 
Atlantic cod 468 26 24 141 
Haddock  10 1 <1 -a 
Redfish  8 <1 1 -a 
Wolffish  4 <1 <1 -a 
Plaice 12 1 <1 -a 
Tuna  49 3 2 -a 
Fatty fish (>5% fat) 648 36 21 113 
Herring (Norwegian spring spawing)  99 6 1 9 
Halibut  15 1 1 -a 
Mackerel  257 14 4 30 
Salmon (wild)  6 <1 < 1 -a 
Salmon (farmed)  323 18 12 83 
Trout (freshwater) 4 <1 < 1 -a 
Trout (farmed)  28 2 1 -a 
Fish roe and liver 248 14 1 7 
Cod roe 237 13 1 5 
Cod roe and liver pate 18 1 <1 -a 
Cod liver 3 <1 <1 -a 
Fish from fish productsb  243 14 7 51 
Fish as bread spreadb  636 36 9 51 
P95 = 95th percentile. 
aNo 95th percentile due to less than 60 consumers.  
bFish from fish products and bread spread are also a part of the lean and fatty fish categories. 
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The mean consumption of fish per day was 52 g, while the 95th percentile participant 
reported to consume 201 g of fish per day. The median intake for total fish was 17 g. Lean 
fish contributed most with 60% of the total fish consumption, while fatty fish contributed 
40%. Cod was the most consumed fish category, and was eaten both as filet and as 
ingredient in fish products. Fish from fish products contributed with approximately 30% of 
the fish consumption. Farmed salmon was the most eaten fatty fish.  
Fish consumption differs with gender, and in this study sample, the daily mean and high 
intakes (95th percentile) were 44 g (175 g) in women and 62 g (239 g) in men. Using the 
average will lead to an underestimation of nutrient intakes from fish in men and an 
overestimation of nutrient intakes in women. However, for contaminant exposures this will 
be evened out as exposure estimates are divided by body weight. VKM decided to use the 
average for both men and women. The proportion of lean and fatty fish was comparable in 
men and women. 
Consumption of fish oils and cod liver oil in adults 
Mean consumption of fish oil/cod liver oil was 3 g/day in adults, while the 95th percentile was 
10 g/day (Table 3.2.2-2). There were 25% of the participants who reported taking fish 
oil/cod liver oil, measured in spoons, while 17% reported to have taken one or several 
capsules with fish oil. A total of 37% of the adults reported to take fish oil/cod liver oil during 
the two 24-hour recalls (Table 3.2.2-3). The adults that took fish oil/cod liver oil as a 
supplement had a mean fish intake of 56 g/day, while those not reporting taking fish oil/cod 
liver oil had a mean fish intake of 50 g/day. There was a significant difference in fish 
consumption between those who reported taking fish oil/cod liver oil, and those who did not 
take fish oil/cod liver oil.  
Table 3.2.2-2 Consumption of fish oil and cod liver oil in adults (Norkost 3, n=1787) 





Fish oil/cod liver oil, n=1787 3 10 
P95 = 95th percentile  
Median is not given, but was zero because less than 50% of the participants had consumed fish oil 
and cod liver oil. 
 
Table 3.2.2-3 Consumption of fish oil and cod liver oil in adults, consumers only (Norkost 3, n=663) 
for each type of fish oil 
Supplement Number of consumers Consumers only 
 







Fish oil/cod liver oil, n=663 663 37 7 2 11 
P95 = 95th percentile.  
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3.2.2.1 Food propensity questionnaire 
In Norkost 3 (Totland et al., 2012), the participants were asked to fill in a food propensity 
questionnaire after having completed the two 24-hour recalls. A total of 1453 out of 1787 
participants filled in the questionnaire. The propensity questionnaire consisted of 216 
frequency questions of different foods, drinks, dishes and supplements. Of these, 21 
questions were asked about fish consumption and three about fish- and cod liver oil. Some 
of the questions were aggregated, and are therefore not possible to directly compare with 
the more specific data from the two 24-hour recalls. Examples of aggregated question in the 
propensity questionnaire are: “Fish casserole, fish soup and fish au gratin” and “Fish/shellfish 
in wok, salad i.e.”.  
Comparison of the percentages of fish consumers measured with the two assessment 
methods; two 24-hour recall (Table 3.2.2-1) and propensity questionnaire (Tabel 3.2.2.2-1), 
shows that the percentage of fish consumers is lower in all categories in the two 24-hour 
recalls. 
Table 3.2.2.2-1 Fish consumers (%) measured with food propensity questionnaire, and 
frequencies per day of each fish category or fish product (n=1453)  
Food item Food propensity questionnaire 
 % fish consumers Frequency per day 
 (n=1453) Mean P95 
Fish, total, n=1453 97 0.80 2.19 
Lean fish (≤ 5% fat) 
Cod, saithe, haddock (boiled/fried) 62 0.08 0.22 
Wolffish, redfish (boiled/fried) 18 0.02 0.08 
Fatty fish (> 5% fat) 
Halibut (boiled/fried) 11 0.01 0.03 
Herring (boiled/fried/salted/smoked) 8 0.01 0.03 
Mackerel (boiled/fried/smoked) 9 0.01 0.03 
Wild salmon or trout (boiled/fried) 18 0.02 0.08 
Farmed salmon or trout (boiled/fried) 54 0.06 0.22 
Fish products 
Fish cakes, fish pudding, fish balls etc b 62 0.06 0.15 
Breaded fish (fish fingers, stuffed plaice etc.) 36 0.03 0.08 
Fish casserole, fish soup, fish au gratin 56 0.05 0.15 
Fish/shellfish in wok, salads etc. 31 0.03 0.15 
Sushi 14 0.01 0.08 
Sandwich spreads from fish 
Caviar (based on cod roe) 53 0.13 0.64 
Cod roe and liver pate 10 0.02 0.10 
Mackerel fillet in tomato sauce 67 0.19 0.64 
Smoked/cured salmon 55 0.08 0.36 
Sardines, pickled herring, anchovies 35 0.06 0.36 
Tuna (canned) 24 0.03 0.14 
Other (fish pudding, fish balls etc.) 48 -c 
Freshwater fish 
Freshwater fish, e.g pike, perch  4 0.01 0.2 
Fish liver (cod, saithe) 2 <0.01  0.01 
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P95 = 95th percentile  
aFish consumer defined as reported eating the fish product at least once a month 
bFish cakes, fish pudding, fish balls etc. are presented here due to difficulties in separating fish cakes 
eaten as bread spread or for dinner in the two 24-hour recalls. 
cFish cakes, fish pudding, fish balls etc. are presented as fish products, and not as bread spread.  
There were significant differences in total fish consumption between those who had filled in 
the propensity questionnaire and those who did not (p=0.02). Those who filled in the 
propensity questionnaire reported eating more fish than those who did not fill in the 
questionnaire (median 18 g vs. 5 g fish per day). 
Contrary to what was seen for fish consumption, use of fish oil/cod liver oil supplements did 
not differ much between the two assessment methods (Table 3.2.2.2-2). A likely explanation 
is that persons using dietary supplements tend to do this on a daily basis.  
Table 3.2.2.2-2 Percentage of fish oil and cod liver oil supplement users according to the food 
propensity questionnaire (n=1453) and two 24-hour recalls (n=1787) 
Supplement 
 
Food propensity questionnaire 
% consumersa 
(n=1453) 
Two 24-hour recalls 
% consumers  
(n=1787) 
Fish oil/cod liver oil, total 32 37 
aSupplement consumer is defined as taking the fish oil and cod liver oil at least once per week. 
bSupplement consumer is defined as taking the fish oil and cod liver oil at least once during the two 
24-hour recalls. 
 Pregnant women 3.2.3
Fish consumption in pregnant women in MoBa is described in Table 3.2.3-1. Fish 
consumption was assessed using a food frequency questionnaire (FFQ) and represents the 
average habitual intake during the first half of pregnancy. The FFQ included 8 questions 
about cold cuts and spreads made of fish or shellfish, 13 questions about fish or shellfish 
eaten for dinner, and four questions about cod liver oil, cod liver oil capsules or fish oil 
capsules. 
Table 3.2.3-1  Consumption of fish in pregnant women (MoBa, n=86277) 
Food item Number of 
consumers 
All participants (n=86277) 
 n % Mean g/day Median g/day P95 g/day 
Fish, total 83848 97 31 27 68 
Lean fish (≤ 5% fat) 80926 94 18 16 41 
Atlantic cod, saithe, haddock 77895 93 15 13 35 
Redfish, catfish 23283 27 1 0 7 
Pike, perch 1231 1 <1 0a <1 
Tuna 16945 18 1 0a 5 
Halibut, flatfish 21093 24 1 0a 4 
Fatty fish (> 5% fat) 75319 87 11 7 36 
Mackerel, herring 59184 69 6 2 28 
 
 
VKM Report 2014: 15  62 
Food item Number of 
consumers 
All participants (n=86277) 
 n % Mean g/day Median g/day P95 g/day 
Salmon, trout 66286 77 5 4 15 
Fish roe and liver 41215 48 2 0a 8 
Fish liver 918 1 <1 0a <1 
Cod roe and liver pate 3761 4 <1 0a <1 
Roe 40162 47 2 0a 8 
P95 = 95th percentile  
aMedian is zero due to less than 50% of the participants eating the fish or fish product.  
Nearly all the women reported fish intake (97%) and for total fish consumption the mean 
and 95th percentile did not differ between all and consumers only. The average total fish 
intake was 31 g/day (corresponding to 217 g/week), median intake was 27 g, and high 
consumption was 68 g/day. Lean fish consumption was reported by 94% and fatty fish by 
87% of the women. Lean fish constituted the largest part of total fish, with 18 g/day (60%), 
fatty fish contributed 11 g/day (37%), corresponding to ratio of 2/3 lean and 1/3 fatty fish. 
Fish liver and roe constituted a small part of total fish consumption.  
The consumption of fish oils and cod liver oil in pregnant women 
Fish oil and cod liver oil supplements were the most frequently used supplements reported 
by pregnant women in MoBa (Haugen et al., 2008). In 40108 women recruited during years 
2002 to 2005, fish oil and cod liver oil supplements were used by 59%, and 19% used more 
than one brand of n-3 supplement. In all women in MoBa (n=86277), which are included in 
the current report, use of fish oil and cod liver oil supplements was reported by 68%, with 
an increasing prevalence of fish oil and cod liver oil supplement use from 2002 to 2009 
(Table 3.2.3-2) 
Table 3.2.3-2 Use of fish oil and cod liver oil supplements in pregnant women (MoBa, n=86277) by 
year 
Year % pregnant women (n=86277) using fish 
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3.3 Previous estimates of fish consumption and changes in fish 
consumptions since 2006  
In the 2006 report (VKM, 2006), information about fish consumption was derived from 
dietary studies available at the time. These were the Norkost 1997 (adults), Spedkost 1998-
99 (infants 6 months and 1-year-olds), Småbarnskost 1999 (2-year-olds), and Ungkost 2000 
(4-, 9- and 13-year-olds). In addition, data from the Norwegian Fish and Game study part A 
was extensively used, and also some preliminary results from the Norwegian Mother and 
Child Cohort Study (MoBa) were presented.  
In order to address changes in fish consumption since 2006, the methods behind the dietary 
surveys used then and now have to be taken into consideration (Table 3.3-1).  
The methods used (FFQ) in Småbarnskost 1999 and Småbarnskost 2007 were similar, and 
data from these two surveys can be compared even though the questions in the FFQs differ 
for some food groups. However, for adults, the methods used in the Norwegian Fish and 
Game study part A (FFQ) and Norkost 3 (two 24-hour recalls) are not similar, and data from 
these two surveys cannot be directly compared. However, both studies were nation-wide and 
participants were invited by arbitrary selection from the population. 
Table 3.3-1 Overview of the different dietary studies used in the VKM benefit-risk assessment of 
fish in 2006 and in the present opinion 




   n % participation 
rate 
method addressed in 
VKM reports 
2-year-olds 
Småbarnskost 1999  
(Used by VKM in 2006) 






(Used in the present opinion) 





Fish and game study, part A 
(Used by VKM in 2006) 





Norkost 3  
(Used in the present opinion) 






(Used by VKM in 2006) 






(Used in the present opinion) 




University of Oslo (UiO) has conducted a calibration study where Norkost 3 and Norkost 
1997 has been compared (A.M.W. Johansen et al., UiO, pers. comm.). The same persons 
have been interviewed both with the two  24-hour recalls used in Norkost 3 and filled in the 
food frequency questionnaire used in Norkost 1997 (n=240 men and women). For fish and 
fish products, the mean intake with the Norkost 3 two 24-hours recalls was 67 g/day (SD 
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95th g/day), and the mean intake with the Norkost 1997 FFQ was 74 g/day (SD 48 g/day) 
(A.M.W. Johansen et al., UiO, pers. comm.). The calibration study concluded that: “It is 
generally not advisable to conclude on changes in diet based on Norkost 1997 and Norkost 
3.” However, since the overall consumption in adults was within the same order of 
magnitude, VKM decided to use the mean consumption at group levels for approximate 
comparison of fish consumption in adults in 2006 and 2014 in the present opinion. Some 
methodological details on the dietary surveys used in VKM assessment from 2006 and in the 
present opinion are found in Appendix III. 
 Two year olds 3.3.1
In the VKM assessment from 2006 (VKM, 2006), fish consumption in 2-year-olds was based 
on food frequency data assessed in 1998-1999 in a nationally representative sample of 1720 
2-year-old children. The mean intake reported in 2006 based on a survey in 1998-99 was 20 
g/day, the median intake was 16 g/day and 95th percentile intake was 46 g/day. In the 
present report, the mean consumption in 2-year-olds is 16 g/day, the median is 14 g and the 
95th percentile is 36 g/day. Both surveys (1998-99 and 2007) used FFQs, but the 
consumption data reported in VKM (2006) included shellfish and the full weight of fish 
products (not only the raw fish proportion), which explains the difference between the two 
time points. Hence, there is no indication of a change in fish consumption in 2-year-olds 
since 2006. (VKM, 2006) reported that lean fish contributed approximately 70% and fatty 
fish 20% of the total fish intake in 2-year-olds in 1999, while the corresponding figures in the 
current update is 63% and 31%. This may indicate a slight shift (about 10%) towards a 
lower proportion of lean fish relative to fatty fish. 
(VKM, 2006) reported that 45% of the 2-year-olds were given cod liver oil in 1999, while in 
the current update 41% were given cod liver oil and fish oil, indicating a small reduction in 
supplement use in this age group. It is likely that fish oil and cod liver oil has been replaced 
by other supplements containing vitamin D. 
In comparison to the VKM assessment from 2006 (VKM, 2006), the estimated total 
consumption of fish in 2-year-olds is basically unchanged. 
 Adults 3.3.2
Fish consumption data and estimated intake of nutrients and exposure to contaminants in 
(VKM, 2006) was based data assessed by a FFQ in the Fish and Game Study part A, a 
nationally representative sample comprising 6015 men and women aged 18-79 year was 
included (Meltzer and Stigum, 2002). The Fish and Game study included other seafood (e.g. 
shellfish) and not only fish as in the current update. A direct comparison with the current 
estimates of fish consumption is not possible and has not been tabulated. However, 
comparison of ”fish and other seafood” consumption (and not just “fish”) shows that the 
mean consumption of “fish and other seafood” which in the VKM assessment from 2006 
(VKM, 2006) was 70 g/day (65 g in women and 75 in men) is similar to the mean 
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consumption of ”fish and other seafood” presented in the Norkost 3 report (Totland et al., 
2012), which is 67 g per person per day (56 g in women and 79 g in men). The pattern of 
adult fish consumption in (VKM, 2006) showed that lean and medium fatty fish (less than 
5% fat) comprised nearly 2/3 of the total fish intake. Hence, there is no indication of a 
change in fish consumption at the individual level since 2006. This is supported by 
Norwegian food supply statistics. These statistics are prepared on an annual basis at the 
request of the Directorate for Health and Social Affairs and show that the sale of fish and 
fish-products has remained stable from 2006 to 2013 (Norwegian Directorate of Health, 
2013).  
 Pregnant women 3.3.3
The VKM assessment from 2006 (VKM, 2006) presented data on fish and seafood 
consumption based on the women recruited in 2002 and 2003, with an estimated average 
daily intake of 46 g total seafood per day. This figure is higher than the estimated average 
daily intake in this update (31 g/day). However, the figure used in 2006 included shellfish 
and the full weight of composite fish dishes is therefore not comparable to the current 
estimate which only includes the fish-part of composite fish-dishes.  
In a study within MoBa focusing on maternal dietary exposure to dioxins and PCBs during 
the time period 2002 to 2008, Caspersen et al. (2013) reported that during this time period 
the total median consumption of fish and seafood remained stable around 31 g/day. 
However, the median consumption of lean fish (less than 2% fat) decreased from 15.8 g/day 
in 2002–2003 to 13.7 g/day, while simultaneously, there was a small increase in 
consumption of medium fatty (2-8% fat) fish (from 1.9 to 2.9 g/day) and salmon/trout (from 
1.9 to 2.9 g/day) (Caspersen et al., 2013).  
The quantitative figure for fish consumption in pregnant women used by VKM (2006) is not 
comparable to newer estimates as the former included shellfish and the full weight of all 
ingredients in composite fish dishes. Fish intake in MoBa reported by year of delivery showed 
stable low fish consumption from 2002 to 2008, but with a slight decrease in lean fish 
accompanied by a slight increase in medium-fatty and fatty fish. Use of fish oil and cod liver 
oil supplements increased from 59% in 2002-2005 to 77% in 2008. 
3.4 Summary of consumption of fish and fish products in 
Norwegian dietary surveys 
In this updated report we have used information about fish consumption from newer 
national dietary surveys in 2-year-olds (Småbarnskost 2007) and adults (Norkost 3, 
2010/2011) as well as information for pregnant women who answered the MoBa FFQ (2002-
2008). The distribution of lean fish and fatty fish (roe and liver included) is about similar in 
the three population groups, as lean fish contribute with 60% and fatty fish contribute with 
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approximately 40% to the total (Figure 3.4-1). The mean consumption expressed as g/day is 
however different in the three groups (Figure 3.4-2). 
 
Figure 3.4-1 Mean distribution of lean and fatty fish consumption (% of total) in 2-year-olds, adults 
and pregnant women, respectively, based on the Småbarnskost 2007, Norkost 3 and MoBa. The 
figures are given in percentage of total raw fish consumption including proportion raw fish in fish 
products and bread spread. 
 
Figure 3.4-2 Mean fish consumption (g/day) given as raw fish including proportion raw fish in fish 
products and bread spread in 2-year-olds, adults and pregnant women, based on Småbarnskost 2007, 
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Consumption data in the current update and comparison to VKM 2006 show that: 
 For the 2-year-olds, fish intake was assessed with comparable instruments (FFQ) in the 
current update and in (VKM, 2006), but differences in estimation of total fish resulted in 
lower intake estimates in the present report.  
o The mean consumption of fish in 2-year-olds is 16 g/day, the median is 14 g and 
the 95th percentile consumption is 36 g/day.  
o The estimated total consumption of fish in 2-year-olds is relatively unchanged 
since 2006.  
 For adults, fish intake was assessed with different dietary instruments in the current 
update than in (VKM, 2006). In addition, consumption data in (VKM, 2006) included both 
fish and other seafood, and differences in estimation of total fish intake. 
o The mean consumption of fish per day in adults is 52 g, the median is 17 g and 
the 95th percentile consumption is 201 g/day.  
o The consumption of fish in the Norwegian Fish and Game Study part A is not 
directly comparable with the Norkost 3 fish consumption. However, the mean 
consumption in the Norwegian Fish and Game study and Norkost 3 appear to be 
about similar.  
 For pregnant women, fish intake was estimated with the MoBa FFQ both in the current 
update and in (VKM, 2006) but consumption data presented in (VKM, 2006) cannot be 
compared directly with the current estimate due to differences in estimation of total fish.  
o The mean consumption of fish in pregnant women is 31 g/day, the median is 27 
g and the 95th percentile consumption is 68 g/day.  
o Fish intake in MoBa reported by year of delivery showed stable fish consumption 
from 2002 to 2008, but with a slight decrease in lean fish accompanied by a slight 
increase in fatty fish.  
The fish consumption in 2-year-olds (Småbarnskost 2007), adults (Norkost 3) and pregnant 
women (MoBa, 2014) will be the basis for the intake and exposure assessment of nutrients 
and contaminants, respectively, in Chapter 7. Additionally, VKM has made various scenarios 
to foresee how possible changes in fish consumption pattern and amounts will affect the 
contribution from fish to recommended intakes of specific important nutrients, as well as to 
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4 Health effects associated with fish 
consumption – epidemiological 
studies 
The VKM benefit-risk assessment of fish consumption in 2006 (VKM, 2006), investigated the 
following clinical health outcomes: cardiovascular disease, cancer, growth and development 
of the foetus and infants as well as allergies against fish and fish products. At the time there 
were no quantitative data available from individual studies that had concurrently assessed 
the negative effects of contaminants in relation to the positive effects of different nutrients. 
Thus, based on a qualitative assessment of existing literature (up to 2006) of epidemiological 
studies, VKM concluded that consumption of fish, lean or fatty, (three fish meals á 200 
g/week; 2/3 lean and 1/3 fatty fish), has a positive overall health effect mainly due to the 
effects of fish consumption on cardiovascular disease and mortality. Furthermore, it 
appeared that intake of marine n-3 fatty acids from fish have a positive impact on length of 
pregnancy and foetal development.  
Since 2006, large prospective studies have been conducted, assessing fish consumption and 
association with several different health outcomes. Furthermore, national and international 
expert organs have assessed risks and benefits associated with fish consumption as such, as 
well as nutrients from fish consumption and contaminants from fish consumption. These are 
introduced in chronological order below, but findings and conclusions from these 
assessments are referred when relevant under each health outcome (Chapters 4.7.1 – 
4.7.5). 
In January 2010, FAO and WHO held an expert consultation on the risks and benefits of fish 
consumption to review data on levels of nutrients (long-chain n-3 fatty acids) and specific 
chemical contaminants (methylmercury and dioxins) in a range of fish species in order to 
compare the health benefits of fish consumption and nutrient intake with the health risks 
associated with contaminants present in fish (FAO/WHO, 2011). In the FAO/WHO report, the 
literature on benefits of fish consumption for optimal neurodevelopment and cardiovascular 
disease, as well the risks from consuming fish containing methylmercury and dioxins 
(including PCBs) were systematically reviewed. 
In 2011, the Norwegian National Council for Nutrition published their dietary advice to 
promote public health and prevent chronic diseases (Norwegian National Council for 
Nutrition, 2011). In this report a systematic literature review of fish consumption and various 
health outcomes (cardiovascular disease, cancer, type-2 diabetes, cognitive and visual 
development, mental health, psoriasis and rheumatoid arthritis, allergy, osteoporosis, 
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Both the abovementioned systematic literature reviews used the system developed by the 
2007 World Cancer Research Fund (WCRF) report (WCRF, 2007) for grading the evidence for 
fish consumption - health outcomes associations. The basic criteria for grading of evidence 
are given in (WCRF, 2007) “Food, nutrition, physical activity and the prevention of cancer: a 
global perspective”, in Box 3.8). The modified use of these criteria are given by FAO/WHO 
(2011) and the Norwegian National Council for Nutrition (2011). Evidence was classified as 
convincing, probable, limited suggestive, and limited – no conclusion depending on the 
number and quality of supporting, non-supporting and contradicting studies.  
Table 4.1 Short description of the terms used for grading of evidence (WCRF, 2007) 
Term Grade Evidence is 
Convincing  High Strong enough to support a judgement of a convincing causal 
relationship, which justifies goals and recommendations designed to 
reduce the incidence of cancer 
Probable Moderate Strong enough to support a judgement of a probable causal 
relationship, which would generally justify goals and 
recommendations designed to reduce the incidence of cancer 
Limitid – suggestive Low Too limited to permit a probable or convincing causal judgement, 
but suggestive of a direction of effect 
Limited – no conclusion Insufficient Too limited to permit a firm conclusion to be made 
EFSA delivered in 2012 an opinion on the risks to human health related to the presence of 
inorganic mercury and methylmercury in food (EFSA, 2012a), addressing several health 
outcomes including cardiac disease and neurodevelopment (the derived tolerable intakes are 
referred in Chapter 2.4.1). 
In May 2014, the US Food and Drug Administration published a quantitative assessment of 
the net effect on foetal neurodevelopment from eating commercial fish (as measured by IQ 
and also by early age verbal development in children) (FDA, 2014). Methylmercury was the 
contaminant addressed in this report.  
Also recently, in June, 2014, EFSA published a Scientific Opinion on health benefits of 
seafood consumption (EFSA, 2014b). They focused on the beneficial effects of seafood 
consumption during pregnancy in relation to functional outcomes of children’s 
neurodevelopment, and the effects of seafood consumption on cardiovascular disease risk in 
adults. They also addressed which nutrients in seafood may contribute to the beneficial 
effects of seafood consumption in relation to the above-mentioned outcomes and considered 
whether the beneficial effects of seafood consumption in relation to the above-mentioned 
outcomes could be quantified. Later EFSA will see the beneficial effects of seafood 
consumption in relation with the health risks associated with methylmercury exposure. 
In this updating of the VKM 2006 benefit-risk assessment, results from the above mentioned 
assessments which are made by national and international health authorities and published 
before 2013 formed the background basis for the literature searched performed by VKM 
(Chapter 4.1). VKM has not systematically assessed reviews/meta-analyses nor individual 
studies for weight of evidence, but merely summarised the studies retrieved from the 
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literature search. It was considered being beyond the scope of this assessment to review 
individual studies included in reviews/meta-analyses. 
In the following, for each health outcome, relevant results from these reports are initially 
summarised followed by brief summaries of other relevant meta-analyses, literature reviews 
and cohort studies retrieved from systematic searches for literature published after 2010. 
Some of the studies resulting from the literature search are also included in the assessments 
from FDA (2014) and EFSA (2014b), however, the main findings in these reports are also 
summarised in the beginning of each chapter when relevant. 
Furthermore, specifically for the reduction of coronary heart disease (CHD) (Chapter 4.2) 
VKM has also reviewed studies which have explored the relationship between marine n-3 
fatty acids and cardiovascular outcomes even if they have not reported on fish consumption. 
This was done because above mentioned reviews have taken into account that convincing 
evidence exist for an effect of marine n-3 fatty acids on the reduction of CHD. Such studies 
are also addressed by the VKM report from 2011 which evaluated negative and positive 
human health effects from intake of n-3 fatty acids from food supplements and fortified 
foods (VKM, 2011b). 
4.1 Literature searches for fish consumption and marine n-3 PUFA 
Two separate literature searches were conducted in order to assess knew knowledge about 
benefit and risk of fish consumption. The main search aimed to retrieve studies addressing 
fish consumption and health outcomes. In addition, a secondary search was conducted 
aiming to identify whether new scientific evidence would imply a change in the previously 
established beneficial effects of supplementary EPA and/or DHA in prevention of 
cardiovascular diseases. A full evaluation of supplementary n-3 long-chain polyunsaturated 
fatty acids (n-3 LCPUFA) and all outcomes was beyond the scope of this update. 
 Search strategy fish consumption and health outcomes 4.1.1
In order to retrieve relevant publications addressing fish consumption and health outcomes, 
systematic literature searches in Medline and Embase were conducted. Both databases were 
used in order to ensure comprehensive study retrieval. The strategy for the searches was 
discussed within the project group and with a professional librarian who also performed the 
searches. 
Initially, an explorative search was performed and thereafter the search set up was adjusted 
both to include more specific terms of salmon (e.g. Atlantic salmon) and to ensure a broader 
inclusion of systematic reviews and meta-analyses. 
The main search included different terms for “fish”, “consumption” and “health effects”, as 
well as for the specific types of health outcomes (e.g. malignant, cancer). The terms of 
health outcomes were based on well-known end points concerning human health and fish 
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consumption and marine long-chain n-3 fatty acids (e.g. cardiovascular events, cancer, 
immunology, cognition), as well as on end points relevant for children and their development 
(e.g. infant birth weight, language development) in accordance with end points used in the 
VKM benefit and risk assessment of breastmilk for infant health in Norway from 2013. For 
view of the search terms used for the literature search done 11. April 2014, the reader is 
advised to Appendix IV. 
The search period was limited to publications from 2009 to today due to the FAO/WHO 
report (FAO/WHO, 2011) which presents the systematic reviews and meta-analyses of fish 
consumption and health effects published until 2010. The search was further limited by 
omitting conference abstracts and set up to include publications written in English or 
Scandinavian languages (Danish, Swedish and Norwegian) only.  
Based on the above described search strategy, the results from the main search were 
restricted to single studies published in 2014 in order to obtain studies not yet included in 
reviews and meta-analyses (restriction 1), or to systematic reviews and meta-analyses only 
(restriction 2), or geographically to Norway, Sweden, Iceland, Finland, and Denmark 
(restriction 3). The geographic restriction was chosen in order to retrieve studies based on 
data especially relevant for fish consumption in the Norwegian population 
Additionally, a few studies not captured by the search but found in reference lists to the 
included studies or obtained by other means (hand searching) have been included. 
 Selection of epidemiological studies 4.1.2
The main study types for inclusion in this chapter were systematic reviews and meta-
analyses of human fish consumption and the associated health outcomes, i.e. restriction 2. 
The criteria for inclusion were: 
Fish or fish consumption in relation to health outcome was the main issue in the article. 
Study population representative for the general population (e.g. not to specific patients 
groups) preferentially in the European Economic Area and North America. 
Studies describing and/or comparing levels of nutrients or other bioactive compounds in 
various diets including fish were not included. We also excluded studies describing dietary 
practices including fish consumption in special patient groups. Studies of supplementary 
marine n-3 PUFA were excluded and handed over to the experts assessing studies on 
supplementary n-3. Additionally, position papers, conference abstracts/summaries, editorial 
comments and various dietary guidelines were excluded.  
The main literature search identified 2460 articles. Restriction 1 resulted in 156 articles 
published in 2014. Restriction 2 resulted in 444 systematic reviews and meta-analyses and 
restriction 3 provided 163 articles from the Nordic countries. Duplicates between the various 
restrictions were eliminated. 
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Study titles were independently reviewed by two persons of the project according to the 
above mentioned inclusion criteria. Titles were selected if chosen of one of the experts. The 
abstracts from the selected titles were then again independently reviewed by two project 
group participants and full text studies were distributed in the project group for full text 
examination. A final total of 74 publications were identified and included in this chapter 

































Figure 4.1.2-1  Flowchart for the literature search for fish consumption and associated health 
outcomes and the subsequent selection of publications.  
  
Main search  
2460 (including duplicates) scientific publications were identified searching Medline and 
Embase 
Restriction 1 
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in Chapter 4 
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 Search strategy for supplementary n-3 fatty acids (EPA and/or DHA) 4.1.3
and health outcomes 
In order to elucidate additional aspects of fish consumption and health effects, a separate 
literature search aiming at supplementary n-3 fatty acids EPA and DHA and health effects 
was done. In 2011, VKM published an evaluation of negative and positive health effects of n-
3 fatty acids as constituents of food supplements and fortified foods. The same search 
strategy as in the VKM report of 2011 was used, but the search period was limited from 
2009. The search was performed 16. December 2013. The systematic literature search was 
conducted in Medline and Embase and aimed to retrieve systematic reviews and meta-
analyses only, which were written in English, Norwegian, Danish or Swedish. For details, see 
Appendix V. 
The search resulted in a total number of 733 abstracts which after removing of doublets left 
559 references. Two experts read the abstracts, selected relevant articles and categorized 
these according to the outcome (cardiovascular, cancer, metabolic, immunologic, 
neurological and developmental). A full evaluation of all outcomes was considered beyond 
the scope of the current update. In the former VKM benefit and risk assessment of fish 
consumption (2006), the positive health effects of EPA and DHA, particularly on 
cardiovascular diseases, were included in the benefit part of the evaluation. The aim of the 
present update was therefore limited to identify whether new scientific evidence would imply 
a change in relation to the previously established beneficial effects of supplementary EPA 
and/or DHA in prevention of cardiovascular diseases.  
Of the 559 references, 16 meta-analysis and systematic reviews addressing cardiovascular 
outcomes were selected for further evaluation. In addition, five meta-analyses that were not 
identified in the original literature search were included by hand-search. A total of six meta-
analyses were selected to highlight and elaborate the recent controversy in the scientific 
community related to the positive health effects of EPA and DHA on cardiovascular diseases 
(Chapter 4.2.5).  
4.2 Fish consumption and cardiovascular disease 
Fish consumption has been associated with protection against cardiovascular disease, both 
as a primary prevention (prevention of first time incidence of cardiovascular disease) and 
secondary prevention (prevention or intervention addressing recurrent disease). Mainly, the 
marine n-3 PUFA are nutrients identified as protective, although other complex interplay 
among a wide range of nutrients commonly found in fish may also play a role. On the other 
hand, mercury (methylmercury) from fish can increase the risk for cardiovascular diseases. 
Thus, consumption of fish with high mercury concentration (especially predatory fish and 
large/old freshwater fish) may increase the risk of developing cardiovascular diseases and/or 
neutralise the positive effect of marine n-3 fatty acids. 
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The FAO/WHO report (FAO/WHO, 2011) gave conclusions on possible risks and benefits of 
fish consumption on cardiovascular disease based on 19 prospective cohort studies and five 
clinical trials. They concluded that there was strong evidence that consumption of long-chain 
n-3 fatty acids from either fish or fish oil supplements lowers the risk of cardiovascular 
disease, especially death from coronary heart disease and sudden cardiac death. The dose-
response relationship did not appear to be linear. A pooled analysis of 20 large studies in 
humans was found to support this non-linear effect for death from coronary disease, with a 
36% risk reduction up to 250 mg EPA+DHA per day and then little additional lowering of risk 
at higher doses. Results were very similar when restricted to prospective cohort studies of 
seafood consumption in generally healthy (primary prevention) populations. Thus, overall 
benefits of fish or fish oil consumption for death from coronary heart disease appeared very 
similar in prospective cohort studies of fish consumption in generally healthy people (primary 
prevention) compared with controlled trials of fish oil in individuals with established heart 
disease (secondary prevention). Population groups included in these trials and cohorts which 
included studies in the USA, Europe, Asia and Australia varied, suggesting that coronary 
heart disease benefits are applicable across a wide range of countries and background diets. 
The Expert Consultation concluded that there is convincing evidence from extensive 
prospective cohort studies and randomised trials in humans of beneficial health outcomes 
from fish consumption for reduction of cardiac death, and there is also emerging, possible or 
probable evidence that fish consumption may reduce the risk of multiple other adverse 
health outcomes, including ischaemic stroke, non-fatal coronary heart disease events, 
congestive heart failure and atrial fibrillation. Furthermore, they concluded that the health 
benefits of fish are most likely due in large part to long-chain n-3 fatty acids, however, fish 
contain other nutrients that also may contribute. FAO/WHO also assessed the health risks 
associated with fish consumption, particularly relating to methylmercury and dioxins, based 
on previous JECFA evaluations (FAO/WHO, 2004; FAO/WHO, 2007) and focusing on 
new/additional information. They concluded that there is an absence of probable or 
convincing evidence of risk of coronary heart disease associated with methylmercury. 
The Norwegian National Council for Nutrition came to the same conclusions as the FAO/WHO 
report on fish consumption (FAO/WHO, 2011) and n-3 fatty acids in fish and cardiovascular 
disease. 
EFSA (2014b) restricted their cardiovascular endpoint to cardiac death. They based their 
conclusions on possible associations of fish consumption and cardiac death on six published 
meta-analyses of observational prospective cohort studies in adult populations without pre-
existing coronary heart disease (CHD). The meta-analyses aimed at quantifying the 
relationship between seafood (or n-3 LCPUFA from seafood) consumption and risk of CHD 
mortality and were based on different combinations of the same 33 cohort studies. They also 
considered a draft version of a quantitative benefit analysis related to CHD mortality 
conducted by FDA in 2009. EFSA (2014b) concluded that the beneficial effects of seafood 
consumption on the risk of CHD mortality are observed at 1-2 servings of seafood per week 
and up to 3-4 servings per week compared to no seafood consumption. No benefit on CHD 
mortality might be expected at higher intakes (more than 4-5 servings per week). Such 
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benefits refer to seafood per se and include beneficial and adverse effects of nutrients and 
contaminants (e.g. methylmercury) contained in seafood (Chapter 4.2.4).  It is furthermore 
concluded that health benefits of seafood consumption in reducing the risk of CHD mortality 
are probably owing to the content of n-3 LCPUFA in seafood. Due to the heterogeneity of the 
studies quantification of the benefit of seafood consumption on CHD mortality could not be 
done with sufficient certainty. Using n-3 LCPUFA intakes from seafood for the quantitative 
benefit analyses introduced an additional uncertainty in the benefit estimate.  
In this updating of the 2006 VKM Report, five systematic reviews and meta-analyses, plus 19 
cohort studies related to fish consumption and cardiovascular disease are included from the 
literature search (Appendix IV). The reviews and meta-analyses include partly overlapping 
sets of individual prospective cohort studies. In addition, brief summaries of some relevant 
studies on supplementary marine n-3 fatty acids and cardiovascular disease are also given.  
In the following, brief descriptions of the systematic reviews and meta-analysis, and the 
relevant cohort studies of fish consumption and marine n-3 fatty acids from dietary fish 
consumption and cardiovascular disease published later than 2010, are briefly described. 
Cardiovascular diseases include several adverse health outcomes in addition to cardiac 
death. 
 Systematic reviews and meta-analysis, primary and secondary 4.2.1
prevention  
Zheng et al. (2012a) did an updated meta-analysis of fish consumption and marine n-3 
fatty acids contributed from dietary fish and coronary heart disease (CHD) 
mortality to investigate the up-to-date pooling effects. They conducted a literature search 
in PubMed and ISI Web of Science for all relevant papers published in English-language 
journals up to September 2010, and they also reviewed secondary references if relevant. 
They included only prospective cohort studies which were providing risk estimates (relative 
risk (RR) or hazard ratio (HR) with the corresponding 95% confidence interval of CHD 
mortality rate for each category of fish consumption. In the meta-analysis the fish 
consumption was categorised into four groups based on the fish intake frequency. Seventeen 
cohorts with 315 812 participants and average follow-up period of 15.9 years were identified. 
Compared with the lowest fish intake (less than 1 serving per month or 1-3 servings per 
month), the pooled relative risk (RR) of fish intake on CHD mortality was 0.84 (95% CI: 
0.75, 0.95) for low fish intake (1 serving per week), 0.79 (95% CI: 0.67, 0.92) for moderate 
fish intake (2-4 servings per week) (lower CHD mortality by 21%) and 0.83 (95% CI: 0.68, 
1.01) for high fish intake (more than 5 servings per week). Furthermore, the dose-response 
analysis indicated that every 15 g/day increase of fish intake reduced the risk of CHD 
mortality by 6% (RR=0.94; 95% CI: 0.90, 0.98). The authors concluded that fish 
consumption of 1 serving per week or 2-4 servings per week has a significant protective 
effect on fatal CHD, the beneficial effect being  stronger among those who had a moderate 
fish consumption (2-4 servings/week) than those who consumed low amounts of fish (1 
serving per week). They also concluded that fish consumption of more than 5 servings per 
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week only marginally decreased CHD mortality, which could be attributed to the limited 
number of studies included in this category of fish consumption. 
Djousse et al. (2012) conducted a meta-analysis to review current evidence on the 
association of fish consumption and marine omega-3 (EPA and DHA) with the 
incidence of heart failure (HF). They identified relevant studies by searching MedLine, 
EmBase, Web of Science and CABI abstracts from 1966 up to August 31, 2011 without 
restrictions and by reviewing reference lists from retrieved articles. The meta-analysis was 
performed in accordance with the guidelines published by the Meta-analysis of observational 
studies in Epidemiology (MOOSE) group. Overall they included any paper that provided 
multivariate adjusted relative risk (RRs) and their corresponding 95% confidence intervals for 
HF, comparing categories of fish consumption, dietary intake or blood concentrations of EPA 
and DHA. If a study reported RR and 95% CI for men and women separately, and the effect 
of fish or EPA/DHA intake on the risk of HF was modified by sex, results by sex was treated 
as two separate studies in the meta-analysis. The quality of each study was assessed. Seven 
prospective studies (four in USA, three in Europe) with 176 441 participants in whom 5480 
incident HF occurred, were retained. The average duration of follow-up was 13.33 years 
(range 7-16 years). Dietary assessment was obtained via food frequency questionnaires, and 
estimates of dietary EPA/DHA intake were derived from nutrient (four studies) or plasma 
phospholipid n-3 measurements (two studies). All reported relative measures of effect for HF 
in each study were adjusted for multiple covariates. Five prospective studies evaluated the 
associations between fish intake and incident HF. In the pooled analysis, a higher intake of 
fish (highest category in each study) was associated with a 15% (95% CI; 1-27%) lower risk 
of HF compared with the lowest category of fish intake (lowest category in each study). 
There was no evidence for heterogeneity among studies or publication bias. The authors 
concluded that the meta-analysis is consistent with a lower risk of heart failure with intake of 
marine n-3 fatty acids. 
Li et al. (2013) conducted a meta-analysis of prospective cohort studies to determine 
whether fish consumption could lower the incidence of heart failure (HF). They 
focused on dose-response relationship between fish intake and HF incidence. They 
conducted a systematic search of PubMed and EmBase from 1953 to June 2012 using 
keywords related to fish and HF and included studies with at least three categories of fish 
consumption reporting relative risk (RR) and corresponding 95% confidence interval (CI) for 
HF incidence. The primary outcome was incidence of HF and the definition of HF was 
accepted as reported in the individual study. Five prospective cohort studies (two conducted 
in USA and three in Europe) including 4750 HF events of 170231 participants and an average 
follow-up of 9.7 years were identified and selected. Two cohorts included only female 
participants, one included only male participants, and others included both males and 
females. Methods of dietary assessment of fish consumption were interviewer-administered 
questionnaire in one study, self-administered or WHO-administered questionnaire in other 
studies. Fish consumption was categorised into five standardised intervals. Compared with 
those who never ate fish or ate fish less than once a month, individuals who ate fish once a 
week exhibited a significantly lower risk of HF (RR: 0.91; 95% CI: 0.84, 0.99). The effect on 
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HF incidence seemed to increase with greater fish consumption. For individuals who 
consumed fish five or more times a week, the incidence of HF was decreased by 14% (RR= 
0.86; 95% CI: 0.84, 0.99). There was no evidence of heterogeneity among the five studies. 
In the stratified analysis, gender and duration of follow-up did not modify the inverse 
association between fish consumption and incidence of HF. The pooled RRs did not 
statistically differ between studies and the sensitivity analysis indicated that diet assessment 
might not affect the outcome (for each category p>0.05). The dose-response analysis 
(generalised least-square trend estimation) showed that for each 20 g/day increment in fish 
intake, the pooled RR was 0.94 (95% CI 0.90-0.97; p for trend =0.001). This meta-analysis 
of prospective cohort studies indicates a substantial inverse association between fish 
consumption and HF incidence and suggests that fish intake once a week could reduce the 
HF. Furthermore, there is a dose-dependent inverse relationship between fish consumption 
and HF incidence.  
Chowdhury et al. (2012) conducted a systematic review and meta-analysis on the association 
between fish consumption, and marine n-3 fatty acids contributed from fish, and 
risk of cerebrovascular disease, where 26 prospective cohort studies and 12 randomised 
controlled trials were included with aggregate data on 794 000 non-overlapping people from 
15 countries and 34817 cerebrovascular outcomes. This review is an updated meta-analysis 
which further extend the findings of previous corresponding reviews (He, 2009; He et al., 
2004; Larsson and Orsini, 2011) that higher fish consumption is moderately but significantly 
associated with a reduced risk of incident cerebrovascular disease (the relative risk, RR, of 
cerebrovascular disease for standardised categories of fish intake, typically adjusted for 
several conventional risk factors, for 2-4 versus 1 or less servings per week was 0.94 (95% 
CI 0.90-0.98) and for 5 or more versus 1 or less servings per week was 0.88 (0.81-0.96), 
based on 18 and 8 studies, respectively. In the dose-response meta- analysis (18 studies), 
an increment of two servings a week of any fish was associated with a 4% reduced risk of 
cerebrovascular disease (95% CI 1-7%). For all 21 studies, when comparing participants in 
the highest with the lowest category of fish intake, RR was 0.88 (0.84-0.93). In a subset of 
studies (62799 participants) the corresponding RR for white fish types was 1.03 (0.90-1.19) 
and for fatty fish types 0.84 (0.72-0.98). By contrast, dietary, circulating biomarkers in 
observational studies (14 prospective studies, involving 305119 participants and 5374 
cerebrovascular outcomes recorded during an average follow-up ranging from four to 30 
years), and supplements of longchain n-3 fatty acids in primary and secondary prevention 
trials (12 randomised controlled trials totalling 62040 participants during an average follow-
up three years) were not significantly associated with risk of cerebrovascular disease, and 
similar results were obtained for ischaemic and haemorrhagic stroke events. The authors 
conclude that available data indicate moderate, inverse associations of fish consumption and 
long chain n-3 fatty acids with cerebrovascular risk. Long-chain n-3 fatty acids measured as 
circulating biomarkers in observational studies or supplements in primary and secondary 
prevention trials were not associated with cerebrovascular disease. Thus, the beneficial 
effects of fish intake on cerebrovascular risk might be mediated through a complex interplay 
among a wide range of nutrients commonly found in fish. 
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Xun et al. (2012) did a meta-analysis of prospective cohort studies through April 2012 to 
assess association of fish consumption with risk of stroke and its subtypes 
accumulatively. A systematic literature survey of MEDLINE and EMBASE was done. 
Additional information was retrieved through Google or a search of reference lists in relevant 
articles. A database was derived from 16 eligible studies (19 cohorts), including 402127 
individuals (10568 incident cases) with a follow-up of an average of 12.8 years. The main 
outcome measure was the weighted hazards ratio (HR) and corresponding 95% confidence 
interval (CI) for incident stroke according to fish consumption using a random-effects model. 
Compared with those who never consumed fish or ate fish less than 1 per month, the pooled 
adjusted HRs of total stroke risk were 0.97 (95% CI 0.87-1.08), 0.86 (0.80-0.93), 0.91(0.85-
0.98), and 0.87 (0.79-0.96) for those who consumed fish 1-3 per month, 1 per week and 5 
or more per week, respectively (P linear trend=0.09; P nonlinear trend=0.02). Study location was a 
modifier, and an inverse association between fish intake and stroke incidence was only found 
in North America. The modest inverse association were more pronounced with ischemic 
stroke and were attenuated with haemorrhagic stroke. The authors conclude that there is 
accumulated evidence that suggests that fish intake may have a protective effect against the 
risk of stroke, particularly ischemic stroke. 
 Cohort studies, primary prevention 4.2.2
Levitan et al. (2009) conducted a population-based, prospective study of 39367 middle-aged 
and older Swedish men. Diet was measured using food frequency questionnaires. Men were 
followed for heart failure (HF) through Swedish inpatient and cause-of-death registers 
from 1 January 1998 to 31 December 2004. Proportional hazards models adjusted for age 
and other covariates were used to estimate hazard ratios (HR). Compared with no fish 
consumption, men who ate fatty fish once per week had an HR of 0.88 (95% CI 0.68–1.13). 
Hazard ratios for consumption two times per week and three times per week were 0.99 and 
0.97, respectively. Hazard ratios across quintiles of marine omega-3 were 1, 0.94 (95% CI 
0.74–1.20), 0.67 (95% CI 0.50–0.90), 0.89 (95% CI 0.68–1.16), 1.00 (95% CI 0.77–1.29). 
The authors concluded that in this population, moderate intake of fatty fish and marine 
omega-3 fatty acids was associated with lower rates of HF, though the association for fish 
intake was not statistically significant; higher intake was not associated with additional 
benefit. 
Levitan et al. (2010) examined the association of fatty fish and marine omega-3 with heart 
failure (HF) in a population of middle-age and older women participating in the Swedish 
Mammography Cohort aged 48–83 years. Intake of fish and marine omega-3 was estimated 
from food frequency questionnaires. Women without history of heart failure (HF), 
myocardial infarction, or diabetes at baseline (n= 36234) were followed from January 1, 
1998 until December 31, 2006 for HF hospitalisation or mortality through Swedish inpatient 
and cause-of-death registers; 651 women experienced HF events. Cox proportional hazards 
models accounting for age and other confounders were used to calculate incidence rate 
ratios (RR) and 95% confidence intervals (CI). Compared to women who did not eat fatty 
fish, RR were 0.86 (95% CI: 0.67, 1.10) for less than 1 serving per week, 0.80 (95% CI: 
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0.63, 1.01) for 1 serving per week, 0.70 (95% CI: 0.53, 0.94) for 2 servings per week, and 
0.91 (95% CI: 0.59, 1.40) for 3 or more servings per week (p for trend=0.049). RR across 
quintiles of marine omega-3 fatty acids were 1 (reference), 0.85 (95% CI: 0.67, 1.07), 0.79 
(95% CI: 0.61, 1.02), 0.83 (95% CI 0.65 - 1.06), and 0.75 (95% CI: 0.58, 0.96) (p for 
trend=0.04). The authors concluded that moderate consumption of fatty fish (one to two 
servings per week) and marine omega-3 fatty acids were associated with a lower rate of first 
HF hospitalisation or death in this population.  
The population-based prospective study of women in Sweden examining the association 
between fish consumption and stroke incidence (Larsson et al., 2011), is included in the 
systematic review and meta-analysis of Chowdhury et al. (2012). Since this is a unique 
Scandinavian study on stroke incidence in women, a short study specific description 
follows. 34670 women (49-83 years of age) had a mean follow-up of 10.4 years, and 1680 
strokes including 1310 cerebral infarctions, 233 haemorrhagic strokes and 137 unspecified 
strokes were diagnosed. They found that fish consumption was significantly inversely 
associated with risk of total stroke, but not cerebral infarction or haemorrhagic stroke. 
Comparison of women in the highest quintile of fish consumption (more than 3.0 servings of 
fish per week) had a 16% lower risk of stroke compared with women in the lowest quintile 
of fish consumption (less than 1.0 servings of fish per week); multivariate RR of total stroke 
was 0.84 (95% CI: 0.71-0.98, p for trend=0.049). Furthermore, consumption of lean fish, 
but not of other fish types, was inversely associated with risk of stroke. The multivariate RR 
of total stroke was 0.67 (95% CI: 0.49-0.93, p for trend=0.07 for 3 or more servings of lean 
fish per week with that of no fish consumption. The results suggest that the consumption of 
fish, especially lean fish, may reduce risk of stroke in women. The multivariate RR of total 
stroke was 0.67 (95% CI: 0.49-0.93, p for trend=0.07 for 3 or more servings of lean fish per 
week with that of no fish consumption. 
Strom et al. (2011) examined the relationship between fish consumption and the risk of 
cardiovascular disease 12-17 years later in a Danish pregnancy cohort of 7429 relatively 
young and initially healthy women (the Aarhus Birth Cohort). In such a cohort a low number 
of cardiovascular events are expected. Therefore a mixed outcome was used, including 
cardiovascular diseases and hypertension (cardiovascular risk factor). Exposure information 
was derived from a questionnaire sent to the women in gestation week 16, and daily fish 
consumption was estimated. During the follow-up, 263 events of cardiovascular disease were 
identified at admission to hospitals. No association between cardiovascular disease and fish 
intake was found. The number of identified events of cardiovascular disease in the study 
may have been too low to detect a potential association between fish consumption and 
cardiovascular disease. The authors concluded that a protective effect of fish intake against 
cardiovascular disease could not be substantiated in a prospective cohort study of relatively 
young and initially healthy women who were followed up to 17 years through high quality 
registries.  
Strom et al. (2012) assessed the association between intake of fish consumption and marine 
LCn3FAs and the risk of cardiovascular disease in a prospective cohort of young women 
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(mean age at baseline: 29.9 years [range: 15.7– 46.9]). Exposure information on 48627 
women from the Danish National Birth Cohort was linked to the Danish National Patients 
Registry for information on events of hypertensive, cerebrovascular, and ischemic heart 
disease used to define a combined measure of cardiovascular diseases. Intake of fish and 
LCn3FAs was assessed by a food frequency questionnaire and telephone interviews. During 
follow-up (1996-2008; median: 8 years), 577 events of cardiovascular disease (328 
hypertensive disease, 146 cerebrovascular disease, 103 ischemic heart disease) were found. 
Low LCn3FA intake was associated with an increased risk of cardiovascular disease (adjusted 
hazard ratio for women in lowest (3%, median 0.06 g/day) versus highest (median 0.73 
g/day) LCn3FA intake group: 1.91 [95% CI 1.26–2.90]). Restricting the sample to women 
who had consistently reported similar frequencies of fish intake across three different dietary 
assessment occasions tended to strengthen the relationship (hazard ratio for lowest (0 g 
fish/day, median LCn3FA 0.10 g/day) versus highest intake (each week, median LCn3FA 0.60 
g/day): 2.91 [95% CI 1.45–5.85]). Furthermore, the observed associations were consistent 
in supplementary analyses where LCn3FA intake was averaged across the three dietary 
assessment occasions, and the associations were persistent for all three of the individual 
outcomes. The authors concluded that the findings based on a large prospective cohort of 
relatively young and initially healthy women indicated that little or no intake of fish and 
LCn3FAs was associated with an increased risk of cardiovascular disease. 
Five papers addressing fish consumption (lean or fatty fish) or intake of n-3 PUFA or adipose 
tissue content of n-3 PUFA and cardiovascular disease (two different adverse health 
outcomes) in healthy subjects in the Danish cohort (Diet, Cancer and Health), are 
individually summarised below. 
Bjerregaard et al. (2010) studied the effect of fish consumption on the risk of acute 
coronary syndrome (ACS) in healthy subjects in Denmark. The study included 57053 men 
and women, 50-64 years in the Diet, Cancer and Health Cohort Study. The follow-up time 
was 7.6 years and a total of 1122 ACS were verified through nationwide medical databases. 
A detailed and validated food frequency questionnaire was used to estimate intake of lean 
and fatty fish. Among men, intake of fatty fish was associated with a lower risk of ACS, the 
hazard ratio was 0.67 (95% CI 0.53-085) when comparing the highest quintile of fish intake 
(more than 27 g/day) with the lowest quintile (0-6 g/day). The inverse association was 
observed for intake more than 6 g fatty fish per day, with no additional benefit for higher 
intakes. No associations were found for lean fish and ACS. Results were not consistent in 
women. The author concluded that a modest intake of fatty fish was associated with a lower 
risk of ACS in middle-aged men, while no consistent associations were found in women. 
Joensen et al. (2010) assessed the hypothesis that dietary intake of marine n-3 PUFA is 
negatively associated with the risk of acute coronary syndrome (ACS) in healthy 
subjects. In the Danish Diet, Cancer and Health cohort study, 57 053 participants were 
enrolled. Dietary intake of total n-3 PUFA, including EPA, docosapentaenoic acid (DPA) and 
DHA, was assessed. During the mean follow-up period (7.6 years), 1150 cases of incident 
ACS diagnosis were identified in the Danish National Patient Registry or the Cause of Death 
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Registry. Diagnoses were verified through medical record review. In Cox proportional hazard 
models, adjustment for established risk factors for CHD was done. A borderline significant 
risk reduction of ACS was found in men only. Men in the four highest quintiles of n-3 PUFA 
intake (0.39 g or more n-3 PUFA per day) had approximately 15% lower incidence of ACS 
than men in the lowest quintile [the hazard ratios were 0.83 (95% CI 0.67, 1.03), 0.81 
(95%CI: 0.65, 1.01), 0.90 (95%CI: 0.71, 1.13) and  0.81 (95%CI: 0.64, 1.04) for second, 
third, fourth and fifth (upper) quintile relative to lowest quintile of n-3 PUFA intake. There 
was no dose-response. Associations for EPA, DPA and DHA examined separately were all 
negative, but less consistent. No convincing associations were found among women. In 
conclusion, a borderline significant negative association was observed for intake of marine n-
3 PUFA and ACS among healthy men. 
Rix et al. (2013) examined the relationship between the content of total and individual 
marine omega-3 fatty acids in adipose tissue and the development of atrial fibrillation 
(AF) in a cohort study. A total of 57 053 Danish participants, 50-64 years of age were 
enrolled between December 1993 and May 1997 in the Diet, Cancer and Health Cohort 
Study. Eligible participants had to be born in Denmark, living in the urban areas of 
Copenhagen and Aarhus, and not be registered with a cancer diagnosis at the time of 
enrolment. For the present study, the study population consists of a randomly drawn sub-
cohort of 3440 participants. The exposure was adipose tissue content of n-3 PUFA and the 
main outcome was incident AF during follow-up. An adipose tissue biopsy was taken from 
the buttocks of all participants at baseline. A total of 190 incidences of AF occurred during a 
median of 13.6 years of follow-up. Complete data were available for multivariate analysis in 
3221 participants, including 179 cases of AF. The median adipose tissue content of total 
marine n-3 PUFA was 0.61% (5th/95th percentiles 0.35/1.08) in men and 0.65% (0.37/1.17) 
in women. The median intake of marine n-3 PUFA was 0.63 g/day as estimated by food 
frequency questionnaire at baseline. Incident AF was more common in men than in women. 
No statistically significant association between the adipose tissue content of n-3 PUFA and 
the risk of incident AF was found. However, the hazard ratio (HR) of AF indicated a 
protective trend (p=0.09). A similar trend towards a lower risk of AF was seen in the second 
(HR=0.87; 95% CI: 0.60, 1.24) and third tertile (HR=0.77; 95% CI: 0.53, 1.10) of marine n-
3 PUFA compared with the lowest tertile. The authors concluded that there was no 
statistically significant association between the content of marine n-3 PUFA in adipose tissue 
and the development of AF; however data were suggestive of a protective trend. 
In a follow up study in the same study population and using the full cohort (57 053 Danish 
participants aged 50-64 years and enrolled in the Diet, Cancer and Health Cohort Study 
between 1993 and 1997), (Rix et al., 2014) examined fish consumption marine n-3 PUFA 
assessed by the food frequency questionnaire in relation to atrial fibrillation (AF). 
Complete data were available for multivariate analysis of 55 246 participants including 3284 
cases of AF (2102 men and 1182 women). The median consumption of total marine n-3 
PUFA was 0.63 g/day. Independent of whether the association between total marine n-3 
PUFA and AF was modelled with marine n-3 PUFA as a continuous variable or according to 
quintiles, the results showed a U-shaped association with the lowest risk close to the median 
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intake and a higher risk at both lower and higher than median intake. The hazard ratio (HR) 
for the third versus the lowest quintile was 0.87 (95% CI 0.78–0.98). In secondary analyses, 
the model was also fitted for intake of total fish, lean fish, and fatty fish as well as separately 
for individual fatty acids EPA, DHA and DPA. For all exposures, the association was U-
shaped, although less so for lean fish. The authors concluded that U-shaped association 
found in this study may explain some of the contradictory results from previous 
observational studies. They found no evidence of a beneficial dose-response effect at higher 
levels of consumption of marine n-3 PUFA and that only moderate consumption of marine n-
3 PUFA may be preferable for primary prevention of AF. 
Bjerregaard et al. (2010)studied the effect of fish consumption on the risk of acute 
coronary syndrome (ACS) in healthy subjects in Denmark. The study included 57 053 
men and women, 50-64 years. The follow-up time was 7.6 years and a total of 1122 ACS 
were verified through nationwide medical databases. A detailed and validated food frequency 
questionnaire was used to estimate intake of lean and fatty fish. Among men, intake of fatty 
fish was associated with a lower risk of ACS, the hazard ratio was 0.67 (95% CI 0.53-085) 
when comparing the highest quintile of fish intake (more than 27 g/day) with the lowest 
quintile (0-6 g/day). The inverse association was observed for intake more than 6 g fatty fish 
per day, with no additional benefit for higher intakes. No associations were found for lean 
fish and ACS. Results were not consistent in women. The author concluded that a modest 
intake of fatty fish was associated with a lower risk of ACS in middle-aged men, while no 
consistent associations were found in women.  
Amiano et al. (2014) examined whether dietary intakes of total omega-3 fatty acids (from 
plants and marine foods) and marine polyunsaturated fatty acids (PUFAs) (EPA, DHA) were 
associated with the risk of coronary heart disease (CHD) in men and women in the 
Spanish Cohort of the European Prospective Investigation into Cancer and nutrition (EPIC) 
project. A total of 41091 men and women aged 20-69 years were recruited 1992-1996. The 
mean follow-up was 10 years. A total of 609 participants (79% men) had a definite CHD 
event. A validated dietary questionnaire was used to estimate the intake of total omega-3 
fatty acids. The fish intakes (g/day, mean (SD) were for men CHD 78.1 (48.4) and men 
cohort 77.1 (48.4), and for women CHD 56.6 (37.2) and women cohort 53.7 (34.7), while 
intakes of total omega-3 fatty acids (g/day, mean (SD) were for men CHD 1.7 (0.7) and men 
cohort 1.7 (0.7), and for women CHD 1.1 (0.5) and women cohort 1.2 (0.5) Only participants 
with definite incident CHD event classified as either definite (fatal or non-fatal acute 
myocardial infarction or unstable angina requiring revascularisation procedures) or possible 
(fatal or non-fatal myocardial infarction in those cases that did not meet all diagnostic criteria 
and fatal CHD with insufficient information) were considered as cases, Cox regression models 
were used to assess the association between the intake of total omega-3 fatty acids , EPA, 
DHA and CHD. Mean intake of total omega-3 fatty acids, EPA and DHA were similar in the 
cases and in the cohort. In the multivariate adjusted model, omega-3 fatty acids, EPA and 
DHA were not related to incident CHD in either men or women. The results did not change 
after exploring the consumption of fish by type, fatty or lean. The hazard ratios (HR) for 
omega-3 fatty acids were 1.23 in men (95% CI0.94-15.9, p=0.20) and 0.77 in women (95% 
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CI 0.46-1.30, p=0.36). The authors concluded that in the Spanish EPIC cohort, with a 
relatively high intake of fish, no association between EPA, DHA and total omega-3 fatty acid 
intake and risk of CHD was found. 
Association between consumption of fish (total, lean or fatty fish) and venous 
thromboembolism (VTE) was studied in a Danish follow-up study, Diet, Cancer and 
Health, including 27178 men and 29876 women recruited in 1993 and 1997, with no history 
of cancer (Severinsen et al., 2014). Information of fish intake and potential confounders 
were obtained from baseline questionnaires. The outcomes were incident VTE (all) and 
idiopathic VTE. During follow-up, ca. 10 years, 641 incident VTE events were verified. Cox 
proportional hazard models with age as time axis was used. No association between total 
fish intake (the 4 higher quintiles, 26 to more than 65 g total fish per day, compared to 
reference of 0-25 g total fish per day) and VTE was observed, but moderate intake (8 to 30 
g per day) of fatty fish was associated with a statistically non-significant 20-40% lower risk 
of idiopathic VTE compared with low consumption (less than 8 g/day) of fatty fish. The 
authors concluded that intake of neither total nor fatty fish were statistically significantly 
associated with VTE events. However, intake of fatty fish may be associated with a reduction 
in risk of idiopathic VTE. 
 Cohort studies, secondary prevention  4.2.3
The following studies are included since they assess intervention with fatty (salmon) and 
lean fish, and/or Scandinavian patients. 
Ramel et al. (2010) conducted a randomised, controlled dietary intervention trial (eight 
weeks) in 324 young overweight and obese (body mass index 27.5-32.5 kg/m2), normo- and 
hypertensive individuals from three European countries (Iceland, Spain and Ireland). The 
aim was to investigate whether salmon consumption three times a week improves blood 
pressure. The subjects were randomised to one of four energy restricted diets (-30% 
relative to estimated requirements): Salmon (150 g three times per week, resulting in a daily 
consumption of 2.1 g of n-3 LCPUFAs per day), cod (150 g three times per week, 0.3 g n-3 
LCPUFAs), fish oil capsules (1.3 g n-3 LCPUFAs per day), or control (sunflower oil capsules, 
no seafood). Body weight, blood pressure (diastolic DBP and systolic SBP), and DHA 
(docosahexaenoic acid) in erythrocyte membrane were measured at baseline and endpoint. 
A significant weight loss and decreases in SBP and DBP after the intervention were found. 
The salmon and fish oil group had significantly lower DBP than the cod group, but not 
significantly lower than the control. The authors conclude that lower DHA content in 
erythrocyte’s membrane at baseline, which might identify infrequent fish eaters, is 
associated with greater DBP reduction during an 8-week intervention providing seafood. 
With the objective to study the relation between dietary intake of n-3 LC PUFAs or fish and 
risk of future coronary events or mortality, Manger et al. (2010) did an intervention 
sub study of participants in a the Western Norway B Vitamin Intervention Trial with a 
minimum follow-up of 57 months. Patients (2412), aged over 18 years diagnosed with well-
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characterised coronary artery disease (CAD) (81% men) completed a food frequency 
questionnaire at baseline, from which daily intakes of DHA, DPA and EPA as well as fish were 
estimated on the basis of diet and intakes of food supplements. The main end point was a 
composite of coronary events, including coronary death, nonfatal acute myocardial 
infarction, and unstable angina pectoris. The mean intakes of n-3 LCPUFAs in quartiles 1-4 
were 0.58±0.29, 0.83±0.30, 1.36±0.44, and 2.64±1.18 g/day, respectively. No dose-
response relation between quartiles of n-3 LCPUFAs (based on intake as the percentage of 
total energy) or fish and coronary events or separate end points was found. A slightly 
increased risk of coronary events at an intake of n-3 LCPUFAs less than ~0.30 g/day was 
seen. The authors concluded that secondary prevention with n-3 LCPUFAs or fish in this 
Norwegian population with established and well-treated CAD and with a relatively high intake 
of n-3 LCPUFAs had no significant effect on risks of coronary events and mortality. Only 
patients with very low intakes of n-3 LCPUFAs may reduce their risks of coronary events by 
increasing their intakes. 
 Fish consumption and exposure to contaminants and cardiovascular 4.2.4
disease 
The Expert Consultation (FAO/WHO, 2011) also assessed the health risks associated with 
fish consumption, particularly relating to methylmercury and dioxins, based on previous 
JECFA evaluations (FAO/WHO, 2004; FAO/WHO, 2007) and focusing on new/additional 
information. They concluded that there is an absence of probable or convincing evidence of 
risk of coronary heart disease associated with methylmercury.  
The mercury opinion from EFSA in 2012 concluded that the observations related to the 
associations between mercury exposure and the endpoints myocardial infarction, heart rate 
variability and possibly blood pressure are of potential importance, but results were still not 
conclusive and were not used for risk assessment (EFSA, 2012a). 
A summary of some more recent cohort studies and relevant Nordic studies relating to fish 
consumption and methylmercury, PCBs and/or dioxins are given below. 
Virtanen et al. (2012) studied the association between serum n-3 LCPUFA (EPA, DPA and 
DHA), and hair mercury concentrations and blood pressure in middle aged and older men 
(848) and women (909), aged 53-73 years, from the Kuopi Ischaemic Heart Disease Risk 
Factor Study in Eastern Finland. Participants with ischaemic heart disease, stroke, diabetes, 
or hypertension treatment were excluded, leaving 396 men and 372 women. Log-
transformed values were used to study associations. The participants were recruited 
between 1984-1989, and the follow-up period was 11 years. The mean serum concentrations 
were 1.63% (SD 0.91) for EPA, 0.77% (SD 0.16) for DPA, and 2.73% (SD 0.90) for DHA of 
all serum fatty acids. After multivariate adjustments, a higher serum EPA+DPA+DHA 
concentration was statistically significantly associated with a lower systolic blood pressure 
(β=-4.41; 95% CI: -6.95, -1.87) and pulse pressure (β=-4.41; 95% CI: -6.95, -1.87), but 
not with diastolic blood pressure (β=-0.45; 95% CI:-2.31, 1.52). Individual evaluation of 
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EPA, DPA and DHA gave similar associations. The mean hair mercury concentration was 1.42 
µg/g (SD 1.54). Hair mercury was not associated with blood pressure and did not modify the 
association between PUFA and blood pressure. The authors conclude that in older men and 
women, higher serum n-3 PUFA levels, mainly reflecting fish intake in the study population, 
were associated with a modestly lower blood pressure. On the other hand, the 
environmental pollutant mercury present in fish was not associated with blood pressure. 
Bergkvist et al. (2014) assessed the association between validated estimates of individual 
dietary PCB exposure, taking into account the fish consumption and the intake of long-chain 
omega-3 fatty acids, with the risk of stroke and its subtypes in a population-based 
prospective cohort study of middle-aged and elderly women (Swedish Mammography 
Cohort). The possible effects of factors (like parity, body mass) influencing the PCB body 
burden and date of birth (surrogate for prenatal exposure) were explored in stratified 
analyses. During 12 years of follow-up (397309 person-year), there were 2015 incident cases 
of total stroke (1532 ischemic strokes, 216 intracerebral haemorrhages, 94 subarachnoid 
haemorrhages, and 173 unspecified strokes). The mean energy-adjusted dietary exposure to 
PCBs was 192 ng/day (median 165 ng/day; 5thand 95th percentiles were 69 and 374 ng/day, 
respectively). Multivariable-adjusted relative risks (RR), controlled for known stroke risk 
factors and fish consumption, were 1.67 (95% CI 1.29-2.17) for total stroke, 1.61 (95% CI 
1.19-2.17) for ischemic stroke, and 2.80 (95% CI 1.42-5.55) for haemorrhagic stroke for 
women in the highest quartile of dietary PCB exposure (median 288 ng/day) compared with 
women in the lowest quartile (median 101 ng/day).They concluded that in this population-
based prospective cohort of middle-aged and elderly women, an exposure to PCBs from 
foods was associated with a statistically significant 67% increased risk of total stroke and 
almost 3-fold higher risk of haemorrhagic stroke when those in the highest exposure quartile 
were compared with those in the lowest. In contrast, the consumption of fatty fish and the 
intake of n-3 PUFA were associated with a decreased risk of total stroke. Further prospective 
studies are needed to clarify the concentrations of PCBs that may offset the beneficial effects 
of fish consumption. 
In a case-control study in Sweden, in which data and samples were collected prospectively, 
Wennberg et al. (2011) assessed how fish consumption and erythrocyte concentrations of 
mercury (Ery-Hg) and selenium (Ery-Se) are related to the risk of myocardial infarction 
(MI) and whether n-3 fatty acids (EPA and DHA) in plasma phospholipids are protective. The 
study included 431 cases with a MI after data and sample collection, including 81 sudden 
cardiac death and 499 matched controls. Another 69 female cases with controls from a 
breast cancer screening registry were included in sex specific analyses. For the whole study 
group, the mean consumption and (range) of fish was 1.26 meals per week (0-8 meals per 
week). Median and (range) concentration of mercury in erythrocytes was 3.54 ug/l (0.01-87 
ug/L) and the median relative level of EPA+DPA was 5.84% (2.78-14.5%). Odds ratios for 
the third compared with the first tertile were 0.65 (95% CI: 0.54-0.91) for Ery-Hg, 0.75 
(95% CI: 0.53-1.06) for Ery-Se, and 0.78 (95% CI: 0.54-1.11) for plasma (P)-EPA+DHA. 
Ery-Hg and P-EPA+DHA were inter-correlated (Spearman`s R=0.34): No association was 
seen for reported fish consumption. Multivariate modelling did not change these associations 
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significantly and sex-specific analyses showed no differences in risk associations. High 
concentrations of Ery-Se were associated with increased risk of sudden cardiac death.       
The authors concluded that the biomarker results indicate a protective effect of fish 
consumption. No harmful effect of mercury was indicated in this low-exposed population.  
Wennberg et al. (2012) also assessed associations between exposure to both marine n-3 
PUFAs and methylmercury and myocardial infarction (MI) using data from Finland and 
Sweden. Matched case-control sets were nested in population-based, prospective cohort 
studies including 361 and 211 men with MI from Sweden and Finland, respectively. MI risk 
was estimated in a logistic regression model with the amount of mercury in hair (hair-Hg) 
and concentrations of n-3 PUFAs (EPA+DHA) in serum as independent variables. The median 
hair-Hg was 0.57 µg/g and 1.32 µg/g in Swedish and Finnish controls respectively, whereas 
the percentage of PUFAs was 4.21% and 3.83%, respectively. In combined analysis, 
regression parameters showed that hair-Hg was associated with higher (p=0.005) and S-
PUFAs with lower (p=0.011) MI risk. The model indicated that even a small change in fish 
consumption (i.e. increasing PUFA in serum by 1%) would prevent 7% of MIs, despite an 
increase in mercury exposure. However, at high hair-Hg, the modelled beneficial effect of 
PUFA on MI risk was counteracted by methylmercury. The authors concluded that exposure 
to mercury was associated with increased risk of MI, and higher S-PUFA concentrations were 
associated with decreased risk of MI. Thus, MI risk may be reduced by the consumption of 
fish high in S-PUFAs and low in methylmercury. 
 Supplementary n-3 fatty acids (EPA and DHA) and cardiovascular 4.2.5
disease 
There is convincing evidence that EPA and DHA prevent death from coronary heart diseases 
(Chapter 4.2). In 2011, VKM evaluated negative and positive health effects of n-3 fatty acids 
as constituents of food supplements and fortified foods (VKM, 2011b). The evaluation of 
positive health effects covered several health outcomes. For cardiovascular diseases it was 
concluded that the strongest evidence for possible beneficial effects of n-3 fatty acid 
supplementation in humans is provided by large randomised controlled trials involving more 
than 43000 study participants suffering from cardiovascular disease (secondary prevention). 
In patients given either 0.8 g EPA and DHA or 1.8 g of EPA as ethyl ester daily, the risk of 
cardiovascular events and mortality was reduced. 
Primary prevention from EPA and DHA supplementation has been less studied. However, 
EFSA has based its recommendation for adults on scientific evidence indicating that fatty fish 
consumption (1-2 meals per week or dietary supplements containing EPA and DHA and 
equivalent to a range of 0.25 to 0.50 g of EPA and DHA daily) decrease the risk of mortality 
from coronary heart disease and sudden cardiac death (EFSA, 2010b). 
During the last few years, several meta-analyses and systematic reviews including 
randomised controlled trials have assessed the beneficial effects of EPA and DHA on 
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cardiovascular risks. Thus, it was of special interest to assess if new evidence had emerged 
since 2011 related to the effects of supplemental EPA and DHA on cardiovascular diseases. 
As described in Chapter 4.1.3, a literature search was conducted aiming to identify whether 
new scientific evidence would imply a change in the previously established beneficial effects 
of supplementary EPA and/or DHA in prevention of cardiovascular diseases. The majority of 
the studies conclude that EPA plus DHA lowers the risk of mortality from coronary heart 
disease. In addition, five meta-analyses not identified in the search were included in order to 
highlight and elaborate the recent controversy in the scientific community related to the 
positive health effects of EPA and DHA on cardiovascular diseases. 
A systematic review on EPA and DHA and cardiovascular disease including 21 articles and 
46737 subjects with high cardiovascular risk concluded that EPA and DHA reduced the risk of 
cardiovascular events and cardiac death (Delgado-Lista et al., 2012). In contrast, a 
systematic review and meta-analysis by Rizos and Elisaf (2013) reviewed 20 randomized 
control trials (RCTs) including 69680 patients, and concluded that EPA and DHA 
supplementation was not associated with a lower risk of all-cause mortality, cardiac death, 
sudden death, myocardial infarction and stroke. The opposite conclusions from these two 
meta-analyses despite a large overlap in the studies included reveal that there are 
differences in how the data are interpreted as well as differences in inclusion and exclusion 
criteria which can lead to different conclusions. 
A recent meta-analysis based on 19 studies, including 24788 adult patients with impaired 
glucose metabolism, concluded that EPA and DHA had no protective effect on 
cardiovascular mortality, major cardiovascular effects and all-cause mortality, but 
reduced triglyceride level (Zheng et al., 2013a). 
One systematic review compared low versus moderate intakes of EPA and DHA from 
supplements on risk of coronary heart disease in a total of 214426 healthy subjects aged 
34 to 84 years old with a follow-up from four to 16 years (Musa-Veloso et al., 2011). They 
concluded that an intake of 250 mg EPA and DHA or more per day reduced the risk of 
sudden cardiac death.  
A recent large double-blind, placebo controlled clinical trial including 12513 subjects with 
multiple cardiovascular risk factors received daily either 1g EPA and DHA or 1g olive oil 
as placebo with a median of five years follow-up (The risk and prevention study collaborative 
group). They concluded that a daily treatment with 1g EPA and DHA did not reduce 
cardiovascular mortality and morbidity. This trial has received some critical comments 
particularly since they changed the primary end point during the trial due to a low incidence 
of cardiovascular events and for using olive oil as placebo because olive oil may reduce 
primary cardiovascular events (Estruch et al., 2013).  
Based on the above mentioned studies, e.g. inclusion and exclusion criteria, doses of EPA 
and DHA, composition of placebo, type of subjects i.e. healthy, healthy but at high risk of 
cardiovascular disease or patients, and subjects with or without impaired glucose control all 
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seem to affect the health outcome from supplementary EPA and DHA. In addition, the 
background diets will also affect the baseline levels of EPA and DHA. In a review by 
Ramsden et al. (2010) they show that the relative amount of n-6 fatty acids to n-3 and 
amounts of ALA versus EPA and DHA both affects the end points and thereby the 
conclusions, i.e. that a high intake of n-6 fatty acids may actually increase the risks of CHD 
and death. The supplemental ALA given to individuals on a Western diet does not have the 
same beneficial effects as EPA and DHA on the vascular system or on the biomarkers of 
disease risk e.g. serum triacylglycerols. 
Despite some conflicting findings i.e. no beneficial versus beneficial effect, in reviews and 
meta-analyses regarding the effects of supplementary EPA and DHA on cardiovascular 
diseases, new scientific evidence does not imply a change in the previously established 
beneficial effects of supplementary EPA and/or DHA in prevention of cardiovascular death. 
4.3 Fish consumption and outcomes related to the central nervous 
system; main focus on neurodevelopment 
In 2006, VKM summarised that it appeared that marine n-3 fatty acids have a positive impact 
on length of pregnancy and foetal development. Although studies of fish consumption have 
not shown that n-3 LCPUFA have a positive effect on the development of the central nervous 
system (CNS) of foetuses and newborn babies, this has been shown to be the case in other 
studies involving n-3 LCPUFA supplementation. Methylmercury in fish may damage the brain 
development of the foetus and infant. In 2006, VKM did not assess other CNS related 
outcome than neurodevelopmental ones. 
A number of fatty acids, particularly the marine n-3 fatty acid DHA, are essential for the 
development of the central nervous system of humans, and there is a growth spurt during 
the last trimester of pregnancy and during the first months post partum as well as important 
development up to two years of age. Thus, neurodevelopment of foetus and children is a 
most sensitive health outcome. 
 Neurodevelopmental outcomes 4.3.1
The national and international health authorities FAO/WHO, the Norwegian National Council 
for Nutrition and recently EFSA have all assessed possible effects (beneficial and adverse) of 
seafood consumption before and/or during pregnancy on functional outcomes of children`s 
neurodevelopment in 2011, 2011 and 2014, respectively.  
The EFSA Opinion on mercury in 2012 based the TWI on neurodevelopment in children 
(EFSA, 2012a). Recently, EFSA addressed benefits of seafood consumption in relation to 
functional outcome of children’s neurodevelopment (EFSA, 2014b). Furthermore, the US 
Food and Drug Administration also recently published an extensive quantitative assessment 
of the net effects on foetal neurodevelopment of eating commercial fish during pregnancy 
(FDA, 2014).  
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The conclusions from the abovementioned assessments/reviews of data on fish consumption 
and neurodevelopmental outcomes all form the basis for the present VKM assessment of 
epidemiological studies addressing risks and benefits of fish consumption of women of 
childbearing age and optimal neurodevelopment of their offspring, and their conclusions are 
briefly summarised below: 
FAO/WHO (2011) concluded that multiple observational studies have demonstrated 
independent beneficial associations with fish consumption during pregnancy, DHA levels in 
maternal blood during pregnancy or in cord blood during delivery with more optimal 
neurodevelopmental outcomes, including better behavioural attention scores, visual 
recognition, memory, and language comprehension in infancy and childhood, in the offspring 
(FAO/WHO, 2011). Thus, there is convincing evidence (Table 4.1) that fish consumption by 
women reduces the risk of suboptimal neurodevelopment by their offspring. Randomised 
controlled trials with DHA supplementation during nursing support this finding. The 
FAO/WHO report concludes that together, maternal consumption of n-3 LCPUFAs during 
pregnancy and nursing improves early brain development in children. Fish, however, contain 
other nutrients that may also contribute to the health benefits of fish.  
Furthermore, FAO/WHO concluded that there is convincing evidence (Table 4.1) of adverse 
neurological/neurodevelopmental outcomes in infants and young children associated with 
methylmercury exposure during foetal development due to maternal fish consumption during 
pregnancy. FAO/WHO also concluded that there is insufficient evidence (Table 4.1) for 
adverse health effects (e.g. endocrine disruption, immunological and neurodevelopmental 
effects) associated with exposures to dioxins from fish consumption. Among infants and 
young children the available data are insufficient to derive a quantitative risk-benefit 
assessment.  
The conclusions of FAO/WHO are in particular based on the two largest longitudinal studies 
of neurobehavioral development in children carried out in the Seychelles and the Faroe 
Islands in populations consuming fish/seafood. It should be noted that the diet in the Faroe 
Islands includes fish and episodic consumption of marine mammals, in particular pilot 
whales, which constitute the major dietary source to methylmercury. Beneficial effects of fish 
consumption might confound the neurotoxic associations in the Faroese studies, causing 
underestimation of the effects of methylmercury. The Seychelles Child Development Study 
was designed to study the developmental effects of prenatal exposure to methylmercury in a 
fish-eating population. No significant neurobehavioural deficits in children regardless of their 
age were found.  
The Norwegian National Council for Nutrition (2011) came to the same conclusions as 
FAO/WHO (2011) on fish consumption and n-3 fatty acids in fish and neurodevelopmental 
outcomes. 
EFSA (2012a) assessed risk from mercury exposure, and did not assess the nutritional 
benefits linked to certain foods. Neurodevelopmental endpoints are the critical end point for 
methylmercury exposure and unborn children constitute the most vulnerable group (Chapter 
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2.3.1). For methylmercury, new developments in epidemiological studies from the Seychelles 
Child Developmental Study Nutrition Cohort have indicated that n-3 LCPUFAs in fish may 
counteract negative effects from methylmercury exposure. Together with the information 
that beneficial nutrients in fish may have confounded previous adverse outcomes in child 
cohort studies from the Faroe Islands, the Panel established a TWI for methylmercury of 1.3 
μg/kg bw, expressed as mercury. EFSA (2012a) included new follow-up data from the Faroe 
Islands Cohort of the children at the age of 14 years, which indicated that the association 
between prenatal exposure and neurological auditory function was still present at 14 years. 
Furthermore, reassessment of the data at the follow-up at seven years of age indicated that 
beneficial effects of fish consumption together with imprecision in the measurement of fish 
consumption and the determination of mercury in hair might underestimate the effects of 
methylmercury. EFSA (2012a) also referred to reassessments of the 4.5 years results and the 
10.5 and 17 years follow up studies from the Main Cohort in the Seychelles Child 
Development Study, which indicated no consistent association between prenatal mercury 
exposure and neurodevelopmental endpoints. New results from the smaller Nutrition Cohort 
in the Seychelles Child Development Study indicated an association between prenatal 
mercury exposure and decreased scores on neurodevelopmental indices at nine and 30 
months after adjustment for prenatal blood maternal n-3 LCPUFAs. No statistically significant 
associations were found at the five years follow up between prenatal mercury exposure and 
developmental endpoints. A positive association between maternal prenatal n-3 LCPUFAs and 
preschool language was reported from the five years follow up study. 
In 2014, both taking into consideration the above mentioned FAO/WHO Report (FAO/WHO, 
2011) and the EFSA report (EFSA, 2012a), as well as the US Food and Drug Administration 
report from 2014 (FDA, 2014), the EFSA Panel on Dietetic Products, Nutrition and Allergies 
has recently evaluated the beneficial effects of seafood and marine n-3 PUFA during 
pregnancy on functional outcomes of children’s neurodevelopment (EFSA, 2014b). Data from 
observational studies on seafood consumption during pregnancy, intakes of n-3 LCPUFA from 
seafood during pregnancy, observational studies on biomarkers of maternal n-3 LCPUFA 
during pregnancy or at delivery, and also intervention studies with n-3 LCPUFA 
supplementation during pregnancy have been reviewed. They concluded that there are 
significant positive associations between fish/seafood consumption during pregnancy and 
children’s neurodevelopment. These observations were observed for fish/seafood intakes of 
about 1-2 servings per week and up to 3-4 servings per week compared to no seafood 
intakes, and refer to fish/seafood per se, including nutrients (e.g. DHA, iodine) and 
contaminants (such as methylmercury) contained in fish/seafood. There appear to be no 
additional benefit with higher fish consumption. The observed positive health effects of fish 
consumption during pregnancy may depend on maternal status of nutrients (e.g. DHA, 
iodine) that have an important role in neurodevelopment of the foetus, and on the 
independent role of fish/seafood to provide these nutrients. That no evidence is found for an 
effect of DHA supplementation during pregnancy on children’s neuro-developmental 
outcomes support this. The data from the various studies are not easily comparable because 
of differences in neurodevelopmental tests used, testing at different ages, and uncertainties 
and differences in the estimation of fish/seafood consumption. The heterogeneity of the 
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studies thus hampers quantitative risk-benefit analyses of fish consumption and risk of a 
neurodevelopmental outcome. 
In May 2014, US Food and Drug Administration (FDA) published a quantitative assessment of 
the net effects on foetal neurodevelopment of eating commercial fish during pregnancy 
(FDA, 2014). This assessment was a modified and expanded version of the original 
assessment first issued by the FDA in 2009. The modelling in the recent assessment provides 
estimates for the net effects of eating commercial fish on three neurodevelopmental 
endpoints: IQ at nine years of age (the primary modelling), early age verbal development 
through about 18 months of age (secondary modelling), and later age verbal development 
through nine years of age (included for purposes of comparison). The assessment estimates 
that for each of the endpoints modelled, consumption of commercial fish during pregnancy is 
net beneficial for most children in the USA. On a population basis, average 
neurodevelopment in USA is estimated to benefit by nearly 0.7 of an IQ point (95% CI of 
0.39-1.37 IQ points) from maternal consumption of commercial fish. For comparison 
purposes, the average population- level benefit for early age verbal development is 
equivalent in size to 1.02 of an IQ point (95% CI of 0.44-2.01 IQ size equivalence). For a 
sensitive endpoint as estimated by tests of later age verbal development, the average 
population level benefit from fish consumption is estimated to be 1.41 verbal IQ points (0.91, 
2.00). The assessment also estimates that depending on the fish types and amounts of fish, 
fish consumption may give a mean maximum improvement of about three IQ points. Fish 
lower in methylmercury generally give larger benefits than fish higher in methylmercury. The 
size of the adverse net effects are estimated to range from -0.01 of an IQ point (95% CI of -
0.13-0.00) to -0.05 of an IQ point (95% CI of -0.56, 0.00). The net effects modelling for 
both early and later age verbal development do not estimate that adverse net effects are 
likely for these endpoints. However, the confidence intervals do estimate small possibilities of 
faint adverse net effects through at least 10% of children for early age verbal development 
and 25% of children for later age verbal development. These results are at least suggestive 
of adverse effects when fish consumption is not sufficient to outweigh the adverse effects of 
methylmercury. The assessment also modelled 47 individual commercial fish species and 
market types. The results were consistent with the population-level results. Almost all 
species and market types were estimated to become net beneficial at relatively low levels of 
consumption. The beneficial net effect increases with consumption up to about 12 ounces 
per week (approximately 340 g) until a maximum possible benefit around three IQ is 
reached. 
The literature search done (Chapter 4.1) did not reveal relevant studies on fish consumption 
and neurodevelopment.  The only relevant study on fish consumption and neurodevelopment 
found addressed negative confounding by n-3 LCPUFA on the association between 
methylmercury exposure and neurodevelopment in the Faroe Islands and is summarized 
below. 
Choi et al. (2014) assessed the potential impact of negative confounding by DHA and EPA on 
the methylmercury effects on children’s neurobehavioural performance by examining 176 
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Faroese children, in whom prenatal methylmercury exposure was assessed from mercury 
concentrations in cord blood (geometric mean 21.4 ug/L) and maternal hair (geometric 
mean 4.10 ug/g). The relative concentrations of fatty acids were determined in cord serum 
phospholipids (sum DHA and EPA ug/L mean (SD) 9.57 (1.71), and neuropsychological 
performance in verbal, motor, attention, spatial, and memory functions was assessed at 
seven years of age. Multiple regression and structural equation models (SEMs) were carried 
out to determine the confounder-adjusted associations with methylmercury exposure. A 
short delay recall (% change) in the California Verbal Learning test was associated with a 
doubling of cord blood methylmercury (-18.9, 95% CI: -36.3, -1.51). The associations being 
stronger after the inclusion of fatty acid concentrations in the analysis (-22.0, 95% CI: -39.4, 
-4.62). In structural equation models, poorer memory function was associated with a 
doubling of prenatal exposure to methylmercury after the inclusion of fatty acid 
concentrations in the analysis (-1.94, 95% CI:-3.39, -0.49). The authors concluded that 
association between prenatal exposure to methylmercury was associated with deficits in 
school age in domains known to be sensitive to this neurotoxicant, with associations being 
strengthened after fatty acid adjustment. Thus, beneficial effects of fish consumption may 
confound the neurotoxic associations with neurobehavioural performance. 
In the following, systematic reviews and meta-analyses, and some relevant cohort studies of 
fish consumption and marine n-3 fatty acids from dietary fish consumption and various CNS 
outcomes published later than 2009, are briefly described. 
 Cognition 4.3.2
In a randomised control trial in schoolchildren (seven to nine years) from the northern Cape 
Province of South-Africa, Dalton et al. (2009) investigated the effect of an experimental fish-
flour bread spread rich in n-3 long-chain fatty acids, on cognition. The children were 
randomly assigned to an experimental (n=91) and control group (n=92), receiving either the 
fish flour spread or a placebo spread for 6 months in a single–blind study. Short dietary 
questionaire revealed no intake of fatty fish and a very low intake of lean fish in this 
community. Plasma and red blood cell phospholipid fatty acid composition and cognition 
(Hopkins Verbal Learning Test Recognition, Discrimination Index and Spelling test) were 
measured at baseline and post-intervention. After the intervention EPA and DHA levels were 
significantly higher in the experimental group compared to the control group (p<0.0001). 
Significant effects on cognition outcomes were also observed for the Hopkins Verbal Learning 
Test Recognition (estimated effect size: 0.80; 95% CI: 0.15, 1.45) and Discrimination Index 
(estimated effect size: 1.10; 95% CI: 0.30, 1.91), as well as the Spelling test (estimated 
effect size: 2.81; 95% CI: 0.59, 5.02 by both per protocol and intention to treat analyses. A 
tendency to improvement was observed for the Reading test. The authors suggest that 
children when supplemented with a fish-flour spread rich in n-3 long-chain fatty acids have 
improved verbal learning and memory. 
In a longitudinal cohort study, Aberg et al. (2009) evaluated fish consumption related to later 
cognitive performance in healthy young male adolescents (15-year-olds). In 2000, all 15-
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year-olds in the western region of Sweden were requested to complete an extensive 
questionnaire with items on diseases, fish consumption and socioeconomic status. 
Questionnaire data from the male responders (n=4792, response rate 52%) were linked with 
records on subsequent intelligence test performance at age 18 from the Swedish Military 
Conscription Register (n=3972). Multivariate linear models were used to estimate 
associations between fish intake and cognitive performance, adjusting for potential 
confounders. They observed a positive association between the number of times having fish 
meals per week at age 15 and cognitive performance measured three years later. Fish 
consumption of more than once per week compared to less than once per week was 
associated with higher stanine scores (method of scaling test scores on a nine-point standard 
scale with a mean of five and a standard deviation of two) in combined intelligence (0.58 
units; 95% confidence interval 0.39, 0.76), in verbal performance (0.45; 0.27, 0.63) and in 
visuospatial performance (0.50; 0.31, 0.69). The association between fish consumption and 
the three intelligence scores was the same in lowly and highly educated groups. This 
indicates that education did not influence the association between the frequency of fish 
meals consumed and cognitive performance. The authors concluded that frequent fish intake 
at age 15 was associated with significantly higher cognitive performance three years later. 
Kim et al. (2010) studied the associations between fish intake and academic achievement 
as cognitive parameters among Swedish school children (n= 18158), aged 15 years. In 2010 
a questionnaire including respiratory items, socioeconomic conditions and dietary information 
was mailed to the school children. One year later, the total school grades for each individual 
who had completed the questionnaire (n=10837), and who included their full identification 
number were obtained from national registers (n=9448; 49.5% boys, 11.7% of foreign 
descent). Multiple linear regression models were used and adjustments for confounders 
applied. When grades of subjects in the highest category of fish consumption were 
compared with grades of subjects with fish consumption of less than once a week (reference 
group) the total mean score was 225.5 vs. 196.6 (p<0.001). Compared with the reference 
group grades were higher in subjects with fish consumption once a week (increment in 
estimate 14.5; 95% CI: 118, 17.1), and even higher in subjects with fish consumption more 
than once a week (increment in estimate 19.9; 95% CI: 16.5, 23.3). There were strong 
association between parents’ education and school children’s grades. In the model stratified 
for parents education, there were still higher grades among school children with frequent 
fish intake in all educational strata (p>0.01). The authors concluded that frequent fish intake 
among school children may provide benefits of academic achievement. 
 Cognitive decline (dementia, Alzheimer's disease) 4.3.3
Fotuhi et al. (2009) performed a systematic review of the literature (MEDLINE and Cochrane 
database from January 1980 to September 2008) to determine the strength of evidence for 
the use of fish consumption and n-3 fatty acids in relation to cognitive impairment and 
dementia, including Alzheimer’s disease (AD). They identified 11 observational studies 
and four small randomised clinical trials on the association between n-3 fatty acids (either in 
the diet or in the form of supplements) and cognition, dementia, mild cognitive impairment 
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or AD. Three observational studies (total n= 4174, age 63-89 years) that used cognitive 
decline as outcome reported significant benefits, while only four out of eight observational 
studies (total n=18720, age 55-88 years) that used incidence of AD or dementia as outcome 
reported positive findings. None of the clinical trials (total n=535) provided convincing 
evidence for the use of n-3 fatty acids in the prevention of or treatment of any form of 
dementia. The authors conclude that the systematic review of observational studies suggests 
that long-chain n-3 fatty acids provide a modest benefit with regard to slowing cognitive 
decline among elderly individuals without dementia. By contrast, clinical trials have failed to 
detect any beneficial role of the use of EPA, DHA or other forms of n-3 fatty acids for 
secondary prevention or treatment of AD.  
Cederholm and Palmblad (2010) have reviewed recent data (13 recent observational studies, 
seven using biochemical indicators and six using dietary recalls for assessment of n-3 levels, 
three randomised intervention studies with duration up to 6 months, and several 
experimental studies) on the potential role of n-3 fatty acids found in oily fish, especially 
DHA, to prevent and treat cognitive decline and Alzheimer’s disease. Observational 
studies provide conflicting results, however the majority of results indicate beneficial effects 
on cognition both when assessed as a continuous variable or as incident dementia, mainly 
Alzheimer`s disease. Experimental studies suggest that n-3 fatty acids play a role in primary 
prevention of cognitive decline by improving blood flow, decreasing inflammation and/or 
reducing amyloid-β pathology. No positive overall effects were reported from the 
intervention studies. The authors conclude that no firm conclusions can be drawn. 
Huang (2010) did a critical review and evaluation of the literature regarding omega-3 fatty 
acids, cognitive decline, and Alzheimer’s disease (AD). He used Ovid Medline 
databases and restricted his search to include only human studies written in English. 
Furthermore, for each original and review paper found, references were searched for 
additional relevant papers. Nine studies that examined cross sectional relationships between 
either plasma, erythrocytes, dietary fatty acids, or fish and dementia, AD, or cognitive 
functioning, 27 relevant prospective studies and eight relevant clinical trials were identified. 
While cross sectional studies imply that n-3 fatty acids might be protective against cognitive 
decline and AD (five of six studies found a relationship between n-3 fatty acids measured in 
blood or plasma and cognitive decline, with better outcomes associated with higher total n-3 
fatty acids or DHA, all three studies that examined fish oil or DHA intake found it to be 
associated with better scores on cognitive tests, and all three studies that examined fish 
intake showed a positive association between fish consumption and cognitive scores), it is 
also likely that one’s diet could change as a result of cognitive impairment. An additional 
study examining 14960 residents across seven countries found that the relationship between 
fish consumption and prevalence of dementia differed between countries suggesting that fish 
is protective under a particular set of circumstances, but that it depends on a variety of 
factors not yet accounted for. With longitudinal studies, findings with fish intake have been 
more consistently seen as protective. This may be because fish intake is easier to measure 
than n-3 fatty acids from multiple sources, or there may be important nutrients in fish that 
are fundamental to optimal absorption and use of DHA and/or EPA. Ten of eleven studies 
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examining fish intake, found significant or non-significant protective effect associated with 
dementia, AD, or cognitive decline; in seven studies a minimum of one to two fish meals per 
week were required to show an effect; in five studies there was a dose-responsive decline in 
risk with increasing consumption. No definite conclusion can be made from the clinical trials 
were supplementation was done with one or a mixture of n-3 fatty acids. The variability in 
outcomes between human studies which are confounded by methodological differences, 
make it difficult for conclusions to be drawn. The author concluded that even though there is 
strong evidence from animal studies that n-3 fatty acids and particularly DHA is protective 
against cognitive decline, AD, and its underlying neuropathology via a variety of different 
mechanisms of action, results across the literature in humans (from epidemiological studies, 
studies of post-mortem n-3 fatty acids in the brain, and clinical trials) are inconsistent and 
thus difficult to interpret. 
Danthiir et al. (2014) examined associations between multiple domains of cognition and 
erythrocyte membrane n-3 PUFA proportions and historical and contemporary fish 
intake in 390 normal older adults, analysing baseline data from the Older People, omega-3, 
and Cognitive Health Trials in Australia. They found no evidence of a beneficial effect of 
increased long-chain n-3 fatty acid concentrations or fish intake on baseline cognitive 
performance in cognitively normal older adults. 
 Depressive episodes and psychological distress 4.3.4
Suominen-Taipale et al. (2010) did a cross-sectional analysis to evaluate whether higher fish 
consumption and n-3 fatty acids intake are associated with lower 12-month prevalence of 
depressive episodes in the Finnish adult population and in a Finish population with high 
fish consumption. Two cross-sectional data sets gathered in Finland were used; the 
nationwide HEALTH 2000 Survey (n=5492) and the Fisherman Study on Finnish professional 
fishermen and their family members (n= 1265). Data were based on questionnaires, 
interviews, health examinations, and blood samples. The Munich version of the Composite 
International Diagnostic Interview (M-CIDI) and a self- report of two CIDI probe questions 
were used to assess depressive episodes. Fish consumption was obtained from a food 
frequency questionnaire (g/day) and independent frequency questions (times per month). 
Dietary intake (g/day) and serum concentrations (% from fatty acids) of PUFAs were 
determined. Fish consumption was associated with decreased prevalence of depressive 
episodes in men. In the women, no consistent associations between fish consumption and 
age-adjusted prevalence of depressive episodes were found. The prevalence of depressive 
episodes decreased from 9% to 5% across the quartiles of fish consumption (g/day) in men 
of the Health 2000 Survey (p for linear trend =0.01), from 17% to 3% across the quartiles 
of fish consumption (times per month) in men of the fishermen Study (p for linear trend 
=0.05). The association was modified by lifestyle. The authors concluded that for men but 
not women, the results give some support to the hypothesis that high fish consumption 
protects against depression. However, since there were no associations between n-3 PUFAs 
and the occurrence of depressive episodes, they suggest that the beneficial effect in men 
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may be associated with other nutritional compounds in fish, and complex associations 
between depression and lifestyle may also play a role. 
Suominen-Taipale et al. (2010) utilised three distinct cross-sectional data sets; the Health 
2000 survey (carried out in 2000/2001, n=8208, participants aged 30 years or more) 
representing the general population of Finland; the Fishermen Study (Finnish fishermen and 
their family members, n= 1282) representing a population with high fish consumption, and 
the Finntwin16 Study (young adults, n= 4986) representing young adults, to assess whether 
high fish consumption and n-3 PUFA intake was associated with reduced self-reported 
psychological distress, as measured by the General Health Questionnaire (GHQ). Data 
were based on self-administered questionnaires, interviews, health examinations and blood 
samples. Psychological distress was measured using the 12-item and 21-item GHQs. Fish 
consumption was obtained from a food frequency questionnaire (g/day) and independent 
frequency questions (times per month). Dietary intake (g/day) and serum concentrations (% 
from fatty acids) of PUFAs were determined. Relations were analysed by regression analysis. 
No associations were found between fish consumption and n-3 PUFA dietary intake and 
psychological distress regardless of measure in any of the data sets. The authors concluded 
that the results do not support the hypothesis that fish consumption or n-3 PUFA intake are 
beneficial for psychological distress in the general population or in a population with high fish 
consumption.   
4.4 Fish consumption and cancer 
Based on experimental animal data it is biologically plausible that n3-PUFA in fish protect 
against various types of cancer, however, the data from epidemiological studies are not 
clear. In 2006 VKM summarised data on breast cancer, colorectal cancer, prostate cancer 
and thyroid cancer and concluded that fish consumption shows no reliable correlation with 
the development of cancer.  
(WCRF, 2007) concluded that there is limited – suggestive evidence that fish and also food 
containing vitamin D protect against colorectal cancer. They also concluded that there is 
probable increased risk of cancer in nasopharynx with consumption of Cantonese-style salted 
fish. The results from WCRF was referred to by the Norwegian Directorate of Health, they 
regarded Cantonese-style salted fish as not relevant for Norway (Norwegian National Council 
for Nutrition, 2011). 
From the literature search, 20 papers addressing fish consumption and cancer were selected 
for review in full-text. Of these, 14 reviews and meta-analyses have been briefly summarised 
below. In addition, a meta-study on colorectal cancer was published in 2007 (Geelen et al., 
2007). This study, along with a Norwegian study published in 2007 (Engeset et al., 2007), 
was included in the WCRF report in 2007. 
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 Breast cancer 4.4.1
Zheng and Li (2013) reported a meta-analysis of data from 21 independent prospective 
cohort studies. Their search in PubMed and Embase covered the time up to December 2012. 
The eligibility criteria were prospective studies reporting RR and 95% CI according to fish 
intake, n-3 PUFA intake, or tissue biomarkers, resulting in 20905 cases of breast cancer and 
in total 883585 participants from the United States, Europe and Asia. Quality assessment 
was conducted according to Newcastle-Ottawa criteria for non-randomised studies.  
The associations between breast cancer risk and fish consumption and breast cancer risk 
and consumption of marine n-3 PUFA were reported separately. Combined results from 11 
studies from 11 independent cohorts, comparing lowest and highest n-tile of fish 
consumption in each study (13323 breast cancer events, 687770 participants) on association 
between fish consumption and breast cancer risk, did not show association (RR=1.03; 95% 
CI: 0.93, 1.14). The study heterogeneity was reported as moderate, but no publication bias 
was observed. No dose – response was observed by 15 g/day increment of fish 
consumption.  
The analysis of marine n-3 PUFA consumption and risk of breast cancer involved 17 papers 
on 16 independent cohorts (16178 breast cancer events, 527392 participants). Marine n-3 
PUFA intake was inversely associated with risk (RR=0.86; 95% CI: 0.78, 0.94). Dose-
response analysis indicated 5% reduction in risk with 0.1g/day or 0.1% energy increment of 
daily marine n-3 PUFA intake from fish. No study heterogeneity was observed. The 
association was present in both western and Asian countries, but was most prominent in 
Asian countries, where fish consumption was higher than in Europe and the USA.  
The authors concluded that their results provide solid and robust evidence that increased 
intake of marine n-3 PUFA from fish resulted in reduced risk of breast cancer, and that the 
protective effects of fish warrants further investigation in prospective studies. 
 Prostate cancer 4.4.2
Szymanski et al. (2010) conducted a review and meta-analysis of cohort and case-control 
studies on fish intake and prostate cancer (incidence and prostate cancer-specific 
mortality, including cancer grade and stage). Their literature search covered Medline and 
Embase up to May 2009. The results showed no significant association between prostate 
cancer incidence and fish consumption when comparing lowest and highest quantile of fish 
consumption. The conclusion was based on 12 case-control studies (5777 cases and 9805 
controls, odds ratio (OR)=0.85 (95% CI 0.72, 1.00) and 12 cohort studies (445820 
participants, 13 924 prostate cancers, RR=1.01 (95% CI 0.90, 1.14). There was significant 
heterogeneity between the case-control studies, but not between the cohort studies after 
exclusion of one paper. There was no indication of publication bias. Based on results from 
four cohort studies they found a significant association between fish consumption and 
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reduction in prostate cancer specific mortality (49661 men, 740 fatal prostate cancers, 
RR=0.37 (95% CI 0.18, 0.74).  
The authors concluded that their analyses of observational studies provided little evidence of 
a protective association of fish consumption with prostate cancer incidence, and that 
additional studies on aggressive and fatal disease are needed. 
 Gastrointestinal cancer 4.4.3
In a systematic review and meta-analysis, Han et al. (2013) addressed fish consumption and 
risk of different types of cancers in the oesophagus. Based on 21 case-control and three 
cohort studies included (6677 cases) identified by search in Medline or Embase up to May 
2012, the RR for squamous cell carcinoma was 0.81 (95% CI: 0.66, 0.99) with significant 
study heterogeneity, and for adenocarcinoma 0.86 (95% CI: 0.61, 1.22). The authors 
concluded that fish consumption is not appreciably related to risk of squamous cell 
carcinoma or adenocarcinoma in the oesophagus.  
Salehi et al. (2013) conducted a systematic review and dose-response meta-analysis of 
associations between oesophageal cancer risk and consumption of meat and fish in 
published studies (1990-2011 in Medline, Embase and Web of Knowledge) using MOOSE 
guidelines (5689 cases). Data from the 17 studies reviewed suggest there is a modest 
inverse association between fish consumption and EC risk (RR for highest vs lowest intake 
was 0.80; 95% CI: 0.64, 1.00), but there was considerable heterogeneity among the studies. 
The authors concluded that the results suggest that low levels of red and processed meat 
consumption and higher levels of fish intake might reduce oesophagus cancer risk. 
Wu et al. (2011) gave a systematic review and meta-analysis of association between fish 
consumption and gastric cancer risk covered the available literature in PubMed up to 
January 2009, and selected 15 case-control studies and two prospective cohorts. No 
statistically significant association was seen (5323 cases, more than 130000 non-cases, 
RR=0.87; 95% CI: 0.71, 1.07). 
As mentioned above, the World Cancer Research Fund (WCRF) concluded in 2007 that there 
is limited – suggestive evidence (Table 4-1) that fish and also food containing vitamin D 
protect against colorectal cancer. This included a meta-analysis of seven cohort studies, 
giving a summary effect estimate of 0.96 (95% CI: 0.92 – 1.00). In their report it was noted 
that additional cohort studies were published after the analyses were conducted, but this did 
not change their overall judgement. Geelen et al. (2007), within the framework of the WCRF 
report in 2007, conducted a meta-analysis of prospective cohort studies published up to 
January 2006, addressing association between fish consumption, or n-3 fatty acids and 
colorectal cancer incidence and mortality. The pooled RR for colorectal cancer incidence 
(4559 cases of colorectal cancer) was 0.88 (95% CI 0.78 – 1.00) and for mortality 1.02 
(95% CI 0.92 – 1.03).  
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Huxley et al. (2009) updated previous meta-analyses (including Geelen et al. (2007), see 
above) and gave a quantitative overview of the relationship between different lifestyle 
factors (alcohol, diabetes, red meat, processed meat, obesity, smoking, physical activity, 
fruits, vegetables, fish and poultry) and the risk of colorectal cancer. They included in total 
103 cohort studies published between 1966 and January 2008 (Embase and Medline). They 
concluded with no apparent association between risk of colorectal cancer and consumption 
of fish (5317 cases on colorectal cancer, RR=0.93; 95% CI: 0.84, 1.04). (Engeset et al., 
2007) reported no significant association in the Norwegian Women and Cancer study, which 
was included in the meta-analysis with 63914 women, of which 254 cases of colon cancer.  
Randi et al. (2010) summarised papers addressing dietary patterns and the risk of 
colorectal cancer, and found that favourable dietary patterns for reducing cancer risk were 
mainly characterised by high consumption of fruits and vegetables, fish and poultry, and 
whole grains. It is possible that this is a result from fish replacing meat as a dietary protein 
source (Chan and Giovannucci, 2010). The association between red meat consumption and 
colorectal cancer is according to WCRF convincing (WCRF, 2007). 
Xu et al. (2013) analysed colorectal risk with intake of white meat (poultry and fish) intake. 
The meta-analysis of 11 observational studies (case-controls and cohorts) for the high versus 
low consumption analysis of colorectal adenoma risk with fish intake gave an effect size 
estimate of 0.98 (95% CI 0.80-1.19) with low heterogeneity across studies (Xu et al., 2013). 
The authors concluded that fish consumption is not associated with colorectal adenoma risk. 
Wu et al. (2012b) concluded that the results from their meta-analysis of fish consumption 
and colorectal cancer risk suggest that fish consumption is associated with lower risk of 
colorectal cancer. The study included relevant studies (22 cohorts and 19 case-control 
studies) identified by Medline and Embase up to May 2011. The pooled OR of colorectal 
cancer for the highest vs lowest fish consumption was 0.83 (95% CI 0.72-0.95) in case-
control studies (with significant heterogeneity) and 0.93 (95% CI 0.86-1.01) in cohort 
studies. 
 Other cancers 4.4.4
Li et al. (2011) performed a meta-analysis including five cohorts and nine case-control 
studies on the association of fish consumption with urinary bladder cancer (including 
ureter and renal pelvis). The authors reported no significant decreased risk of these cancers 
(relative risk 0.86; 95% CI: 0.61, 1.12) with increased fish consumption. There was 
significant heterogeneity across the studies, and this could not be explained by study design, 
geographical region or method of exposure assessment. 
Bai et al. (2013) conducted a meta-analysis of fish consumption and renal cancer, including 
12 case-control studies and three cohort studies conducted between 1990 and 2011 (9324 
cases, 608753 participants). The authors followed the PRISMA (preferred reporting items for 
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systematic reviews and meta-analyses) and MOOSE (meta-analysis of observational studies 
in epidemiology) guidelines. They found no association (RR=0.99; 95% CI: 0.92, 1.07).  
Qin et al. (2012) found no association between fish consumption or LCPUFA intake and 
pancreatic cancer risk in a meta-analysis and systematic review. The paper included nine 
cohorts (n=1209265, 3082 cancer events) and 10 case-control studies (2514 cases and 
18779 controls), and covered papers identified by PubMed and Embase up to February 2012.  
Kolahdooz et al. (2010) concluded in a study on meat and fish consumption and ovarian 
cancer risk that low consumption of processed meat and higher consumption of poultry and 
fish may reduce the risk. The review and meta-analysis included eight studies on fish 
consumption with a pooled RR of 0.84 (95% CI 0.68-1.03). The papers were extracted with 
Medline and Embase up to November 2009 and the meta-analysis was conducted according 
to MOOSE guidelines. 
Hosnijeh et al. (2014) investigated dietary intakes and risk of leukaemia (lymphoid and 
myeloid) in the EPIC cohort (n=477325, which includes 35170 women from Norway). During 
a mean follow up time of 11 years, 34773 leukaemia cases were identified. There were no 
significant associations between fish consumption and risk of leukaemia.  
 Contaminants in fish and cancer 4.4.5
Evidence based on occupational or accidental exposures at high doses and experimental 
animal studies show that dioxins can cause a variety of adverse health effects, including 
cancer. No studies specifically addressing contaminants in fish and cancer development were 
identified by the literature search.  
The report of the joint FAO/WHO expert consultation on the risks and benefits of fish 
consumption concluded that there is insufficient evidence (Table 4.1) for adverse health 
effects (e.g. endocrine disruption, immunological and neurodevelopmental effects, cancer) 
associated with exposure to dioxins from fish consumption (FAO/WHO, 2011). However, 
epidemiological studies show that dioxins are carcinogenic at much higher exposure levels 
than obtained by dietary exposure from fish consumption. The WHO expert consultation 
concluded that potential cancer risks associated with dioxins are well below established 
coronary heart disease benefits from fish consumption. 
4.5 Fish consumption and type-2 diabetes and metabolic outcomes 
Association between fish consumption and type-2 diabetes or other metabolic outcomes 
were not addressed in the VKM benefit-risk assessment of fish consumption in 2006. In 2012 
the Norwegian Directorate of Health did not directly address associations between fish 
consumption and type-2 diabetes, but referred to reports from WHO on protective 
associations between intake of marine n-3 PUFA and type-2 diabetes (WHO, 2003), and a 
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large prospective cohort study (Djousse et al., 2011) indicating increased risk of type-2 
diabetes with increased intake of marine n-3PUFA.  
From the literature search conducted by VKM, 14 papers addressing fish consumption and 
type-2 diabetes were selected for review in full-text. Seven of these are referred to in the 
summary below of more recent papers on fish consumption and risk of type-2 diabetes or 
other metabolic outcomes. The reviews and meta-analyses included the study by Djousse et 
al. (2011) mentioned above. 
 Type-2 diabetes mellitus 4.5.1
We identified six recent meta-analyses addressing fish consumption and incidence of type-2 
diabetes mellitus (T2DM), all restricted to prospective cohort studies (Wallin et al., 2012; 
Wu et al., 2012a; Xun and He, 2012; Zheng et al., 2012b; Zhou et al., 2012; Zhang et al., 
2013). Zhang included studies to May 2013, whereas the other five included studies up to 
January – December 2011. Although these meta-analyses comprised over-lapping (but not 
identical) studies, their overall conclusions were partly conflicting. 
Wu et al. (2012a) covered 16 prospective studies (18 separate cohorts, 540184 participants, 
of them 25670 cases) addressing relations of dietary n-3 PUFA, dietary fish and/or seafood, 
and n-3 PUFA biomarkers in humans with incidence of T2DM. Quality of included studies was 
assessed by predefined criteria. The study showed that consumption of fish and/or seafood 
was not associated with DM (n=13 studies, RR per 100g/day: 1.12; 95% CI: 0.94, 1.34). 
Substantial heterogeneity among studies was however observed. Study location (Asia vs 
North America/Europe), mean BMI and duration of follow-up modified the association 
between fish/seafood consumption and T2DM risk. Lower risk was seen in studies from Asia, 
in studies with lower mean BMI (less than 24.5 kg/m2), and in studies with shorter durations 
of follow up (less than 10 years). However, the independent effects of these factors could 
not be determined due to limited statistical power and high colinearity, and the authors 
concluded that the reasons for this (true biological heterogeneity, publication bias or chance) 
deserve further investigation. 
Wallin et al. (2012) included 13 studies addressing total and/or oily fish consumption and 
three addressing only fatty acids (in total 527441 participants, 24082 diabetes cases) and 
found large heterogeneity between different continents (Europe, Asia/Australia, USA). 
Therefore, results across all studies were not combined into an overall summary risk 
estimate. They concluded that the risk of T2DM is not significantly associated with one 
serving per week increment of total fish consumption in Europe, but found an increased RR 
in the US, and reduced risk in Asia/Australia. Studies were however also partly inconsistent 
within study areas.  
Xun and He (2012), in the same issue of Diabetes Care as the paper by Wallin et al. (2012), 
reported  based on nine studies on fish consumption, including 438214 individuals, that they 
found no support for an overall inverse association between fish consumption and incidence 
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of T2DM (RR=0.99; 95% CI: 0.85, 1.16). In agreement with Wallin et al. (2012), they 
reported geographical heterogeneity. The divergent associations observed by Wallin et al. 
(2012) and Xun and He (2012) were also discussed in a commentary in the same issue of 
Diabetes Care Wylie-Rosett et al. (2012).  
Zheng et al. (2012b) searched Chinese databases in addition to PubMed, EmBase, and 
Cochrane library for prospective studies on fish/seafood/n-3 PUFA exposure and incidence of 
T2DM, and results were reported according to PRISMA guidelines. Of the included 24 
studies, seven reported association between fish intake and T2DM risk, 10 studies reported 
associations with n-3 PUFA intake and T2DM risk, and five studies reported both fish intake 
and n-3 PUFA intake in association with T2DM risk. The authors reported no association 
between total fish intake (highest vs lowest category, RR=1.07; 95% CI: 0.91, 1.25) or n-3 
PUFA intake (RR 1.07, 95%CI 0.95 - 1.20) and risk of T2DM. Stratification into lean fish, oily 
fish and shellfish intake did not modify the conclusion. They observed high degree of 
heterogeneity, and subgroup analysis indicated reduced risk of T2DM with increased fish 
consumption and n-3 PUFA intake in Asian populations.  
Zhou et al. (2012) included 10 papers on 13 cohorts in a meta-analysis. The study quality 
was assessed using the nine star Newcastle-Ottawa scale, and all included studies ranged 
from six to seven stars. In the highest versus lowest category analyses, the pooled RR of 
type-2 diabetes for intake of fish was 1.146 (95% CI 0.975 - 1.346, involving 367757 
subjects) and for intake of n-3 fatty acids 1.076 (95% CI 0.955 - 1.213, involving 506665 
subjects). Based on statistically significant linear dose-response trends for fish intake 
(involving three publications, five cohort studies) and n-3 fatty acids (involving four papers, 
six cohort studies) the authors concluded that higher fish consumption (nine cohorts, 367757 
subjects) might be associated with a weak increase in T2DM risk), These authors also 
reported substantial between-study heterogeneity, but did not address geographical 
heterogeneity.  
Zhang et al. (2013), the most recent meta-analysis, found no significant effect of 
fish/seafood (10 studies, 549955 participants, pooled RR=1.04; 95% CI: 0.9, 1.2) or marine 
n-3 LCPUFA intake (six studies, 346710 participants, pooled RR=1.08; 95% CI: 0.9, 1.3) on 
risk of T2DM, but observed a significant protective effect of oily fish intake (four studies, 
pooled RR=0.89; 95% CI: 0.82, 0.96). They also observed significant study heterogeneity 
with no obvious sources.  
Of notice, all the above mentioned meta-analyses concluded that further investigation is 
warranted.  
Patel et al. (2012) reported that results from the EPIC-InterAct Study, addressing fish 
consumption and T2DM in eight European countries (not Norway), showed a weak inverse 
association with oily fish consumption, and no association with lean fish, shell fish or total 
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Rylander et al. (2014) published recently results from a prospective study on T2DM risk in 
33740 participants in the Norwegian women and cancer study (NOWAC), and this study is 
not included in any of the meta-analyses above. The participants (mainly residing in the 
north and west of Norway) had no self-reported T2DM or history of stroke, angina or heart 
attack at inclusion in 1996-1998, when the mean age was 47.9 years. At follow up 6-9 years 
later, 479 participants reported diabetes. The overall prevalence was 2.6%, and the age-
adjusted incidence rate per person years was 2.41 (95% CI 2.20-2.63). Mean intake of total 
fish was 93 g/day, dominated by fish products (mean 37 g/day) and lean fish (mean 29 
g/day). Mean oily fish intake was 15 g/day. After confounder adjustment they found that 
lean fish consumption was inversely associated with T2DM compared to zero intakes and the 
decreased risk was dose-related. The rate ratio (RR) (95% CI) for 75 g lean fish/day was 
0.71 (0.51-0.98). Although the RR for intake of total fish, oily fish and fish products was less 
than 1, it had no statistical significant effect on T2DM. The authors stressed that it was 
unclear whether lean fish in itself had a protective effect on T2DM, or that lean fish 
consumers have a protective life style that could not be taken into account in the study. 
However, unfavourable effects of fatty fish consumption or cod liver oil were not observed. 
 Overweight and metabolic syndrome 4.5.2
Jakobsen et al. (2013) investigated the associations between fish consumption and 
subsequent change in body weight among participants in the EPIC study (n=344757, 
including 10 European countries, among them Norway) that were followed for a median of 
five years and concluded that fish consumption (total and lean or fatty fish separated) has 
no appreciable association with body weight gain. In line with this, a previous publication 
from the EPIC study (n=89432, from five European countries, not including Norway, 
(Jakobsen et al., 2012) concluded that fish consumption did not prevent increase in waist 
circumference. A small study (n=109) on healthy adolescent Danish girls and boys reported 
positive association between red blood cell DHA concentration (an indicator of n-3 LCPUFA 
intake) and blood pressure and plasma insulin, which was contrary to what was expected 
(Lauritzen et al., 2012).  
 Contaminants in fish and type-2 diabetes and other metabolic 4.5.3
outcomes 
The literature search described in Chapter 4.1 identified no studies addressing fish 
consumption in relation to contaminant exposure from fish and association with type-2 
diabetes and other metabolic outcomes. A workshop in 2011 on role of environmental 
chemicals in the development of diabetes and obesity which was organised by the US 
National Toxicology Program concluded that there is support for positive associations 
between type-2 diabetes and certain chlorinated POPs (Taylor et al., 2013). 
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4.6 Fish consumption and asthma, allergy and other atopic 
diseases 
Association between fish consumption and allergic/atopic diseases was not addressed in the 
VKM benefit-risk assessment of fish consumption in 2006. Allergy to fish was discussed by 
VKM in 2006. Results in a report from the National Register of Severe Allergic Reactions to 
Food in 2011 show that reactions to fish are rare in the period from 2000 to 2010 (Namork 
et al., 2011). Allergies to different fish species are not further addressed in this report.  
Studies addressing associations between fish consumption and asthma, allergy in general 
and other atopic diseases are summarized below. 
Three meta-analyses addressing fish consumption and allergic/atopic diseases were 
identified by the literature search (Chapter 4.1.1).  
Kremmyda et al. (2011) systematically reviewed atopy risk in infant and children in relation 
to early life exposure to fish. The search strategy and inclusion/exclusion criteria were not 
described in the paper, and the review did not address strength and weaknesses of the 
studies included. All five epidemiological studies (three prospective cohorts with total n= 
4315, one retrospective cohort with n=998, and one case-control study with 279 cases and 
412 controls) investigating maternal fish consumption during pregnancy concluded with 
protective associations with the investigated outcomes (asthma, atopy, eczema, IgE, skin 
prick test, hay-fever). Regarding fish consumption in childhood and different atopic 
outcomes (skin prick test, asthma, wheeze, persistent cough, allergic rhinitis, hay fever, 
eczema allergic dermatitis, IgE, food allergy) the review included 14 studies with different 
study design (prospective cohorts, retrospective case-control, case-controls, cross sectional). 
Nine of 14 studies reported that fish consumption was protective against atopic outcomes in 
infants/children. Three studies did not observe associations, and two studies showed 
increased risk of atopy with higher fish consumption. The review concluded that the 
evidence is inconsistent, although a number of studies would support a protective effect of 
fish consumption.  
Hooper et al. (2010) used a meta-analytic approach to identify dietary patterns common to 
different European countries in relation to current asthma, asthma symptoms and 
bronchial responsiveness. Two patterns emerged, one associated with intake of meats 
and potatoes, the other with fish, fruit and vegetables. There was no evidence that any of 
these patterns were related with the outcomes. 
Yang et al. (2013) performed a systematic review and meta-analysis of prospective cohort 
studies up to December 2012 on fish intake in relation to risk of asthma. Based on three 
studies on infant fish consumption (total n=9212, of them 471 cases) the meta-analysis 
concluded with a protective association with fish consumption (RR=0.75; 95% CI: 0.61, 
0.94). Two of the studies were from Norway (Nafstad et al., 2003; Oien et al., 2010) and the 
third from Sweden (Kull et al., 2006). Regarding two cohort studies on adult fish 
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consumption (total n=4687, of them 551 cases), no association was seen (RR=0.75; 95% 
CI: 0.69, 1.18) in the meta-analysis. The studies on maternal fish consumption and risk of 
asthma in offspring could not be pooled, but none of the two included studies indicated 
significant associations. 
Some additional studies have been published after the above-mentioned reviews and meta-
analysis. 
Magnusson et al. (2013) recently published a 12 years follow up study of children in the 
Swedish BAMSE study (results in 4-year-olds presented in (Kull et al., 2004), and included in 
(Yang et al., 2013)). Their main finding was that children who consumed fish at 1 year had a 
dose-dependent overall reduced risk of prevalent asthma, rhinitis and eczema up to age 
12 years. Adjusting for fish intake at age eight years did not change the results, and fish 
consumption at eight years was not associated with allergic disease at 12 years. In order to 
avoid influence of disease-related modification of exposure, since early onset of allergic 
disease delayed the introduction of fish in the child’s diet, the analyses were also restricted 
to children without symptoms of allergy the first year of life. The associations were then 
attenuated, but still present, for rhinitis (OR=0.63; 95% CI: 0.46, 0.87, p-trend<0.001) and 
eczema (OR= 0.74; 95%CI: 0.52, 1.03, p-trend 0.008), but not for asthma (OR= 0.81, 
95%CI: 0.48, 1.37, p-trend 0.303). The BAMSE study included 4089 newborns, and the 
blood samples from 2470 children (60%) were analysed for different IgE antibodies at 12 
years of age. 
Maslova et al. (2013) addressed maternal fish consumption and the risk of asthma and 
child rhinitis (doctor diagnosis reported by the parents) at 18 months and seven years in 
the Danish National Birth Cohort (n=28936). Mothers taking fish oil during the pregnancy 
were excluded. Never eating fish was associated with a higher risk of reported asthma at 18 
months (n approximately 22000, OR= 1.30; 95%CI: 1.05, 1.63), but not with recurrent 
wheeze or allergic rhinitis. At seven years (n approximately 17000), high versus no maternal 
fish consumption during pregnancy was protective against early and ever asthma, but not 
against rhinitis. When early childhood fish intake, which was only modestly associated with 
maternal fish intake, was included in the analyses there was a slight attenuation of the effect 
estimates, but this did not alter the conclusion.  
 Contaminants in fish and asthma/allergy/atopy  4.6.1
The literature search described in Chapter 4.1 did not identify any studies addressing fish 
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4.7 Fish consumption and pregnancy related outcomes; other than 
neurodevelopment 
VKM (2006) concluded that no negative effects of various nutrients and contaminants on 
growth and development of the foetus and infants were found after the use of n-3 fatty 
acids as a food supplement during pregnancy or as an addition to breastmilk during the post 
natal period. The increased intake of n-3 fatty acids seems to exercise a positive effect on 
the visual function of premature babies.  
The benefit-risk assessment of VKM from 2006 did not address birth size and other 
pregnancy related outcomes. However, the literature search described in Chapter 4.1 
identified studies from Norway that are relevant in the present report and these are 
summarised below.  
 Birth size 4.7.1
Leventakou et al. (2014) concluded that in a study with pooled and harmonised individual 
data from 19 European birth cohort studies (n=15188 mother-child pairs), moderate fish 
intake (fish consumption more than one but less than three times per week) during 
pregnancy is associated with lower risk of preterm birth (RR=0.87; 95% CI: 0.82, 0.92) and 
a small, but significant increase in birth weight (8.9 g; 95% CI: 3.3, 14.6 g). Women with 
more frequent fish consumption (more than three times per week) gave birth to children 
with higher weight (15.2 g; 95% CI: 8.9, 21.5 g). The association was greater in smokers 
and in overweight and obese women. A sub-study with 13 of the cohorts indicated that the 
associations were strongest for oily fish. This conclusion differs from that seen when data 
from the Norwegian MoBa study (62099 mother-child pairs) were analysed separately 
(Brantsaeter et al., 2012). Here it was found that lean fish was positively associated with 
birth weight, length and head circumference (adjusted beta for birth weight 0.45 g; 95% CI: 
0.16, 0.65) while fatty fish was not associated with any of the birth size measures (adjusted 
beta for birth weight 0.04 g; 95% CI: -0.22, 0.26). For total fish the adjusted estimate for 
birth weight was 0.27 g, 95% CI: 0.12, 0.42). The relative risk of giving birth to a small baby 
(less than 2500 g) in full-term pregnancies was significantly lower in women who consumed 
more than 60 g/day of seafood than in women who consumed 5 g or less per day (OR= 
0.56; 95% CI: 0.35, 0.88) (Brantsaeter et al., 2012). 
 Fish consumption and exposure to contaminants in relation to birth 4.7.2
size 
Papadopoulou et al. (2013) investigated the associations between maternal dietary intake of 
dioxins and PCBs during pregnancy and birth size in the Norwegian MoBa study (n=50651). 
As explained above, fish consumption shows positive association with fetal growth in this 
cohort, but is also the main dietary source of dioxins and PCBs. Seafood contributed on 
average to 41% of the dioxins and the dl-PCBs intake in the study population, but a low 
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proportion (2.2%) of the women had intakes of dioxins and dl-PCBs above the TWI of 14 pg 
TEQ/kg bw/week. In confounder-adjusted analyses, infants of mothers in the upper quartile 
of dioxins and dl-PCBs intake had lower birth weight (-62 g; 95% CI: -73, -50g), shorter 
birth length (-0.26 cm; 95%CI: -0.31, -0.20 cm) and shorter head circumference (-0.10 cm; 
95% CI: -0.14, -0.06 cm) than infants of mothers in the lowest quartile of intake. The 
negative association was however weaker as seafood consumption was increasing. There 
was no statistically significant association between intake of dioxins and PCBs and the risk 
for having a small for gestational age neonate.  
As described before, seafood is the main contributor to dietary mercury exposure. Vejrup et 
al. (2014) reported the association between maternal dietary exposure to mercury and infant 
birth weight in the Norwegian MoBa study (n= 56 988). Women in the highest quintile of 
mercury intake had infants with lower birth weight (-34 g; 95% CI: -46,-22 g) than women 
in the lowest quintile. Furthermore, they had an increased risk of giving birth to small-for-
gestation-age offspring (OR=1.19; 95% CI: 1.08, 1.30). Although seafood intake was 
positively associated with birth weight, there were negative associations between Hg intake 
and birth weight within each of four strata of seafood intake. Only 10 of the women had 
calculated dietary intake of mercury above 1.6 µg/kg bw/week, indicating that a very low 
proportion had an intake above the TWI of 1.3 µg/kg bw/week which set by EFSA in 2012 
(EFSA, 2012a). 
 Other pregnancy related outcomes 4.7.3
Haugen et al. (2011) reported that in a study on 7710 pregnant women in the Norwegian 
MoBa cohort, being in the upper tertile of seafood consumption in the year prior to the index 
pregnancy was associated with a lower risk of developing hyperemesis gravidarum 
(severe nausea and vomiting in early pregnancy) than beeing in the lower tertile (OR=0.56; 
95% CI: 0.32, 0.98)  
4.8 Summary of health effects associated with fish consumption 
Since publication of the VKM report from 2006 (VKM, 2006), several extensive observational 
studies and intervention studies have been conducted, addressing beneficial and/or adverse 
effects of fish and EPA plus DHA supplementation on specific health outcomes in the general 
population and/or specific subgroups. Different population and specific cohort studies have 
systematically been reviewed by scientists as well as national and international health 
authorities with focus on one or several health outcomes. Thus, at present, the knowledge-
base for assessing health effects associated with fish consumption is considerably 
strengthened.  
VKM conducted two searches on literature published between 2009 -2014. VKM has not 
systematically weighted the evidence from national and international comprehensive reports, 
reviews/meta-analyses and individual studies, but summarised the results. Single studies 
from the Nordic region were included because they were considered of special relevance. In 
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addition, single studies published in 2014 were included in order to cover the most recent 
information.  
In this summary of health effects associated with fish consumption, VKM has aimed at 
integrating the most important conclusions from both the assessments done by the national 
and international health authorities (FAO/WHO, EFSA, the Norwegian National Council for 
Nutrition) as well as relevant data retrieved from the present literature search of 
epidemiological studies on fish consumption and specific health outcomes. The assessments 
from the international health authorities mainly address possible association with fish 
consumption and cardiovascular disease and optimal neurodevelopment, since these are 
most thoroughly addressed in previous research. However, more information was available 
also on cancer, type 2 diabetes, atopic disease and pregnancy related endpoints than in the 
VKM assessment in 2006.  
 Fish consumption and cardiovascular diseases  4.8.1
The reviews, meta-analyses and other cohort or population-based studies, that have been 
summarised address fish consumption and n-3 fatty acids (EPA and DHA) from fish and the 
same or different type of end point for cardiovascular disease. The studies, however, may 
differ in the tools used for the estimation of fish consumption, in the tools used to measure 
the particular cardiovascular outcome of interest, and in the adjustment for confounding 
variables. The heterogeneity of the epidemiological studies thus hampers quantitative risk-
benefit analyses of fish consumption and risk of a particular cardiovascular outcome. 
Cardiac mortality  
With regard to this health outcome, the reviews, meta-analyses and other cohort or 
population-based studies summarised in the present VKM opinion reinforce the conclusions 
of VKM (2006), FAO/WHO (2011), the Norwegian National Council for Nutrition (2011) and 
EFSA (2014b), that there is strong evidence or Convincing evidence (FAO/WHO) in humans 
that fish consumption and marine n-3 fatty acids reduce the risk of cardiac mortality in 
adults. The beneficial effect is observed at 1-2 servings of fish up to 3-4 servings per week. 
No benefit is found at higher intakes (more than 5 servings per week). The dose-response 
relationship appears to be non-linear. However, the limited number of high and very high 
fish consumers in these epidemiological studies does not allow for drawing firm conclusions 
about the actual balance of risk and benefit at these high intakes. The health benefits of fish 
on cardiac mortality are most likely due to EPA and DHA, however, the nutritional impact of 
fish consumption may be higher than the sum of the benefits of the individual nutrients 
consumed separately. Despite some conflicting findings in reviews and meta-analyses 
regarding the effect of supplementary EPA and DHA on cardiovascular diseases, new 
scientific evidence does not imply a change in the previously established beneficial effect of 
supplementary EPA and/or DHA in prevention of cardiac death. 
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Based on the conclusions from VKM (2006), FAO/WHO (2011), the Norwegian 
National Council for Nutrition (2011), EFSA (2014b), and the studies summarised 
in this report on fish consumption and cardiac mortality, VKM concludes that 
there is strong evidence in humans that fish consumption and EPA plus DHA 
reduce the risk of cardiac mortality in adults. VKM acknowledges that this effect 
is observed at relatively low fish consumption, 1-2 servings of fish per week, and 
up to 3-4 servings per week. Furthermore, VKM notes that the calculated benefits 
of fish consumption in relation to cardiac mortality refer to net effects combining 
beneficial, neutral, and adverse effects of nutrients and non-nutrients, including 
contaminants such as methylmercury, dioxins, dl-PCBs. VKM also notes that EPA 
and DHA play an important role, however, the beneficial effects of fish intake on 
cardiac mortality risk are most likely mediated through a complex interplay 
among a wide range of nutrients commonly found in fish, fat or lean.   
Other cardiovascular outcomes  
EFSA (2014b) only assessed cardiac death as cardiovascular health outcome. With regard to 
other cardiovascular health outcomes, the reviews, meta-analyses and other cohort or 
population-based studies summarised in the present VKM Opinion reinforce the conclusions 
of FAO/WHO (2011) that there is also emerging or probable evidence that fish consumption 
may reduce the risk of multiple other adverse cardiovascular health outcomes, including 
ischaemic stroke, non-fatal heart disease events, congestive heart failure and atrial 
fibrillation. The beneficial effect of fish consumption on the different outcomes being 
stronger among those who had moderate (2-4 servings per week) than dose who consumed 
low amounts (1 serving or less per week). The dose-response relationship appears to be 
non-linear since consumption of more than 4 servings per week gave no additional health 
effect. In a pooled analysis based on five prospective studies evaluating associations 
between fish intake and incident heart failure, Djousse et al. (2012) concluded that an 
inverse dose dependent relationship between fish consumption and EPA plus DHA with heart 
failure incidence exist, and that fish intake of 1-4 servings per week is associated with a risk 
reduction of up to 15% compared to less than 1 serving of fish per week. Furthermore 
results from recent cohort or population-based studies, particularly from Scandinavia, 
(results a.o. that consumption of fish, especially lean fish may reduce risk of stroke in 
women in a cohort of Swedish women), concluded that the beneficial effects of fish intake 
on cerebrovascular risk might be mediated through a complex interplay among a wide range 
of nutrients commonly found in fish, fat or lean.   
VKM supports the conclusions of FAO/WHO (2011) and the studies summarised in 
this report on fish consumption and other cardiovascular outcomes, and 
concludes that the beneficial effect of fish consumption on the risk of multiple 
other adverse cardiovascular health outcomes, including ischaemic stroke, non-
fatal coronary heart disease events, congestive heart failure and atrial fibrillation 
being stronger among those who had moderate (2-4 servings per week) than 
those who consumed low amounts (1 serving or less per week). Dose-response is 
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non-linear.  VKM acknowledges that a dose dependent inverse relationship 
between fish consumption and EPA plus DHA with heart failure incidence exists; 
fish intake 1-4 servings per week is associated with a risk reduction of up to 15% 
compared to less than 1 serving of fish per week. 
All the studies referred above have demonstrated that consumption of fish may be 
associated with beneficial effects even though contaminants are present in the fish 
consumed. Very few studies have examined the influence of beneficial effect of fish taken 
into account the contaminants present. When balancing the benefits of fish consumption on 
cardiovascular disease with the risk from contaminants such as PCBs, dioxins and 
methylmercury in fish, the outcome may be affected by the contaminant exposure. 
FAO/WHO (2011) concluded that in the general adult population there is an absence of 
probable or convincing evidence of risk of coronary heart disease associated with 
methylmercury. The mercury opinion from EFSA in 2012 concluded that the observations 
related to mercury exposure and myocardial infarction, heart rate variability and possibly 
blood pressure are of potential importance, but still not conclusive. 
Recent cohort or population-based studies, particularly from Scandinavia state that exposure 
to methylmercury is associated with increased risk of myocardial infarction (MI), and higher 
sum marine n-3 PUFA serum concentrations are associated with decreased risk of MI in a 
combined Swedish and Finnish population. This indicates that n-3 LCPUFA may be more 
beneficial if mercury exposure from fish consumption was lower. However, few studies on 
beneficial effects on fish take contaminant exposure into consideration. 
VKM acknowledges that the net benefit of fish consumption on cardiovascular 
disease is affected by the concentrations of methylmercury. 
 Fish consumption and neurodevelopmental outcomes  4.8.2
The reviews, meta-analyses and other cohort or population-based studies that have been 
summarised, address fish consumption and n-3 fatty acids (EPA and DHA) from fish and the 
same or different type of end point for neurodevelopment. The studies, however, may differ 
in the tools used for the estimation of fish consumption, in the tools used to measure the 
particular neurodevelopmental health outcome of interest, and in the adjustment for 
confounding variables. Thus, the heterogeneity of the epidemiological studies makes 
quantitative risk-benefit analyses of fish consumption and neurodevelopmental outcomes 
challinging.  
In 2006, a positive association between fish consumption and n-3 fatty acids during 
pregnancy and neurodevelopmental health outcomes was indicated. The reviews, meta-
analyses and other cohort or population-based studies summarised in the present VKM 
Opinion reinforce the the conclusions made by FAO/WHO (2011) and EFSA (2014b) that 
there is significant positive associations (convincing evidence, FAO/WHO) between 
fish/seafood consumption and EPA plus DHA intake during pregnancy and children’s 
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neurodevelopment. The beneficial effects are observed at fish/seafood consumption of about 
1-2 servings per week and up to 3-4 servings per week compared to no fish/seafood 
consumption, and there appears to be no additional benefit with higher fish consumption. 
However, the limited number of high and very high fish consumers in these epidemiological 
studies does not allow for drawing firm conclusions about the actual balance of risk and 
benefit at these high intakes. 
Based on the conclusions from FAO/WHO (2011), EFSA (2014b) and the studies 
summarised in this report on fish consumption and neurodevelopmental 
outcomes, VKM concludes that there is significant positive associations between 
fish consumption and EPA plus DHA intake during pregnancy and children’s 
neurodevelopment. VKM acknowledges that this association is observed at 
relatively low fish consumption of about 1-2 servings per week and up to 3-4 
servings per week compared to no fish/seafood consumption. VKM also notes 
that the calculated benefits of fish consumption in relation to 
neurodevelopmental outcomes in foetuses and infants refer to fish/seafood per 
se, including nutrients (e.g. DHA, iodine) and contaminants (such as 
methylmercury, dioxins and dl-PCBs) contained in fish/seafood. Furthermore, 
VKM also acknowledges that the observed health benefits of fish consumption 
during pregnancy on neurodevelopment may depend on the maternal status with 
regard to nutrients and the contribution from fish relative to other sources of 
nutrients essential for neurodevelopment. 
VKM also notes the results from a recent quantitative assessment published by the US Food 
and Drug Administration of the net effects on foetal neurodevelopment of eating fish during 
pregnancy (FDA, 2014). As large approximations were necessary to fit the data, VKM agrees 
with EFSA (EFSA, 2014b) that quantitative benefit assessments are generally hampered by 
the heterogeneity of the studies.  
All the studies referred above have demonstrated that consumption of fish may be 
associated with beneficial effects even though contaminants are present in the fish 
consumed. There are few studies that have examined the influence of beneficial effect of fish 
taken into account the contaminants present. A single study from the Faroe Islands show 
negative confounding by EPA and DHA on the associations between mercury exposure and 
neurodevelopmental endpoints. Indication of such effect has also been reported from the 
Seychelles, and was taken into account when the TWI for methylmercury was set (EFSA, 
2012a). 
VKM acknowledges that high exposure to methylmercury may reduce the 
beneficial effect of fish consumption on neurodevelopment. 
Other health outcomes related to the central nervous system  
Several observational studies, intervention studies and experimental studies have 
investigated the potential role of EPA and DHA found in fatty fish to prevent and treat 
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cognitive decline and Alzheimer’s disease. Conflicting results have been published, and the 
evidence for beneficial effect of fish consumption and cognitive decline or Alzheimer’s 
disease is weak. 
 Fish consumption and cancer 4.8.3
In 2007 WCRF concluded with limited-suggestive evidence that fish protects against 
colorectal cancer. Meta-analyses published since 2009 do not find associations between fish 
consumption and colorectal cancer risk. 
Meta-analyses published since 2009 summarising studies that measure fish consumption as g 
fish/day or the number of servings per week, show no association with risk of cancer in the 
urinary bladder, kidneys, stomach, intestines, pancreas, breast, ovaries or prostate. 
VKM concludes that meta-analyses conducted since 2009 do not show association between 
fish consumption and cancer. None of the studies controlled for contaminant exposure from 
fish, and it is not known whether this would have affected the outcome. 
 Fish consumption and type-2 diabetes and other metabolic outcomes 4.8.4
Results from six reviews and meta-analyses published since 2009 indicate that there are no 
strong associations between fish consumption and type-2 diabetes. However, there is large 
regional heterogeneity between studies, and no firm conclusions can be drawn. 
From the Nordic countries, a new study on Norwegian women show a reduced risk of 
developing type-2 diabetes with increasing lean fish consumption, and no indications of 
unfavourable effects of fatty fish consumption. A study in Finnish middle-aged and old men 
showed reduced long-term risk of type-2 diabetes with increasing serum concentration of 
EPA, DHA and DPA.  
VKM concludes that the studies summarized have not revealed strong associations between 
fish consumption and type-2 diabetes, although some Nordic studies indicate protective 
associations. None of the studies controlled for contaminant exposure from fish and it is not 
known wheter this would have affected the outcome. 
No conclusions can be drawn based on the few prospective studies on fish consumption and 
weight increase identified in the literature search conducted by VKM. 
 Fish consumption and asthma, allergy and other atopic diseases 4.8.5
The majority of cohort studies addressing atopic diseases indicate a protective association 
with maternal fish consumption and/or early life fish consumption. There is little evidence for 
any association between fish consumption later in childhood or adulthood and atopic disease. 
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VKM concludes that the studies indicate a protective association between maternal fish 
consumption and/or early life fish consumption and atopic diseases. None of the studies 
controlled for contaminant exposure from fish and it is not known wheter this would have 
affected the outcome. 
 Fish consumption and pregnancy related outcomes 4.8.6
Most of the studies included from the literature search came from the Norwegian MoBa 
cohort. VKM notes that one study reported that women with high fish consumption during 
the year previous to pregnancy had a lower risk of developing severe nausea and vomiting in 
early pregnancy. 
Results from MoBa indicate that fish consumption during pregnancy, and in particular lean 
fish consumption, is associated with increased birth weight and lower risk of preterm birth. 
Studies also indicate that prenatal exposure to both mercury and dioxins and PCBs can 
decrease birth weight. VKM concludes that this implies that the overall beneficial effect of 
fish consumption on birth weight might have been more beneficial in the absence of 




VKM Report 2014: 15  115 
5 Changes in farmed Atlantic salmon 
feed composition – the significance 
for nutrients and contaminants in 
the fillet 
Over the last 10 years there has been a dramatic change in raw materials used in fish feeds 
(Ytrestøyl et al., 2014). Since 2006 the production of farmed Atlantic salmon and trout has 
increased dramatically followed by the same percentage of increase in volumes of feed 
produced (Figure 5-1). Fish feed volumes have increased but the fish meal and fish oil 
available for feed production have remained constant (Figure 5-2). Hence, new raw materials 
have increasingly replaced fish meal as a protein source and fish oil as a lipid source (Figure 
5-3). Thus far plant proteins and vegetable oils are the alternative ingredients, accounting 
for 70% of the feed in 2013 (Shepherd and Jackson, 2013), (Global Production by production 
source 1950-2011, Release date: March 2013). 
 
Figure 5-1 Fish feed used in Norwegian fish farming from 2000 to 2013. Numbers are in million 
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Figure 5-2 An example from one of the large fish feed companies in Norway with their own 
figures on a stable use of marine ingredients concomitant with about a two-fold increase in tonnes of 
fish feed produced. Source: www.ewos.com 
 
Figure 5-3 Development of ingredients in commercial fish feed over the past 20 years in 
Norwegian aquaculture. Numbers on the bars indicate the percent of the ingredients. Source: 
Ytrestøyl et al. (2014) 
The total oil inclusion in farmed Atlantic salmon feed increased from 23.4% oil as fish oil in 
1990 to approximately 30% oil as fish oil in 2000 (Figure 5-3). From 2000 to 2010 the feed 
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(Figure 5-3). The clear trend for fish feed development is decreased fish oil and fish meal 
levels, and it is expected that future feeds for farmed Atlantic salmon and trout contain lower 
amounts of fish oil and hence lower amounts of EPA and DHA. Ultimately, the farmed fish 
own nutrient requirements for EPA and DHA will set the minimum possible EPA and DHA 
content of fish feed. Future feeds for farmed fish is also expected to contain new raw 
materials as alternatives to plant proteins and vegetable oils.  
When replacing the raw materials fish meal and fish oil with plant ingredients as protein and 
lipid sources, also a range of other nutrients and undesirable components will change. In this 
chapter, we present the changes of nutrients and contaminants in fish feed for Norwegian 
farmed Atlantic salmon and trout. Further, time-trends for the same nutrients and 
contaminants in Norwegian farmed Atlantic salmon and trout is shown, and any changes in 
fillet composition are seen in relation to changes in the feed content from 2006 until farmed 
fish harvested in 2013. The main bulk of data is extracted from two surveillance programs 
financed by Norwegian Food Authorities and carried out by NIFES (Annual Feed surveillance 
program and 93/23 annual surveillance of farmed fish). Annual reports from both 
surveillance programs are available at www.matilsynet.no and www.nifes.no. Emerging risks 
with changes of fish feed raw material composition is also included in this chapter. 
5.1 Nutrients in feed and farmed fish 
 Alternative protein ingredients in fish feed 5.1.1
Fish and other seafood are recognised as an important source of animal protein with 
balanced amino acid profile. The balance of amino acids is optimal for human requirement of 
essential amino acids, and seafood protein is easily digestible due to low amount of 
connective tissue. Typically fish fillet contain 15 to 20 g protein per 100 g fillet on wet weight 
basis, thus varying much less than the lipid content. Fish fillet, similar to other animal protein 
sources, do not contain any significant amount of carbohydrates.  
Irrespective of which raw material that provides the dietary amino acids for the fish, the fish 
muscle protein composition will remain the same. Hence, there are no difference in fillet 
amino acid composition when comparing salmon from 2006 and 2014. Plant protein sources 
commonly used in fish feeds are legumes. Soybean is dominating, but options of using other 
beans and peas are continuously being investigated. Legumes also contain anti-nutrients; 
these latter are thoroughly described by VKM (2009). None of the anti-nutrients present are 
identified to be transferred to the fish fillet, and are therefore not considered any further in 
the present report. In 2013, regulations opened the possibility to use processed animal 
proteins (PAPs) in feed for salmon (Hatlen et al., 2014; Liland et al., 2014). These protein 
sources (from poultry and swine) have a more similar amino acid profile compared to fish 
proteins, and does not contain the anti-nutrients as found to challenge fish health when 
plant proteins are used. Still, for the consumer, the salmon muscle protein is exactly the 
same independent of feed protein source. Replacing marine proteins with plant proteins will 
probably introduce new contaminants, such as pesticides (Chapter 5.3). 
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 Fatty acid levels and profiles 5.1.2
The use of high-lipid feeds for cultured fish may affect fish flesh quality by increasing the 
percentage of lipids stored in the edible muscle (Arzel et al., 1993; Arzel et al., 1994; 
Bendiksen et al., 2003; Hemre and Sandnes, 1999; Watanabe, 1982). Generally, increased 
dietary lipid resulted in increased fillet lipid levels, whereas changing dietary fatty acid 
composition by replacing fish oil with a vegetable oil blend, did not change the amount of 
total body lipid stores in Atlantic salmon (Nanton et al., 2007). 
Globally, the inclusion of vegetable oils in aqua feeds as a replacement for fish oil is 
increasing. In contrast to fish, vegetable oils and terrestrial animal fats are lacking in n-3 
LCPUFA, such as eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), and are 
characterised by a low to very low n-3/n-6 ratio. As reviewed by Turchini and co-workers 
(Turchini et al., 2009), a number of studies have shown that the complete or partial dietary 
replacement of fish oil with vegetable oils or a vegetable oil blend affects the fatty acid 
composition of the edible portion.  
Replacing fish oil with vegetable oils in fish feed results in increased content of the plant 
fatty acids linoleic acid (LA), oleic acid (OA) and alpha-linolenic acid (ALA), and decreased 
content of EPA, DPA (docosapentaenoic acid) and DHA both in fish whole body, various 
organs and fillet. However, the magnitude of fatty acid change is dependent on the type of 
tissue (Bell et al., 2001; Bell et al., 2003; Torstensen et al., 2004) and the amount of 
phospholipids (PL) relative to neutral lipids in the tissue. The storage triacylglycerol (TAG) 
fraction (neutral lipids) of the lipids of different tissues more closely resembles the fatty acid 
make-up of the diet than does the structural PL fraction.  
Fatty acid composition of the diets is reflected in the fatty acid compositions of the fish 
muscle in almost all species studied. However, the positive correlation observed for the other 
fatty acids is not that obvious for saturated fatty acids (Kennish et al., 1992; Mugrditchian et 
al., 1981; Turchini et al., 2003; Viola et al., 1981). It has been demonstrated that saturated 
fats are deposited into fish fillet at a specific physiological level and being less dependent on 
dietary level. For example, Atlantic salmon fed up to 50% saturated fatty acids by using palm 
oil as dietary oil, did not increase the level of saturated fat in salmon fillet beyond the 
maximum of 25% seen in fish oil fed salmon (Bell et al., 2002; Torstensen et al., 2000). 
It is clear that when fish oil is replaced by vegetable oil, the most significant modifications of 
the fatty acid composition of fish tissues are increased C18 PUFA content (particularly the n-6 
fatty acid linoleic acid; Figure 5.1.2-1), decreased EPA, DPA and DHA content and a 
modification of the monounsaturated (MUFA) composition from C20 and C22 MUFA to C18 
MUFA. For these reasons, the content of linoleic acid (18:2 n-6) in an alternative lipid source 
is one of important parameters to be considered, as an increase in this fatty acid contribute 
to the decrease in n-3/n-6 ratio and increase in total n-6. As illustrated by Figures 5.1.2-1 
and 5.1.2-2 the content of EPA+DHA has gradually decreased whereas total n-6 has 
gradually increased in Atlantic salmon fillets due to a shift in raw materials from only fish 
meal and fish oil to more vegetable oils, and especially rapeseed oil replacing fish oil. Fish 
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feed EPA, DHA and n-6 levels are not analysed and given in detail in the same time period, 
hence only fish fillet concentrations are presented in this report. 
The gradual replacement of fish oil with vegetable oils in commercial fish feed is also 
reflected in the ratio between n-3 and total n-6 in fish feed decreasing from 4.7 in 2006 to 
1.6 in 2013 (Sanden et al., 2014). The feed surveillance program reported EPA+DHA fish 
feed levels of 3.2% EPA+DHA in the feed in 2012 (n=23) and 2.5% EPA+DHA in the feed in 
2013 (n=69) (Sanden et al., 2014), whereas n-6 were 3.1% of the feed in 2012 and 3.4% of 
the feed in 2013 (Sanden et al., 2014). The replacement of fish oil with vegetable oils of 
commercial fish feed was also reflected in the Norwegian Atlantic salmon fillet EPA+DHA 
content (Fig. 5.2-1) and n-6 content (Figure 5.1.2-2). The fatty acid DPA was not included in 
Figure 5.1.2-1. Hence, all the figures are 15 to 20% lower compared to the total 
EPA+DPA+DHA sum. The reason for illustrating EPA+DHA in fish fillet is to be able to 
compare directly with dietary intake recommendations, which refer to EPA and DHA. In 
addition, studies on human health effects of n-3 mainly refer to EPA and DHA intakes, and 
only occasionally to DPA intake. 
 
Figure 5.1.2-1 Atlantic salmon fillet content of eicosapentaenoic acid (EPA) and 
docosahexaenoic acid (DHA) (g/100 g fillet) from 1993 to 2013 presented as mean with lowest and 
highest measured value. Numbers of sampled fish per year were: n=1 (pooled sample) (1993); n=1 
(pooled sample (2001); n=47 (2005); n=10 (2006); n=28 (2008); n=28 (2009); n=33 (2010); n=100 
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Figure 5.1.2-2 Atlantic salmon fillet content of n-6 fatty acids (g/100 g fillet) from 1993 to 
2013 presented as mean with lowest and highest measured value. Numbers of fish per year were: 
n=1 (1993, pooled sample); n=1 (2001, pooled sample); n=47 (2005); n=10 (2006); n=28 (2008); 
n=28 (2009); n=33 (2010); n=100 (2011); n=100 (2012); n=90 (2013). Source: 
www.nifes.no/sjomatdata. 
 Vitamin D 5.1.3
Atlantic salmon is regarded as a good source of vitamin D (measured as vitamin D3). In 2006 
the commercial fish feed held quite high levels of marine ingredients which naturally 
contained high vitamin D levels. With steadily decreasing use of marine ingredients and 
increasing use of alternatives, vitamin D3 levels in fish feed has decreased during the last 
decade as shown in data obtained from the Norwegian fish feed surveillance program (Figure 
5.1.3-1) (Sanden et al., 2014; Sissener et al., 2013). There is no data on Atlantic salmon 
fillet vitamin D content during the same time period. However, as Atlantic salmon fillet 
vitamin D content reflects the feed levels of vitamin D3 (Horvli et al., 1998), it is expected to 
be decreased compared to the content in 2006. 
Farmed Atlantic salmon harvested in 2012 contained an average of 0.06 mg vitamin D per kg 
fillet with a range of 0.002 to 0.18 mg per kg. This is a 25% decrease in Norwegian farmed 
Atlantic salmon fillet since 2006 when the average vitamin D content was reported to be 
0.08 mg per kg, ranging from 0.04 mg/kg to 0.16 mg/kg (www.nifes.no; seafood data, 
(VKM, 2006). However, since the content of vitamin D in the fillet reflects the fish feed 
vitamin D3 content (Graff et al., 2002), replacing marine ingredients with plant based 
material will further decrease the feed vitamin D3 content and thus fillet vitamin D content. 
Cleaning fish oil for marine contaminants will also remove vitamins D, E and A from fish oil, 
which may be a concern for the vitamins A and D, which cannot be restored in fish feed due 
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Figure 5.1.3-1 Fish feed content of vitamin D3 (mg/kg feed) in the period from 2004 to 
2013 presented as mean with lowest and highest measured value. Numbers of feed samples per year 
were: n=21 (2004); n=20 (2005); n=20 (2006); n=22 (2007); n=21 (2008); n=69 (2013). Source: 
Sanden et al. (2014) 
 Selenium and iodide in feed and farmed Atlantic salmon 5.1.4
The feed surveillance program years 2000-2014, provides information on contents of 
selenium and iodine in feed (Sanden et al., 2014). 
Mean fish feed selenium levels have decreased with approximately 50% since 2006, and 
today’s mean selenium levels are 0.7 mg/kg feed (Sanden et al., 2014). Maximum limit of 
selenium allowed to add to feed is 0.5 mg/kg, which limits the possibility to add selenium 
back to former high selenium levels above 1.2 mg selenium/kg feed experienced with high 
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Figure 5.1.4-1 Fish feed content of selenium (Se) (mg/kg feed) in the period from 2004 to 
2013 presented as mean lowest and highest measured value. Numbers of feed samples per year 
were: n=40 (2004); n=23 (2005); n=49 (2006); n=22 (2007); n=21 (2008); n=69 (2013). Source: 
Sanden et al. (2014) 
Farmed Atlantic salmon fillet is regarded as a good source of selenium. Figure 5.1.4-2 shows 
that the reduction in selenium in the feed has resulted in reduced Atlantic salmon fillet 
concentrations (Sanden et al., 2014). A further decrease in feed and Atlantic salmon fillet 
selenium content is a likely scenario if plant protein sources lower in bioavailable selenium 
than fish meal increase any further. 
 
Figure 5.1.4-2 Atlantic salmon fillet content of selenium (Se) (mg/kg fillet) in 2007-2013 
presented as mean with lowest and highest measured value. Each sample analysed is a pooled sample 
of five fish. Numbers of pooled samples per year were: n=135 (2007); n=131 (2008); n=148 (2009); 
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Farmed Atlantic salmon is not regarded as a good source for iodine. There has been a steady 
decline in iodine level in fish feed from just above 4 mg iodine per kg in 2004 to just above 2 
mg iodine per kg in 2007 (Sanden et al., 2014), likely due to decreased fish meal inclusion. 
In 2007-2013 the fish feed iodine levels however, have remained relatively constant at 2.2 
mg/kg (Sanden et al., 2014). For seawater fish the main source of iodine is the surrounding 
water (direct uptake through gills and intestine). The iodine concentration (mainly in the 
forms of iodide and iodate) in the sea varies between 0.44 and 0.49 μmol/L, which is high 
enough to satisfy the fish’s iodine requirement. No data showing time-trends from 2006 to 
2013 for farmed Atlantic salmon and trout fillet iodine levels have been found. 
In the human diet, salmonids, such as Atlantic salmon and trout, are not considered as any 
major sources of dietary iodine. Wild lean fish like cod and saithe, are regarded as good 
dietary iodine sources.  
5.2 Contaminants in feed and farmed fish 
When the use of feed raw materials have changed from fish meal and fish oil to other 
sources as described above, the content of POPs and heavy metals has decreased 
significantly as presented in detail below for dioxins, dl-PCBs and mercury. In addition, the 
content of PCB-6 and new risks introduced by new raw materials are described below.  
The data presented are taken from the annual surveillance programs for fish feed (Sanden et 
al., 2014) and farmed fish (Hannisdal et al., 2014).The data are presented as mean with the 
variation showing the lowest and highest measured values for each year. The samples are 
randomly collected during the whole year, and originate from different fish farms and fish 
feed producers. Hence, it is not possible to identify differences in data variations observed 
within each year. 
 Dioxins and dioxin-like-PCBs 5.2.1
Overall, the surveillance of commercial fish feed shows a substantial reduction in marine 
POP’s including dioxins and dioxin-like (dl) PCBs (Figures 5.2.1-1 and -2) which follows the 
change in inclusion levels of fish oil from early 2000 until 2014 (Sanden et al., 2014; Sissener 
et al., 2013). The data on fillet levels of dioxins and dl-PCBs from Norwegian commercial 
Atlantic salmon show a similar decrease from 2004 to 2013, Figure 5.2.1-3;(Hannisdal et al., 
2014). Hence, the mean upper bound concentration of sum dioxin and dl-PCBs was 0.5 ng 
TEQ per kg fillet in 2012 and 2013 compared to 1.5 ng TEQ per kg fillet in 2006. 
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Figure 5.2.1-1 Fish feed content of dioxins and dioxin-like PCBs (dl-PCBs) presented as as 
upper bound mean total toxicological equivalents (total TEQ) in the period from 2003 to 2013, with 
lowest and highest measured value (µg/kg feed). Upper bound imply that concentrations lower than 
the limit of detection or limit of quantification is substituted with the actual value of these limits and 
not zero, which most likely represent an overestimate of the true values. Current and previous 
maximum limits of total TEQ permitted in fish feed are marked with a red line. Source: (Sanden et al. 
(2014); Sissener et al. (2013))  
 
Figure 5.2.1-2 Fish feed content of sum dioxins (PCDD/F) and dioxin-like PCBs (dl-PCBs) in 
2013 given as upper bound mean total toxicological equivalents (2005-TEQ) with lowest and highest 
measured value (µg/kg feed). Upper bound imply that concentrations lower than the limit of detection 
or limit of quantification is substituted with the actual value of these limits and not zero, which most 
likely represent an overestimate of the true values. Source: Sanden et al. (2014) 
As illustrated in Figure 5.2.1-2, sum dl-PCBs and sum dioxins have decreased in a similar 
manner in fish feed, however the decrease has been 10 percent points greater for the dl-
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has decreased with 60%. Of this, total sum dl-PCBs TEQ has decreased 61% and sum dioxin 
TEQ has decreased 51% from 2003 to 2013. In today’s fish feed, the dioxins and dl-PCBs 
contribute more equal amounts to the total sum TEQ compared to the composition 10 years 
ago when dl-PCBs was dominating over sum dioxins (Figure 5.2.1-2). Interestingly, fish feed 
levels of sum dioxins and dl-PCBs was higher in 2009 and 2010 compared to the previous 
years 2007 and 2008 (Figure 5.2.1-1). This was reflected in a 2010-exception of the steadily 
and gradual decreasing Atlantic salmon fillet dioxin and dl-PCBs content (Figure 5.2.1-3). As 
prices of raw materials are fluctuating, lower prices of fish oil in the time period 2009-2010 
resulted in higher fish oil inclusion in fish feed and thus higher levels of dioxins and dl-PCBs 
in fish feed and Atlantic salmon fillets during this period. After 2010, however, the fish oil 
levels have generally decreased in fish feed for Norwegian farmed Atlantic salmon and trout 
due to the increased production volume and unchanged fish oil volumes available on the 
global markets. This is reflected in the lowest content of dioxins and dl-PCBs measured in 
fish feed during this time period (1.09 ng TEQ per kg fish feed in 2013). 
 
Figure 5.2.1-3 Norwegian farmed Atlantic salmon fillet contents of dioxins and dioxin-like 
(dl-PCBs) in the period from 2004 to 2013 given as total toxicological equivalents (2005-TEQ; ng/kg 
fillet). Values are upper bound mean with minimum and maximum. Upper bound imply that 
concentrations lower than the limit of detection or limit of quantification is substituted with the actual 
value of these limits and not zero, which most likely represent an overestimate of the true values. 
Numbers of pooled samples of five fish each per year were: n=40 (2004); n=155 (2005); n=125 
(2006); n=580 (2007); n=430 (2008); n=270 (2009); n=183 (2010); n=140 (2011); n=155 (2012); 
105 (2013). Source: www.nifes.no/sjomatdata 
Research has revealed that both dioxins and dl-PCBs are reflected in Atlantic salmon fillet 
depending on the level in the feed (Berntssen et al., 2005). Farmed Atlantic salmon and 
farmed trout surveillance data, showing a decline in sum dioxins and dl-PCBs from 2006 until 
2013 (Figures. 5.5.1-3 and -4), confirm this. Nøstbakken et al. (2015) have demonstrated 
that the decline in sum TEQ per kg fillet in farmed salmon is statistically significant. Since 
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down to 0.5 ng TEQ per kg fillet in 2013. For farmed trout, the concentration was the same 
as farmed Atlantic salmon in 2012 and 2013 (Figure 5.2.1-4). 
 
Figure 5.2.1-4 Norwegian farmed trout fillet contents of dioxins and dl-PCBs in the period 
from 2006 to 2013 given as total toxicological equivalents (2005-TEQ)(ng/kg fillet). Values are «upper 
bound» mean with minimum and maximum. Upper bound imply that concentrations lower than the 
limit of detection or limit of quantification is substituted with the actual value of these limits and not 
zero, which most likely represent an overestimate of the true values. All years each sample analysed 
was a pooled sample of five fish. Numbers of pooled samples per year were: n=10 (2006); n=12 
(2007); n=10 (2008); n=8 (2009); n=4 (2010); n=0 (2011); n=1 (2012); n=16 (2013). Source: 
www.nifes.no/sjomatdata 
Fish feed and Atlantic salmon fillet content of PCBs (Figs. 5.2.1-5 and -6) follow the same 
trend as dioxins and dl-PCBs (Figs. 5.2.1-1 and -2). Compared with 2006, PCB-6 in Atlantic 
salmon fillet decreased with more than 50% down to a mean concentration of 3.6 µg/kg 
fillet (Hannisdal et al., 2014). Since 2012, a maximum limit was implemented in Norway and 
EU of 40 µg/kg PCB-6 in fish feed (Commission Regulation (EU) No 277/2012 of the 
European Parliament and of the Council on undesirable substances in animal feed). The sum 
of PCB6 does not include PCB-118, which was previously included in the PCB-7 sum. Since 
2012, PCB-118 is included as one of the congeners in the maximum limit of sum TEQ for 
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Figure 5.2.1-5 Fish feed content of sum PCB-6 and PCB-7 in the period from 2006 to 2013. 
Values are upper bound mean with minimum and maximum in µg/kg feed. The maximum limit for 
sum PCB-6 is marked with a red line (40 µg/kg). Upper bound imply that concentrations lower than 
the limit of detection or limit of quantification is substituted with the actual value of these limits and 
not zero, which most likely represent an overestimate of the true values. Numbers of feed samples 
per year were: n=54 (2006); n=57 (2007); n=57 (2008); n=25 (2009); n=23 (2010); n=25 (2011); 
n=23 (2012); n=69 (2013). Source: Sanden et al. (2014)  
 
Figure 5.2.1-6 Norwegian farmed Atlantic salmon fillet contents of sum PCB-6 in the 
period from 2002 to 2013 presented as upper bound mean with the lowest and highest value (µg/kg 
fillet). From 2005, each sample analysed is a pooled sample of five fish, whereas samples before 2005 
represent a mix of individual fish and pooled samples of five fish each. Numbers of pooled samples of 
five fish each per year were: n=32x (2002); n=37 (2003); n=36 (2004); n=36 (2005); n=19 (2006); 
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5.2.1.1 Cleaned fish oil reduce persistent organic contaminants in farmed salmon 
In addition to reducing persistent organic pollutants (POPs) in Atlantic salmon fish feed and 
fillet by replacing fish oil with vegetable oils, the fish oil can also be cleaned of POPs.  
A number of physical-chemical refining methods can be used to remove fat-soluble 
contaminants such as dioxins, dl-PCBs and brominated flame-retardants from marine oils. 
Several methods exist that can potentially be used for this purpose, such as activated carbon 
(Maes et al., 2005; Oterhals et al., 2007; Usydus et al., 2009), steam deodorization/steam 
distillation (De Kock et al., 2004), thin-film deodorization, short path distillation (Breivik and 
Thorstad, 2005; Olli et al., 2013; Oterhals et al., 2010), super critical fluid extraction 
(Krukonis, 1989). In addition, combination techniques are used such as active carbon 
followed by thin-film deodorization (Berntssen et al., 2010a; Berntssen et al., 2010b; 
Sprague et al., 2010), or countercurrent supercritical CO2 extraction in combination with 
active (Kawashima et al., 2009). 
Activated carbon effectively removes dioxins and non-ortho dl-PCBs from fish oil, but is less 
effective in removing mono-ortho-PCBs (Oterhals et al., 2007). Activated carbon does not 
remove PBDEs from fish oil. Short path distillation (also called molecular distillation) is, 
however, an effective method of removing dioxins, dl-PCBs, ndl-PCBs and PBDEs from oils 
(Oterhals et al., 2010; VKM, 2011a). However, when cleaning the oil efficiently for POPs this 
also affect the level of fat-soluble vitamins (depending on the process), but only to a minor 
extent affect the fatty acid profile (Oterhals and Berntssen, 2010). Removal of the 
contaminants mentioned here from fish meal requires totally different methods, which are 
based primarily on the removal of fat by organic solvent extraction and improved fat 
separation, or solid–liquid extraction (leaching) where the intermediate processed fishmeal is 
contacted with a triglyceride oil (Oterhals and Kvamme, 2013). 
Two long-term feeding (more than 16 months) trials have been conducted where cleaned 
fish oil was used in feeds to Atlantic salmon (Berntssen et al., 2010b; Olli et al., 2010). In 
the first study, Atlantic salmon were fed a diet with a 100% inclusion of fish oil which was 
decontaminated with a short path distillation technique (Olli et al., 2010). In the second 
study, the diets were based on half plant oil and half fish oil (representing the salmon feed 
composition at that time) in which the fish oil was decontaminated with a combined active 
carbon and thin-film deodorization technique (Berntssen et al., 2010b; Lock et al., 2011). In 
a third short term trial (less than 3 months) (Sprague et al., 2010), salmon were fed a full 
fish oil diets in which the fish oils were decontaminated with the same combined active 
carbon and thin-film deodorization as in (Berntssen et al., 2010b). Finally in a fourth trial, a 
decontaminated finishing feed (6 months before slaughter) was fed to Atlantic salmon that 
previously were fed on a full fish oil diet. The oil was subjected to an activated carbon 
decontamination treatment (Bell et al., 2012). All studies efficiently removed POPs resulting 
in 76.6% reduction (2.31 vs 0.54 ng (2005 TEQ-WHO)/kg (Olli et al., 2010), 94% reduction 
(6.42 vs 0.34 1998 TEQ-WHO)/kg)(Sprague et al., 2010), 80.8% reduction (1.3 vs. 0.25 ng 
(1998 TEQ-WHO)/kg)(Berntssen et al., 2010b), and approximately 25% reduction (1.94 vs 
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approx. 1.45  (1998 TEQ-WHO)/kg) (Bell et al., 2012) in sum dioxins and dl-PCBs in fish 
fillets. These data are achieved by three different studies where Atlantic salmon were fed 
either feed with standard fish oil or cleaned fish oil. The lowest level of dioxins and dl-PCBs 
achieved by using cleaned fish oil was 0.25 ng TEQ (1998 TEQ-WHO)/kg Atlantic salmon 
fillet (Berntssen et al., 2010b). 
5.2.1.2 Cleaned fish oil and Atlantic salmon nutrient composition 
The cleaning process that removed more than 93% of the POPs in the fish oil Berntssen et 
al. (2010b) also removed lipid soluble vitamins but had only very minor effects on the fatty 
acid profile. How much vitamins that is lost in the cleaning process is however dependent on 
processing conditions and type of cleaning technique (Lock et al., 2011; Oterhals and 
Berntssen, 2010). Farmed fatty fish is traditionally good sources for vitamin D. In one long-
term feeding trials with Atlantic salmon, the lipid soluble vitamins A, D and E were added to 
achieve fish oil-like concentrations in the fish feed (Lock et al., 2011), and no negative 
effects on fish fillet vitamin D concentrations or fish health were reported. In the long term 
trial of Olli et al. (2010), no supplies were made to compensate for potential vitamin loss and 
no negative effect was reported on fish health (vitamin levels were not reported). Lock et al. 
(2011) reported only a slight reduction in EPA and DHA in decontaminated oils and fish fed 
on these oils, whereas Olli and colleagues (2010) reported even an increased EPA and DHA 
concentration in cleaned fish oil fed fish, despite lower levels in the cleaned oil compared to 
the unprocessed oil. Although lipid soluble vitamins can be added from a practical point of 
view, current feed legislation hinders this for vitamin D. As discussed previously the 
maximum limit for vitamin D addition to fish feed is 0.075 mg/kg and far below the vitamin D 
concentrations added in the two referred experiments. Consequently, commercially produced 
Atlantic salmon with cleaned fish oil will have lower vitamin D fillet levels than Atlantic 
salmon fed non-cleaned fish oil.  
5.2.1.3 Cleaned fish oil in fish feeds - modelling of the resulting concentrations of 
dioxins and dl-PCBs in Atlantic salmon fillet 
The two feeding trials were performed with high fish oil inclusion levels (100% or 50% of oil 
source in diet), which are no longer relevant for present and future commercial fish oil 
inclusion levels (Figure 5-4). We have therefore calculated the expected concentrations of 
sum dioxins and dl-PCBs based on a scenario relevant for today’s and future feeds where 
feed consists of 10% fish meal, 56% plant protein sources, 10% cleaned fish oil and 20% 
vegetable oil. The level of dioxins and dl-PCBs in the feed was determined by calculating the 
total sum dioxins and dl-PCBs contributed from fish meal, plant protein sources, cleaned fish 
oil and vegetable oils. The model published by Berntssen and Lundebye (2007), take into 
account the initial concentration of dioxins and dl-PCBs in the smolt at the start of a 
seawater production cycle, uptake and elimination rates of each dioxin and dl-PCBs, feeding 
rate, and growth of the fish. When using commercial relevant data for growth and data on 
dioxins and dl-PCBs in fish meal, plant protein sources and vegetable oils from the feed 
surveillance (Sanden et al., 2014), the calculated fillet concentration of sum dioxins and dl-
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PCBs was 0.3 ng TEQ dioxins and dl-PCBs/kg fillet. One may expect that the dioxin and dl-
PCBs levels would be even lower than the 0.25 ng TEQ dioxins and dl-PCBs/kg fillet in 
Atlantic salmon fed cleaned fish oil (15% of the feed) as reported by Berntssen et al. 
(2010b). However, in this trial the growth was much higher than is normally found under 
commercial conditions, thus giving lower final levels than the model predicted levels that 
uses lower but commercial relevant growth rates. When the model is run with growth rate 
and feed intake levels as found in the experimental trial of (Berntssen et al., 2010b), the 
model predicts levels of 0.23 ng TEQ dioxins and dl-PCBs/kg fillet which is close to the actual 
analysed levels of 0.25 ng TEQ dioxins and dl-PCBs/kg fillet. Please note that predicted levels 
of dioxins and dl-PCBs in fish fed cleaned fish oil will vary because of variation in the other 
feed ingredients contaminant concentrations, fish growth, initial contaminant concentrations 
and if data are given as upper bound, medium bound or lower bound concentrations of sum 
dioxins and dl-PCBs.  
When the decontaminated fish oil is defined as the only source for dioxins+dl-PCBs and no 
initial smolt dioxins+dl-PCBs levels are given, the model predicts fillet levels of 0.06 ng TEQ 
dioxins and dl-PCBs/kg fillet. However, also the other feed ingredients will contribute with 
dioxins and dl-PCBs resulting in a higher minimum concentration level. The predicted 
concentrations presented here are in the same range as other fatty foods such as cheese 
(0.29 medium bound WHO-TEQ 2006 ng/kg product) and somewhat higher than beef (0.18 
medium bound WHO-TEQ 2006 ng/kg product) (De Mul et al., 2008). 
 Mercury 5.2.2
Some industrial fish (e.g. blue whiting) used as marine feed ingredients are naturally high in 
mercury. Mercury is found primarily in organic form (75 to 95%), specifically as 
methylmercury which represent a potential health hazard (Chapter 2.3.1). The assimilation 
of methylmercury from feed to salmon is relatively high (23 to 41%), and the muscle is an 
important organ for storage (Berntssen et al., 2004). In 2013, the fish feed surveillance 
reported levels of mercury which ranged from 0.006 to 0.19 mg/kg with a mean of 0.03 mg 
Hg/kg feed (Sanden et al., 2014). This represents 50% reduction in total feed mercury levels 
compared to 2004-2006 values (Sanden et al., 2014; Sissener et al., 2013). Fish meal is the 
main source of Hg in fish feed, and the decline in total feed mercury is likely due to the 
decreased fish meal inclusion as protein source in fish feed (Figure 5.2.2-1). The maximum 
limit for mercury in feed is 0.1 mg/kg.  
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Figure 5.2.2-1 Fish feed content of total mercury (Hg) in the period from 2009 to 2013. 
Values are in mg/kg presented as upper bound mean with the lowest and highest value. Upper bound 
imply that concentrations lower than the limit of detection or limit of quantification is substituted with 
the actual value of these limits and not zero, which most likely represent an overestimate of the true 
values. Numbers of feed samples per year were: n=2 (2009); n=23 (2010); n=25 (2011); n=23 
(2012); n=69 (2013). Source: Sissener et al. (2013)  
 
Figure 5.2.2-2 Norwegian farmed Atlantic salmon fillet contents of mercury (Hg) (mg/kg 
fillet) in the period from 2005 to 2013 presented as upper bound mean with the lowest and highest 
value. Upper bound imply that concentrations lower than the limit of detection or limit of 
quantification is substituted with the actual value of these limits and not zero, which most likely 
represent an overestimate of the true values. Each sample represents five fish. Numbers of pooled 
samples of five fish each per year were: n=26 (2005); n=104 (2006); n=x149 (2007); n=137 (2008); 




















































































VKM Report 2014: 15  132 
 
Figure 5.2.2-3 Norwegian farmed trout fillet contents of mercury (Hg) (mg/kg) in the 
period from 2005 to 2013 presented as upper bound mean with the lowest and highest value. Upper 
bound imply that concentrations lower than the limit of detection or limit of quantification is 
substituted with the actual value of these limits and not zero, which most likely represent an 
overestimate of the true values. Each sample represents five fish. Numbers of pooled samples of five 
fish each per year were: n=1 (2005); n=7 (2006); n=17 (2007); n=13 (2008); n=19 (2009); n=31 
(2010); n=15 (2011); n=24 (2012); n=20 (2013). Source: www.nifes.no/sjomatdata 
As expected, farmed Atlantic salmon and trout fillet Hg reflects the feed Hg decreases 
(Figures 5.5.2-2 and -3). The magnitude of decrease in mean fillet Hg content is similar for 
Atlantic salmon and trout (60% and 70%, respectively), and today’s Norwegian farmed 
Atlantic salmon and trout have a mean Hg level of 0.014 mg per kg fillet and 0.018 mg per 
kg fillet, respectively. In the current exposure estimates (Chapter 7), data for farmed Atlantic 
salmon is used due to the very similar nutrient and contaminant concentrations. It is also 
difficult to differentiate between trout and salmon in the food consumption surveys. 
 Other persistent organic pollutants (POPs)/legacy POPs 5.2.3
In the 2006 report a thorough identification of hazards was done discussing a range of 
chemical contaminants which may be present in fish feed and fish. Since the 2006 report 
concluded that intake from marine organisms did not represent a significant health risk, 
these substances are not discussed further in this report as no new information has been 
identified which may change the conclusion on risk.  
The substances relevant for fish feed are legacy POPs including pesticides which are not 
legal to use but is present in the environment. The concentrations in fish feed ingredients 
and fish feed is being monitored and regulated through maximum limits in animal and fish 
feed and feed raw materials. These include the two iso-forms of DDT (dichlor-difenyl-
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components are annually monitored, i.e. toxaphene number 26, 50, 62, 32, sum toxaphene 
40+41 and toxaphene 42), cis- og trans- chlordan plus cis- and trans- nonachlor and 
oksychlordan, aldrin and dieldrin, mirex, endrin, isodrin, hexachlorbenzene (HCB), heptachlor 
and heptachlor-endo-epoxide are all included in the annual feed surveillance and results 
from 2013 are recently reported by Sanden et al. (2014).  
5.3 Emerging risks from new ingredients in fish feed 
All feed ingredients contribute with unwanted substances. Replacing fish oil and fish meal 
with alternative ingredients decrease the levels of marine contaminants, however, the new 
ingredients may contribute with similar and/or other types of contaminants. Since today’s 
aquaculture mainly replaces marine raw materials with plant proteins and vegetable oils, 
contaminants originating from these will be emphasised. 
 Pesticides from plant raw materials 5.3.1
The pesticides included in the feed surveillance are mainly the ones which are not legal to 
use any more (Chapter 5.5), but exist in the environment. In addition, legal pesticides are 
being used for crops all over the world, and residues can be present in plant protein and lipid 
raw materials. Raw materials for fish feed are purchased on the global market, and can 
therefore contain a range of pesticide residues. To date the knowledge of composition and 
concentration of pesticide residues in fish feed ingredients and fish feed are limited, but have 
recently been screened (Nacher-Mestre et al., 2014). Based on screening results, analyses of 
chlorpyriphos and pirimiphos-methyl have been included in the yearly Norwegian feed 
surveillance program (Sanden et al., ongoing surveillance; pers. comm.). Knowledge on 
transfer of these pesticides from feed to fish is lacking. 
Current legislation on pesticides (396/2005) include 451 substances with maximum residue 
levels (MRL) for plant and land-produced food, however MRL for seafood and raw materials 
solely used for feed is not yet established. 
Endosulfan is a pesticide on the Stockholm Conventions list of persistent organic pollutants 
and its use is being phased out. Endosulfan is not authorised in the European Union and is 
regulated as an undesirable substance in animal feed including fish feed. Endosulfan is still 
used in some parts of the world that export food and feed ingredients to Europe. The EU 
MRL for endosulfan in animal feed is 0.1 mg/kg, while the MRL in fish feed is 0.05 mg/kg 
(Commission Regulation (EU) No 744/2012). Surveillance of fish feed reports levels between 
0.0006 and 0.001 mg endosulfan/kg in the last six years and in 2013 the average content 
was 0.0007 mg/kg (Figure 5.3.1-1). Surveillance of farmed Atlantic salmon reports low 
endosulfan levels in farmed Atlantic salmon with 0.006 mg endosulfan per kg fish fillet as the 
highest value measured in 2013 (Hannisdal et al 2014). There is currently no maximum 
residue level (MRL) in the European Union or Norway for endosulfan in farmed fish, but 
there is a MRL for endosulfan in meat at 0.1 mg/kg. Endosulfan exposure estimates from a 
daily consumption of 300 g farmed Atlantic salmon will constitute approximately 0.5% of the 
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acceptable daily intake (ADI) of 0.006 mg/kg bw/day for a person weighing 70 kg. ADI is the 
acceptable daily intake of e.g. a pesticide, that a person can be exposed to every day 
throughout life without representing health risk (see Glossary). 
 
Figure 5.3.1-1 Fish feed content of sum endosulfan in the period from 2006 to 2013. 
Values are upper bound mean with minimum and maximum in µg/kg feed. Upper bound imply that 
concentrations lower than the limit of detection or limit of quantification is substituted with the actual 
value of these limits and not zero, which most likely represent an overestimate of the true values. The 
maximum limit is marked with a red line (currently 50 µg/kg which previously was 5 µg/kg). Number 
of feed samples per year were: n=20 (2006); n=20 (2007); n=21 (2008); n=24 (2009); n=0 (2010); 
n=25 (2011); n=23 (2012); n=69 (2013). Source: Sanden et al. (2014) 
 Synthetic antioxidants  5.3.2
Synthetic antioxidants are used as preservatives in fish feed ingredients to prevent auto-
oxidation of unsaturated lipids in fish meal or fish oil. These include propylgallate (PG), 
butylhydroksyanisol (BHA), butylhydroksytoluen (BHT) and ethoxyquin (EQ) as laid down in 
EC 1831/2003. Ethoxyquin (EQ) is predominantly used in fishmeal and is a prerequisite for 
sea transport of fishmeal over long distances to avoid oxidation and the subsequent danger 
of self-ignition. BHT and BHA are predominantly used in fish oils and the maximum permitted 
level of these and other synthetic antioxidants is 150 mg/kg feed. The synthetic antioxidants 
were not assessed in the 2006 VKM report (VKM, 2006). However, public concern about 
negative health effects of synthetic antioxidants, in particular EQ, in seafood has led to 
public interest in this issue. The safety of synthetic antioxidants has been evaluated several 
times by the Joint FAO/WHO Expert Committee on Food Additives (JECFA), the former 
European Commission’s Scientific Committee for Food (SCF) and the Joint FAO/WHO Meeting 
on Pesticide Residues (JMPR) in the case of EQ, since this compound is also used as a 
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all feed additives that have applied for re-authorisation and the European Commission has 
given EQ top priority.  
In feed for Atlantic salmon, the concentration of synthetic antioxidants varies between years 
and do not seem to reflect the last years change in ingredient composition (Figure 5.3.2-1). 
Although synthetic antioxidants such as EQ can be found in plant ingredients (NIFES, 
unpublished data), the levels are low compared to in fishmeal. 
 
Figure 5.3.2-1 Fish feed content of ethoxyquin (EQ) in the period from 2007 to 2013. Values are 
upper bound mean with minimum and maximum in mg/kg feed. Upper bound imply that 
concentrations lower than the limit of detection or limit of quantification is substituted with the actual 
value of these limits and not zero, which most likely represent an overestimate of the true values. The 
maximum limit for EQ in fish feed is currently 150 mg/kg. Numbers of feed samples per year were: 
n=22 (2007); n=21 (2008); n=25 (2009); n=23 (2010); n=25 (2011); n=23 (2012); n=69 (2013). 
Source: Sanden et al. (2014) 
There are currently no MRLs in the European Union for synthetic antioxidants in food 
products from farmed animals. In contrast, Japan has set MRLs of 10 mg BHT/kg, 1 mg EQ 
per kg and 0.5 mg BHA per kg for fish (Japanese Ministry of Health, Labour and Welfare 
www.mhlw.go.jp/english/). Lundebye et al. (2010) have calculated the intake of EQ, BHT 
and BHA from fillets from a number of farmed species (cod, salmon, halibut and trout) and 
showed that EQ can constitute between 4 and 15%, BHT can constitute between 34 and 
74%, and BHA can constitute with less than 1% of their respective ADIs on daily 
consumption of a 300 g portion of fish. However, in 2012 EFSA re-evaluated the ADI of BHT 
and it was from 0.05 mg/kg bw/day to 0.25 mg/kg bw/day 
(http://www.efsa.europa.eu/de/efsajournal/pub/2588.htm). Thus, BHT will constitute 
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 Mycotoxins 5.3.3
Plant protein ingredients used in fish feed may contain mycotoxins. A risk assessment on 
mycotoxins in cereal grain in Norway (VKM, 2013c), however, states that too little data and 
knowledge exist on this issue for fish health. Information of the transfer of mycotoxins from 
feed to fillet in Atlantic salmon, is scarce. However, recent available data on deoxynivalenol 
(DON) and ochratoxin A (OTA) show that the transfer from fish feed to fillet is negligible 
implying no risk for consumers of the fish (Bernhoft et al., 2014). 
 Polycyclic aromatic hydrocarbons 5.3.4
Vegetable oils may be contaminated by polycyclic aromatic hydrocarbons (PAHs) due to 
technological processes such as direct fire drying of grain and oilseeds. Thus vegetable oil 
are a potential contamination source of PAHs in fish feed (EFSA, 2007; Speer et al., 1990). 
The PAH levels in vegetable oils for human consumption are reduced by processing 
techniques (EFSA, 2007) or direct decontamination with the use of active carbon and 
deodorisation (Larsson et al., 1987). In a research project where 80% of the fish meal and 
70% of the fish oil in Atlantic salmon diets was replaced with vegetable ingredients, the diets 
contained 16-fold more of the most toxic PAH, benzo[a]pyrene (Berntssen et al., 2010a). 
However, due to high degree of metabolism of PAHs in fish the transfer of PAHs from feed to 
fillet was so low that the sum of all 16 PAHs in fillet was 25-fold lower than the maximum 
limit for one of the PAHs, benzo[a]pyrene, in seafood (Berntssen et al., 2010a). Fish feed 
surveillance revealed a mean concentration of PAH4 in 2013 at 1.9 µg/kg (Figure 5.3.4-1; 
(Sanden et al., 2014). Based on the relatively limited number of feed samples analysed the 
last 4 years showing large variation, no trend is obvious. This is expected since PAHs are 
components produced during certain processing procedures which will vary between plant 
ingredients and also between batches of the same type of plant ingredient. 
 
Figure 5.3.4-1 Fish feed content of sum polycyclic aromatic hydrocarbons (PAH4) in the 
period from 2010 to 2013. Values are upper bound mean with minimum and maximum in µg/kg feed. 
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substituted with the actual value of these limits and not zero, which most likely represent an 
overestimate of the true values. Numbers of feed samples per year were: n=23 (2010); n=25 (2011); 
n=23 (2012); n=68 (2013). Source: Sanden et al. (2014)  
 Brominated flame retardants and perfluorated compounds 5.3.5
In recent years, information has become available about numerous other organic 
contaminants that may accumulate in the marine food chains. Because these compounds 
have only recently been identified in marine organisms, however, their potential to transfer 
from fish feed to fish fillet is not known for all. One group of brominated flame-retardants, 
seven of the polybrominated diphenyl ethers (PBDE-7), have been monitored for fish feed 
and farmed Atlantic salmon and trout fillets over the last decade, and trends from the feed 
surveillance show decreasing concentrations, Figure 5.3.5-1;(Sanden et al., 2014). In 2013, 
the PBDE-7 content in farmed Atlantic salmon fillet and trout was identical at 0.4 µg/kg 
(number of samples were 102 and six for Atlantic salmon and trout, respectively). 
 
Figure 5.3.5-1 Fish feed content of polybrominated diphenyl ethers (PBDE-7) in the period 
from 2003 to 2013 (left), and the contents of the individual seven PBDE congeners measured in 2013 
(right). Values are given as upper bound mean with minimum and maximum levels in µg/kg feed. 
Upper bound imply that concentrations lower than the limit of detection or limit of quantification is 
substituted with the actual value of these limits and not zero, which most likely represent an 
overestimate of the true values. Numbers of feed samples per year were: n=22 (2003); n=10 (2004); 
n=19 (2005); n=20 (2006); n=22 (2007); n=21 (2008); n=25 (2009); n=23 (2010); n=25 (2011); 
n=22 (2012); n=69 (2013). Source: Sanden et al. (2014) 
The other brominated flame-retardants, hexsabromocyclododecan (HBCDs) and 
tetrabromobisphenol A (TBBPAs), were in 2013 included in the surveillance programs for fish 
feed, and knowledge on transfer from feed to fish fillet is limited. However, one of the HBCD 
isomers, HBCDα, was demonstrated to efficiently transfer from fish feed to fish fillet 
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µg/kg fillets with higher levels when the fish oil inclusion was high, and according to the 
authors of the paper; farmed Atlantic salmon can contribute to a maximum of 6% of the 
estimated provisional food reference dose for HBCD (Berntssen et al., 2011). The Atlantic 
salmon surveillance showed that mean fillet total HBCD, of which HBCDα is the dominating 
isomer, was 0.4 µg/kg (n=46 samples each of five pooled fish) (Hannisdal et al., 2014). In 
2013, Atlantic salmon fillet levels of TBBPA were above the limit of quantification in five of 46 
samples. The LOQ ranged from 0.04 to 0.20 µg/kg (Hannisdal et al., 2014). 
The perfluorated compounds (18 compounds including PFOS and PFOA) have been included 
in the monitoring of farmed fish the recent years, and all samples including the 49 sampled 
in 2013 contained levels below the limit of quantification (LOQ) (Hannisdal et al., 2014). For 
example for PFOS, the LOQ was between 0.3 and 0.8 µg/kg. 
For a range of the compounds there is little data on the levels in fish feed and farmed fish, 
but if the substances are present in fish feed, it will be important to establish knowledge on 
their eventual transfer from feed to farmed fish. 
 Genetically modified plants in fish feed 5.3.6
Through the Agreement of the European Economic Area (EEA), Norway is obliged to 
implement the EU regulations on genetically modified (GM) food and feed (regulations 
1829/2003, 1830/2003). Until implementation of these regulations, Norway has a national 
legislation concerning processed GM food and feed products that are harmonised with the 
EU legislation. These national regulations entered into force 15 September 2005. For 
genetically modified feed and some categories of genetically modified food, no requirements 
of authorisation were needed before this date. Such products, lawfully placed on the 
Norwegian marked before the GM regulations entered into force, the so-called existing 
products, could be sold in a transitional period of three years when specific notifications were 
sent to the Norwegian Food Safety Authority (NFSA). Within three years after 15. September 
2005, applications for authorisation had to be sent to the Authority before further marketing.  
The Norwegian Seafood Federation (FHL) has once a year since 2008, applied for an 
exemption of the authorisation requirements of 19 existing GM products. These 19 GM 
events are all authorised in the EU, and the NFSA has granted exemption for a period of one 
year at the time. 
According to the NFSA, FHL has applied for an exemption in the case of a feed shortage, but 
no GM ingredients has so far been used by the Norwegian fish feed industry. In October 
2014, a new application from the FHL to prolong the exemption was rejected by the NFSA. 
The use of GM ingredients in fish feed is surveyed by the NFSA by special surveillance 
programs. Of the surveilled fish feed samples, none of the abovementioned GM ingredients 
have been detected. 
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Due to the limited global supply of marine lipid sources, the inclusion of non-marine plant 
oils in aqua feeds has increased over the last decades to meet the increased demand from 
the rapidly expanding production from aquaculture (Nasopoulou and Zabetakis, 2012; 
Nichols et al., 2014). Further large changes in lipid sourcing are unavoidable if the prognoses 
for increases in aquaculture production are to be fulfilled (SINTEF, 2013).  
Increases in the content of n-3 fatty acids in plant crops can be obtained by traditional 
breeding. However, genetic modification (GM) is needed for development of plants that can 
produce long-chain n-3 fatty acids (Opsahl-Ferstad et al., 2003). Some GM varieties of 
soybean and oilseed rape with modified lipid content and fatty acid profile (lauric (C12), oleic 
(C16) and linolenic acid (C18 omega-3)) are authorised for food and feed uses (European 
Chemicals Agency, 2012), but none of these have been modified to produce and accumulate 
the long-chain n-3 fatty acids. However, transgenic oilseed plants with high-level 
accumulation of long-chain n-3 fatty acids are under development (Mansour et al., 2014; 
Miller et al., 2008; Ruiz-Lopez et al., 2014). As such no GM products are yet commercially 
available, and no scientific information is currently available that can be used for safety 
assessment of these lipid sources. 
Marine protein sources in fish feed can to a large extent be replaced by plant ingredients 
without genetic modification. Among the protein rich plant ingredients, there are many 
showing nutritional value that allow inclusion in fish diets at relatively high levels (VKM, 
2009). Over the last decade, GM varieties of soybean (80%) and maize have become the 
dominating varieties on the world market. These raw materials are already replacing non-GM 
varieties to a large extent in terrestrial animal production. 
At present, the GM plant varieties most relevant for fish feeds are derived from soya and 
maize. Most GM varieties are made resistant against insect or herbicide tolerant by genetic 
modification. Knowledge on safety of GM feed ingredients in fish diets are accumulating. A 
thorough review of available relevant fish studies on this issue has been provided by 
Sissener et al. (2011). The VKM Panel on Genetically Modified Organisms, has in several 
reports evaluated the safety of the GM feed Event MON810 and considered it, based on 
current knowledge, to be as safe as non-GM varieties (VKM, 2007; VKM, 2013b). 
5.4 Summary of changes in farmed Atlantic salmon feed 
composition – the significance for nutrients and contaminants 
in the fillet 
The raw materials used in feed for Norwegian farmed Atlantic salmon and trout have 
substantially changed since 2006. Up to 70% of the fish meal and fish oil are replaced by 
plant proteins and vegetable oils resulting in some changes in nutrient composition and 
contaminant composition of fish feed which is reflected in the fish fillet.The changes in feed 
and the following farmed fish fillet composition since 2006 is; 
 Protein (amino acid) composition of farmed fish fillet is not changed. 
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 Concentrations of EPA+DHA in farmed Atlantic salmon have decreased from ca 3 
g/100 g fillet in 2006 to about 1.3 g/100 g in 2013. 
 Concentrations of n-6 fatty acids in farmed Atlantic salmon have increased from 1.4 
g/100 g in 2005 to ca. 2.3 g/100 g in 2013.  
 Since 2006, Atlantic salmon feed concentration of vitamin D3 has decreased 36% to 
0.15 mg vitamin D/kg, concentration of selenium has decreased 45% to 0.15 mg 
selenium/kg and iodine has decreased 50% to 2.2 mg iodine/kg. 
 Concentrations of marine POPs have decreased in fish feed and farmed Atlantic 
salmon and farmed rainbow trout fillets since 2006. The levels of dioxins and dl-PCBs 
in 2013 are reduced by almost 70% compared to 2006. In 2013, farmed Atlantic 
salmon contained 0.5 ng TEQs dioxins and dl-PCBs per kg fillet.  
 Mercury has decreased in Atlantic salmon fish feed and fillets due to the increasing 
fish meal replacement with plant protein sources. Mercury present as methylmercury 
in farmed Atlantic salmon fillet has decreased 50% since 2006 to 0.014 mg mercury 
per kg fillet. 
 Decontamination of fish oil may further decrease the levels of POPs without affecting 
the fillet fatty acid levels and composition. Decontamination of fish oil, however, will 
remove fat-soluble vitamins such as vitamin D. 
 The predicted concentrations in fillet following decontamination of fish oil in feed 
indicate that dioxin and dl-PCBs will be in the same range as in other fatty foods such 
as cheese (0.29 medium bound WHO-TEQ 2006 ng/kg product) and somewhat 
higher than beef (0.18 medium bound WHO-TEQ 2006 ng/kg product).  
 Fish feed levels of the pesticide endolsulfan has been low and stabile from 2006 until 
2013. In 2013, the level of endosulfan in farmed salmon fillet was low and one dinner 
serving farmed Atlantic salmon constituted less than 1% of acceptable daily intake. 
 New contaminants such as PAH, mycotoxins, and new pesticides are introduced into 
fish feed when feed ingredients change from marine to plant origin. So far, few 
studies are available, but those existing indicate that the levels of PAHs and 
mycotoxins in the feed seem to be low and therefore not expected to represent any 
risk for food safety. However, more knowledge are needed on the concentrations in 
fish feed and transfer from feed to fish fillet of new contaminants as well as for the 
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6 Nutrients and contaminants in fish 
on the Norwegian market 
Data reported in this chapter are based on analytical methods which are accredited in 
accordance with the standard ISO 17025 (NIFES). The analytical methods for the 
contaminants and their Limit of Detection (LOD) and Limit of Quantification (LOQ) are 
described for each set of data reported by Hannisdal et al. (2014), Julshamn and Frantzen 
(2010), Julshamn et al. (2010) , Julshamn et al. (2013d), Nilsen et al. (2010), Nilsen et al. 
(2012), Nilsen et al. (2013a), Duinker et al. (2013), Frantzen et al. (2009) and Frantzen et 
al. (2010). The limit of detection (LOD) is the lowest level at which the method is able to 
detect the substance, while the limit of quantification (LOQ) is the lowest level for a reliable 
quantitative measurement. 
For the calculations of nutrient intake presented in Chapter 7, choices have been made 
regarding which fish/fish products to include in the calculations of nutrient intake and of 
which contaminant exposure to use for the various fish/fish products (Chapter 6, Appendix 
VII). Based on the reported fish consumed in one or several of the surveys (Chapter 3), data 
on nutrient and contaminant content had both to be available, and representative for fish on 
the Norwegian market. The concentrations and the rationale for fish species/fish products 
used for nutrient and contaminant intake and exposure calculations can be found in 
Appendix VII. 
6.1 Content of nutrients in fish and fish products 
For further details of sampling, methods for chemical analyses and quality assurance of 
nutrients and contaminants in fish, see Appendix VI. 
 Wild and farmed fish species 6.1.1
The content of selected nutrients presented in Table 6.1.1-1 is divided into categories of lean 
and medium fat fish species, fatty fish species, and fish products. Generally, data available 
on nutrient composition of wild and farmed fish is limited and based on a relatively low 
numbers of fish. In contrast to contaminants in wild and farmed fish, which have been either 
yearly surveilled or included in large baseline studies (as described in Appendix VI), similar 
major efforts have not yet been done to characterise the nutrient composition in wild and 
farmed fish. For some wild fish species data are lacking (e.g. redfish and haddock) or most 
recent data available are analysed in 2005. The data from 2005 are still included in this 
report since variation in wild fish nutrients is not expected to change significantly over time. 
This is in contrast to farmed fish, where the diet composition have changed since the 2006 
report having consequences for the composition of several of the nutrients in farmed fish 
fillet. The time-trends for farmed Atlantic salmon are presented in Chapter 5 in this report. 
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6.1.1.1 Fat content 
In the category lean and medium fatty fish, the mean total fat content range from 0.6 g per 
100 g in haddock to 2.8 g per 100 g in redfish. In the fatty fish category total fat content 
ranges from 7.6 g per 100 g in farmed halibut to 32.1 g per 100 g in mackerel. Wild halibut 
was analysed in 2005 for nutrients, and although the size of halibuts analysed included small 
and large specimens (as described in Appendix VI) mean total fat content was analysed to 
be only 2.3 g per 100 g. This low total fat content is likely due to only the lean part of the 
fillet being analysed, which is the part of the halibut that normally is consumed whereas the 
fattier outer part is cut away. In spite of the analysed value of total fat in wild halibut is 
within the range of lean and medium fat fish, halibut is normally categorised as fatty fish and 
hence also here included as fatty fish. The halibut analysed for nutrients were not the same 
fish samples described for analyses of contaminants. 
6.1.1.2 Fatty acid content 
The highest level of sum EPA+DPA+DHA was found in mackerel and the lowest in Greenland 
halibut. DPA typically contributes with 20%, of sum EPA+DPA+DHA, whereas EPA+DHA 
contribute with the remaining 80%. Sum n-3 is always higher than sum EPA+DPA+DHA 
since additional n-3 fatty acids are included in sum n-3. These are 16:3n-3, 16:4n-3, 18:3n-
3, 18:4n-3, 20:3n-3, 20:4n-3, 24:5n-3 and 24:6n-3. Generally, the difference between sum 
EPA+DPA+DHA and sum n-3 is higher in the fattier fish species than the lean fish species. 
For example, the fattiest species mackerel had 1.5 fold higher sum n-3 than sum 
EPA+DPA+DHA whereas Atlantic cod fillet had hardly any increase in sum n-3 compared to 
sum EPA+DPA+DHA. In fish, most of EPA, DPA and DHA are membrane bound structural 
lipids. Surplus EPA+DPA+DHA and other n-3 fatty acids are mainly stored in body fat as 
triacylglycerols (TAGs) resulting in a higher sum n-3. Cod has negligible TAG stores in 
muscle, whereas fatty fish can have substantial TAG levels as fat stores in the fillet. This is 
reflected in the similar EPA+DPA+DHA and sum n-3 in lean fish fillet (e.g. cod), whereas 
sum n-3 is higher than EPA+DPA+DHA in fatty fish fillets (e.g. mackerel). 
Farmed Atlantic salmon has almost twice the sum of n-3 PUFA compared to sum 
EPA+DPA+DHA, and 18:3n-3 (linolenic acid) from vegetable oil is the main fatty acid 
contributing to the higher sum of n-3. Compared to 2006, sum EPA+DPA+DHA in fish fillets 
has decreased by 50% whereas sum n-3 has decreased by 30%. The lower decrease in sum 
n-3 is due to the increase in 18:3n-3 (linolenic acid, mainly from raps oil) in farmed salmon 
fillet in 2013 compared to the 2006 report. 
Sum of n-6 PUFA is included in Table 6.1-1 to document the increase in n-6 PUFA when fish 
oil is replaced by vegetable oils. In the wild fish species, sum of n-3 PUFA is typically 10 fold 
higher than sum of n-6 PUFA. In farmed Atlantic salmon in 2013, sum of n-3 PUFA is 
approximately equal to sum of n-6.  
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In the 2006 VKM report, farmed Atlantic salmon was reported to contain 520 mg n-6 PUFA 
per 100 g, 3200 mg n-3 PUFA per 100 g, and 2700 mg EPA+DPA+DHA per 100 g, thus 
containing six times more sum n-3 PUFA than sum n-6 PUFA. 
The fatty acids included in the sum n-6 PUFA are 18:2n-6, 18:3n-6, 20:2n-6, 20:3n-6, 20:4n-
6, 22:4n-6 and 22:5n-6. Of the sum n-6 PUFA, 18:2n-6 (linoleic acid) is the dominating fatty 
acid in farmed Atlantic salmon, whereas the long-chain 20:4n-6 (arachidonic acid) accounts 
for a higher relative portion of sum n-6 PUFA in wild fish species.  
6.1.1.3 Vitamin D 
The content of vitamin D (as D3) is naturally highest in the fatty fish species. Also within the 
fatty fish species, the content of vitamin D varies independently of fillet lipid content. Herring 
contain the highest vitamin D at 14.5 µg/100 g whereas mackerel has the lowest vitamin D 
content at 2.8 µg per 100 g. This is in contrast to mackerel containing 2-fold more fat per 
100 g compared to herring. 
In the 2006 VKM report, farmed Atlantic salmon contained 8 µg vitamin D/100 g. The current 
vitamin D concentration (analysed as D3) in farmed Atlantic salmon is reported to be similar 
(7.5 µg/100 g) compared to 2006. 
6.1.1.4 Selenium and iodine  
Selenium fillet concentrations were all within a relatively narrow range in the wild fish 
species varying from 24 µg/100 g in cod to 58 µg/100 g in herring. Farmed Atlantic salmon 
contained 12 µg/100 g in 2013, as also described and discussed in Chapter 5. 
Lean marine fish, such as Atlantic cod and saithe, contain the highest levels of iodine being 
100-fold higher compared to the fatty fish species. 
Data on nutrients in freshwater fish is scarce and mainly lacking. 
In the 2006 VKM report, farmed Atlantic salmon contained 30 µg selenium per 100 g and 6-
34 µg iodine per 100 g. Todays farmed Atlantic salmon contains less selenium (12 µg per 
100 g) and iodine (4 µg per 100 g) than the corresponding levels in 2006. 
6.1.1.5 Sandwich spreads  
The sandwich spreads based on liver from codfish were typically high in fat, EPA+DPA+DHA, 
vitamin D, iodine and selenium. All these nutrients were present in higher concentrations in 
the cod liver compared to in fillets of wild and farmed fish species. The ratio between sum n-
3 and sum n-6 were approximately 10 to 1 as it were for all the wild fish species. For 
concentrations of n-3 fatty acids, vitamin D, iodine and selenium used in the intake 
assessment in Chapter 7, see Appendix VII. 
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Table 6.1.1-1 Concentration of nutrients in lean and fatty fish and fish products given as mean per 100 grams fish fillet/edible product 





















Lean fish (≤ 5% fat)a 
Atlantic codb 51 2006/07/11 1.1 (0.1) 273 (53) 282 (53) 22 (4) <1  323 (425) 24 (3) 
Saithec 40 2006/11 1.4 (0.6) 439 (191) 458 (199) 27 (11) 1.4 (0.2) 160 (95) 30 (14) 
Haddock d - No data 0.6 No data No data No data 0.7 No data 28 
Plaice  15-20 2007 2.6 (1.0) 623 (271)  709 (308)  74 (29)  6.5 (8.2) 14 (3) 34 (7)  
Redfishd  - - 2.8 No data No data No data No data No data 50 
Wolffishe 3 2011 0.9 (0.5-1.1) 223 (137-325) 250 (149-346) 121 (89-175) <0.1 124 (114-
133) 
29 (25-31) 
Tuna, cannedd - - 1 No data No data No data 1.6 8  200 
Fatty fish (>5% fat) a 
Atlantic halibutf 53 2005 2.3 (2.0) 612 (410) 709 (502) 80 (58) 12 (8.2) 18 (10) No data 
Farmed Atlantic halibut  15 2005 7.6 (2.3) 1450 (399) 1822 (516)  389 (126) 8.5 (3.1) No data 28 (8) 
Greenland halibutg 18 2006/11 13 (2.0) 1053(141) 1358 (91) 258 (36) 12 (0.2) 10 (2) 50 (16) 
Herring (Norwegian spring 
spawning)h  
30 2005/10 9.9 (5.0) 1655 (1130) 2213 (1637) 170 (90) 15 (9.2) 2 (1) 58 (8) 
Herring (North Sea)i 44 2005/06/10 14 (2.1) 2479 (388) 3543 (666) 375 (123) 7.7 (1.7) 12 (3) 50 (8) 
Mackerel (North Sea)  10 2006 32 (1.4) 6471 (498) 9568 (751) 755 (59) 4.4 (1.4) No data 49 (3) 
Mackerel (North East Atlantic)  10 2010 23 (3.7) 4456 (629) 6738 (1045) 605 (105) 2.8 (0.8) 17 (3) 52 (4) 
Wild Atlantic salmon (Sørfjorden) 27 2012 8.7 (2.8) 2016 (363)  2485 (520)  268 (61)  11 (5.3)  14 (6)  46 (8)  
Wild Atlantic salmon (Finnmark)  99 2012 8.0 (2.7) 1765 (515)  2126 (650)  193 (72)  No data No data 44 (15)  
Farmed Atlantic salmonj 90 2013 15 (2.2) 1311 (166) 2303 (285) 2296 (377) 7.5 (2.6) 4 (2) 12 (3) 
Farmed Atlantic salmonk 100 2012 14 (2.7) 1590 (345) 2582 (494) 2149 (557) 6.3 (3.0) 2 (1) 14 (3) 
Freshwater fish 
Perchd - - 1.3 No data No data No data 0.8 18 28 
Brown trout   - No data No data No data No data No data No data No data 
Piked - - 0.7 No data No data No data 0.9 20 22 
Sandwich spreads from fish 
Cod roe and liver pated - 2014 39 No data No data No data 39 234 60 
Cod roe and liver patel - - 33 5500 (EPA+DHA) 6600 No data  No data  No data  No data  
Mackerel in tomato sauced  - 2014 19 No data No data No data  2.9 No data 30 
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Mackerel in tomato sauce
e




1886 (888-2557) 4.3 (2.3-8.4) No data 30 (20-40) 
Caviar (based on cod roe)d  - 2014 35 No data No data No data 0 85 41 
Cod roe 
Atlantic cod roel 5 2014 6.4 300 (EPA+DHA) 700 No data No data No data No data 
Atlantic cod roed - 2014 2.7 No data No data No data 12 104 9.0 
Fish liver 
Saithe liverm 30 2006 76 (2.6) 15402 (349) 18417 (838) 1796 (639) 120 (30) 144 (20) 82 (6)  
Atlantic cod livern 41 2006/07 59 (4.3) 11296 (655) 13477 (731) 1323 (34) 89 (24) 379 (186) 80 (3) 
Cod liver for use in cod roe and 
liver pâtél 
6 2014 61 13050 (EPA + DHA) 14570 176 No data No data No data 
aLean fish is fish with fat content below 2%, medium fatty fish have 2-5% fat, and fatty fish have more than 5% fat. Halibut is categorised as fatty fish in this 
opinion, bMean of cod harvested in the Norwegian Sea 2006 (10 samples), North Sea 2011 (10 samples) and Barents Sea 2006 (20 samples) and 2007 (11 
samples). For vitamin D, 42 samples were analysed, cMean of saithe harvested in the North Sea 2006, Barents Sea 2006 and 2011, Haltenbank 2006 (10 
samples per harvesting), dValues according to the Norwegian Food Composition Table, 2014, eDue to few samples, SD is not given but minimum and 
maximum values, fMean of 53 samples of halibut harvested in Norwegian Sea and North Sea in 2005, gMean of Greenland halibut harvested in Barents Sea 
2006 (8 samples) and 2011 (10 samples). For iodine, 10 samples were analysed, hMean of Norwegian Spring Prawning herring from the Norwegian Sea 2005 
and 2010, and the North Sea 2005 (10 samples per harvest). For iodine, 10 samples were analysed, iMean of North Sea herring harvested in the North See 
2005 (9 samples), 2006 (10 samples) and 2010 (25 samples), jMean of 90 samples of farmed salmon harvested in 2013, except for analysis of vitamin D 
where 70 samples were analysed, kMean of 100 samples of farmed salmon harvested in 2012, except for analysis of vitamin D where 69 samples were 
analysed, lValues from the food industry, 2014. Samples of cod liver for use in cod roe/liver pâté were pooled samples taken from six whole cans, mFor iodine, 
nine samples were analysed, and for selenium, 71 samples were analysed, nMean content in cod liver from cods harvested in the Barents Sea in 2006 (21 
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 Fish oil and/or cod liver oil 6.1.2
Only eight cod liver oil samples were analysed for nutrient composition from 2007 to 2010 
(Table 6.1.2-1). Of these the EPA+DPA+DHA content was naturally high with 5 ml of oil 
contributing with approximately 1.4 g EPA+DPA+DHA. Vitamin D content was expected to 
be approximately 200 µg per 100 g based on the labelling of cod liver oil (10 µg per 5 ml). 
The mean vitamin D content was analysed to be 233 µg per 100 g, and the 95th percentile 
were 105 µg per 100 g. Hence, the mean vitamin D content was within the range that can 
be expected in cod liver oil. 
Table 6.1.2-1  Nutrients in cod liver oils and n-3 oil based food supplements of the 
Norwegian market given as mean with minimum and maximum values in parentheses 












Fish oils 2007-2011 13 100 28100 (12594-82600) 34500 (19500-
69200) 
73 (<1-460) 
Source: NIFES (unpublished data) 
Fish oils are a heterogeneous group with no standard regarding vitamin D content. It is 
therefore as expected that the vitamin D content varies widely (from not detected to 460 µg 
per 100 g) whereas the sum n-3 and sum EPA+DPA+DHA was at comparable concentrations 
as cod liver oil. 
6.2  Contaminants in fish and fish products 
 Wild and farmed fish species and fish products 6.2.1
6.2.1.1 Concentration of mercury in fish 
The available data on contaminant concentrations in wild and farmed fish, and fish products 
have been expanded substantially since 2006 due to yearly surveillance of farmed fish and 
several large base line studies of the commercially relevant wild fish species. The data used 
in this report is thus considered representative for the vast majority of species (Table 
6.2.1.1-1). There are some exceptions, such as wolffish (n=10 from 2003 and n=25 from 
2005), haddock (n=25), tuna (n=6) and sprat (n=14) with low number of fish being 
analysed and where most recent data are from before 2006. However, for the species being 
most relevant for consumption in Norway, which is the target for this report, data are 
available from large base line studies and/or national and/or EU surveillance programs 
(Appendix VI). 
As expected, the large wild fish species such as halibut, Greenland halibut and tuna have the 
highest mercury fillet concentrations of the marine fish species. Fresh water species 
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contained even higher concentrations than the marine fish, and pike contained the highest 
mercury concentrations at 0.57 mg per kg (Table 6.2.1.1-1). The lowest mercury 
concentrations were found in farmed Atlantic salmon in 2012 and 2013 at 0.014 mg per kg 
fillet. This was expected based on the feed ingredients used (Chapter 5) combined with fast 
growth and relatively short production time in modern farming of Atlantic salmon. In the 
2006 VKM report, farmed Atlantic salmon were reported to contain 0.030 mg mercury /kg 
fillet (w.w.). 
In fish fillets the majority of mercury is present as methylmercury. As an example farmed 
Atlantic salmon and rainbow trout were analysed for methylmercury and mercury, and data 
show that all the mercury was present as methylmercury. Therefore, as a conservative 
approach in this report all total mercury data in fish is considered as methylmercury. 
Except for “cod roe and liver pate” (in Norwegian: Svolværpostei) which was analysed to 
have mercury levels below LOQ, mercury was present in quantifiable levels (above LOQ) in 
all fish species. This is also evident by the upper bound (UB) and lower bound (LB) levels 
being the same or very similar in all fish species analysed. 
Cod liver oil and fish oil contained very low mercury levels compared to fillets of wild and 
farmed fish (Table 6.2.1.1-2), down towards, or at, the limit of quantification. 
For details of sampling, methods for chemical analyses and quality assurance of 
contaminants in fish, see Appendix VI. For mercury concentrations used in the exposure 
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Table 6.2.1.1-1 Concentration of mercury (Hg) in fish and fish products. Upper and lower mean levels with minimum and maximum values in 
parenthesis. 
Fish species/fish product Sampling n Mean mg Hg/kg fillet (wet weight) (min.-max.) LOQ  
 year  Lower bound Upper bound mg Hg/kg fillet (ww) 
Lean fish (≤ 5% fat)a      
Cod, all populations  2009-2011 2109 0.075 (0.004-0.70) 0.075 (0.004-0.70) 0.001 
Cod (coastal) 2010-2011 687 0.11 (0.012-0.71) 0.11 (0.012-0.71) 0.001 
Cod (North Sea) 2010-2011 516 0.11 (0.004-0.54) 0.11 (0.004-0.54) 0.001 
Cod (North East Atlantic) 2009-2010 906 0.035 (0.006-0.17) 0.035 (0.006-0.17 0.001 
Saithe 2010-2012 1620 0.051 (0.01-0.66) 0.051 (0.01-0.66) 0.001-0.002 
 2006-2013 124 0.051 (0-0.21) 0.051 (0.007-0.21) 0.001-0.008 
Haddock  2003 25 0.08 (0.04-0.12) 0.08 (0.04-0.12) Not given 
Plaice 2007 156 0.070 (0.009-0.40) 0.070 (0.009-0.40) 0.004-0.008 
Redfish 2007 178 0.13 (0.011-1.1) 0.13 (0.011-1.1) 0.005-0.009 
Wolffish  2003 10 0.021 (0-0.18) 0.025 (0.006-0.18) 0.006 
 2005 25 No data 0.11 (0.056-0.15) Not given 
Tuna, canned  2006 6 0.10 (0.035-0.20) 0.10 (0.035-0.20) 0.008 
Fatty fish (>5% fat)a      
Atlantic halibutb 2006-2010 88 0.26 (0.020-1.2) 0.26 (0.020-1.2) 0.001-0.02 
B-section  40 0.29 (0.020-1.2) 0.29 (0.020-1.2) 0.001-0.02 
I- section  39 0.21 (0.020-0.77) 0.29 (0.020-1.2) 0.001-0.02 
B+I- section  79 0.25 (0.020-1.2) 0.25 (0.020-1.2) 0.001-0.02 
Greenland halibut 2006-2008 1288 0.22 (0.009-1.2) 0.22 (0.009-1.2) 0.003-0.01 
Herring (Norwegian spring spawning)  2006-2007 800 0.039 (0.008-0.40) 0.039 (0.008-0.40) 0.006-0.015 
Herring (North Sea)  2009-2010 862 0.050 (0.010-0.23) 0.050 (0.010-0.23) 0.001-0.003 
Mackerel (North East Atlantic)  2007-2009 845 0.039 (0-0.36) 0.039 (0.009-0.36) 0.009-0.03 
Spratc  2010 14 0.019 (0.009-0.027) 0.019 (0.009-0.027) 0.005 
Wild Atlantic salmon  2012 98 0.036 (0.014-0.13) 0.036 (0.014-0.13) 0.001-0.002 
Farmed Atlantic salmond 2013 132 0.014 (0.007-0.041) 0.014 (0.007-0.041) 0.002 
 2012 305 0.014 (0.007-0.042) 0.014 (0.007-0.042) Not given 
Farmed troutd 2013 20 0.018 (0.011-0.053) 0.018 (0.011-0.053) 0.002 
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Fish species/fish product Sampling n Mean mg Hg/kg fillet (wet weight) (min.-max.) LOQ  
 year  Lower bound Upper bound mg Hg/kg fillet (ww) 
 2010 155 No data 0.02 (0.01-0.04) Not given 
Farmed Arctic char 2010 25 No data 0.03 (0.02-0.04) Not given 
Freshwater fishe      
Perch  1965-2008 >5000 0.33 (0.01-4.2) 0.33 (0.01-4.2) Not given 
Brown trout  1965-2008 >2500 0.12 (0.01-3.1) 0.12 (0.01-3.1) Not given 
Pike 1965-2008 24520 0.57 (0.01-6.0) 0.57 (0.01-6.0) Not given 
Sandwich spreads from fish      
Cod roe and liver patef 2008 2 <0.02 <0.02 0.02 
Cod roe and liver pateg 2014 7 <0.011 <0.011 0.005 -0.011 
Cod roeg 2014 - Not detected Not detected 0.005 -0.011 
Fish liver      
Cod liver, all populations  2009-2011 1908 0.042 (0.00-1.6) 0.045 (0.004-1.6) 0.004-0.03 
Cod (coastal) 2010-2011 638 0.073 (0.00-1.6) 0.074 (0.004-1.6) 0.005-0.03 
Cod (North Sea) 2010-2011 434 0.051 (0.00-0.21) 0.051 (0.01-0.21) 0.01-0.03 
Cod (North East Atlantic) 2009-2010 836 0.014 (0.00-0.12) 0.019 (0.004-0.12) 0.004-0.02 
Saithe liver  2010-2012 1590 0.013 (0.0-0.42) 0.015 (0.002-0.421) 0.002-0.03 
aLean fish is fish with fat content below 2%, medium fatty fish is fish with 2-5% fat, and fatty fish is fish with >5% fat. Halibut is categorised as fatty fish in this opinion. 
bFor halibute, see Appendix VII for definition of B and I sections, cWhole, freshly caught sprat were analysed, dFor farmed salmon and trout, pooled samples of five fish each 
were analysed, eValues for fresh water fish are from Jenssen et al. (2012), fTwo pooled samples of five cans each based on ten samples from different batches. Each can 
consisted of 40% cod roe, 24% cod liver, soy oil, cod liver oil, vinegar, tomato puree and water (Julshamn and Frantzen (2009); Julshamn and Frantzen (2010)), gData from 
the food industry. 
Table 6.2.1.1-2 Concentrations of mercury in cod liver oil and n-3 oil based food supplements on the Norwegian market.  




Level of quantification (LOQ) 
mg/kg 
Cod liver oila  2010-2013 6 <0.005 0.004 (0.003-0.005) 0.003-0.005 
Fish oilsa 2009-2013 33 <0.003-0.029 0.009 (0.003-0.029) 0.003-0.029 
aData from (Julshamn and Frantzen (2009); Julshamn and Frantzen (2010))
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6.2.1.2 Dioxins and PCBs  
The available data on contaminant concentrations in wild and farmed fish and fish products 
have been expanded substantially since 2006 due to yearly surveillance of farmed fish and 
several large base line studies of the commercially relevant wild fish species. However, as 
described in Appendix VI, analyses of dioxins and dl-PCBs were done for a limited number of 
samples of lean fish fillet such as Atlantic cod (n=136) and a high number of lean fish livers 
such as Atlantic cod livers (n=2050). 
The majority of analyses have been performed after the 2006 report, and hence updated 
and solid data sets are available for the vast majority of relevant fish species for human 
consumption. 
As expected, the lean fish fillets contained several fold lower concentrations of dioxins and 
dl-PCBs compared to the medium fatty and fatty fish fillets. Livers and roe from Atlantic cod 
contained the highest concentrations at more than 21 ng 2005-TE dioxins and dl-PCBs (Table 
6.3-1). Of the fatty wild fish species halibut, both Greenland- and Atlantic halibut, contained 
the highest concentrations at 4.4 ng 2005-TE per kg fillet, whereas NVG herring had the 
lowest concentrations at 0.63 ng 2005-TE per kg fillet. Farmed Atlantic salmon fillets 
containing 0.5 ng 2005-TE dioxins and dl-PCBs per kg fillet (Table 6.2.1.2-1) had lower 
concentrations than all the wild fatty fish species. In the 2006 VKM report, farmed Atlantic 
salmon were reported to contain 1.7 ng dioxins and dl-PCBs TEQ/kg, 1.2 ng dl-PCBs TEQ/kg, 
and 0.5 ng dioxins TEQ/kg. Hence, the content of dioxins and dl-PCBs were more than tree-
fold higher in 2006 compared to todays farmed Atlantic salmon. 
Concentration of dioxins and dl-PCBs in cod liver oil and fish oil (Table 6.2.1.-2) ranged from 
0.59 to 1.1 ng 2005-TE per kg based on upper bound (UB) values. It is, however, important 
to note that the difference between LB and UB concentrations was from 2 to 5 fold, 
indicating that a high proportion of the UB concentration was due to using LOQ of different 
congeners. 
For further details of sampling, methods for chemical analyses and quality assurance of 
contaminants in fish, see Appendix VI. For concentrations of dioxin and dl-PCBs used in the 
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Table 6.2.1.2-1 Sum dioxins and dioxin-like PCBs given as mean nanogram (ng) 2005-TE/kg wet weight (ww) fish fillet and fish products. Upper and 
lower mean levels with minimum and maximum values in parenthesis. 
Food item  Year n Mean sum dioxins and dl-PCBs 
ng TEQ/kg ww 
Mean dioxinsa  
ng TEQ/kg ww 




   Lower bound  Upper bound Lower bound  Upper bound Lower bound  Upper bound 
Lean fish (≤ 5% fat)c 
Atlantic cod  2007-2010 136 0.035 (0.0049-0.12) 0.056 (0.0057-0.16) 0.005 (0-0.042) 0.025 (0.0024-0.14) 0.030 (0.0016-
0.12) 
0.030 (0.0026-0.12) 
Saithe  2006 41 0.072 (0.031-0.14) 0.097 (0.054-0.16) 0.005 (0-0.033) 0.029 (0.020-0.082) 0.067 (0.029-0.13) 0.067 (0.029-0.13) 
Haddock  2003 7 0.045 (0.026-0.069) 0.054 (0.030-0.091) 0.010 (0.004-
0.017) 
0.020 (0.013-0.028) 0.034 (0.017-
0.063) 
0.034 (0.017-0.064) 
Plaice 2007 25 0.33 (0.12-1.4) 0.34 (0.14-1.4) 0.098 (0.025-0.35) 0.11 (0.045-0.36) 0.23 (0.088-1.0) 0.23 (0.088-1.0) 
Redfish  2004 24 0.60 (0.18-2.0) 0.61 (0.19-2.2) 0.20 (0.052-0.35) 0.22 (0.060-0.53) 0.39 (0.12-1.6) 0.39 (0.12-1.6) 
Wolffish  2003 10 0.49 (0.046-2.6) 0.49 (0.051-2.6) 0.23 (0.013-1.3) 0.23 (0.016-1.3) 0.26 (0.024-1.3) 0.26 (0.024-0.3) 
Tuna, canned - - No data No data No data No data No data No data 
Fatty fish (>5% fat) c 
Atlantic halibute  2006-2010 90 4.0 (0.068-48) 4.4 (0.10-48) 1.1 (0.010-11) 1.1 (0.036-11) 3.3 (0.052-39) 3.3 (0.052-39) 
Greenland halibute  2006-2008 1028 4.3 (0.37-17) 4.4 (0.38-17) 1.7 (0.09-9.3) 1.7 (0.09-9.3) 2.6 (0.28-9.7) 2.6 (0.29-9.7) 
Herring (Norwegian spring 
spawning) 
2006-2007 799 0.56 (0.14-2.7) 0.63 (0.21 -2.9) 0.28 (0.061-1.8) 0.32 (0.11-1.9) 0.28 (0.077-0.90) 0.31 (0.086-0.99) 
Herring (North Sea)  2009-2010 875 1.0 (0.13-5.2) 1.2 (0.27-5.4) 0.52 (0.064-2.9) 0.72 (0.16-3.9) 0.48 (0.053-2.3) 0.53 (0.06-2.5) 
Mackerel (North East Atlantic)  2007-2009 785 0.63 (0.019-9.4) 0.87 (0.12-9.7) 0.14 (0-2.8) 0.37 (0.054-3.1) 0.49 (0.013-6.5) 0.49 (0.036-6.8) 
Sprat d  2010 14 1.1 (0.22-2.4) 1.3 (0.40-2.4) 0.49 (0.10-1.1) 0.66 (0.21-1.2) 0.64 (0.12-1.2) 0.64 (0.12-1.2) 
Wild Atlantic salmon  2012 92 0.82 (0.29-1.50) 0.96 (0.36-2.04) 0.28 (0.07-0.58) 0.42 (0.13-1.69) 0.54 (0.23-0.95) 0.54 (0.227-0.95) 
Farmed Atlantic salmon  2013 102 0.36 (0.02- 1.49) 0.52 (0.18-1.5) 0.08 (0.00-0.54) 0.24 (0.12-0.56) 0.28 (0.02-0.94) 0.28 (0.026-0.94) 
Farmed trout  2013 6 0.33 (0.17-0.52) 0.58 (0.30-0.86 ) 0.06 (0.04-0.07) 0.31 (0.17-0.42) 0.27 (0.12-0.46) 0.27 (0.12-0.46) 
Freshwater fish 
Perch  - - No data No data No data No data No data No data 
Brown trout  - - No data No data No data No data No data No data 
Pike - - No data No data No data No data No data No data 
Sandwich spreads from fish 
Cod roe and liver patee 2008 2 2.3-3.7 2.3-3.8 0.38-0.53 0.46-0.63 1.9-3.1 1.9-3.1 
Cod roe and liver patef  2010-2014 7 No data 4.43 (3.5- 5.0) No data 0.61 (0.56-0.75) No data 3.82 (2.9-4.39) 
Mackerel in tomato sauceg 2001-2005 4 0.75 No data  0.22 No data 0.53 No data 
 
 
VKM Report 2014: 15  152 
Food item  Year n Mean sum dioxins and dl-PCBs 
ng TEQ/kg ww 
Mean dioxinsa  
ng TEQ/kg ww 




   Lower bound  Upper bound Lower bound  Upper bound Lower bound  Upper bound 
Cod roeg 2005 4 0.32 No data  No data 0.074 0.25 No data 
Cod liver h 2009-2011 2050h1 No data 21.3 (1.0-276) No data 4.7 (0.27-86) No data 167 (0.49-263) 
 2009-2011 528h2 21 (1.7-175) 22 (2.4-176 ) 0.98 (0.18-24) 4.8 (0.96-26) 16.9 (1.4-168) 17 (1.4-168) 
a Dioxin = PCDD/F - polychlorinated dibenzo-para-dioxins (PCDD) and polychlorinated dibenzo furans (PCDF), bdl-PCBs = dioxin-like PCB (non-ortho and 
mono-ortho substituted PCBs),c Lean fish has fat content below 2%, medium fatty 2-5% fat and fatty fish more than 5% fat. Halibut is categorised as fatty 
fish in this opinion, dWhole, freshly caught sprat were analysed, eTwo pooled samples of five cans each based on ten samples from different batches. Each 
can consisted of 40% cod roe, 24% cod liver, soy oil, cod liver oil, vinegar, tomato puree and water (Julshamn and Frantzen (2009); Julshamn and Frantzen 
(2010)), fData from the food industry: one pooled samples in 2010, 2013, 2014 and two in 2011 and 2012, respectively, gData fromKvalem et al. (2009), 
hData from (Julshamn and Frantzen (2009); Julshamn and Frantzen (2010)) h1All cod liver samples, h2Data based on a subset of the samples with given LOQ. 
Table 6.2.1.2-2 Sum dioxins and dioxin-like PCBs given as mean nanogram (ng) 2005-TE/kg cod liver oil and fish oil. Upper and lower mean levels 
with minimum and maximum values in parenthesis. 
Supplement Year n Mean sum dioxins and dl-PCBs 
ng 2005-TEQ/kg ww  
Mean dioxinsa  
ng TEQ/kg ww 
Mean dl-PCBs b  
ng TEQ/kg ww  
   Lower Upper Lower Upper Lower Upper 










Cod liver oild 2006, 2010-2013 12 No data 1.1  
(0.47-2.1) 
No data 0.48 
(0.24-1.2) 
No data 0.66 
(0.18-1.8) 












Fish oilsd 2006,  
2008-2013  
51 No data 1.1  
(0.19-9.2) 
No data 0.65  
(0.16-1.7) 
No data 0.43 
(0.016-7.5) 












a Dioxin = PCDD/F - polychlorinated dibenzo-para-dioxins (PCDD) and polychlorinated dibenzo furans (PCDF), bdl-PCBs = dioxin-like PCB (non-ortho and 
mono-ortho substituted PCBs), c Information from food industry in Norway: Eight pooled samples based on 97 individual samples LOQ 0.11 for sum PCDD/F + 
dl-PCBs, 0.07 for PCDD/F, and 0.04 for dl-PCBs. The methods uncertainty is 16%, dData from (Julshamn and Frantzen (2009); Julshamn and Frantzen (2010))
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6.3 Summary of nutrients and contaminants in fish on the 
Norwegian market 
 The available data on nutrient concentrations in wild fish and fish products have 
expanded since 2006, but data is still lacking for some nutrients, and number of fish 
analysed is still very limited for several of the species. For some wild fish species, 
data are lacking, or the most recent data available are analysed in 2005. Compared 
to VKM (2006), the overall conclusions in 2014 are that there are few changes in 
composition and concentrations of nutrients in wild caught fish. 
 The available data on contaminant concentrations in wild and farmed fish and fish 
products have expanded substantially since 2006 due to several large base line 
studies of the commercially relevant wild fish species and yearly surveillance of 
farmed fish. Taking into consideration the scarce data available in 2006, there are 
minor or no changes in levels of mercury and sum dioxins and dl-PCBs in wild fish 
species since 2006. The exception is sum dioxins and dl-PCBs in herring, where data 
in the 2006 report showed 1.9 ng/kg, which has decreased to 0.63 ng TEQ/kg in 
2014. 
 Nutrient and contaminant concentration data in farmed Atlantic salmon is the most 
recent, i.e. fish sampled during 2013 and analyses finalised in 2014. Compared to the 
2006 VKM report, the contaminants and nutrients in Atlantic salmon fillet have 
changed as described in Chapter 5, and summarised here;  
o In the 2006 VKM report nutrient data for farmed Atlantic salmon were; 8 µg 
vitamin D per 100 g, 30 µg selenium per 100 g, 6-34 µg iodine per 100 g, 520 
mg n-6/100 g, 3200 mg n-3/100 g, and 2700 mg/100 g EPA+DPA+DHA. 
o In the current VKM report nutrient data for farmed Atlantic salmon were; 7.5 
µg vitamin D per 100 g, 12 µg selenium per 100 g, 4 µg iodine per 100 g, 
2296 mg n-6 per 100 g, 2303 mg n-3 per 100 g, and 1311 mg per 100 g 
EPA+DPA+DHA. 
o In the 2006 VKM report, contaminant data for farmed Atlantic salmon were; 
0.030 mg/kg mercury, 1.7 ng dioxins and dl-PCBs TEQ/kg, 1.2 ng dl-PCBs 
TEQ/kg, and 0.5 ng dioxins TEQ/kg.  
o In the current VKM report, contaminant data for farmed Atlantic salmon were; 
0.014 mg/kg mercury, 0.52 ng dioxins and dl-PCBs TEQ/kg, 0.28 ng dl-PCBs 
TEQ/kg, and 0.24 ng dioxins TEQ/kg. 
For concentrations of nutrients and contaminants used in the intake and exposure 
assessment in Chapter 7, see Appendix VII.  
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7 Intake and exposure assessment 
7.1 Current intake and exposure assessment from fish 
consumption 
The assessments of intake of nutrients and exposure to contaminants in the Norwegian 
population from fish consumption have been performed on three different population 
groups: 2-year-olds, pregnant women and adults 18-70 years of age. The dietary surveys 
are conducted with different dietary assessment methods. The fish consumption data which 
is the basis for calculating nutrient intakes and contaminant exposures are described in 
Chapter 3. A short overview of consumption data is given in Table 7.1-1. For concentrations 
used in the calculations of nutrient intake and contaminant exposure, see Appendix VII. The 
basis for the occurrence data in Appendix VII is shown in Chapter 6. 
As can be seen from table 7.1-1, the difference between median and mean total fish intake 
is much larger in adults (Norkost 3) than in both 2-year olds (Småbarnskost 2007) and 
pregnant women (MoBa). Likewise, the 95th percentile fish intake in adults is almost 4-fold 
higher than the mean, whereas the 95th percentile consumption in 2-years-olds and in 
pregnant women is 2.2-fold. Because of the method used in Norkost 3 (two 24-hour recalls), 
the 95th percentile represents participants reporting fish for dinner on both recall days. This 
represents an overestimation of the weekly fish consumption in high consumers, because 
having fish for dinner two recall days reported one month apart, does not imply that they 
consume fish for dinner all days of a week. Likewise, the median most likely underestimates 
the long term fish consumption, because it is influenced by those who did not have fish for 
dinner any of the recall days, but usually eat fish on a weekly basis. Because of the large 
number of participants mean consumption can be used for comparison between the dietary 
surveys. The interpretation of the 95th percentile intake estimates for nutrients and the 95th 
percentile exposure estimates for contaminants is affected by the above described 
overestimation, and illustrates major reasons why direct comparisons between high intakes 
and exposures between the surveys conducted with different methods should not be done.   
The combined average fish consumption of both gender have been used for estimation of 
intake of nutrients and exposure to contaminants, although consumption differs by gender 
(i.e. men eat in general more than women). This leads to underestimation of nutrient 
contributed by fish in men, and to an overestimation in women. However, whereas intake of 
nutrients is given as amount per person, exposure to contaminants is assessed based on 
body weight in kilogram. Thus, the use of combined average fish consumption has minor 
implications for estimation of contaminant exposure.   
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Table 7.1-1 Fish consumption (g/day) in 2-year-olds (Småbarnskost 2007, n=1674), adults 
(Norkost 3, n=1787) and pregnant women (MoBa, n=86277) 




 Mean Median P95 Mean Median P95 Mean Median P95 
2-year-olds  16  14 36 10 9 24 5 2 16 
Adultsa  51 17 201 30 0b 162  21 0b 113 
Pregnant women 31 27 68 18 16 41 11 7.3 36 
aMedians are considered an underestimate and 95th percentiles (P95) are considered an overestimate 
because of the dietary assessment method used. 
bMedian is zero because less than 50% of the participants were consumers. 
 Nutrient intake estimates from food consumption surveys 7.1.1
In the following, intake estimates have been done for the most important nutrients in fish; 
the n-3 LCPUFAs EPA, DPA and DHA, vitamin D, selenium and iodine. Intake estimates have 
also been included for the total sum n-3 in order to illustrate how much EPA, DPA and DHA 
constitute of sum n-3. Furthermore, even though fish is normally not an important source of 
n-6 PUFAs, the total sum of n-6 fatty acids has also been included since an increased use of 
vegetable oils in the feed for farmed fish has resulted in an increased concentration of n-6 
PUFAs (Chapter 5).  
7.1.1.1 Two-year-olds 
In 2-year-olds, fish intake was assessed using a food frequency questionnaire; fish was 
consumed by nearly all (98%) (Chapter 3.2.1).  
Polyunsaturated fatty acids (PUFAs); focus on eicosapentaenoic acid (EPA), 
docosahexaenoic acid (DPA) and docosapentaenoic acid (DHA) 
The calculated intakes of fatty acids contributed by fish in 2-year-olds are presented in Table 
7.1.1.1-1.  
Table 7.1.1.1-1 Intake of fatty acids from fish in 2-year-olds (Småbarnskost 2007, n=1674), 
presented as contribution from total fish intake and the subgroups lean fish, fatty fish and fish roe and 
liver 
Food item Sum EPA+DPA+DHA 
mg/day 
Sum n-3  
mg/day 
Sum n-6  
mg/day 
 Mean Median P95 Mean Median P95 Mean Median P95 
Fish, total, n=1674 204 89 696 300 125 1047 52 34 159 
Lean fish (≤5% fat)a 28 24 66 29 25 69 2.3 2.0 5.4 
Cod, saithe  4.9 2.7 17 5.0 2.8 17 0.39 0.22 1.3 
Fish balls, fish pudding 8.1 6.0 25 8.4 6.2 26 0.65 0.48 2.0 
Fish au gratin  2.2 1.2 7.6 2.3 1.2 7.9 0.18 0.10 0.62 
Fish burgers  7.8 5.4 23 8.1 5.6 24 0.63 0.44 1.8 
Fish fingers  4.5 2.6 17 4.6 2.7 17 0.36 0.21 1.3 
Jarred baby food w/fish 0.60 0c <0.01 0.62 0 c <0.01 0.05 0c <0.01 
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Food item Sum EPA+DPA+DHA 
mg/day 
Sum n-3  
mg/day 
Sum n-6  
mg/day 
 Mean Median P95 Mean Median P95 Mean Median P95 
Fatty fish (>5% fat) 165 38 631 254 67 959 50 33 156 
Salmon (farmed)  17 7.7 54 30 14 94 30 14 94 
Mackerel in tomato sauce  148 0 c 615 224 0 c 930 20 0 c 84 
Fish roe and liver  11 0 c 22 16 0 c 52 na na na 
Cod roe and liver páte 8.1 0 c -b 9.7 0 c -b na na na 
Roe (in caviar) 2.8 0 c 12 6.5 0 c 29 na na na 
na: no data available for content of fatty acids,  aOnly raw fish content from the different food 
products are included, mostly cod, b P95= 95th percentile; was not calculated due to less than 60 
consumers, cMedian was zero because less than 50% of the participants had consumed the fish/fish 
product. 
In 2-year-olds, total fish consumption contributed on average 204 mg EPA+DPA+DHA per 
day, the median was 89 mg and high consumption (95th percentile) was 696 mg/day. Lean 
fish contributed on average 14%, fatty fish contributed 81% and cod roe and liver 
contributed 5% to the total intake of EPA+DPA+DHA. Mackerel in tomato sauce was the 
major contributor to fatty fish. Fatty fish also contributed most to the intake of sum n-3 
PUFA (85%) and sum n-6 PUFA (96%) in 2-year-olds from fish. 
Vitamin D, iodine and selenium 
The calculated intake of vitamin D, iodine and selenium from fish in 2-year-olds are 
presented in Table 7.1.1.1-2.  
Table 7.1.1.1-2 Intake of vitamin D, iodine and selenium from fish in all 2-year-olds 
(Småbarnskost 2007, n=1674), presented as contribution from total fish intake and the subgroups 
lean fish, fatty fish and fish roe and liver 






 Mean Median P95 Mean Median P95 Mean Median P95 
Fish, total (n=1674) 0.51 0.36 1.3 35 31 82 4.5 3.5 12 
Lean fish (≤5% fat) a 0.14 0.13 0.34 33 29 79 2.5 2.2 5.8 
Cod, saitheb  0.03 0.01 0.09 5.8 3.2 20 0.43 0.24 1.5 
Fish balls, fish puddingb 0.04 0.03 0.13 9.6 7.1 30 0.71 0.53 2.2 
Fish au gratinb  0.01 0.01 0.04 2.6 1.4 9.0 0.19 0.11 0.67 
Fish burgersb  0.04 0.03 0.12 9.2 6.4 27 0.69 0.48 2.0 
Fish fingersb  0.02 0.01 0.09 5.3 3.1 20 0.39 0.23 1.5 
Jarred baby food w/fishb <0.01 0c <0.01 0.71 0c <0.01 0.05 0c <0.01 
Fatty fish (>5% fat) 0.19 0.14 0.65 0.62 0.12 2.4 1.9 0.34 7.3 
Salmon (farmed)  0.10 0.04 0.31 0.05 0.02 0.16 0.16 0.07 0.49 
Mackerel  0.09 0c 0.39 0.57 0c 2.3 1.7 0c 7.2 
Fish roe and liver  0.17 0c 0.89 1.3 0c 7.7 0.17 0c 0.66 
Cod roe and liver pâté 0.06 0c -b 0.35 0c -d 0.08 0c -d 
Roe (in caviar) 0.11 0c 0.50 0.97 0c 4.3 0.08 0c 0.37 
aAll lean fish is defined as cod, 
bOnly raw fish content from the different food products are included, 
cMedian was zero because less than 50% of the participants had consumed the fish/fish product, 
d95th percentile (P95) was not calculated due to less than 60 consumers. 
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In the 2-year-olds, fish consumption contributed on average with 0.51 µg vitamin D per 
day, the median was 0.36 and high consumption (95th percentile) was 1.3 µg/day. Although 
fatty fish has higher concentration of vitamin D, vitamin D contributed by fish in this age 
group originated both from fatty fish (38%) and lean fish (28%), as well as from cod roe 
and liver (34%).  
Fish consumption contributed on average with 35 µg iodine per day, the median was 31 µg 
and high consumption (95th percentile) contributed 82 µg/day. Nearly all (95%) iodine 
contributed by fish originated from lean fish.  
Fish consumption contributed on average with 4.5 µg selenium per day, the median was 
3.5 µg and high consumption (95th percentile) contributed 12 µg. Selenium contributed by 
fish consumption originated both from lean and fatty fish (56% and 42%, respectively).  
Intake of nutrients from fish oil and cod liver oil in 2-year-olds 
Fish oil and cod liver oil supplements were given to 41% of the 2-year-olds. Fish oil and cod 
liver oil supplements contribute substantially with fatty acids and vitamin D only among 
those who are consumers. For illustrating this, the contribution in consumers only (i.e. only 
among those reported consumption) has been calculated. The average contribution of 
EPA+DPA+DHA from supplements in all participating 2-year-olds was 454 mg/day (Table 
7.1.1.1-3). Among users of fish oil and cod liver oil supplement, the supplements contributed 
on average with 1103 mg/day (Table 7.1.1.1-4). Vitamin D contributed by fish oil and cod 
liver oil was on average 3.2 µg/day in all participants and 7.8 µg in supplement users. Sum 
EPA, DPA and DHA amounted 83% of sum n-3 PUFA. 
Table 7.1.1.1-3 Intake of fatty acids and vitamin D from fish oil and cod liver oil in 2-year-olds 
(Småbarnskost 2007, n=1674) 




Vitamin D  
µg/day 
 Mean P95 Mean P95 Mean P95 
Fish oil and cod liver oila 
n=1674 
454 1779 545 2136 3.2 13 
P95 = 95th percentiles. aFor intake estimates of nutrients, data for fish oil and cod liver oil were 
combined, and a weighted mean was used.  
Table 7.1.1.1-4 Intake of fatty acids and vitamin D from fish oil and cod liver oil in 2-year-olds 
(Småbarnskost 2007), for consumers only (n=689) 




Vitamin D  
µg/day 
 Mean Median P95 Mean Median P95 Mean Median P95 
Fish oil and cod liver 
oila, n=689 
1103 1271 1805 1325 1526 2167 7.8 9.0 13 
P95 = 95th percentiles. aFor intake estimates of nutrients, data for fish oil and cod liver oil were 
combined, and a weighted mean was used. 
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A daily intake of 5 ml fish oil and cod liver oil (manufacturer’s recommendation) would 
contribute a mean intake of 1280 mg EPA+DPA+DHA and 10 µg vitamin D per day. 
7.1.1.2 Adults  
In adults, fish intake was assessed using two 24-hour recalls by telephone at least one 
month apart (Chapter 3, Table 3.2.2-2). Fish was consumed by 61% of all participants. The 
intake of nutrients contributed by fish was presented as combined mean of both sexes. 
Furthermore, the percentage of consumers for each fish or fish product was below 50% and 
thus the median was not presented in the following tables, but the medians for total fish 
intakes are presented in the text (see the introduction of this chapter).  
Polyunsaturated fatty acids (PUFAs); focus on eicosapentaenoic acid (EPA), 
docosahexaenoic acid (DPA) and docosapentaenoic acid (DHA) 
The calculated intakes of fatty acids from fish in adults are presented in Table 7.1.1.2-1.  
Table 7.1.1.2-1 Intake of fatty acids from fish in adults (Norkost 3, n=1787), presented as 
contribution from total fish intake and the subgroups lean fish, fatty fish and cod roe and liver. Mean 
is the mean of two 24-hour recalls 
Food item Sum EPA+DPA+DHA 
mg/day 
Sum n-3  
mg/day 
Sum n-6  
mg/day 
 Mean P95 Mean P95 Mean P95 
Fish, total, n=1787 475 2132 713 3248 339 2066 
Lean fish (≤ 5% fat) 82 452 86 474 6.7 36 
Saithe 14 -c 15 -c 0.9 -c 
Cod  65 384 67 396 5.2 31 
Haddock na na na na na na 
Plaice 2.9 -a 3.3 -a 0.3 -a 
Redfish na na na na na na 
Wolffish 0.5 -a 0.5 -a 0.3 -a 
Tuna  na na na na na na 
Fatty fish (> 5% fat) 375 1904 603 3052 332 2043 
Herring (Norwegian spring 
spawning) 
23 149 30 199 2.3 15 
Halibut  4.8 -a 5.5 -a 0.6 -a 
Mackerel  167 1353 252 2046 23 184 
Salmon (wild)  6.3 -a 7.6 -a 0.7 -a 
Trout (freshwater) na na na na na na 
Salmon (farmed)b  175 1142 307 2005 306 1999 
Fish roe and liver 17 20 25 47 0.4 -a 
Cod roe 3.8 16 8.8 38 na na 
Cod roe and liver paté 10 -a 13 -a na na 
Cod liver 3.1 -a 3.7 -a 0.4 -a 
na: no data available for fatty acid content in the food item.  
a95th percentiles (P95) are considered an overestimate because of the dietary survey method used. 
bFarmed salmon includes farmed trout both with respect to consumption and level of fatty acids. 
c95th percentile (P95) are zero, due to less than 5% consumers. 
In adults, total fish consumption contributed on average with 475 mg EPA+DPA+DHA per day, the 
median was 101 mg and high consumption (95th percentile) was 2.1 g/day. Lean fish contributed on 
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average with 17%, fatty fish with 79% and cod roe and liver with 4% of EPA+DPA+DHA from fish. Of 
the fatty fish species, farmed salmon and mackerel were the major sources. Fatty fish (salmon and 
mackerel) was the main contributor to sum n-3 PUFA (84%), and salmon was the main contributor to 
sum n-6 (98%). Median intakes of sum n-3 PUFA and sum n-6 PUFA from total fish consumption in 
adults were 119.3 mg/day and 7.96 mg/day, respectively.  
Vitamin D, iodine and selenium 
The calculated intakes of vitamin D, iodine and selenium in adults are presented in Table 
7.1.1.2-2.  
Table 7.1.1.2-2 Intake of vitamin D, iodine and selenium from fish in adults (Norkost 3, 
n=1787), presented as contribution from total fish intake and the subgroups lean fish, fatty fish and 
cod roe and liver. Mean is the mean of two 24-hour recalls. 






 Mean P95 Mean P95 Mean P95 
Fish, total, n=1787 2.1 10 86 475 15 59 
Lean fish (≤5% fat) 0.44 2.3 82 466 10 48 
Saithe  0.05 -c 5.1 -c 1.0 -c 
Cod  0.33 2.0 77 454 5.7 34 
Haddock  <0.01 -a na na 0.13 -a 
Plaice  0.03 -a 0.07 -a 0.16 -a 
Redfish  na na na na 0.28 -a 
Wolffish <0.01 -a 0.27 -a 0.06 -a 
Tuna 0.02 -a 0.12 -a 3.1 -a 
Fatty fish (>5% fat) 1.4 8.7 1.4 6.8 4.5 22 
Herring (Norwegian spring spawning)  0.20 1.3 0.03 0.18 0.80 5.2 
Halibut  0.09 -a 0.14 -a na na 
Mackerel  0.10 0.85 0.64 5.2 1.9 16 
Salmon (wild)  0.04 -a 0.05 -a 0.16 -a 
Trout (freshwater) na na na na na na 
Salmon (farmed)b 1.0 6.5 0.53 3.5 1.6 10 
Fish roe and liver 0.25 0.82 1.9 7.0 0.25 0.61 
Cod roe 0.15 0.65 1.3 5.6 0.11 0.49 
Cod roe and liver paté 0.07 -a 0.45 -a 0.11 -a 
Cod liver 0.02 -a 0.10 -a 0.02 -a 
na: no data available for mineral content in the food item. 
95th percentiles (P95) are considered an overestimate because of the dietary survey method used. 
a95th percentile (P95) was not calculated due to less than 60 consumers. 
bFarmed salmon includes farmed trout both with respect to consumption and level of fatty acids. 
In adults, fish consumption contributed on average with 2.1 µg vitamin D per day, the 
median was 0.56 µg/day, and for high consumption (95th percentile) the contribution was 10 
µg/day. The fish items contributing most to vitamin D were farmed salmon (47%), cod 
(15%) and herring (9%).  
Fish consumption contributed on average with 86 µg iodine per day, median was 2.3 µg and 
high consumption (95th percentile) contributed 475 µg/day in adults. Lean fish was the 
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source of nearly all iodine contributed by fish. The large difference between mean (86 µg) 
and median (2.3 µg) is due to one participant with exceptionally high consumption of lean 
fish in the 24-h recalls.  
Fish consumption contributed on average with 15 µg selenium per day the median was 4.2 
µg and high consumption (95th percentile) contributed 59 µg/day in adults. In adults, the 
lean species contributed a larger proportion of selenium than fatty fish (67% and 30%, 
respectively). 
Intake of nutrients from fish oil and cod liver oil in adults 
Fish oil and cod liver oil supplements were used by 37% of the adults during the two 24-
hour recalls, and the average contribution of EPA+DPA+DHA from supplements in all 
participants was 735 mg/day (Table 7.1.1.2-3). Sum EPA, DPA and DHA amounted 83-84% 
of sum n-3 PUFA. For fish oil and cod liver oil supplement users only, the supplements 
contributed on average with 1982 mg/day and high intake (95th percentile) was 3000 
mg/day (Table 7.1.1.2-4). A daily intake of 5 ml fish oil and cod liver oil (manufacturer’s 
recommendation) would contribute a mean intake of 1280 mg EPA + DPA + DHA per day.  
Vitamin D contributed by fish oil and cod liver oil was on average 3.5 µg/day in all 
participants (Table 7.1.1.2-3) and 9.4 µg/day in supplement users (Table 7.1.1.2-4). A daily 
intake of 5 ml fish oil and cod liver oil (manufacturer’s recommendation) would contribute a 
mean intake of Vitamin D of 10 µg/day. 
Table 7.1.1.2-3  Intake of fatty acids from fish oil and cod liver oil in adults, all participants 
(Norkost 3, n=1787)  






 Mean P95 Mean P95 Mean P95 
Fish oil and cod liver oila, 
n=1787 
735 2796 880 3346 3.5 13 
P95: 95th percentiles. aFor intake estimates of nutrients, data for fish oil and cod liver oil were 
combined, and a weighted mean was used. 
Table 7.1.1.2-4  Intake of fatty acids from fish oil and cod liver oil in adults, consumers only 
(Norkost 3, n=663)  




 Mean P95 Mean P95 Mean P95 
Fish oil/cod liver oila, n=663 1982 2999 2372 3589 9.4 14 
P95: 95th percentiles. aFor intake estimates of nutrients, data for fish oil and cod liver oil were 
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7.1.1.3 Pregnant women   
As described in Chapter 3.2.3, data for pregnant women are derived from studies within the 
national Mother and Child Cohort Study (MoBa). Fish was consumed by nearly all participants 
(97%). 
Polyunsaturated fatty acids (PUFAs); focus on eicosapentaenoic acid (EPA), 
docosahexaenoic acid (DPA) and docosapentaenoic acid (DHA) 
The calculated intakes of fatty acids from fish in pregnant women are presented in Table 
7.1.1.3-1. 
Table 7.1.1.3-1 Intake of fatty acids from fish in pregnant women (MoBa, n=86277) 
Food item Sum EPA+DPA+DHA  
mg/day 
Sum n-3  
mg/day 
Sum n-6  
mg/day 
 Mean Median P95 Mean Median P95 Mean Median P95 
Fish, total  312 200 992 464 293 1497 143 114 392 
Lean fish (≤5% fat) 48 43 114 50 44 119 4.1 3.5 9.8 
Cod, saithe, haddock 40 35 97 42 36 100 3.2 2.8 7.8 
Redfish, catfish 3.5 0a 19 3.7 0a 20 0.28 0a 1.5 
Pike, perch <0.01 0a 0 <0.01 0a 0 <0.01 0a 0 
Tuna na na na na na na na na na 
Halibut, flatfish 4.4 0a 27 5.0 0a 31 0.53 0a 3.2 
Fatty fish (>5% fat) 251 140 901 395 229 1387 139 110 386 
Mackerel, herring 186 73 828 281 110 1252 25 9.9 112 
Salmon, troutb 65 50 191 114 87 336 114 87 335 
Fish roe and liver 13 0a 37 19 0a 65 0.08 0a 0 
Cod roe 2.8 0a 15 6.6 0a 36 <0.01 0a 0 
Cod roe and liver pate 9.2 0a 0 11 0a 0 <0.01 0a 0 
Cod liver 0.7 0a 0 0.85 0a 0 0.08 0a 0 
na: No data available for fatty acids in the food item. 
aMedian was zero because less than 50% of the participants had consumed the fish/fish product. 
bFarmed salmon represent salmon and trout with respect to consumption and content of fatty acids.  
In pregnant women, mean total fish consumption contributed with 312 mg EPA+DPA+DHA 
per day, median was 200 and high consumption (95th percentile) 990 mg/day. Fatty fish 
contributed 80% of EPA+DPA+DHA, and of the fatty fish species, mackerel and herring 
contributed substantially more EPA+DPA+DHA and sum n-3 PUFA than salmon and trout. 
Sum EPA+DPA+DHA amounted about 66-68% of sum n-3 PUFA. Fatty fish was also the 
main contributor to sum n-6 from fish (97%) and salmon and trout contributed most (80%).  
Vitamin D, iodine and selenium 
The calculated intakes of vitamin D, selenium and iodine from fish in pregnant women are 
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Table 7.1.1.3-2 Intake of vitamin D, selenium and iodine from fish in pregnant women (MoBa, 
n=86277) 






 Mean Median P95 Mean Median P95 Mean Median P95 
Fish, total, n=86277 0.96 0.79 2.3 54 48 127 9.0 7.0 23 
Lean fish (≤5% fat) 0.29 0.24 0.69 52 46 123 6.1 4.6 16 
Cod, saithe, haddock 0.21 0.18 0.50 48 42 114 3.5 3.1 8.5 
Redfish, catfish 0.02 0
a
 0.10 4.2 0
a
 23 0.31 0
a
 1.7 
Pike, perch <0.01 0
a
 0 <0.01 0
a





 0.08 0.08 0
a
 0.42 2.0 0
a
 10 
Halibut, flatfish 0.05 0
a
 0.28 0.10 0
a
 0.61 0.24 0
a
 1.5 
Fatty fish (>5% fat) 0.49 0.39 1.4 0.91 0.48 3.4 2.8 1.4 10 
Mackerel, herring 0.12 0.05 0.53 0.71 0.28 3.2 2.2 0.85 9.7 
Salmon, trout 0.37 0.28 1.1 0.20 0.15 0.58 0.59 0.45 1.8 
Fish roe and liver 0.18 0
a
 0.79 1.4 0
a
 6.2 0.09 0
a
 0.50 
Cod roe 0.11 0
a
 0.62 0.98 0
a
 5.3 0.09 0
a
 0.46 
Cod roe and liver pate 0.12 0
a
 0.66 0.39 0
a
 0 0.19 0
a
 0.68 
Cod liver 0.01 0
a
 0 0.02 0
a
 0 0.01 0
a
 0 
P95: 95th percentiles. aMedian was zero because less than 50% of the participants had consumed the 
fish or fish product  
In pregnant women, fish contributed on average 0.96 µg vitamin D, the median was 0.79 
µg and high consumption was 2.3 µg/day. Fatty fish contributed 51% of vitamin D from fish, 
with salmon being the most influential contributor. Lean fish and cod roe also contributed to 
vitamin D from fish in pregnant women (30% and 19%, respectively).  
Fish contributed on average 54 µg iodine per day, the median was 48 µg and high 
consumption (95th percentile) was 127 µg/day in pregnant women. Iodine contributed by fish 
originated almost completely from lean fish species (96%).  
Fish contributed on average 9 µg selenium per day, the median was 7 µg and high 
consumption (95th percentile) was 23 µg/day in pregnant women. Selenium contributed by 
fish originated mostly from lean fish (68%).  
Intake of nutrients from fish oil and cod liver oil in pregnant women 
Nutrients contributed by fish oil and cod liver oil have not been estimated for the current 
update. However, a sub-study in nulliparous women enrolled in MoBa during the years 2002 
to 2005 estimated that the median amount of EPA+DHA contributed by fish oil and cod liver 
oil supplements was 190 mg/day (Haugen et al., 2009).  
A daily intake of 5 ml cod liver oil (manufacturer’s recommendation) would contribute with a 
mean intake of 1280 mg EPA+DPA+DHA per day. Furthermore, this would also contribute 
with a mean intake of vitamin D of 10 µg/day. 
 
 
VKM Report 2014: 15  163 
 Summary of current nutrient intake from food consumption surveys 7.1.2
Polyunsaturated fatty acids (PUFAs); focus eicosapentaenoic acid (EPA), 
docosahexaenoic acid (DPA) and docosapentaenoic acid (DHA) 
In 2-year-olds, the mean intake of EPA+DHA+DPA contributed by fish is 204 mg 
EPA+DPA+DHA per day and the 95th percentile 696 mg/day. In adults, the amount of 
EPA+DPA+DHA from mean total fish intake is approximately 475 mg/day, and the 95th 
percentile is 2132 mg/day. In pregnant women the mean estimated intake of 
EPA+DHA+DPA is 312 mg per day, and the 95th percentile is 992 mg/day. The major 
contributors to EPA+DHA+DPA from fatty fish were mackerel in tomato sauce, mackerel 
(1/2) and farmed salmon (1/2), and mackerel (2/3) and farmed salmon (1/3), in 2-year-olds, 
adults and pregnant women, respectively. 
EPA+DHA+DPA from fish constituted between 70-80% of sum n-3 PUFAs for all age groups, 
and above 80% for fish and cod liver oils. The main contributor of sum n-6 PUFAs was fatty 
fish for all age groups; farmed salmon in adult and pregnant women, and farmed salmon 
and mackerel for the 2-year olds. 
The main source of EPA+DHA+DPA is fatty fish, besides fish oil and cod liver oil which is 
consumed by a relative large part of two of the populations (41% of the 2-year-olds and 
37% of the adults, Figure 7.1.2-1).  
 
Figure 7.1.2-1 Mean intake of EPA+DPA+DHA from fish, and cod liver oil (including fish oil) 
in Norwegian 2-year-olds (Småbarnskost, 2007), adults (Norkost 3) and in pregnant women (MoBa, 
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Vitamin D  
Vitamin D contributed by fish in 2-year-olds and adults are on average 0.51 and 2.1 
µg/day, respectively. In pregnant women, the mean vitamin D intake is 0.96 µg/day. The 
main source for vitamin D is fatty fish, besides fish oil and cod liver oil which is consumed by 
a relatively large part of two of the populations (41% of the 2-year-olds and 37% of the 
adults Figure 7.1.2-2). 
 
Figure 7.1.2-2 Mean intake of vitamin D from fish, and cod liver oil (including fish oil) in 2-
year-olds (Småbarnskost 2007), adults (Norkost 3) and in pregnant women (MoBa, not including cod 
liver oil). Fish is grouped into fatty fish, lean fish, fish roe and liver, and cod liver oil.  
Iodine, selenium 
In 2-year-olds average fish consumption contributes with 35 µg iodine per day. In adults the 
mean intake is 86 µg iodine per day from fish and in pregnant women 54 µg/day. Lean fish 
is the main source for iodine (Figure 7.1.2-3). 
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Figure 7.1.2-3 Mean intake of iodine from fish in 2-year-olds (Småbarnskost 2007, adults 
(Norkost 3) and in pregnant women (MoBa). Fish is grouped into fatty fish, lean fish, fish roe and 
liver. 
In 2-year-olds the contribution of selenium from average fish consumption is 4.5 µg/day. 
In adults the mean selenium intake from fish is 15 µg per day and in pregnant women 9 
µg/day. The selenium concentration is about the same in lean and fatty fish (Figure 7.1.2-4).  
 
Figure 7.1.2-4 Mean intake of selenium from fish in Norwegian 2-year-olds (Småbarnskost 
2007), adults (Norkost 3) and in pregnant women (MoBa). Fish is grouped into fatty fish, lean fish, 
fish roe and liver. 
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 Contaminant exposure estimates from food consumption surveys 7.1.3
In the present chapter, the exposure assessments of mercury and dioxins through fish 
consumption have been presented in tables as mean and 95th precentile of both upper and 
lower bound for the three different population groups (2-year-olds, adults, and pregnant 
women), and median exposure have been given for 2-year-olds and pregnant women. Upper 
bound (UB) is when the concentrations lower than the limit of quantification (LOQ) or limit of 
detection (LOD) is substituted with the LOQ or LOD. This most likely represents an 
overestimate of the exposure. For lower bound (LB), concentrations lower than the LOQ or 
LOD is substituted with 0. This most likely represents an underestimate of the exposure.  
For mercury there are small differences between lower bound and upper bound estimates 
because concentration in most samples has been quantified. Therefore, the description on 
mercury exposure in the text is based on upper bound estimates. For dioxins and dl-PCBs 
the uncertainty in concentrations in fish is higher and in order to reflect this, both upper- and 
lower bound results are described also in the text. 
Total mercury analysed in fish is regarded as methylmercury. This is a conservative estimate 
since reports indicate that methylmercury generally constitutes 80-100% of total mercury in 
fish (EFSA, 2012a). 
For the concentrations used in the calculations of contaminant exposure, the reader is 
advised to Appendix VII “Concentrations of nutrients and contaminants used in the exposure 
estimates”. 
7.1.3.1  Body weights used in contaminant exposure calculations 
Exposure to contaminants is calculated per kilo body weight (in contrast to intake of 
nutrients). In this chapter, the individual body weights reported in the different dietary 
surveys (Chapter 3) have been used. In individuals who have not reported their body weight, 
exposure calculations have been based on mean body weight in the group. Among the 2-
year-olds, 37% (n=620) were given the group mean body weight of 12.8 kg. In Norkost 3, 
only 1.7% (n=20) of the adults did not report their body weight, and were given the group 
mean body weight of 77.5 kg. In the MoBa study the group, individual pre-pregnancy body 
weight was used. Of the 86277 MoBa participants body weights were not reported for 2494, 
thus exposure to contaminants has been based on 83782 participants. 
7.1.3.2 Two-year-olds 
Mercury 
Calculated mercury exposure from fish in 2-year-olds is shown in Table 7.1.3.2-1. Mean 
mercury UB exposure from fish was 0.51 µg/kg bw/week and high UB (95th percentile) 
exposure was 1.2 µg/kg bw/week. Lean fish contributed with 84% to the mean exposure. 
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The lean fish was mainly consumed in the form of fish balls/pudding, fish burger and fish 
fingers. 
Table 7.1.3.2-1 Exposure to mercury from fish in 2-year-olds (Småbarnskost 2007, n=1674) 
Food item Lower bound  
µg Hg/kg bw/week 
Upper bound  
µg Hg/kg bw/week 
 Mean Median P95 Mean Median P95 
Fish, total (n=1674) 0.50 0.44 1.1 0.51 0.45 1.2 
Lean fish (cod) (≤5% fat) 0.42 0.37 1.0 0.42 0.37 1.0 
Cod, saithe  0.07 0.04 0.25 0.07 0.04 0.25 
Fish balls, fish pudding 0.12 0.09 0.38 0.12 0.09 0.38 
Fish au gratin  0.03 0.02 0.11 0.03 0.02 0.11 
Fish burgers  0.12 0.08 0.35 0.12 0.08 0.35 
Fish fingers  0.07 0.04 0.25 0.07 0.04 0.25 
Jarred baby food w/fish <0.01 0b <0.01 0.01 0b <0.01 
Fatty fish (> 5% fat) 0.08 0.02 0.31 0.08 0.02 0.31 
Salmon, farmed 0.01 <0.01 0.04 0.01 <0.01 0.04 
Mackerel 0.07 0b 0.29 0.07 0b 0.29 
Fish roe and liver  0 0b <0.01 <0.01 0b 0.03 
Cod roe and liver páte 0 0b -a <0.01 0b -a 
Roe (in caviar) 0 0b <0.01 <0.01 0b 0.02 
a95th percentile (P95) was not calculated due to less than 60 consumers.  
bMedian was zero because less than 50% of the participants had consumed the fish or fish product. 
Dioxins and dl-PCBs 
Calculated exposure to dioxins and dl-PCBs in 2-year-olds is shown in Table 7.1.3.2-2. Total 
exposure to dioxins and dl-PCBs from fish was at mean lower bound (LB) 2.0 pg TEQ/kg 
bw/week and at mean upper bound (UB) 2.6 pg TEQ/kg bw/week. High exposure from fish 
(95th percentile) was at LB 7.3 pg TEQ/kg bw/week and at UB 9.4 pg TEQ/kg bw/week. Fatty 
fish was the major contributor (72%). Among fatty fish species, mackerel was the major 
contributor, reflecting a high mean consumption of mackerel in tomato sauce in this age 
group (mackerel 3 g/day versus farmed salmon 1 g/day, Table 3.2.1-1). Of note, cod roe 
and liver pate contributed with 17% of the total mean LB exposure, although the mean 
consumption was less than 1 g/day (Table 3.2.1-1). Exposure from other food than fish 
comes in addition. 
Table 7.1.3.2-2 Exposure to dioxins and dl-PCBs from fish in 2-year-olds (Småbarnskost 2007, 
n=1674) 
Food item Lower bound  
Sum dioxins and dl-PCBs
a
  
pg TEQ/kg bw/week 
Upper bound 
Sum dioxins and dl-PCBs
a
  
pg TEQ/kg bw/week 
 Mean Median P95 Mean Median P95 
Fish, total, n=1674  2.0 0.93 7.3 2.6 1.3 9.4 
Lean fish (cod) (≤5% fat) 0.20 0.17 0.47 0.32 0.27 0.75 
Cod, saithe  0.03 0.02 0.12 0.05 0.03 0.19 
Fish balls, fish pudding 0.06 0.04 0.18 0.09 0.06 0.28 
Fish au gratin  0.02 0.01 0.05 0.02 0.01 0.09 
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Food item Lower bound  
Sum dioxins and dl-PCBs
a
  
pg TEQ/kg bw/week 
Upper bound 
Sum dioxins and dl-PCBs
a
  
pg TEQ/kg bw/week 
 Mean Median P95 Mean Median P95 
Fish burgers  0.05 0.04 0.16 0.09 0.06 0.26 
Fish fingers  0.03 0.02 0.12 0.05 0.03 0.19 
Jarred baby food w/fish <0.01 0b <0.01 <0.01 0b <0.01 
Fatty fish (> 5% fat) 1.4 0.64 5.2 1.9 0.80 7.1 
Salmon (farmed)  0.29 0.13 1.0 0.36 0.16 1.3 
Mackerel  1.1 0b 4.8 1.6 0b 6.6 
Fish roe and liver  0.36 0b 0.13 0.36 0b 0.13 
Cod roe and liver pate 0.34 0b -c 0.34 0b -c 
Roe (in caviar) 0.02 0b 0.07 0.02 0b 0.07 
aDioxins = polychlorinated dibenzo-para-dioxins (PCDD) and polychlorinated dibenzo furans (PCDF), 
dioxin-like (dl) PCBs (non-ortho and mono-ortho substituted PCBs). 
bMedian was zero because less than 50% of the participants had consumed the fish or fish product.  
c95th percentile (P95) was not calculated due to less than 60 consumers. 
Exposure to contaminants from fish oils and cod liver oil in 2-year-olds 
Since mercury is not associated with lipids, intake of mercury from fish oil and cod liver oil is 
very low and not of relevance.  
Mean LB intake of dioxins and dl-PCBs from fish oil and cod liver oil among 2-year-olds was 
0.24 pg TEQ/kg bw/week in all participants and 0.58 pg TEQ/kg bw/week in consumers only 
(Tables 7.1.3.2-3 and 7.1.3.2-4). For consumers only (41% of the participants), this 
constitutes 35% of the mean total exposure, and comes in addition to the exposure from fish 
and other food. As explained in Chapter 3, those who eat fish are more often consumers of 
fish oils or cod liver oil as supplement than those who do not eat fish regularly. The relatively 
high contribution from fish oil and cod liver oil in 2-year-olds compared to adults can be 
explained by the low body weight in children, and that the recommended daily volume of 
cod liver oil is similar for children and adults. Daily consumption of 5 ml fish oil or cod liver 
oil with a mean LB (UB) concentration of 0.27 (0.95) pg TEQ/g, corresponds to an exposure 
to dioxins and dl-PCBs of 0.66 (LB) to 2.34 (UB) pg TEQ/kg bw/week in 2-year-olds with 
mean body weight of 12.8 kg. 
Table 7.1.3.2-3 Exposure of dioxins and dl-PCBs from fish oil and cod liver oil in 2-year-olds 
(Småbarnskost 2007, n=1674)  
Supplement Lower bound  
Sum dioxins and dl-PCBsa 
pg TEQ/kg bw/week 
Upper bound 
Sum dioxins and dl-PCBsa 
pg TEQ/kg bw/week 
 Mean P95 Mean P95 
Fish oil and cod liver oil
b
, n=1674 0.24 0.93 0.84 3.3 
P95: 95th percentiles.  
aDioxins = polychlorinated dibenzo-para-dioxins (PCDD) and polychlorinated dibenzo furans (PCDF). 
dl-PCBs - dioxin-like PCB (non-ortho and mono-ortho substituted PCBs). 
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bFor exposure calculations data for fish oil and cod liver oil were combined and a weigthed mean was 
used. 
Table 7.1.3.2-4 Exposure to dioxins and dl-PCBs from fish oil and cod liver oil in 2-year-olds 
(Småbarnskost 2007), consumers only for fish oil and cod liver oil  
Supplement Lower bound  
Sum dioxins and dl-PCBs
a
 
pg TEQ/kg bw/week 
Upper bound  
Sum dioxins and dl-PCBs
a
 
pg TEQ/kg bw/week 
 Mean Median P95 Mean Median P95 
Fish oil and cod liver oil
b
, n=689  0.58 0.59 1.0 2.0 2.1 3.7 
P95: 95th percentiles.  
aDioxins = polychlorinated dibenzo-para-dioxins (PCDD) and polychlorinated dibenzo furans (PCDF). 
dl-PCBs - dioxin-like PCB (non-ortho and mono-ortho substituted PCBs). 
bFor exposure calculations data for fish oil and cod liver oil were combined and a weigthed mean was 
used. 
7.1.3.3 Adults  
Mercury 
Exposure to mercury from fish in adults (Norkost 3) is shown in Table 7.1.3.3-1.  Mean 
exposure was 0.30 µg/kg bw/week. Lean fish contributed with 79% of the exposure, and 
cod was the main source among the lean fish species (Figure 7.1.3.3-1). This reflects merely 
the high consumption of cod, since the concentration of mercury in cod is not particularly 
high compared to less consumed species (Table 6.2-1). The median exposure from total fish 
was 0.036 (LB) and 0.041 (UB) µg/kg bw/week. The medians for individual fish species were 
zero because less than 50% were consumers.  
7.1.3.3-1 Exposure to mercury (Hg) from fish in adults (Norkost 3, n=1787).  
Food item Lower bound 
µg Hg/kg bw/week 
Upper bound 
µg Hg/kg bw/week 
 Mean P95
a Mean P95a 
Fish, total 0.29 1.2 0.30 1.2 
Lean fish (≤5% fat) 0.23 1.2 0.23 1.2 
Saithe  0.02 0 0.02 0 
Cod  0.16 0.95 0.16 0.95 
Haddock  <0.01 -c <0.01 -c 
Plaice  0.03 -c 0.03 -c 
Redfish  <0.01 -c <0.01 -c 
Wolffish 0 -c <0.01 -c 
Tuna  0.01 -c 0.01 -c 
Fatty fish (>5% fat) 0.06 0.21 0.06 0.21 
Herring (Norwegian spring spawning) 0.01 0.03 0.01 0.03 
Halibut  0.019 -c 0.02 -c 
Mackerel  0.013 0.10 0.01 0.10 
Salmon (wild)  0.001 -c <0.01 -c 
Trout (freshwater) 0.005 -c 0.01 -c 
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Food item Lower bound 
µg Hg/kg bw/week 
Upper bound 
µg Hg/kg bw/week 
 Mean P95
a Mean P95a 
Salmon (farmed)b 0.018 0.12 0.02 0.12 
Fish roe and liver <0.01 -cd <0.01 0.01 
Cod roe 0d 0 d <0.01 0.01 
Cod roe and liver paté 0 d -c 0 -c 
Cod liver <0.01 -c <0.01 -c 
a95th percentiles (P95) are considered an overestimate because of the dietary method used.  
bFarmed salmon includes exposure from farmed trout. 
c95th percentile (P95) was not calculated due to less than 60 consumers. 
dZero is used due to concentration values under limit of quantification. 
Dioxins and dl-PCBs 
Calculated exposure to dioxins and dl-PCBs in adults in Norkost 3 is shown in Table 7.1.3.3-
2. Dioxins and dl-PCBs were found above the LOQ in most of the fatty fish samples, but not 
in all lean fish samples. Thus, the lower bound (LB) and upper bound (UB) intakes may differ 
for the lean fish species in particular. The mean LB exposure from all fish species was 1.4 pg 
TEQ/kg bw/week, whereas the mean UB exposure was 1.7 pg TEQ/kg bw/week. The median 
exposure from total fish was 0.18 (LB) and 0.26 (UB) pg TEQ/kg bw/week. The medians for 
individual fish species were zero because less than 50% were consumers. The 95th percentile 
exposure was at LB 5.6 pg TEQ/kg bw/week and at UB 6.8 pg TEQ/kg bw/week. As 
expected for lipid soluble contaminants as dioxins and dl-PCBs, fatty fish was the main 
source, contributing 76% of the exposure from fish. Farmed salmon contributed 36% of the 
mean exposure from fish. Exposure from other food than fish comes in addition. 
7.1.3.3-2 Exposure to sum dioxins and dl-PCBs from fish in adults (Norkost 3, n=1787). Mean is 
the mean of two 24-hour recalls. 
Food item Lower bound  
Sum dioxins and dl-PCBsa  
pg TEQ/kg bw week 
Upper bound  
Sum dioxins and dl-PCBsa 
pg TEQ/kg bw week 
 Mean P95b Mean P95b 
Fish, total (n=1787) 1.4 5.6 1.7 6.8 
Lean fish (≤ 5% fat) 0.16 0.62 0.21 0.93 
Saithe  0.02 <0.01 0.03 <0.01 
Cod  0.08 0.45 0.12 0.71 
Haddock  <0.01 -c <0.01 -c 
Plaice  0.01 -c 0.01 -c 
Redfish  0.03 -c 0.03 -c 
Wolffish 0.01 -c 0.01 -c 
Tuna  No data No data No data No data 
Fatty fish (> 5% fat) 1.1 4.6 1.3 5.9 
Herring (Norwegian spring spawning)  0.07 0.37 0.08 0.42 
Halibut  0.31 -c 0.32 -c 
Mackerel  0.22 1.7 0.30 2.3 
Salmon (wild)  0.03 -c 0.03 -c 
Trout (freshwater)  No data No data No data No data 
Salmon (farmed)d 0.50 3.4 0.63 4.2 
Fish roe and liver 0.16 0.18 0.16 0.18 
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Food item Lower bound  
Sum dioxins and dl-PCBsa  
pg TEQ/kg bw week 
Upper bound  
Sum dioxins and dl-PCBsa 
pg TEQ/kg bw week 
 Mean P95b Mean P95b 
Cod roe 0.03 0.15 0.03 0.15 
Cod roe and liver pate 0.08 -c 0.08 -c 
Cod liver 0.05 -c 0.05 -c 
aDioxins = polychlorinated dibenzo-para-dioxins (PCDD) and polychlorinated dibenzo furans (PCDF), 
dioxin-like (dl) PCBs (non-ortho and mono-ortho substituted PCBs). 
b95th percentiles (P95) are considered an overestimate because of the dietary method used. 
c95th percentile (P95) was not calculated due to less than 60 consumers. 
dFarmed salmon includes exposure from farmed trout.  
Exposure from fish oil and cod liver oil in adults 
Since mercury is not associated with lipids, intake of mercury from fish oil and cod liver oil is 
very low and not of relevance. 
Estimated intake of dioxins and dl-PCBs from fish oil in adults in Norkost 3 was low, as 
shown in Table 7.1.3.3-3, and the contribution to exposure compared with fish was low. This 
was also the case when mean intake was estimated among consumers only (Table 7.1.3.3-
4). Daily consumption of 5 ml cod liver oil with a mean LB (UB) concentration of 0.27 (0.95) 
pg TEQ/g, would correspond to an exposure to dioxins and dl-PCBs of 0.11 (LB) to 0.39 (UB) 
pg TEQ/kg bw/week in adults with mean body weight of 77.5 kg. 
Table 7.1.3.3-3 Exposure to dioxins and dioxin-like PCBs from fish oil and cod liver oil in adults 
(Norkost 3, n=1787) 
Food item Lower bound  
Sum dioxins and dl-PCBsa  
pg TEQ/kg bw/week 
Upper bound 
Sum dioxins and dl-PCBsa  
pg TEQ/kg bw/week 
 Mean P95 Mean P95 
Fish oil and cod liver oilb, n=1787 0.1 0.3 0.3 0.9 
P95: 95th percentiles.  
aDioxins = polychlorinated dibenzo-para-dioxins (PCDD) and polychlorinated dibenzo furans (PCDF), 
dioxin-like (dl) PCBs (non-ortho and mono-ortho substituted PCBs).  
bFor exposure estimates, data for fish oil and cod liver oil were combined and a weighted mean were 
used.  
Table 7.1.3.3-4 Exposure to dioxins and dioxin-like PCBs from fish oil in consumers only 
(Norkost 3, n=663) 
Food item Lower bound  
Sum dioxins and dl-PCBsa  
pg TEQ/kg bw/week 
Upper bound 
Sum dioxins and dl-PCBsa  
pg TEQ/kg bw/week 
 Mean P95 Mean P95 
Fish oil and cod liver oilb, n=663 0.2 0.3 0.6 1.1 
P95: 95th percentiles.  
aDioxins = polychlorinated dibenzo-para-dioxins (PCDD) and polychlorinated dibenzo furans (PCDF), 
dioxin-like (dl) PCBs (non-ortho and mono-ortho substituted PCBs). bFor exposure estimates, data for 
fish oil and cod liver oil were combined and a weighted mean were used.  
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7.1.3.4 Pregnant women  
Mercury 
Exposure to mercury from fish in pregnant women is shown in Table 7.1.3.4-1. The mean 
exposure was 0.17 µg/kg bw/week, whereas 95th - and 97.5th percentile exposure was 0.39 
and 0.45 µg/kg bw/week, respectively. Lean fish contributed with 82% of the mean 
exposure, and cod, saithe and haddock were the main sources of mercury among the lean 
species. This reflects merely the high consumption of cod, since the concentration of Hg in 
cod is not particularly high compared to less consumed species (Table 6.2-1). The median 
intake was 0.15 µg Hg/kg bw/week, which is more or less equal to the mean intake. The 95th 
percentile exposure was 2.3-fold higher than the mean exposure. The 97.5th percentile 
exposure for total fish was 0.45 µg/kg bw/week, for lean fish 0.40 µg/kg bw/week, for fatty 
fish 0.12 µg/kg bw/week and for cod roe and liver 0.01 µg/kg bw/week (not shown in Table 
7.1.3.4-1). 
Very few pregnant women reported to have eaten pike and perch (Tables 3.2.3-1 and 3.2.3-
2), and although these species may contain higher mercury levels than other more 
commonly eaten species, they contributed little to exposure even at high percentiles of 
mercury exposure. 
Table 7.1.3.4-1 Exposure to mercury from fish in pregnant women (MoBa, n= 83782)  
Food item Lower bound  
µg Hg/kg bw/week 
Upper bound  
µg Hg/kg bw/week 
 Mean Median P95 Mean Median P95 
Fish, total, n= 83782 0.17 0.15 0.38  0.17 0.15 0.39  
Lean fish (≤5% fat) 0.14 0.13 0.34  0.14 0.13 0.34  
Cod, saithe, haddock 0.12 0.10 0.29  0.12 0.10 0.28  
Redfish, catfish 0.01 0a 0.06  0.01 0a 0.06  
Pike, perch <0.01 0a 0  <0.01 0a 0 
Tuna 0.01 0a 0.06  0.01 0a 0.06  
Halibut, flatfish 0.01 0a 0.03  0.01 0a 0.03  
Fatty fish (>5% fat) 0.02 0.01 0.09  0.02 0.01 0.08  
Mackerel, herring 0.02 0.01 0.07  0.02 0.01 0.07  
Salmon, trout 0.01 0.01 0.02  0.01 0.01 0.02  
Fish roe and liver <0.01 0a <0.01 <0.01 0a 0.01  
Cod roe <0.01 0a <0.01 <0.01 0a 0.01  
Cod roe and liver pate <0.01 0a <0.01 <0.01 0a <0.01 
Cod liver <0.01 0a <0.01 <0.01 0a <0.01 
aMedian was zero because less than 50% of the participants had consumed the fish/fish product.  
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Dioxins and dl-PCBs 
Calculated exposure to dioxins and dl-PCBs in pregnant women is shown in Table 7.1.3.4-2. 
The mean lower bound exposure was 0.75 pg TEQ/kg bw/week, whereas the mean UB 
exposure was 0.94 pg TEQ/kg bw/week. The 95th percentile exposure was at LB 2.2 pg 
TEQ/kg bw/week and at UB 2.7 pg TEQ/kg bw/week. Fatty fish was the main source, 
contributing 66% of the exposure from fish. Farmed salmon contributed 28% of the mean 
exposure from fish. Cod liver was eaten by few pregnant women, but contributed 23% of 
the mean exposure from fish. This is caused by a high contribution in women that consume 
cod liver in the form of bread spread (cod roe and liver pate), as can be seen at the high 
percentiles. The UB 97.5th percentile exposure was 3.7 pg TEQ/kg bw/week from total fish, 
0.39 pg TEQ/kg bw/week from lean fish, 2.8 pg TEQ/kg bw/week from fatty fish and 1.3 pg 
TEQ/kg bw/week from cod roe and liver (not indicated in Table 7.1.3.4-2). 
Table 7.1.3.4-2 Eposure to dioxins and dl-PCBs from fish from fish in all pregnant women 
(MoBa, n=83782) 
Food item Lower bound  
Sum dioxins and dl-PCBsa  
pg TEQ/kg bw/week 
Upper bound  
Sum dioxins and dl-PCBsa  
pg TEQ/kg bw/week 
 Mean Median P95 Mean Median P95 
Fish, total (n=83782) 0.75 0.46 2.2  0.94 0.59 2.7  
Lean fish (≤5% fat) 0.085 0.062 0.24  0.12 0.097 0.32  
Cod, saithe, haddock 0.055 0.047 0.13  0.088 0.075 0.21  
Redfish, catfish 0.005 0c 0.026  0.008 0c 0.041  
Pike, perch <0.001 0c 0  <0.001 0c 0  
Tuna <0.001 0c 0 <0.001 0c 0  
Halibut, flatfish 0.025 0c 0.15  0.026 0c 0.16  
Fatty fish (>5% fat) 0.49 0.32 1.6  0.65 0.42 2.1  
Mackerel, herring 0.28 0.11 1.2  0.39 0.15 1.7  
Salmon, troutb 0.21 0.16 0.64  0.26 0.20 0.80  
Fish roe and liver 0.17 0c 0.47  0.17 0c 0.47  
Cod roe 0.032 0c 0.17  0.032 0c 0.17  
Cod roe and liver pate 0.13 0c 0  0.13 0c 0 
Cod liver 0.014 0c 0  0.014 0c 0  
P95 = 95th percentile. 
aDioxins = polychlorinated dibenzo-para-dioxins (PCDD) and polychlorinated dibenzo furans (PCDF), 
dioxin-like (dl) PCBs (non-ortho and mono-ortho substituted PCBs). 
bFarmed salmon represents salmon and trout. 
cMedian was zero because less than 50% of the participants had consumed the fish/fish product. 
Exposure from fish oil and cod liver oil in pregnant women 
Exposure from fish oil and cod liver oil has not been calculated for pregnant women in the 
present opinion. However, a high proportion of pregnant women are consumers of fish oil 
and cod liver oil (77% in 2008, Chapter 3.2.3).  
Daily consumption of 5 ml fish oil or cod liver oil with a mean LB (UB) concentration of 0.27 
(0.95) pg TEQ/g, would correspond to an exposure to dioxins and dl-PCBs of 0.13 (LB) to 
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0.45 (UB) pg TEQ/kg bw/week in pregnant women with mean pre-pregnancy body weight of 
67 kg. 
 Summary of current contaminant exposure from food consumption 7.1.4
surveys 
Methylmercury exposure 
For methylmercury exposure, fish is the only notable source. Methylmercury constitutes 80-
100% of the total mercury in fish. The main source is lean fish (Figure 7.1.4-1).  
The updated exposure assessments indicated mean and 95th percentile exposure in 2-year-
olds at 0.51 and 1.1 µg/kg bw/week. In adults the mean and 95th percentile exposures 
were 0.30 and 1.2 µg/kg bw/week, and in pregnant women the mean and 95th percentile 
exposures were 0.17 and 0.39 µg/kg bw/week, respectively. For mercury exposure from fish, 
the upper and lower bounds are quite similar. 
 
Figure 7.1.4-1 Mean upper bound (UB) exposure to mercury from fish in Norwegian 2-year-
olds (småbarnskost), adults (Norkost 3) and in pregnant women (MoBa). For mercury exposure from 
fish, the upper and lower bounds are quite similar. Fish is grouped into fatty fish and lean fish, and 
fish roe and liver. 
Dioxins and dl-PCBs 
The updated exposure assessments from fish indicated mean exposure in 2-year-olds 
between 2.0 (LB) and 2.6 (UB) and 95th percentile exposure between 7.3 (LB) and 9.4 (UB) 
pg TEQ/kg bw/week. In adults the mean exposure was between 1.4 (LB) and 1.7 (UB) pg 
TEQ/kg bw/week, and the 95th percentile exposure was between 5.6 (LB) and 6.8 (UB) pg 
TEQ/kg bw/week.In pregnant women the mean exposure was between 0.75 (LB) and 0.94 
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(UB) pg TEQ/kg bw/week and the 95th percentile exposure was between 2.2 (LB) and 2.7 
(UB) pg TEQ/kg bw/week.  
Fatty fish was the major contributor (Figure 7.1.4-2), but consumption of cod liver oil may 
contribute in addition. In adults, cod liver oil contributed a smaller part, whereas cod liver oil 
constitutes a larger part in 2-year-olds.  
 
Figure 7.1.4-2 Mean upper bound (UB) exposure to dioxins and dl-PCBs from fish and cod 
liver oil (including fish oil) in Norwegian 2-year-olds (Småbarnskost 2007), adults (Norkost 3) and in 
pregnant women (MoBa, not including cod liver oil). Fish is grouped into fatty fish, lean fish and 
liver/roe.  
7.2 Previous dietary estimates and changes in nutrient intake 
and contaminant exposure from fish since 2006 
As summarised in Chapter 3.4, the fish consumption is largely unchanged between the VKM 
opinion in 2006 and the present assessment. The methods used for intake and exposure 
assessment particularly in adults in 2006 and in the present report are however not directly 
comparable and any differences between intakes of nutrients and contaminants need to be 
interpreted with caution. The mean is however to some extent comparable between the 
surveys because of the large number of participants. Data from the food consumption 
surveys for 2-year-olds from 2006 (Småbarnskost 1998) and the present assessment 
(Småbarnskost 2007) are comparable as the same method was used in both these surveys 
(semi-quantitative food frequency questionnaire). For both 2-year-olds, pregnant women and 
adults, lean fish contributes with about 60 percent of the total fish consumption, while fatty 
fish contributes with about 40 percent, which is more or less similar as in 2006 given the 
methodological differences (Chapter 3.3).  
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 Eicosapentaenoic acid (EPA), docosapentaenoic acid (DPA) and 7.2.1
docosahexaenoic acid (DHA) 
In the (VKM, 2006) fish contributed on average  200 mg EPA+DPA+DHA per day in 2-year-
olds, the median was 100 mg and high consumption (95th percentile) was 700 mg/day. Use 
of supplements contributed on average 400 mg/day. Compared to (VKM, 2006), the amount 
of EPA+DPA+DHA (mg/d) from both mean and high fish consumption (95th percentile) in 2-
year-olds is unchanged, providing 200 mg and 700 mg EPA+DPA+DHA per day, 
respectively. 
No quantitative assessment of EPA+DPA+DHA contributed by fish was given for pregnant 
women in (VKM, 2006). However, in 40108 women recruited during years the 2002 to 
2005, fish oil and cod liver oil supplements were used by 59%, which will contribute 
substantially to the intake of these fatty acids (Chapter 3.2.3). 
In 2006, in the adults, fish contributed on average 500 mg EPA+DPA-DPA, the median was 
300 mg and high consumption (95th percentile) was 1300 mg/day (VKM, 2006). Use of 
supplements contributed on average 300 mg/day. The amount of EPA+DPA+DHA mg per 
day from mean total fish intake is unchanged also in adults, providing 500 mg 
EPA+DPA+DHA per day. 
In 2006, the average contribution of EPA+DPA-DPA from dietary supplements was not 
estimated. In the current update, the average contribution of EPA+DPA-DPA from fish oil 
and cod liver oil supplements for adults was 735 and for 2-year-olds 454 mg/day. 
 Vitamin D 7.2.2
In (VKM, 2006), it was estimated that fish contributed on average with 0.50 µg vitamin D per 
day in the 2-year-olds and up to 1.9 µg/day for high consumers (95th percentile). In the 
current update, fish contributed on average 0.36 µg vitamin D per day, and high 
consumption contributed 1.32 µg/day. There has been a modest decline in estimated vitamin 
D contributed by fish in 2-year-olds.  
The contribution from fish to vitamin D intake in adults was in (VKM, 2006) estimated to be 
on average 2.6 µg vitamin D per day. The current estimated average contribution from fish 
in adults is 2.1 µg vitamin D per day. In 2006, the average contribution of vitamin D from 
dietary supplements for adults was 5.9 µg/day. In the current update, the average 
contribution of vitamin D from fish oil and cod liver oil supplements for adults was 3.5 
µg/day. Since 2006, vitamin D contributed by fish has been calculated and published in the 
Fish and Game Study, part C. In 101 men and women who did not consume fish liver, the 
median intake of vitamin D from fish was 2.2 µg/day, which is comparable to the current 
estimate in adults (Birgisdottir et al., 2012).  
In (VKM, 2006) estimated vitamin D contributed by fish in pregnant women was not 
reported. In a study in 40108 MoBa participants recruited during years 2002 to 2005, fish oil 
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and cod liver oil supplements were used by 59%, which contributed substantially to the 
intake of vitamin D (Haugen et al., 2009). 
 Iodine 7.2.3
(VKM, 2006) did not report the contribution of iodine from fish in 2-year-olds or pregnant 
women. In scenarios in adults with low (27 g/day), median (65 g/day) and high 
consumption of “fish and other seafood” (119 g/day) and a distribution with 2/3 lean and 1/3 
fatty fish, iodine contributed by the three different scenario intakes were estimated to be 76, 
180 or 340 µg/day.  
The updated mean estimate of iodine in adults is 86 µg iodine per day, which is apparently 
lower than the scenario based on median fish consumption in 2006. The reason for this 
difference is not fully known, but the iodine data in the present exposure assessment is 
based on levels in different fish species as described in Chapter 6, whereas the iodine levels 
used for exposure assessment in the scenario from 2006 are described as a range for 
different species, and the exact figures used were not given. There is no environmental or 
biological reason why iodine intake from fish should be decreased since 2006 as long as the 
fish consumption is unchanged, and the discreapancy may be explained by a better database 
and thus less uncertainty in the exposure assessment than in 2006.  
 Selenium 7.2.4
(VKM, 2006) did not report the contribution of selenium from fish in 2-year-olds or 
pregnant women. In adults, selenium contributed by fish was estimated in the same 
scenario as described above for iodine. Low, median and high fish consumption with 2/3 lean 
and 1/3 fatty fish contributed 9, 22 and 41 µg selenium per day in 2006.   
In the current update, average adult fish consumption contributed 15 µg selenium per day, 
which is apparently lower than that at the scenario at median fish consumption in 2006. As 
for iodine, the reason for the difference is not fully known. The selenium data in the present 
exposure assessment is based on levels in different fish species as described in Chapter 6, 
whereas the selenium levels used for exposure assessment in the scenario from 2006 
generally were slightly higher in the different fish species.  
 Mercury  7.2.5
The main difference regarding mercury exposure from fish is that the database on mercury 
concentrations in fish has been substantially improved since the VKM assessment in 2006, 
and this has reduced the uncertainty in the exposure estimates. 
The mercury exposure from fish in 2-year-olds was at median 0.3 µg/kg bw/week (95th 
percentile 0.8 µg/kg bw/week) in 2006, and the exposure in the present opinion is at UB 
median 0.45 µg/kg bw/week (mean and 95th percentile of 0.51 and 1.16 µg/kg bw/week).  
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The median exposure to mercury from fish and other seafood was in adults in 2006 
estimated to 0.4 µg/kg bw/week, whereas the mean adult exposure in the present opinion 
based on Norkost 3 is 0.3 µg/kg bw/week, and in pregnant women in MoBa 0.17 µg/kg 
bw/week in the present opinion. The lower exposure in pregnant women than in adults can 
be explained by lower fish consumption among pregnant women than in the general 
population, in addition to different dietary recall methods.  
There are no good time-trend data on mercury levels in fish however, the data do not 
indicate a reduction in mercury levels in fish. The exposure data indicate an increase in 
children, while differences in dietary methods prevent conclusions on differences in exposure 
levels in adults. 
Since publication of the VKM report in 2006 (VKM, 2006), two studies on dietary exposure to 
mercury have been published in Norway, as summarised below. For these two publications, 
the database used for exposure assessment in (VKM, 2006) was extended and improved. 
Total mercury exposure from fish and other food was calculated in the Norwegian Fish and 
Game study part C (n=184) based on the FFQ in the study and an extensive database on 
levels in food in Norway, covering the total diet. The median mercury exposure was 0.3 and 
0.4 µg/kg bw/week in a group of adult consumers considered representative for The Fish- 
and Game study part B (which was representative for selected counties in Norway) and in a 
group including high fish consumers, respectively. Seafood contributed to 95% of the 
exposure. A commonly used toxicokinetic model indicated that the dietary intake exposure 
estimate moderately underestimated the measured mercury in blood among participants 
with the highest blood mercury level (Jenssen et al., 2012).  
Total mercury exposure from fish and other food has also been calculated for participants in 
MoBa (n=62 941), based on the same database as in (Jenssen et al., 2012). Median 
exposure to Hg was 0.15 µg/kg bw/week (P5-P95: 0.03-0.38). The mean contribution from 
seafood consumption was 88% of total mercury exposure (Vejrup et al., 2014). 
Both the abovementioned studies report mercury exposure quite similar as found in the 
present exposure assessment in adults and pregnan women.  
 Dioxins and PCBs 7.2.6
Also for dioxins and dl-PCBs the database on concentrations in fish has improved 
substantially since the assessment in 2006, reducing the uncertainty in the exposure 
assessments. There is a decreasing trend of dioxins and dl-PCBs in humans, indicating 
decreasing exposure (VKM, 2013a). Since food is a major source, this means that the levels 
in food are decreasing, although there are no trend data in food in Norway available to show 
this decrease.  
In adults, the median UB intake of dioxins and dl-PCBs from fish and other seafood was 
estimated to be 4.7 pg TEQ/kg bw/week in 2006, and in the present opinion the mean UB 
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exposure was 1.7 pg TEQ/kg bw/week (LB 1.4 pg TEQ/kg bw/week). The mean exposure 
from fish in adults in 2014 is thus substantially lower, approximately 36% of what was 
calculated in 2006.  
In the present opinion the mean UB exposure from fish in pregnant women (MoBa) was 
0.94 pg TEQ/kg bw/week (LB 0.75), which is lower than the mean in adults (Norkost 3). The 
lower exposure in MoBa than in adults in Norkost 3 can be explained by lower fish 
consumption among pregnant women than in the general population, in addition to different 
dietary recall methods. 
Exposure in children at 2-years-olds was only shown in figures in (VKM, 2006), and no 
numerical data were given. Exposure in pregnant women was not shown. 
Since publication of the VKM report in 2006 (VKM, 2006), two studies on dietary exposure to 
dioxin and dl-PCBs have been published in Norway, as summarised below. For these two 
publications, the database used for exposure assessment in the VKM report (VKM, 2006) was 
extended and improved. 
In the Norwegian Fish- and Game study part C (conducted in 2003), 73 representative 
consumers and 111 high consumers of fish and game filled in a food-frequency questionnaire 
(FFQ) that covered the entire diet. The food consumption data were couplet to an extensive 
database on levels of dioxins and dl-PCBs in food in Norway in the period 2000-2006. The 
estimated median intakes (LB) of dioxins and dl PCBs were 5.46 and 8.75 pg TEQ/kg 
bw/week in two groups of consumers with different seafood consumption, respectively. In 
these groups, fish and other seafood contributed with 70 and 71% of the exposure, 
respectively (Kvalem et al., 2009).  
The same database on levels of dioxins and dl-PCBs in food as the one used in (Kvalem et 
al., 2009) has been used to calculate the intake of dioxins and dl-PCBs and PCB-153 in 
participants in the MoBa cohort between 2002 and 2009 (83524 participants). The mean 
(median) LB intake of dioxins and dl-PCBs was 4.73 (3.56) pg TEQ/kg bw/week (Caspersen 
et al., 2013). Fish and other seafood contributed with 41% of the exposure, corresponding 
to 1.95 pg TEQ/kg bw/week (personal communication, IH Caspersen).  
Based on the above, it can be concluded that the mean exposure from fish in pregnant 
women based on the database of levels of dioxins and dl-PCBs in fish in the present opinion 
(Chapter 5.5.1) is approximately 40% of the level calculated based on the previous 
database, which contained fish analysed in the period 2000 to 2006. The decrease is likely 
due to a combination of more accurate data on levels in fish, which reduces the uncertainty, 
and decreased levels of dioxins and dl-PCBs in the environment. 
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 Summary of changes in nutrient intake and contaminant exposure 7.2.7
since the benefit-risk assessment in 2006 
The updated nutrient calculations in the current opinion indicate no change in 
EPA+DPA+DHA contributed by fish consumption, a modest decline in the amount of vitamin 
D contributed by fish, and a substantial decline in iodine and selenium. There is no 
environmental or biological reason why iodine and selenium intake from fish should be 
decreased since 2006, as long as the fish consumption is unchanged. The observed 
differences may be explained by better databases and thus less uncertainty now than in the 
exposure assessments in 2006. 
The main difference regarding mercury exposure from fish is that the database on mercury 
concentrations in fish has been substantially improved since the assessment in 2006, and 
this has reduced the uncertainties in the exposure estimates. Overall, the exposure estimates 
for mercury from fish in 2006 and 2014 are quite similar. 
Also for dioxins and dl-PCBs the database on concentrations in fish has improved 
substantially since the assessment in 2006, reducing the uncertainty in the exposure 
assessments.  
There is a decreasing trend of dioxins and dl-PCBs in the environment and therefore also in 
food. A decrease in exposure to dioxins and dl-PCBs from fish can be seen since 2006, as 
present exposure is estimated to be in the range of 40% of the exposure calculated in 2006. 
The decrease is likely due to a combination of more data on levels of dioxins and dl-PCBs in 
fish in 2014 than in 2006, and decreased levels of dioxins and dl-PCBs in the environment. 
VKM has made various scenarios to foresee how possible changes in fish consumption 
pattern and amounts will affect the contribution from fish to the recommended intakes of 
specific important nutrients, as well as to exposure to tolerable weekly intakes (TWI) of 
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8 Benefit and risk characterisation of 
fish consumption 
8.1 Background  
Fish is an important component of a varied diet for the Norwegian population-at-large, 
providing a number of nutrients that are important for achieving a balanced diet for children, 
adults and the elderly. The nutritional benefits of fish consumption have long been 
recognised by health authorities in Norway and many other countries. Thus, in 2006, the 
Norwegian recommendation for fish consumption was to eat more fish both for dinner and 
as bread spread. In 2014, based on the VKM assessment in 2006 (VKM, 2006) and the 
report “Dietary advice to promote public health and prevent chronic diseases in Norway” 
(Norwegian National Council for Nutrition, 2011), these recommendations were altered and 
made quantitative by the Norwegian Directorate of Health (2014). The current 
recommendation is to eat fish as dinner meals 2-3 times per week for all age groups, 
representing 300-450 g fish per week for adults, including at least 200 g fatty fish such as 
salmon, trout, mackerel and herring. Fish is also recommended as bread spread. A further 
exception is given for young females and pregnant women, who should, over time, avoid 
eating more than the equivalent to two meals of fatty fish per week, including fish like 
salmon, trout, mackerel and herring (Chapter 1). The Norwegian health authorities also 
recommend a daily supplement of vitamin D to infants from 4 weeks of age, and if this 
supplement is taken as cod liver oil it will in addition ensure an adequate supply of n-3 
LCPUFAs. 
Norwegians have traditionally had a relatively high fish and seafood consumption, especially 
in the coastal areas. Furthermore, fishing and hobby angling contribute to higher fish 
consumption in subgroups of the population. During the last decade farmed Atlantic salmon 
and to some extent also farmed rainbow trout, have become important food items in the 
Norwegian diet. Norway is globally one of the largest producers of farmed Atlantic salmon 
and rainbow trout (Chapter 5). 
Fish, as other food, contain both beneficial (i.e. nutrients) and potential hazardous 
compounds (i.e. contaminants), and the weighing of benefits and risks of food/fish 
consumption has become a main public health issue. For some decades, concerns about 
potential risks associated with exposure to contaminants from food have resulted in strong 
focus on chemical management and policy both nationally and internationally. Stricter 
controls, use-restrictions and bans of the most hazardous contaminants, have resulted in a 
significant decline in concentrations the last 20 years, both in the environment and in 
humans (Chapter 2). 
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In 2006, VKM published a benefit-risk assessment of fish in the Norwegian diet (VKM, 2006). 
At that time, there was little experience with benefit-risk assessment. For the benefit 
assessment VKM therefore mirrored the risk assessment paradigm that was well established 
(hazard identification and characterization (including dose-response assessment), exposure 
assessment and risk characterisation). Thus, the beneficial effect of fish was assessed by the 
following four steps; positive health effect identification, positive health effect 
characterisation (dose-response assessment), exposure assessment and benefit 
characterization. In the final benefit-risk assessment a comparison of the benefits and risks 
was done (VKM, 2006).  
A similar approach is recommended by EFSA (2010a) in the Opinion “Guidance on human 
health risk-benefit assessment of foods”. Furthermore, a stepwise approach; i) initial 
assessment, addressing the question whether the health risks clearly outweigh the health 
benefits or vice versa, ii) refined assessment, aiming at providing semi-quantitative or 
quantitative estimates of risks and benefits at relevant exposure by using common metrics, 
and iii) comparison of risks and benefits using a composite metric such as disability-adjusted 
life year (DALY) or quality-adjusted life year (QALY) to express the outcome of the risk-
benefit assessment as a single net health impact value is recommended. In the same opinion 
EFSA also emphasizes the importance to discuss strength and weaknesses of the data sets 
used in the different steps as well as its associated uncertainties.  
The present benefit-risk assessment is comprised of three elements, i.e. benefit 
assessment, risk assessment and benefit-risk comparison. This methodology is in 
accordance with EFSA EFSA (2010a) for steps i) - ii). To estimate the effect of fish 
consumption on disability-adjusted life year (DALY) or quality-adjusted life year 
(QALY) to express the outcome of the risk-benefit assessment as a single net 
health impact value for the Norwegian population was not considered necessary 
based on the outcomes of the first two steps. Uncertainties are addressed in 
Chapter 9.   
8.2 Fish consumption in Norway 
On an average, Norwegians eat more fish than most other Europeans (except Spaniards and 
Italians) (EFSA, 2014b). In this assessment, VKM has used information about fish 
consumption from more recent national dietary surveys among 2-year-olds (Kristiansen et 
al., 2009) and adults (18-70 years of age, (Totland et al., 2012) as well as information for 
pregnant women who answered the Norwegian Mother and Child Cohort Study (MoBa) food- 
frequency questionnaire (FFQ) (Brantsaeter et al., 2008; Magnus et al., 2006; Meltzer et al., 
2008). 
The distribution in terms of portions depends on the portion sizes of dinners and amount of 
spread used on bread. (VKM, 2006) defined a dinner portion as 200 g and a portion of fish 
spread as 25 g. The national food-based dietary guidelines for total fish consumption 
(Norwegian Directorate of Health, 2014) could be met by two fish dinners and two slices of 
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bread with fish spread weekly. When a smaller dinner portion is used, e.g. 150 g as used in 
this report, two fish dinners and fish spread on six bread slices weekly is needed to meet the 
recommendation.  
In 2006, dietary intakes of fish by the age groups 4-, 9-, and 13-year-olds were estimated 
from the national food consumption survey Ungkost 2000 (VKM, 2006). These food 
consumption data are considered too old to be used in this opinion. Thus, fish consumption 
by these particular age groups has not been assessed in the present report, and it is 
therefore not known if the fish consumption patterns have changed, neither in amount 
consumed nor type of fish eaten for these age groups (Chapter 3.3).   
Fish consumption per week of the different age groups is summarised in the table Table 8.2-
1. 
Table 8.2-1 Fish consumption (expressed as raw fish), mean grams (g) per week in 2-year-olds 
(Småbarnskost 2007, n=1674), adults (Norkost 3, n=1787) and pregnant women (MoBa, n=86277)  
Population groups Mean fish consumption g/week  
 Fish,  
total 
Lean fish, cod  
(≤ 5% fat) 
Fatty fish  
(> 5% fat) 
Fish roe and 
liver 
2-year-olds  112 70 35 7 
Adults  364 210 147 7 
Pregnant women 217 126 77 14 
Adults eat on average 364 g/week (equivalent to 2-3 fish dinner servings per week given a 
portion size of 150 g), pregnant women eat 217 g per week (equivalent to 1-2 dinner 
servings per week given a portion size of 150 g), while 2-year-olds eat 112 g/week 
(equivalent to 1-2 dinner servings per week given a portion size of 75 g).  
Approximately sixty percent of the consumption consists of lean fish and minced fish 
products. Pregnant women eat fatty fish in amounts equivalent to half a dinner serving per 
week. For all age groups Atlantic cod is the most eaten lean fish species, and for pregnant 
women mackerel and farmed Atlantic salmon are equally important fatty fish species (on 
average 42 g mackerel versus 35 g farmed salmon per week), while for adults farmed 
salmon is more important than mackerel as a fatty fish species consumed (on average 84 g 
farmed salmon versus 28 g mackerel per week). For 2-year-olds, mackerel is the most eaten 
fatty fish species (on average 21 g mackerel versus 7 g farmed salmon per week). For 
details on fish consumption in Norway, see Chapter 3. 
 Comparison of fish consumption; 2014 versus 2006 8.2.1
Pregnant women and 2-year-olds: Although the methods used to assess fish 
consumption in this assessment are not directly comparable with the respective methods 
used by VKM in 2006 (Chapter 3.3), the fish consumption (g/week) does not appear to have 
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changed substantially since 2006 for 2-year-olds and young women (represented as 
pregnant women in the present report).  
Adults: For adults, the methods used for assessment of fish consumption differ substantially 
between 2006 and 2014 (Chapter 3.3), however a rough comparison of mean intake does 
indicate fish consumption in the same order of magnitude. 
For both 2-year-olds, adults and pregnant women, lean fish contributes with about 60 
percent of the total fish consumption, while fatty fish contributes with about 40 percent, 
which is similar as to 2006 given the methodological differences (Chapter 3.3).  
 Comparison of fish consumption in Norway with food based dietary 8.2.2
guidelines 
The Norwegian Directorate of Health (per 2014) recommends fish as dinner meal 2-3 times 
per week for all age groups. Fish is also recommended as bread spread. This 
recommendation represents totally 300-450 g fish per week for adults, and less for children 
due to smaller portion size. For adults, at least 200 g should be fatty fish such as salmon, 
trout, mackerel and herring (Chapter 1). 
Two-year-olds: There are no specific dietary guidelines for fish intake for 2-years-olds, 
however, the Norwegian Directorate for Health recommends (per 2014) fish as dinner meal 
2-3 times per week for all age groups. The average fish intake (112 g fish per week) is 
about one third of adult intake equivalent to approximately one and a half dinner serving per 
week. 
Adults: The average fish intake (364 g/week) reaches the recommended intake of total fish 
consumption (300-450 g fish/week), but the average intake of fatty fish (147 g/week) does 
not reach the recommendation for fatty fish consumption (200 g/week).  
Pregnant women: The average fish intake (217 g/week) does not reach the recommended 
intake of total fish consumption (300-450 g/week). The average intake of fatty fish (77 
g/week) is about 1/3 of the recommended intake of fatty fish (200 g/week). However, high 
fish consumers (95th percentile: 476 g/week, which refers to approximately three dinner 
servings per week) do reach the recommended intake of total fish consumption. 
Furthermore, the high intake of fatty fish (95th percentile: 252 g/week) reaches the 
recommended intake of at least 200 g fatty fish per week. A study in a subset of the same 
population of pregnant women found that only 23% of the women reached the 
recommended intake of 300-450 g fish per week, and only 6.7% reached the recommended 
intake of at least 200 g fatty fish per week (von Ruesten et al., 2014). 
VKM concludes that of the different population groups, only adults (18-70 years 
of age) with an average or higher fish consumption reach the food based dietary 
guidelines for total fish consumption (Norwegian Directorate of Health, 2014). 
Both the mean total and fatty fish consumption in children (2-year-olds) and 
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pregnant women as well as the mean fatty fish consumption in adults are lower 
than recommended. Pregnant women especially have too low fish consumption to 
meet the dietary guidelines. 
8.3 Health effects of fish consumption 
Epidemiological studies can demonstrate statistical significant associations between dietary 
exposures and health outcomes. However, because of all the other exposures occurring 
simultaneously in the complex lives of humans that can never be completely accounted for, 
such studies cannot provide evidence of cause and effect. Only randomized controlled trials 
have a study design that can demonstrate causal effects in humans. Such trials are however 
not feasible for long-term dietary exposure. Therefore, evidence from observational studies 
of dietary exposures and disease outcomes are necessary and important. When sufficient 
studies exists, in diverse settings and with adequate elimination of random error, systematic 
error (bias), and logical error (confounding), then the causal nature of observed associations 
can be reasonably assessed. The evidence contributed by observational epidemiological 
studies is inversely related to the degree of uncertainty. For more details regarding general 
limitations and uncertainties in interpretation of data from epidemiological studies, see 
Chapter 9.3. 
Fish contain both beneficial components (e.g. nutrients like n-3 LCPUFA and vitamin D) and 
possible hazardous compounds (e.g. methylmercury, dioxins and PCBs). Very few studies 
have examined the influence of beneficial effects of fish, taking into account the 
contaminants present. When balancing the benefits of fish consumption on a specific health 
outcome, i.e. cardiovascular disease and optimal neurodevelopment, with the risk from 
contaminants such as PCBs, dioxins and methylmercury in fish, the net outcome may be 
affected by the degree of contaminant exposure. Thus, “negative confounding”, which 
denote that two opposing forces coexist in the same food and influence the outcome in 
opposite directions is a particular challenge when conducting and evaluating studies of fish 
consumption (Stern and Korn, 2011). For a comprehensive summary of health effects 
associated with fish consumption, see Chapter 4.8. 
 Epidemiological studies addressing fish consumption and different 8.3.1
health outcomes 
In VKM (2006), possible health effects associated with fish consumption was assessed by 
reviewing relevant available epidemiological data on associations between fish consumption 
and the health outcomes cardiovascular disease, cancer, growth and development of foetus 
and infant, and allergy to fish and other seafood. The data sources were guite limited. Since 
then, several extensive observational studies and intervention studies have been conducted, 
addressing beneficial effects of fish and EPA+ DHA supplementation on specific health 
outcomes in the general population and/or specific subgroups. Thus, since 2006, the 
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knowledge-base for assessing health effects associated with fish consumption is considerably 
strengthened. 
In the present VKM report, the literature reviewed (Chapter 4) addressing fish consumption 
and effects on specific health outcomes that was considered relevant for the benefit-risk 
evaluation includes systematic reviews and meta-analyses, assessments prepared by 
international scientific bodies as well as some single cohort or population-based studies 
published after 2006, (see Chapter 4.1 for details with regards to strategy for selection of 
epidemiological studies assessed). It appears that of the health endpoints assessed, there 
are more studies and more evidence related to fish consumption and cardiovascular 
endpoints and neurodevelopment than for the other endpoints assessed in this up-date 
(cancer; type-2 diabetes and other metabolic outcomes; asthma, allergy, and other atopic 
diseases; pregnancy related outcomes; neurodevelopment; and cognitive decline including 
Alzheimers disease).  
Criteria for objectively evaluating the level of causality of associations observed in 
epidemiology were stated by Hill (1965). These criteria, which include consistency and 
strength of the association, dose-response, time order, specificity, consistency on replication, 
predictive performance, biological plausibility and coherence, must be applied when 
discussing the results observed in every study. For characterisation of a possible beneficial 
health effect of fish consumption, a dose-response assessment is a prerequisite.   
VKM has summarized research on association between fish consumption and several health 
effects (cardiac disease, neurodevelopment and other outcomes related to the central 
nervous system, cancer, type-2 diabetes and other metabolic outcomes, asthma, allergy and 
other atopic outcomes, and pregnancy related outcomes). A comprehensive summary of 
health effects associated with fish consumption is given in Chapter 4.8. 
VKM concludes that meta-analyses conducted since 2009 do not show association between 
fish consumption and cancer. Furthermore, the studies summarized have not revealed 
consistent associations between fish consumption and type-2 diabetes, although some 
Nordic studies indicate protective associations. None of the studies controlled for 
contaminant exposure from fish, and it is not known whether this would have affected the 
outcome.  
No studies reported association between fish consumption and adverse health effects. A few 
studies showing positive health effects of fish consumption reported negative confounding by 
contaminants in fish. 
 Fish consumption in Norway and beneficial health effects 8.3.2
For pregnancy-related outcomes, results from MoBa indicate that fish consumption 
during pregnancy, and in particular lean fish consumption, is associated with increased 
birth weight and lower risk of preterm birth. Studies also indicate that prenatal 
exposure to both mercury and dioxins and PCBs can decrease birth weight. VKM concludes 
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that this implies that the overall beneficial effect of fish consumption on birth weight might 
have been more beneficial in the absence of contaminants, and that the findings need to be 
confirmed in other cohorts.  
Regarding atopic diseases, VKM noted that the studies indicate a protective association 
between maternal fish consumption and/or early life fish consumption and atopic diseases. 
None of the studies controlled for contaminant exposure from fish and it is not known 
whether this would have affected the outcome. 
No dose-response assessment was possible for the abovementioned end points. 
It is only for the health outcomes cardiovascular diseases and neurodevelopment that 
adequate data on relationships between dose (fish consumed) and response are available 
(Chapter 4). It should be noted that information on type of fish species constituting “fish 
consumption” in the epidemiological studies was generally absent. Thus, in the following a 
comparison is attempted of the present Norwegian fish consumption (in terms of fish 
servings per week or g fish per week) and the corresponding fish consumption in 
epidemiological studies associated with effects on cardiovascular diseases and optimal 
neurodevelopment. 
It should be noted that servings used in different studies were not always quantified and 
varied considerably. The servings were generally lower than the portion sizes used in this 
opinion.  
Cardiac mortality: VKM notes that the beneficial effect of seafood consumption on cardiac 
mortality is observed at relatively low fish consumption, 1-2 servings of fish per week, and 
up to 3-4 servings per week. Furthermore, VKM notes that the calculated benefits of fish 
consumption in relation to cardiac mortality refer to net effects combining beneficial, neutral, 
and adverse effects of nutrients and non-nutrients, including contaminants such as 
methylmercury, dioxins, dl-PCBs. VKM also notes that EPA and DHA play a role. However, 
the beneficial effects of fish intake on cardiac mortality are most likely mediated through a 
complex interplay among a wide range of nutrients commonly found in fish, thus fatty and/or 
lean fish may be involved. 
Other cardiovascular outcomes: VKM notes that the beneficial effect of fish consumption 
on the risk of multiple other adverse cardiovascular health outcomes, including ischaemic 
stroke, non-fatal coronary heart disease events, congestive heart failure and atrial fibrillation 
being stronger among those who had moderate (2-4 fish servings per week) than those who 
consumed low amounts of fish (1 or less fish serving per week). A dose dependent inverse 
relationship between fish consumption and EPA+DHA with heart failure incidence exist; fish 
intake 1-4 servings per week is associated with a risk reduction of up to 15% compared to 
less than 1 serving of fish per week. However, the beneficial effects of fish intake on 
cardiovascular risk are most likely mediated through a complex interplay among a wide 
range of nutrients commonly found in fish, thus fatty and/or lean fish may be involved. 
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Norwegian fish consumption and cardiovascular disease: The average fish 
consumption of adult Norwegians, 364 g/week equivalent to about 2-3 fish servings per 
week, is within the range considered to be beneficial according to epidemiological studies, 
and should give significant beneficial effects on cardiovascular outcomes on a population 
level. The average fish consumption in pregnant women, about 200 g/week including 77 g 
fatty fish, is at the lower end of fish consumption that may have beneficial effect on cardiac 
death, while the high consumers (95th percentile) are within the range of beneficial fish 
consumption. Adults including pregnant women, who eat little or no fish, may miss the 
beneficial effects of fish consumption on cardiovascular outcomes.  
VKM notes that when balancing the benefits of fish consumption on cardiovascular disease 
with the risk from contaminants such as PCBs, dioxins and methylmercury in fish, the net 
outcome is affected by the degree of contaminant exposure. Furthermore, VKM notes that it 
is difficult and sometimes even impossible to compare contaminant exposure between 
studies. However, for all age groups in Norway, both with average and high fish 
consumption, the exposures from fish is well below the tolerable weekly intake for 
methylmercury and dioxins and dl-PCBs also for the high consumers (95th percentile). 
Neurodevelopmental outcomes: VKM notes that the beneficial effect of fish/seafood 
consumption and children’s neurodevelopment is observed at relatively low fish consumption, 
of about 1-2 servings per week, and up to 3-4 servings per week, compared to no 
fish/seafood consumption. VKM also notes that the calculated benefits of fish consumption in 
relation to neurodevelopmental outcomes refer to fish/seafood per se, including nutrients 
(e.g. DHA, iodine) and contaminants (such as methylmercury, dioxins and dl-PCBs) 
contained in fish/seafood. Furthermore, VKM acknowledges that the observed health benefits 
of fish consumption during pregnancy on neurodevelopment may depend on the maternal 
status with regard to nutrients and the contribution from fish relative to other sources of 
nutrients important for neurodevelopment. 
VKM notes that high prenatal methylmercury exposure due to maternal consumption of fish 
high in methylmercury may reduce the beneficial effect of fish consumption on 
neurodevelopment. VKM also notes that high exposure to dioxins and PCBs may reduce the 
beneficial effect of fish consumption on neurodevelopment. The tolerable weekly intakes 
(TWIs) of both methylmercury and dioxins and dl-PCBs, respectively, are set to protect the 
most vulnerable groups (unborn children and infants). VKM (present report) has calculated 
that for 2-year-olds, pregnant women and adults, both mean exposure and 95th percentile 
exposures from fish are below the TWIs for these contaminants.  
Norwegian fish consumption and optimal neurodevelopment: The average fish 
consumption in pregnant women, about 200 g including 77 g fatty fish per week, is at the 
lower end of fish consumption that may have beneficial effect on neurodevelopment 
according to epidemiological studies. The high consumers (95th percentile) have sufficient 
consumption to be in the range of beneficial effect. Pregnant women, who eat little or no 
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fish, may miss the beneficial effects on neurodevelopmental outcomes in foetuses and 
infants.  
VKM is of the opinion that according to epidemiological studies, the net effects of 
the present average fish consumption in Norway for adults including pregnant 
women is beneficial for specific cardiovascular diseases (particularly cardiac 
mortality, but also with regard to ischaemic stroke, non-fatal coronary heart 
disease events, congestive heart failure and atrial fibrillation) as well as for 
optimal neurodevelopment of foetuses and infants. VKM notes that EPA and DHA 
play a role however, the beneficial effects of fish consumption on these health 
outcomes are most likely mediated through a complex interplay. Furthermore, 
VKM is of the opinion that adults and pregnant women with fish consumption less 
than one serving per week may miss these beneficial effects. The health benefit 
of fish consumption is reported from 1-2 dinner servings per week and up to 3-4 
dinner servings per week. For higher fish intake per week the limited number of 
consumers in epidemiological studies does not allow for drawing firm conclusions 
about the actual balance of risk and benefit at these high intakes. More 
knowledge is needed to reveal the beneficial mechanisms of fish consumption. 
8.4 Benefit characterisation of nutrients in fish 
Fish provide us with a number of nutrients. The nutrient composition, with the exception of 
protein, may vary between fish species and within a species depending on factors like age, 
reproductive and nutritional status. Fish are recognised as an important source of animal 
protein with balanced amino acid profile optimal for human requirement of essential amino 
acids. Fish species high in fat such as salmon, herring and mackerel are usually rich in n-3 
LCPUFAs and lipid-soluble vitamins like vitamin D. Fish is also regarded as a valuable source 
of minerals and trace elements like iodine and selenium.   
Based on intake estimates in comparison with upper limits of nutrients, it is unlikely that fish 
consumption in Norway could lead to harmful high intake of vitamins, minerals or n-3 
LCPUFAs for any age group. Therefore, in the present assessment of nutrients VKM focuses 
on the possible benefits of intake of nutrient from fish consumption in relation to 
recommended nutrient intakes. 
 Comparison of nutrients in fish; 2014 versus 2006 8.4.1
Wild caught fish: The available database on nutrient concentrations in wild fish have been 
expanded somewhat since 2006, but is still generally limited and based on relatively low 
numbers of fish. For some wild fish species, data are lacking or the most recent data 
available are analysed in 2005. The databases both in 2006 and 2014 are somewhat limited 
for optimal trend analyses, however there seem to be minor or no changes of the 
composition and concentrations of nutrients in wild caught fish.  
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Farmed Atlantic salmon: The available database on nutrients is expanded substantially 
since 2006, and nutrient concentration data in farmed Atlantic salmon is the most recent 
available (2013). The expanded database on nutrients reduces the uncertainties in the intake 
estimates compared to 2006. 
Since 2006, the raw materials used in feed for Norwegian farmed Atlantic salmon and trout 
have substantially changed (Chapter 5). Up to 70% of the fish meal and fish oil are replaced 
by plant proteins and vegetable oils which has resulted in a change in nutrient composition 
in Atlantic salmon fillet since 2006 (VKM, 2006). The changes are shown in Table 8.4.1-1.  











VKM report 2006 2700 8 30 6-34 520 
VKM report 2014 1311 7.5 12 4 2300 




VKM concludes that with regard to EPA, DPA and DHA, and selenium, the 
concentrations in farmed Atlantic salmon are about 50 and 40%, respectively, of 
the corresponding levels in 2006, while the concentration of vitamin D is 
unchanged. The level of iodine in farmed Atlantic salmon was low in 2006, and is 
still low. The level of n-6 fatty acids is about 4-fold higher than in 2006. The 
composition and concentrations of nutrients in wild caught fish are not 
substantially different in 2014 and 2006.  
 Comparison of nutrient intake estimates with recommended intakes 8.4.2
In the following, VKM has estimated the contribution from fish to the recommended intakes 
of certain nutrients (see Terms of reference). Fish is the major source of EPA+DPA+DHA, 
but for Vitamin D, iodine and selenium there are also other substantial sources. Fish is not a 
major dietary source of n-6 fatty acids. However, inclusion of plant oils in the feed for 
farmed Atlantic salmon has led to an increased amount of n-6 fatty acids in the fillet 
compared to 2006. The current average intake of n-6 fatty acids in Norwegian adults is 
approximately 11 g/day, i.e. 5 percentage of energy intake (E%) (Norwegian Directorate of 
Health, 2014). In the present report, the average daily intake of n-6 fatty acid from farmed 
Atlantic salmon in adult is estimated to be 0.306 g. Thus, farmed Atlantic salmon contributes 
with less than 3% of the daily n-6 fatty acid intake based on a total energy intake of 2000 
kcal/day. The contribution of dietary n-6 fatty acids from farmed salmon compared to the 
overall dietary intake of n-6 fatty acids is low and will not be discussed further.  
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8.4.2.1 Eicosapentaenoic acid (EPA), docosapentaenoic acid (DPA) and 
docosahexaenoic acid (DHA) 
Norway does not have any specific EPA, DPA or DHA recommendations for adults and 
children, while for pregnant and breastfeeding women the recommendation from the 
Norwegian Directorate of Health is 200 mg DHA per day. The intake recommendations from 
EFSA (2010b) are used; 250 mg EPA+DHA per day for adults and 250 mg EPA+DHA plus 
100 mg DHA for pregnant. For 2-year-olds, the EFSA recommendation (EFSA, 2010b) for 
adults is adjusted for portion size (50% of adult portion) and set to 125 mg EPA+DHA 
(Chapter 2.3).  
Adverse effects of high intakes of EPA+DPA+DHA has not been reported, and there is no 
Upper level (UL) established (VKM, 2011b). 
Two year olds: Fish consumption contributes on average 204 mg EPA+DPA+DHA per day 
and up to 696 mg day for high fish consumption (95th percentile). Thus, the average fish 
intake in 2-year-olds is sufficient to meet the EFSA recommendation (EFSA, 2010b) of ~125 
mg/day (Chapter 2.2.1). Contribution from fish oil/cod liver oil comes in addition.   
Adults: Fish consumption contributes on average with 475 mg EPA+DPA+DHA per day, 
thus, the average fish intake in adults is sufficient to meet the EFSA recommendation (EFSA, 
2010b) of 250 mg/day (Chapter 2.3). Noteworthy, high consumption of lean fish will also 
contribute with EPA+DPA+DHA. Contribution from fish oil/cod liver oil comes in addition. 
Pregnant women: Fish consumption contributes on average 312 mg EPA+DPA+DHA per 
day and up to 992 mg/day for high fish consumption (95th percentile). EPA and DPA 
constitute more than 20 percent of the fatty acids (i.e. EPA+DPA+DHA), thus the average 
total fish intake is insufficient to meet the EFSA recommendation (EFSA, 2010b), but 
sufficient to meet the national recommendation of DHA per day. In contrast, high 
consumption (95th percentile) will meet both the national and EFSA recommendations (EFSA, 
2010b) for DHA. Contribution from fish oil/cod liver oil comes in addition.  
In all three population groups, consumption of cod liver oil or other fish oil is common, and 
daily consumption in amounts as suggested on the products will contribute four times the 
recommended intake of EPA+DHA. Thus, a daily intake of 5 ml cod liver oil (manufacturer’s 
recommendation) contributes in addition with a mean intake of 1280 mg EPA+DPA+DHA per 
day.  
Comparison of intake estimates of EPA+DPA+DHA and reference values is visualised in 
Figure 8.4.2.1-1.  
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Figure 8.4.2.1-1  EPA+DPA+DHA contributed by fish in 2-year-olds, adults and 
pregnant women in relation to the recommended intake (RI). Blue solid lines indicate RI of 125 mg 
EPA+DHA per day in 2-year-olds, 250 mg EPA+DHA per day in adults (EFSA, 2010b), with an addition 
of 100 mg DHA per day (=350 mg) in pregnant women. DPA is not part of the RI and constitutes 
approximately 10% of the sum EPA+DPA+DHA. Blue dotted line indicates national RI of 200 mg DHA 
for pregnant women (Norwegian Directorate of Health, 2014). Since DHA constitutes about 80% of 
EPA+DPA+DPA, this is adjusted for in the figure. The 95th percentile for adults is considered an 
overestimate (Chapters 3 and 7). 
8.4.2.2 Vitamin D 
The Norwegian dietary recommendations (Norwegian Directorate of Health, 2014) of vitamin 
D are 10 µg/day for children and adults up to 75 years (Chapter 2.3). For adults above 75 
years the recommendation is 20 µg/day.  
Two-year-olds: The estimated daily intakes of vitamin D from mean and high (95th-
percentile) fish consumption (0.51 and 1.3 µg) contribute with 5 and 13%, respectively, of 
the recommended daily intake.  
Adults: The estimated daily intake of vitamin D contributed by average fish consumption 
(2.1 µg) corresponds to 21% of the recommended intake. Comparison of intake estimates of 
vitamin D and reference value is visualised in Figure 8.4.2.2-1. The 95th percentile for adults 
will reach the recommended intake, but is considered an overestimate (Chapters 3 and 7). 
Pregnant women: The estimated daily intakes of vitamin D from mean and high (95th-
percentile) fish consumption (0.96 and 2.3 µg) contributed with 10 and 23%, respectively, of 
the recommended daily intake.  
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Figure 8.4.2.2-1 Vitamin D contributed by fish in 2-year-olds, adults (up to 70 years old) and 
pregnant women in relation to the recommended intake of 10 µg/day (RI, blue line). The 95th 
percentile for adults is considered an overestimate (Chapters 3 and 7). 
VKM notes that fish consumption, mean or high, contributes from 5 to 23% of the 
recommended intake of vitamin D. However, in all three population groups, consumption of 
cod liver oil is common (37-68%), and daily consumption in amounts as suggested on the 
products will contribute with the recommended intake of vitamin D in children and adults 
under 75 years (10 µg), and with 50% of the recommended intake (20 µg) in adults above 
75 (Chapter 7). 
8.4.2.3 Iodine 
The Norwegian dietary recommendations (Norwegian Directorate of Health, 2014) of iodine 
is 90 µg/day in 2-year-olds, 150 µg/day in adults, and 175 µg/day in pregnant women 
(Chapter 2.3).  
Two-year olds: The estimated daily intakes of iodine from mean and high (95th percentile) 
fish consumption (35 and 82 µg) contribute with 39 and 91%, respectively, of the 
recommended daily intake (90 µg).  
Adults: Fish consumption contributes on average with 86 µg iodine per day corresponding 
to on average 57% of the recommended intake (150 µg/day). The 95th percentile for adults 
is considered an overestimate (Chapters 3 and 7). 
Pregnant women: The estimated daily intakes of iodine from mean and high (95th 
percentile) fish consumption (54 and 127 µg) contribute with 31 and 73%, respectively, of 
the recommended daily intake (175 µg).  
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Figure 8.4.2.3-1 Iodine contributed by fish in 2-year-olds, adults and pregnant women in 
relation to the recommended intake (RI, blue lines, 90 µg/day in 2-year-olds, 150 µg/day in adults, 
175 µg/day in pregnant women). The 95th percentile for adults is considered an overestimate 
(Chapters 3 and 7). 
8.4.2.4 Selenium 
The Norwegian dietary recommendations (Norwegian Directorate of Health, 2014) of 
selenium are 25 µg/day in 2-year-olds, in average 55 µg/day in adults (50 µg/day in women, 
60 µg/day in men), and 60 µg/day in pregnant women (Chapter 2.3). 
Two-year-olds: The estimated daily intakes of selenium from mean and high (95th 
percentile) fish consumption (4.5 and 12 µg) contribute with 18 and 48%, respectively, of 
the recommended daily intake (25 µg).  
Adults: Fish consumption contributes on average with 15 µg selenium per day 
corresponding to 27% of the recommended selenium intake (30% in women and 25% in 
men). The 95th percentile for adults will reach the recommended intake, but is considered an 
overestimate (Chapters 3 and 7). 
Pregnant women: The estimated daily intakes from mean and high (95th percentile) fish 
consumption (9.0 and 23 µg) contribute with 15% and 38%, respectively, of the 
recommended daily intake in pregnancy (60 µg). 
Comparison of intake estimates of selenium and reference value is visualised in Figure 8.4.2-
4-1.   
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Figure 8.4.2.4-1 Selenium contributed by fish in 2-year-olds, adults and pregnant women in 
relation to the recommended intakes (RI, blue lines, 25 µg/day in 2-year-olds, 55 µg/day in adults (50 
in women, 60 in men), 60 µg/day in pregnant women). The 95th percentile for adults is considered an 
overestimate (Chapters 3 and 7).  
VKM concludes that with current average consumption of fish, the contribution of 
EPA and DHA from fish will reach the European recommended intake (EFSA, 
2010b) of EPA and DHA for adults and 2-year-olds, while for pregnant women the 
intake is lower than recommended for this group. However, for pregnant women, 
the intake of DHA is sufficient to meet the national intake recommendation for 
pregnant women. For the high fish consumers, all age groups will reach the 
recommended intakes of EPA and DHA.  
The contribution of dietary n-6 fatty acids from farmed salmon compared to the 
overall dietary intake of n-6 fatty acids is low (less than 3%). 
For vitamin D, current fish consumption contributes approximately to 1/5 of the 
national recommended intakes for adults but less for pregnant women and 2-
year-olds. 
Furthermore, with current fish consumption, low intakes of selenium and iodine 
from fish relative to the national recommended values may be complemented by 
intake from a diversity of other dietary sources.  
 Comparison of nutrient intake estimates from scenarios with 8.4.3
recommended intakes 
VKM has made various scenarios to foresee how possible changes in fish consumption 
pattern and amounts will affect the contribution from fish to recommended intakes of 
specific essential nutrients. Since fatty fish is the most important dietary source for EPA and 
DHA (although lean fish also contributes depending on the amounts consumed), as well as of 
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vitamin D, scenarios of dietary intake of EPA and DHA as well as vitamin D, with current 
concentrations of these nutrients in farmed Atlantic salmon have been made. The present 
total mean fish consumption in the different age groups are used to model different 
consumption patterns, like increased intake of fatty fish to 50% of the total fish 
consumption, along with scenarios of all fish eaten being either lean (cod) or fatty fish 
(farmed Atlantic salmon).  
Thus, the scenarios in Tables 8.4.3-1 and 8.4.3-2 are based on current concentrations of 
nutrients in cod and farmed Atlantic salmon, present consumption of fish, about 60 percent 
lean fish and 40 percent fatty fish, and possible changes in distribution of consumption of 
fatty and lean fish. Cod is used for lean fish, and farmed Atlantic salmon for fatty fish. In 
order to compare the intake of nutrients with the food-based dietary guidelines (Norwegian 
National Council for Nutrition, 2011), scenarios with 450 g fish consumption per week are 
also included. 
8.4.3.1 Eicosapentaenoic acid (EPA), docosapentaenoic acid (DPA) and 
docosahexaenoic acid (DHA) - scenarios 
As demonstrated in Table 8.4.3.1-1, adults reach adequate intake of EPA+DHA (EFSA, 
2010b) (Chapter 2.3) based on today’s consumption of fish, and also for the scenarios 
including farmed salmon. The scenario where all fish consumed (450 g) is cod (lean fish) will 
give a mean intake of EPA+DHA below the recommended intake.  
In 2-year-olds and pregnant women both today’s intake and the scenarios based on cod give 
intakes of EPA+DHA below the recommended intakes.  
Furthermore, a scenario mimicking today’s food-based dietary guidelines for fish 
consumption (450 g fish of which 200 g is fatty fish), demonstrates that all age groups reach 
the recommended intakes of EPA and DHA if the fatty fish species is farmed Atlantic salmon 
with today’s concentrations of EPA and DHA.   
Fatty fish is, of course, the most important source of fatty acids, but also lean fish 
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Table 8.4.3.1-1 Intake of sum EPA+DPA+DHA and different scenarios of fish intake in 













Intake by different 
scenarios of today’s mean 
fish consumption  
 
mg/day 
Intake by consumption of 


























 204 127 44 210 221 88 421 
Adult ~250
b










312 246 85 406 442 176 843 
aAccording to EFSA, 2010b and adjusted for portion size for children being 50% of an adult portion of 
150 g, b according to EFSA, 2010b, c according to Norwegian dietary recommendations (Norwegian 
Directorate of Health, 2014), which were based on the Nordic Nutrition Recommendations 5th edition 
(NNR5, 2012), dcod represents lean fish; efarmed Atlantic salmon represents fatty fish, ffor adults, the 
recommended fish consumption of 450 g/week is used, and half of this for 2-year-olds, i.e. 225 g fish 
per week. 
8.4.3.2 Vitamin D - scenarios 
It can be seen in Table 8.4.3.2-1 that for all population groups, fish consumption per se is 
not enough to reach the recommended intake of vitamin D (Norwegian Directorate of Health, 
2014), see Chapter 2.3) neither with regard to today’s intake (5-20% of recommended 
intake) nor with regard to the different scenarios.  
Fatty fish species, like farmed Atlantic salmon, are more important sources of vitamin D than 
lean fish species.  
The highest scenario based on an intake of 450 g farmed Atlantic salmon (225 g for 2-year-
olds) per week will contribute to half the recommended vitamin D intake. By substituting all 
farmed salmon with the fatty fish species representing the highest (herring) and lowest 
(mackerel) fillet vitamin D concentration, the vitamin D intake from fish would nearly double 
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Table 8.4.3.2-1 Intake of vitamin D and different scenarios of fish intake in 2-year-olds, 













Intake by different 
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µg/day 
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2-y-olds 10 0.51 0.7 0.2 1.2 1.2 0.5 2.4 
Adult 10 2.1 2.3 0.7 3.9 2.5 0.9 4.8 
Pregnant 
women 
10 0.96 1.4 0.4 2.3 2.5 0.9 4.8 
aaccording to Norwegian dietary recommendations (Norwegian Directorate of Health, 2014); bcod 
represents lean fish.  
cfarmed salmon represents fatty fish; dfor adults, the recommended fish consumption of 450 g/week 
was used, and half of this for 2-year-olds, i.e. 225 g fish per week. 
8.4.3.3 Iodine – scenarios 
It can be seen in Table 8.4.3.3-1 that for all population groups, fish consumption per se is 
not enough to reach the recommended intake of iodine (Norwegian Directorate of Health, 
2014), see Chapter 2.3. Lean marine fish species, like Atlantic cod, are more important 
sources of iodine than fatty fish species. If today’s consumption consists of only cod, adults 
will meet the recommended intake.  
The highest scenario based on an intake of 450 g (225 g for 2-year-olds) Atlantic cod per 




VKM Report 2014: 15  199 
Table 8.4.3.3-1 Intake of iodine and different scenarios of fish intake in 2-year-olds, adults 













Intake by different 
scenarios of today’s mean 
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2-y-olds 90 35 26 52 0.64 63 104 1.3 
Adult 150 86 85 168 2.1 126 208 2.6 
Pregnant 175 54 51 100 1.2 126 208 2.6 
aaccording to Norwegian dietary recommendations (Norwegian Directorate of Health, 2014); bcod 
represents lean fish, cfarmed salmon represents fatty fish, dfor adults, the recommended fish 
consumption of 450 g/week was used, and half of this for 2-year-olds, i.e. 225 g fish per week. 
VKM concludes that for 2-years-old and adult EFSA’s recommended intake of EPA 
and DHA are met by the average fish consumption, while for pregnant women the 
intake is lower. For vitamin D, selenium and iodine current average or high fish 
consumption alone does not contribute sufficient amounts to meet the national 
recommendations. According to scenarios, increasing the consumption of fatty 
fish will increase the intake of vitamin D, EPA and DHA while increasing 
consumption of lean fish will increase the intake of iodine. Furthermore, VKM 
notes that the choice of fatty fish species, i.e. farmed Atlantic salmon, mackerel 
and herring is also of importance due to differences in nutrient concentrations. 
8.5 Risk characterisation of undesirable substances in fish 
High consumption of certain fish species may be associated with a relatively high exposure 
to contaminants and other undesired compounds that may be potentially hazardous to 
human health. The potentially highest risk from contaminants and other undesired 
compounds is posed by dioxins and dl-PCBs as well as methylmercury. These chemicals may 
cause various adverse health effects, and the most sensitive life stage for exposure is during 
foetal development (Chapter 3). Due to the physico-chemical properties of dioxins and PCBs, 
the highest levels are found in fatty fish, while the highest methylmercury levels are found in 
predatory fish high in the food chain, independently of percentage of fat in the fish. Lean 
species are the major sources in Norway. Methylmercury constitutes 80-100% of total 
mercury in fish. The contaminant levels and composition vary between fish species and 
within a species depending on factors like sex, age, size, trophic level, reproductive and 
nutritional status and environmental status. 
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 Comparison of contaminants in fish; 2014 versus 2006 8.5.1
Both for wild caught fish, farmed fish and fish products, the data base on concentrations of 
specific contaminants, particularly mercury, dioxins and dl-PCBs has improved greatly since 
2006 (Chapter 6). Thus, the uncertainties in the exposure estimates have been reduced. 
Since 2006, more information is also available on occurrence and concentrations of other 
undesirable substances in farmed fish, such as pesticides and mycotoxins originating from 
new feed sources. Medicine residues from treatment of diseases in fish farming have been 
monitored according to production volume regulated by EU-directive 96/23. 
Wild caught fish: For dioxins and dl-PCBs, consumption of fatty fish like mackerel, herring, 
wild salmon and trout contributes substantially to exposure. The available data for wild 
caught fish are not suitable to show time-trends of contaminant levels, e.g. regular sampling 
of the same species from the same area over a long period of time, however there seem to 
be minor or no changes of the composition and concentrations of contaminants in wild 
caught fish. There is, however, a decreasing trend of dioxins and dl-PCBs in the environment 
and therefore also in food like wild caught fish resulting in a decreased exposure for humans. 
Lean fish like cod, even though the mercury level is low, is a substantial source of this 
contaminant in the Norwegian diet because of a relatively high consumption. High quality 
relevant time-trend data on mercury levels in fish are not available. Thus, temporal trends in 
fish cannot be elucidated. However, the exposure data indicates a modest higher exposure in 
children in the present assessment than in 2006. The methodological differences in food 
consumption surveys used in 2006 and 2014 prevent conclusions on differences in mercury 
exposure levels in adults (Chapters 3 and 7). 
Farmed Atlantic salmon: Farmed Atlantic salmon is a dietary source of dioxins and dl-
PCBs. Although there has been a decline in concentrations of dioxins and PCBs in some wild 
caught fish since 2006 (VKM; 2006), the corresponding decline in Atlantic salmon and in 
trout has been more pronounced since the raw materials used in feed for Norwegian farmed 
Atlantic salmon and trout have substantially changed since then (Chapter 5). Up to 70% of 
the fish meal and fish oil is replaced by plant proteins and vegetable oils, respectively, which 
has resulted in changes in composition and levels of contaminants in Atlantic salmon fillet 
since 2006 (VKM; 2006). The most important changes are shown in Table 8.5.1-1.  
Table 8.5.1-1  Contaminant levels in farmed Atlantic salmon in 2006 and 2014 
Year Mercury 
mg/kg fillet 
Sum dioxins and dl-PCBs  
ng TEQ/kg fillet 
2006 0.030 1.7 
2014 0.014 0.52 
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VKM concludes that the most significant changes with regard to undesirable 
substances in fish are found for farmed Atlantic salmon where current 
concentrations of dioxins and dl-PCBs, and mercury, are reduced to about 30 and 
50%, respectively, of the corresponding levels in 2006. There are minor or no 
changes in concentrations of dioxins and dl-PCBs and mercury in wild fish species 
since 2006, however, the suitability of the databases is not optimal to reveal 
time-trends. 
 Comparison of contaminant exposure estimates with tolerable 8.5.2
intakes 
In the following, dietary exposure to contaminants contributed by fish is compared with the 
tolerable intakes (Chapter 7). A tolerable intake is the amount of a substance, or substance 
group, which can be consumed safely throughout a person's lifetime without appreciable risk 
of adverse health effects. Tolerable intakes are set by large international risk assessment 
bodies, such as WHO or EFSA, and incorporate safety margins, in order to protect all parts of 
the population (Chapter 2.3). 
Regarding the environmental contaminants brominated flame retardants, VKM refers to the 
conclusions in a risk assessment from EFSA in 2011 that the health risk associated with the 
current exposure to these compounds is low. The amount of fluorinated compounds such as 
PFOS and PFOA in the Norwegian diet is much lower than what is tolerable according to an 
EFSA assessment in 2008 (Chapter 2). 
8.5.2.1 Mercury  
The tolerable weekly intake (TWI) for methylmercury is 1.3 µg/kg bw (EFSA, 2012a) 
(Chapter 2.3). 
Two-year olds: Both mean and high mercury exposure (95th percentile) is below the 
tolerable weekly intake. 
Pregnant women:  The exposure is lower than the tolerable intake. This includes high fish 
consumers, which were represented in the high percentiles (95th and 97.5th percentiles) of 
mercury exposure. 
Adults: Mean mercury exposure is below the tolerable weekly intake, as well as the 95th 
percentile although it represents an overestimation (Chapter 3 and introduction to Chapter 
7). 
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Figure 8.5.2.1-1 Mean upper bound (UB) exposure to mercury (Hg) from fish in 2-year-olds, 
adults, and pregnant women in relation to the tolerable weekly intake of 1.3 µg/kg bw/week (TWI, 
red line). The 95th percentiles are also shown, which for adults is an overestimate (Chapters 3 and 7). 
There are no other substantial dietary sources to methylmercury than fish in the Norwegian 
diet. The exposure estimate is based on mean occurrence of mercury in fish, and exposure 
may be higher if fish with higher concentrations is consumed regularly, i.e. fish from 
contaminated coastal areas. The Norwegian Food Safety Authority issues restrictions for 
consumption of fish from contaminated areas. 
8.5.2.2 Dioxins and dioxinlike PCBs 
Tolerable weekly intake for dioxins and dl-PCBs is of 14 pg TEQ/kg bw (SCF, 2001) (Chapter 
2.3). 
Two-year-olds: Neither mean nor high exposures (95th percentile) to dioxins and dl-PCBs 
from fish alone exceed the TWI. High exposure makes up 52% (LB) to 67% (UB) of the TWI 
(Figure 8.5.2.2-1). The higher exposure in 2-year-olds than in adults can be explained by 
higher food consumption per kg bw in children than in adults. 
Adults: Exposure from fish does not exceed the TWI (Figure 8.5.2.2-1). In high fish 
consumers (95th percentile exposure) the weekly exposure constitutes 41% (LB) to 50% (UB) 
of TWI. 
Pregnant women: The UB mean and 95th percentile weekly intakes from fish are 0.94 and 
2.7 pg TEQ/kg bw respectively, and the 95th percentile UB exposure constitutes 19% of the 
tolerable weekly intake. The 97.5th percentile exposure is 3.7 pg TEQ/kg bw/week and 
contributes with 26% of the TWI.  
The contribution to total exposure from other food commodities has not been included in any 
of the age groups, and the exposure from fish oil also comes in addition. 
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Figure 8.5.2.2-1 Mean upper bound (UB) exposure to dioxins and dl-PCBs from fish in 2-year-
olds, adults, and pregnant women in relation to the tolerable weekly intake of 14 pg TEQ/kg bw (TWI, 
blue line). The 95th percentile for adults is an overestimate (Chapters 3 and 7). 
 
Figure 8.5.2.2-2 Mean upper bound (UB) exposure to dioxins and dl-PCBs from fish as food 
and 5ml cod liver oil in 2-year-olds (Småbarnskost 2007), adults (Norkost 3) and pregnant women 
(MoBa) in relation to the tolerable weekly intake of 14 pg TEQ/kg bw(TWI, red line). Mean exposure 
from 5 ml cod liver oil has been added to the exposure from fish both at the mean and the 95th 
percentile exposure from fish. The 95th percentile for adults is an overestimate (Chapters 3 and 7). 
The recommended daily intake of cod liver oil represents a mean exposure of 0.11 (LB) to 
2.34 (UB) pg/TEQ/kg bw/week, dependent on the body weight and comes in addition to 
exposure from fish among consumers (illustrated in Figure 8.5.2.2-2). The relatively high 
contribution from fish oils in 2-years olds compared to adults can be explained by the low 
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VKM concludes that with the present mean level of mercury in fish and the 
present fish consumption in Norway, the methylmercury exposure from fish being 
below the TWI of 1.3 µg/kg bw/week for more than 95% of the population of 2-
year-olds, adults and pregnant women, represents negligible risk and is of no 
concern. 
With the present mean level of dioxins and dl-PCBs in fish and the present fish 
consumption in Norway, high fish consumption (the 95th percentile) contributes 
with up to 50, 19, 67% of the TWI of 14 pg TEQ/kg bw/week for adults, pregnant 
women and 2-year-olds respectively. Daily consumption of cod liver oil or fish oil 
(which is common in all population groups) in amounts as suggested on the 
product will in addition contribute with 0.8 to 16% of the TWI, depending on the 
body weight. With the present TWI and taking into consideration that fish and 
fish products are main contributors to dioxins and dl-PCBs in the Norwegian diet, 
VKM concludes that the exposure from fish to dioxins and dl-PCBs represents 
negligible risk and is of no concern. 
 Comparison of other undesirable substances in farmed fish fillet 8.5.3
with maximum residue limits and levels (MRLs) 
To avoid the presence of residues of veterinary medicinal products (VMPs) at levels that 
might cause harm for the consumers, acceptable legal residue concentrations (MRL) in food 
producing animals have been established. A maximum residue limit (MRL) is the highest 
permitted residual concentration of legally applied pharmacologically active substances in 
products (food) intended for human consumption. Consumption of food with medicine 
residues below the MRL should, by a wide safety margin, not pose any health risk to the 
consumer. When setting MRLs, eventual effects of VMPs on future processing of food, and if 
the VMP has additional use (e.g. as pesticide) which could lead to additional exposure for the 
consumer, are taken into account. The MRLs for fish are set for muscle and skin in natural 
proportions. For more details, see Chapter 2.2.4.  
No residues of banned substances or residues above EU maximal residue limits for veterinary 
medicinal products have been detected in any of the about 30 000 samples from farmed fish 
(1998-2013). The residues controlled include e.g. antibiotics and agents against sea lice. 
VKM is of the opinion that the present exposure to veterinary medicine residues 
including residues of antibiotics in farmed fish in the Norwegian diet is of no 
concern since the levels are very low and often not detectable even with sensitive 
analytical methods. 
For new contaminants in fish feed like the pesticide endosulfan, polycyclic 
aromatic hydrocarbons (PAH) and mycotoxins, VKM is of the opinion that their 
concentration in farmed fish in the Norwegian diet is likely not a food safety issue 
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since the concentrations are very low and often not detectable even with 
sensitive analytical methods.  
With regard to the synthetic antioxidants (ethoxyquin (EQ), butylhydroksyanisol 
(BHA) and butylhydroksytoluen (BHT)), as well as the pesticide endosulfan, the 
calculated exposures from a 300 g portion of farmed fish fillets are reported to be 
below their respective ADIs and therefore of no concern. 
 Scenarios on dietary exposure of contaminants in farmed salmon 8.5.4
with changed composition of lean and fatty fish  
VKM has made various scenarios to foresee how possible changes in fish consumption 
pattern and amounts will affect the exposure from fish to tolerable intakes (TWI) of mercury, 
dioxins and dl-PCBs.  
Since lean fish is the only substantial dietary source of mercury, and fatty fish is an 
important dietary source for dioxins and dl-PCBs (although there are other food sources than 
fish for these contaminants), scenarios of dietary exposure to mercury, and dioxins and dl-
PCBs, with today’s concentrations of these contaminants in farmed Atlantic salmon have 
been made. The total mean fish consumption in the different age groups are used to model 
different consumption patterns, like increased intake of fatty fish to 50% of the total fish 
consumption, along with scenarios of all fish eaten being either lean (cod) or fatty fish 
(farmed Atlantic salmon). 
Thus, the scenarios in Tables 8.5.4.1-1 and 8.5.4.2-1 og 2 are based on current 
concentrations of mercury, and dioxins and dl-PCBs in farmed Atlantic salmon, today’s 
consumption of fish, and possible changes in distribution of consumption of fatty and lean 
fish. Cod is representing lean fish, and farmed Atlantic salmon fatty fish. In order to compare 
the intake of contaminants with the food based dietary guidelines (Norwegian Directorate of 
Health, 2014), scenarios with 450 g fish consumption per week are also included. 
8.5.4.1 Mercury - scenario 
As demonstrated in Table 8.5.4.1-1 and based on current consumption of fish, about two 
third lean fish and one third fatty fish, the exposure to mercury is below the TWI of 1.3 
µg/kg bw/week (20-40% of the TWI) in all population groups. If only farmed salmon is 
consumed, the mercury exposure is less than 10% of the TWI. If all fish consumed by adults 
is lean fish (cod), approximately 450 g cod per week, fish consumption will contribute to 
about 40% of the mercury TWI. For 2-year-olds, 225 g lean fish (cod) per week will 
contribute with mercury exposure similar to the TWI. By substituting cod with farmed 
Atlantic salmon, the mercury exposure from lean fish will decrease with around 70%.  
Estimates in Table 8.5.4.1-1 are based on the mean body weights reported in Småbarnskost 
2007, Norkost 3 and MoBa. 
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Table 8.5.4.1-1 Exposure to methylmercury (µg MeHg as Hg/kg bw/week) and different 











Exposure by different 
scenarios of today’s mean 
fish intake per week  
µg Hg/kg bw/week 
Exposure by intake of 450 
g (225g)e fish/week  
 
µg Hg/kg bw/week 























2-year-olds 1.3 0.51 0.40 0.70 0.10 0.90 1.3 0.30 
Adults 1.3 0.30 0.21 0.35 0.07 0.29 0.44 0.08 
Pregnant 
women 
1.3 0.17 0.14 0.24 0.05 0.34  0.50 0.09 
aaccording to (EFSA, 2012a) 
bupper bound means of total exposure of Hg from fish are used, see Table 7.1.2.2-1, Table 7.1.2.3-1, 
Table 7.1.2.4-1. 
ccod represents lean fish. 
dfarmed Atlantic salmon represents fatty fish. 
efor adults, the recommended fish consumption of 450 g/week was used, and half of this for 2-year-
olds, i.e. 225 g fish per week 
8.5.4.2 Dioxins and dioxin-like PCBs - scenario 
Based on today’s consumption of fish, about two thirds lean fish and one third fatty fish, the 
exposure to dioxins and dl-PCBs is below the tolerable weekly intake (TWI) of 14 pgTEQ/kg 
bw (13-19% of TWI) for all population groups (Table 8.5.4.2-1).  
Fatty fish species like mackerel, herring and salmon have relatively high concentrations of 
dioxins and dl-PCBs, and therefore contribute to exposure to these contaminants. In Table 
8.5.2.2-1, it is shown that if only farmed Atlantic salmon is consumed, the fish contributes 
with 11-31% of the TWI of dioxins and dl-PCBs for all population groups.  
If adult consumption is set to 450 g farmed salmon per week, the fish consumption will 
contribute to about 21% (adults and pregnant women) of the TWI. For 2-year-olds, 225g 
farmed salmon per week will contribute with about 63% of the TWI.   
By substituting all farmed salmon with mackerel the dioxins and dl-PCBs exposure will 
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Table 8.5.4.2-1 Exposure to dioxins and dl-PCBs (pg TEQ/kg bw/week) from different 
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pg TEQ/kg bw/week 
 




















2-year-olds 14 2.6 2.5 0.49 4.4 4.1 0.98 8.8 
Adults 14 1.7 1.3 0.26 2.3 1.4 0.33 2.9 
Pregnant 
women 
14 0.94 0.90 0.18 1.6 1.6 0.38 3.4 
aaccording to SCF (2001). 
bupper bound mean of total exposure of sum dioxins and dl-PCBs from fish is used, see Table 7.1.2.2-
2.  
ccod represents lean fish.  
dfarmed Atlantic salmon represents fatty fish.  
efor adults, the recommended fish consumption of 450 g/week was used, and half of this for 2-year-
olds, i.e. 225 g fish per week. 
VKM is of the opinion that there is negligible risk associated with eating lean or 
fatty fish with the present concentrations of dioxins and dl-PCBs, and mercury, in 
amounts equivalent to the present mean weekly fish consumption for 2-year-
olds, pregnant women and adults since exposures are below the respective TWIs.  
Based on these scenarios, VKM is of the opinion that fish consumption in line with 
the food-based dietary guideline of 300-450 g fish, hereof 200 g fatty fish per 
week, does not contribute with exposures to dioxins and dl-PCBs and mercury 
from either lean or fatty fish exceeding the respective TWIs. Fish consumption in 
line with the food based dietary guideline of 450 g fish per week is therefore of 
no concern from a contaminant exposure perspective.  
 Scenarios on changing dietary exposure to dioxins and dl-PCBs 8.5.5
from farmed Atlantic salmon  
In the above described scenarios, VKM has considered only exposure to dioxins and dl-PCBs 
from fish. Since there are other food sources in the Norwegian diet that contribute to the 
exposure to these contaminants, a simple model estimate of weekly intake of dioxins and dl-
PCBs in adults from various amounts of farmed salmon and other food has been done.   
Even though the change in feed composition since 2006 has reduced the concentrations of 
dioxins and PCBs in farmed Atlantic salmon fillets (by about 70%), the levels can be further 
reduced by decontamination of the fish oil included in the feed without reducing the 
composition and levels of EPA and DHA (see Chapter 6 for details). Thus, VKM also made 
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scenarios where concentrations of dioxins and PCBs have been lowered by decontamination 
of the fish oil. 
Thus, in figure 8.5.5-1, simple model estimates of weekly intake of dioxins and dl-PCBs in 
adults for consumption of various amounts farmed salmon with different levels of 
contamination are shown. The levels of contamination given represent both farmed Atlantic 
salmon grown on feed prepared with cleaned fish oil (0.2 pg TEQ per kg filet), the present 
mean upper bound concentration found in farmed Atlantic salmon (0.5 pg TEQ per g filet), 
and the maximum upper bound value of the present concentration in farmed Atlantic salmon 
(1.5 pg TEQ per g filet) (Table 6.2.1.2-1). The category “other food” is the estimated sum of 
weekly intake of contaminants from other food than fish (2.8 pg TEQ/kg bw/week, based on 
results in Caspersen et al. (2013), personal communication, IH Caspersen), and the 
recommended daily intake of cod liver oil (0.55 pg TEQ/kg bw/week). The horizontal 
unbroken red line represents the tolerable weekly intake (TWI) for dioxins and dioxin-like 
PCB (14 pg TEQ per kg bw). Generally, an adult fish serving is equivalent to about 150-200 g 
fish. 
 
Figure 8.5.5-1 Illustration of weekly consumption of farmed fish and the concurrent exposure 
to dioxin and dioxin-like PCBs dependent on level of contamination and amount of consumption. 
“Other food” includes background exposure and exposure from cod liver intake.  
Thus, consumption of other food and 600 g farmed salmon per week with the current 
concentrations of dioxins and dl-PCBs (0.5 pg/TEQ/g fish), contributes with about 60% of 
the TWI. Furthermore, when taking into consideration background exposure including cod 
liver oil, and based on Figure 8.5.5-1 it can be seen that TWI will not be exceeded even if an 
adult consumes either 600 g farmed Atlantic salmon with the current highest concentration 
of dioxins and dl-PCBs (1.5 pg/TEQ/g fish) or 1400 g farmed Atlantic salmon with the current 
mean concentration of dioxins and dl-PCBs (0.5 pg TEQ/g fish), which will represent 4 or 9 
dinner servings per week, respectively.  
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In comparison, an adult can consume 800 g mackerel weekly (representing 5 dinner servings 
per week) with current mean concentration of dioxins and dl-PCBs (0.9 pg/TEQ/g fish) 
without exceeding TWI.  
VKM is of the opinion that from a contaminant exposure perspective there is 
negligible risk for adults associated with eating farmed Atlantic salmon in 
amounts equivalent to 1400 g weekly (representing 9 weekly dinner servings) 
with the present mean concentration of dioxins and dl-PCBs since TWI is not 
exceeded even when exposure to dioxins and dl-PCBs from other food including 
cod liver oil is taken into consideration.  
8.6  Benefit – risk comparison 
Taking the present-day levels of nutrients and contaminants in fish, and the consumption of 
fish in different population groups in Norway into account, VKM concludes that:  
The consumption of fish in Norway differs from the situation in many other countries in 
that the amount of fish is high and that the proportion of lean fish is large. Norwegians also 
eat fish in the form of cold cuts and spread since several meals per day may consist of open 
faced sandwiches. Adults eat on average 364 g/week (equivalent to 2-3 fish dinner servings 
per week given a portion size of 150 g), pregnant women eat 217 g/week (equivalent to 1-2 
dinner serving per week given a portion size of 150 g), while 2-year-olds eat 112 g/week 
(equivalent to 1-2 dinner serving per week given a portion size of 75 g). Two thirds of the 
consumption consists of lean fish and minced fish products. Pregnant women eat fatty fish in 
amounts equivalent to less than half a dinner serving per week. VKM concludes that of the 
different population groups, only adults (18-70 years of age) reach the food based dietary 
guidelines for fish consumption (Norwegian Directorate of Health, 2014), while the fish 
consumption of children (2-year-olds) and pregnant women is lower.  
From a nutrient benefit assessment perspective, VKM is of the opinion that for the 
different age groups, increase in both lean and fatty fish consumption will improve the role 
of fish as a source for important nutrients (EPA+DPA+DHA, vitamin D, iodine and selenium) 
relative to recommended intakes. Increased consumption of fatty fish will increase the intake 
of EPA+DPA+DHA and vitamin D, while an increase in the consumption of lean fish will 
increase the intake of iodine. Generally, an increase of marine fish consumption will increase 
the intake of selenium. 
From a benefit assessment perspective, VKM is of the opinion that the average fish 
consumption in Norway for adults should give substantial benefit (positive health effects) 
with regard to specific cardiovascular disease. Pregnant women, who eat little or no fish, 
may miss the beneficial effects of fish consumption on neurodevelopmental outcomes in 
foetuses and infants. 
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From a risk perspective it is the opinion of VKM that with the present concentrations of 
dioxins and dl-PCBs, and mercury, the exposure to these compounds is below the tolerable 
intakes when fish is consumed in accordance with the dietary advice of 300-450 g fish 
(representing 2-3 dinner servings) hereof 200 g fatty fish per week and is therefore of no 
concern. This also applies if the fish consumed in adults consist of 1400 g farmed Atlantic 
salmon (representing 9 dinner servings) or 800 g mackerel weekly (representing 5 dinner 
servings). VKM is of the opinion that the present exposure to medicine residues including 
residues of antibiotics, new contaminants like the pesticide endosulfan, polycyclic aromatic 
hydrocarbons (PAH) and mycotoxins, and synthetic antioxidants (ethoxyquin (EQ), 
butylhydroksyanisol (BHA) and butylhydroksytoluen (BHT)) in farmed Atlantic salmon are of 
no concern. 
Regarding the environmental contaminants brominated flame retardants, VKM refers to the 
conclusions in a risk assessment from EFSA in 2011 that the health risk associated with the 
current exposure to these compounds is low. The amount of fluorinated compounds such as 
PFOS and PFOA in the Norwegian diet is much lower than what is tolerable according to an 
EFSA assessment in 2008 (Chapter 2). 
Following a comprehensive assessment of the scientific literature on the positive 
health effects of fish consumption and the contribution from fish to intake of 
beneficial compounds as well as exposure to hazardous contaminants in Norway, 
VKM concludes that the benefits clearly outweighs the negligible risk presented 
by current levels of contaminants and other known undesirable substances in 
fish. Furthermore, in Norway, adults including pregnant women with fish 
consumption less than one serving per week may miss the beneficial effects on 
cardiovascular diseases and optimal neurodevelopment in the foetuses and 
infants. In contrast to the conclusion in 2006, VKM concludes that there is no 
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9 Uncertainties 
This benefit-risk assessment is composed of several different parts. Various databases are 
used, including data on levels of nutrients and contaminants in fish feed and fish which may 
all contain uncertainties which in turn may influence the overall assessment. Furthermore, 
there may be uncertainties in the estimated fish consumption data retrieved from the dietary 
food surveys and there may be weaknesses in the epidemiological studies about health 
effects of fish consumption. The uncertainties associated with the different parts of this 
benefit-risk assessment are explained below. 
9.1 Methodological challenges for assessing dietary 
consumption of fish, intake of nutrients and exposure to 
contaminants 
 Dietary assessment 9.1.1
Every dietary assessment is connected with uncertainty. A description of the most important 
uncertainties and assumptions in the dietary exposure calculations is described below.  
Three concepts are fundamental to understanding the limitations of dietary assessment: 
habitual consumption, validity and precision (Livingstone and Black, 2003). 
The habitual consumption of an individual is the person’s consumption averaged over a 
prolonged period of time, such as weeks and months rather than days. However, this is a 
largely hypothetical concept; the consumption period covered in a dietary assessment is a 
compromise between desired goal and feasibility. In the dietary surveys used in this report 
the time periods covered are 14-days among the 2-year-olds (Småbarnskost 2007), the first 
4-5 months of pregnancy in the MoBa-cohort (Brantsaeter et al., 2008; Meltzer et al., 2008), 
and two non-consecutive days at least one month apart among the adults (Norkost 3). The 
different time periods covered gives a challenge when comparing the fish consumption 
results from the three dietary assessment methods. The mean consumption can be 
considered comparable between the different dietary assessment methods; however, for the 
high percentiles the use of two 24-hour recalls has shown to be a problem. Twenty-four-hour 
recalls capture rich information on food consumption, but suffer from inadequately 
measuring usual intakes of weekly but not daily consumed foods like fish and fish products 
(Subar et al., 2006). Even when two 24-hour recalls are collected, the probability of 
consumption for most foods is poorly captured at the individual level.  
However, the European Food Consumption Survey Method project has recommended to 
apply 24-hour recalls on at least two non-consecutive days per participant as the primary 
instrument for food consumption surveys (Brussaard et al., 2002), to account for intra-
individual variation.  
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When only two days of food intake are the basis for the fish consumption in Norkost 3, 
persons that have eaten fish for dinner on both recall-days will be represented in the 95th 
percentile. It is unlikely that even a high fish consumer eats fish every day for a prolonged 
time, and therefore, the mean fish consumption over the two consumption days among 
those who reported fish for dinner both days represents an overestimate when it is 
transferred to weekly fish consumption. Also, many participants with no registered fish 
intake during the two 24-hour recalls will usually eat fish. This leads to a lower median 
weekly intake compared to a food-frequency method. Results from the Food propensity 
questionnaire are therefor included in this opinion (Chapter 3), as background for further 
discussion of the uncertainty of the fish intake.  
Portion size estimation is one of the important sources of uncertainty in dietary assessment 
of the individual, especially for the 24-hour recall method where the participant is asked to 
accurately recall, describe, and quantify the food items and ingredients of mixed dishes that 
were consumed the previous day (Souverein et al., 2011). However, portion sizes of fish and 
fish products might not be among the most difficult foods to estimate, as fish cakes, fish 
fingers and tins of mackerel in tomato come in recognisable units and thus have less 
influence on the uncertainty.  
The validity of a dietary assessment method refers to the degree to which the method 
actually measures the aspect of diet that it was designed to measure (Nelson and Margetts, 
1997). Lack of validity is strongly associated with systematic errors (Burema et al., 1988). 
With systematic errors all respondents in a dietary study or each subgroup in a population 
produce the same type of error, like systematic underestimation or overestimation of intake. 
There is no dietary assessment method that measures the habitual diet without error, and 
thorough validation is required for all dietary assessment methods.  
The FFQ used for the 2-year-olds were a slightly modified version of a FFQ that has been 
validated. The results from the validation showed fair agreement for most nutrients, but a 
significantly higher energy intake were reported with the FFQ than with the reference 
method, weighed record (Andersen et al., 2003; Andersen et al., 2004; Andersen et al., 
2009). 
The validation study of the MoBa FFQ showed fair agreement between food and nutrient 
intakes relative to the weighed record reference method. Furthermore, the estimated intakes 
of main food groups including seafood and supplementary n-3 fatty acids were reflected by 
biological markers (Brantsaeter et al., 2007b; Brantsaeter et al., 2009; Brantsaeter et al., 
2007a; Brantsaeter et al., 2010).  
The results of the validation of the Norwegian 24-hour recall method used among adults in 
Norkost 3 have not been published yet (A.M.W. Johansen et al., UiO, pers. comm.). When 
evaluating the energy intake with the Goldberg and Black cut off values (Black, 2000), the 
results showed that 16% of the participants in Norkost 3 underreported the energy intake, 
while 1.5% overreported the total energy intake (Totland et al., 2012). Other similar 24-hour 
recall methods have been validated and show an underestimation in energy intake of around 
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15% (Poslusna et al., 2009; Subar et al., 2003). Underestimation of energy intake indicates 
that not all foods eaten are reported, but not which foods are underreported.  
It has been shown that foods perceived as unhealthy such as fats, sweets, desserts and 
snacks tend to be underreported to a larger degree than foods perceived as healthy 
(Olafsdottir et al., 2006). However, among children and adolescents there have been studies 
were this selective underreporting was not shown (Lillegaard and Andersen, 2005; Sjoberg 
et al., 2003). As the fish and fish products are perceived by most to be healthy foods, it 
might lead to a certain overestimation of reported intake. On the other hand, if 
underreporting of fish and fish products is of the same magnitude as for total energy, the 
estimates for fish used in the exposure calculations can also be underreported. 
The precision of a technique is one that gives the same answer on repeated 
administrations (Livingstone and Black, 2003). Poor precision derives from large random 
errors in the techniques of dietary assessment. The effect of random errors can be reduced 
by increasing the number of observations, but cannot be entirely eliminated (Rothman, 
2002). 
The data collections of the different dietary surveys were performed from 2003 till 2011, and 
most of the contaminant data are from the same period 2006-2012. Dietary patterns are 
constantly changing. In a cohort study with a long data collection period, like in the MoBa 
study, changes in fish consumption during the study period has been documented 
(Caspersen et al., 2013).  
MoBa is one of the largest pregnancy cohorts in the world and dietary data from 86 277 
pregnancies was available for this report. However, the participation rate in MoBa is a 
concern. Of those invited during the years from 1999-2008, 40.6% consented to participate. 
Studies have shown that women in MoBa are older, better educated, and less often smokers 
compared with the general pregnant population. However, despite differences in the 
prevalence of exposures and outcomes between cohort participants and the general 
pregnant population, no statistically significant differences in associations between exposures 
and outcomes, e.g. prenatal smoking and low birth weight, maternal vitamin use and 
placental abruption, and parity and preeclampsia (Nilsen et al., 2013b; Nilsen et al., 2009). 
The cross sectional studies Norkost 3 and Småbarnskost 2007 also have rather low 
participation rates with 37% and 56%, respectively. It is unclear to which extent a low 
participation rate will influence the assessment of exposures contributed by fish. It has been 
shown that health-conscious people are more likely to participate in a dietary survey. This 
can indicate a somewhat different dietary pattern among the participants than among the 
whole population. The direction of the uncertainty is difficult to estimate. Health-conscious 
people tend to choose a more diverse diet, and even if the majority of the population 
(Norkost 3), 97%, reported to eat fish at least once a month, it might be that health-
conscious people eat fish more often.  
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Individual consumption data reported in the dietary surveys have been paired with person 
specific self-reported body weights for the same individuals. However, when no body weights 
were given the mean body weights from the studies were imputed in 2-year-olds and adults.  
 Gender and body weight 9.1.2
Fish consumption was not divided by gender. The fish consumption among 2-year-olds was 
not significantly different between the genders (Kristiansen et al., 2009). For the 
contaminants, person specific body weights were used. This approach gave a good 
understanding of the diversity in the population. For the nutrients the intake was not divided 
by body weight, and therefore the level of intake will be somewhat higher in men than the 
average values given in this report, while the level of intake of nutrients for women will be 
somewhat lower.  
 Analytical measurements 9.1.3
The exposure estimates were based on levels in raw fish. There may be a certain reduction 
and/or increase of nutrients and contaminants during food processing. For instance, whereas 
loss of water during food preparation may lead to increased concentration of protein- or 
lipid-associated substances, loss of lipids or water-soluble substances into cooking water may 
be associated with decrease in concentration. However, such changes are considered to be 
relatively small (Jakobsen and Knuthsen, 2014; Rana and Raghuvanshi, 2013), compared 
with other uncertainties. The changes of nutrients and contaminants during food processing 
are not included in the exposure estimates in this report. 
Any uncertainties related to the representativeness of the sampling of fish are described for 
each species, number and type of sample in Appendix VI.  
There are always uncertainties related to analytical measurements. The methods used in fish 
surveillance, and which are used to analyse the contaminants and nutrients given in this 
report, are accredited and quality checked by Norwegian Accreditation. Still each single 
method has uncertainty, a limit of detection (LOD) and a limit of quantification (LOQ). The 
methods used are harmonized with methods from NMKL (Nordisk metodikk komité), and 
CEN (European Committee for Standardization). The principles for each method can be 
found in Appendix VI, together with references to each single method description.  
The use of upper bound (UB) for dioxins and dl-PCBs most likely represents an overestimate 
of the exposure. For lower bound (LB), concentrations lower than the LOQ or LOD are 
substituted with zero. This most likely represents an underestimate of the exposure.  
For commercial products containing fish like fish cakes and fish balls, nutrient and 
contaminant data for cod have been used. This might represents both underestimation and 
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9.2 Epidemiological studies 
There are uncertainties related to all kind of epidemiological studies, e.g. inclusion and 
exclusion criteria, serving size, type of fish consumed, type of subjects i.e. healthy, healthy 
but at high risk of cardiovascular disease or patients. 
Criteria for objectively evaluating the level of causality of associations observed in 
epidemiology were stated by Hill (1965). These criteria, which include consistency and 
strength of the association, dose-response, time order, specificity, consistency on replication, 
predictive performance, biological plausibility and coherence, must be applied when 
discussing the results observed in every study.  
In epidemiological studies, there is uncertainty related to the exposures as well as the health 
outcomes, and there is uncertainty related to whether reported effects are indeed related to 
the exposure and not confounded by other factors correlated with exposures and outcomes 
such as e.g. demographic factors, lifestyle, and home environment. Epidemiological studies 
use statistical models to adjust for confounding factors, but the possibility of unmeasured or 
residual confounding cannot be excluded. Misclassification of dietary exposure is likely to 
attenuate the effect-estimates in studies of diet and disease (Parr et al., 2006). 
9.3 Summary of uncertainties 
Evaluations of the overall effect of identified uncertainties are presented in Table 9.3-1, 
highlighting the main sources of uncertainty and indicating whether the respective source of 
uncertainty might have led to an overestimation or underestimation of the exposure and/or 
the resulting risk or benefit (EFSA 2006). 
Table 9.3-1 Qualitative evaluation of influences of uncertainties on the benefit and risk assessment 
of intake of nutrients and exposure of contaminants from fish and fish products 
Source of uncertainty Direction  
Dietary assessment  
Different dietary assessment methods +/- 
Measurement uncertainty in the concentrations analysed +/- 
Bias due to misreporting  +/- 
Use of upper bound (UB) in exposure assessment + 
Use of lower bound (LB) in exposure assessment - 
Data for cod has been used for lean fish content in all types of fish products  +/- 
Småbarnskost 2007  
Use of 95th percentile +/- 
Food frequency questionnaire (FFQ) time span is 14 days +/- 
Norkost 3, Adults   
Low participation rate (selection bias) +/- 
Two registration days + 
Use of 95th percentile + 
MoBa, pregnant women  
Low participation rate (40.6% of those invited) (selection bias) +/- 
Recall 4-5 months back in time and possible misreporting of consumption (recall bias) +/- 
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Source of uncertainty Direction  
Epidemiological studies  
Inclusion and exclusion criteria +/- 
Definition of fish consumption frequency and the exposure e.g. types of fish +/- 
Variation of contaminant levels in the same fish species +/- 
Confounding factors +/- 
Nutrients and contaminants in fish  
Annual variation (especially for small samle sizes)  +/- 
Small number of samples for some fish species +/- 
Sampling methods and representativity +/- 
Precision of analytical methods +/- 
Nutrients and contaminants analysed in raw fish +/- 
Fish feed  
Small number of samples for some years +/- 
Sampling methods and representativity +/- 
Precision of analytical methods +/- 
+: uncertainty likely to cause over-estimation of exposure. 
- : uncertainty likely to cause under-estimation of exposure. 
Despite some limitations in assessing the fish consumption and the uncertainties related to 
the estimated intakes of nutrients and exposures to contaminants from fish and fish 
products, VKM concludes that the intake and exposure estimates presented in this opinion 
are within realistic ranges for each study population.  
VKM compared intakes of nutrients with national recommended intake values and exposures 
to contaminants with internationally recognised health based guidance values (tolerable 
weekly intakes - TWIs). Likewise, the benefits for health associated with fish consumption 
were also evaluated by international bodies, and the uncertainties in these assessments were 
not evaluated by VKM. VKM considers the overall uncertainty in the outcome of the present 
assessment on benefit and risk of fish consumption in Norway to be low.  
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10 Answers to the terms of reference  
The Norwegian Food Safety Authority (NFSA) requests an update of the benefit risk 
assessment published by VKM in 2006, “A comprehensive assessment of fish and other 
seafood in the Norwegian diet”. VKM is requested to base the updated assessment on new 
knowledge about fish, and farmed fish in particular. Furthermore, VKM is requested to focus 
on levels of specific nutrients, (n-3 fatty acids eicosapentaenoic acid (EPA) and 
docosahexaenoic acid (DHA), vitamin D, iodine and selenium) and specific contaminants 
(dioxin and dioxin-like PCBs, mercury) in fish fillet for impact of positive and negative health 
effects of fish consumption, respectively.  
VKM has the following answers to the questions in the terms of reference (ToR): 
ToR 1: What are the main changes in the use of raw 
materials in feed, and how are these changes reflected in the 
levels of nutrients, dioxins and dioxin-like PCBs and mercury? 
Since 2006 the production volume of farmed Atlantic salmon and trout has increased 
dramatically followed by increased requirement for feed volume. During the same period fish 
meal and fish oil available for feed production have remained constant. Hence, new raw 
materials have increasingly replaced fish meal as protein source and fish oil as lipid source. 
Thus, over the last 10 years there has been a great change in raw materials used in fish 
feeds, and in 2013 terrestrial plant proteins and vegetable oils accounted for 70% of the 
feed. In 2013, vegetable oil (mainly as rapeseed oil) constitutes approximately 64% of the 
feed oil.  
Main changes in the levels of nutrients: Replacing fish oil with vegetable oils in fish feed 
results in increased content of the long-chain polyunsaturated fatty acids (PUFAs) from 
terrestrial plants, n-6 PUFAs (linoleic acid (LA) and alpha-linolenic acid (ALA), and decreased 
content of PUFAs of marine origin, n-3 LCPUFAs (eicosapentaenoic acid (EPA), 
docosahexaenoic acid (DHA) and docosapentaenoic acid (DPA). Comparable data on fish 
feed levels of EPA, DHA and n-6 PUFAs in 2006 and 2014 are not available. Furthermore, 
VKM states that for vitamin D, selenium and iodine the change in raw materials for use in 
fish feed since 2006 has resulted in 36, 45, and 50% decreases, respectively, of the 
corresponding feed levels in 2014.  
Main changes in levels of contaminants in fish feed: The change in inclusion levels of 
fish oil from early 2000 has also affected the levels of persistent organic pollutants (POPs) in 
fish feed, and the level of dioxins and dl-PCBs is reduced by almost 60% in 2013 compared 
to 2006. Mercury levels have also decreased by approximately 50% in feed for Atlantic 
salmon and rainbow trout since 2006 due to the increasing fishmeal replacement with 
terrestrial plant protein sources. For details see Chapter 5.  
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ToR 2: To what extent have levels of nutrients and 
contaminants in fish changed since 2006? Describe this change.  
There is no difference in amino acid composition when comparing fillet of farmed Atlantic 
salmon from 2006 and 2014, since irrespective of which raw material that provides the 
dietary amino acids the fish muscle protein composition remains the same. 
The change in concentrations of nutrients and contaminants in fish feed for farmed Atlantic 
salmon and trout due to replacement of fish oil and fish protein with plant proteins and 
vegetable oils, is reflected in changed concentration and composition of the same nutrients 
and contaminants in the farmed fish fillet. The major changes are that the concentrations of 
EPA+DHA and selenium have decreased about 50 and 60%, respectively since 2006, and 
that concentrations of dioxins and dl-PCBs have been reduced by almost 70% and mercury 
by about 50% in the current report compared to the VKM report from 2006. 
For wild caught fish species the composition of nutrient and contaminant composition of the 
diet is also reflected in the edible part of the fish. The available databases of nutrient and 
contaminant concentrations for wild caught fish are not suitable to reveal time-trends of 
nutrient and contaminant levels, however there seem to be minor or no changes of the 
composition and concentrations of nutrients and contaminants in wild caught fish since 2006.  
For details see Chapter 5. 
ToR 3: Calculate the intake and exposure of these substances 
(nutrients and contaminants) on the basis of recent dietary 
data. 
Since 2006, the data bases on both nutrient and contaminant concentrations in both wild 
and farmed fish have been improved substantially and updated information on fish 
consumption in 2-year-olds (conducted in 2007), adults (conducted in 2010-2011, 18-70 
years of age) and pregnant women (conducted in 2002-2008) has become available. The 
expanded databases reduce the uncertainties in the intake and exposure estimates of 
nutrients and contaminants, respectively, in 2014 compared to 2006. For details see 
Chapters 3, 6 and 7. 
Nutrient intake estimates: Current nutrient intakes for 2-year-olds, adults (18-70) and 
pregnant women have been calculated from fish consumption data derived from the 
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EPA, DPA and DHA 
The main source is fatty fish, besides fish oil and cod liver oil which is consumed by a 
relative large part of the populations (41% of the 2-year-olds, 37% of the adults and 77% 
for pregnant women). In 2-year-olds, the mean intake of EPA+DHA+DPA contributed by 
fish is 204 mg/day. In adults, the amount of EPA+DPA+DHA from mean total fish intake is 
approximately 500 mg/day, and the 95th percentile is 2132 mg/day which is an overestimate. 
In pregnant women, the mean estimated intake of EPA+DHA+DPA is 312 mg/day, and 
the 95th percentile is 992 mg/day. 
Vitamin D  
The main source for vitamin D is fatty fish, besides fish oil and cod liver oil which is 
consumed by a relatively large part of the populations (41% of the 2-year-olds, 37% of the 
adults and 77% of pregnant women). Vitamin D contributed by fish in 2-year-olds and 
adults are on average 0.36 and 2.1 µg/day, respectively. In pregnant women, the mean 
vitamin D intake from fish is 0.96 µg/day.  
Iodine 
Lean fish is the main source for iodine. In 2-year-olds average fish consumption 
contributes with 35 µg iodine per day. The mean intake of iodine from fish in adults is 86 µg 
iodine per day and in pregnant women 54 µg.  
Selenium 
The selenium concentration is about the same in lean and fatty fish. In 2-year-olds, the 
contribution of selenium from average fish consumption is 4.5 µg/day. In adults, the mean 
selenium intake from fish is 15 µg/day and in pregnant women 9 µg/day.  
Contaminant exposure estimates: Current exposure estimates for 2-year-olds, adults 
(18-70 years) and pregnant women have been calculated from fish consumption data 
derived from the respective food consumption surveys and data on contaminants levels in 
the fish/fish product consumed.  
The exposure to mercury and dioxins and dl-PCBs through fish consumption has been given 
both in upper bound (UB) and lower bound (LB). In UB calculations the concentrations lower 
than the limit of quantification (LOQ) or limit of detection (LOD) is substituted with the LOQ 
or LOD. This most likely represents an overestimate of the exposure. In LB calculations, 
concentrations lower than the LOQ or LOD is substituted with 0. This most likely represents 
an underestimate of the exposure. For mercury there are small differences between lower 
bound and upper bound estimates because concentrations in most samples have been 
quantified. Therefore, the description on mercury exposure in the text is based on UB 
estimates. For dioxins and dl-PCBs the uncertainty in concentrations in fish is higher and in 
order to reflect this, both UB and LB results are described also in the text. 
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Methylmercury 
For methylmercury exposure, fish is the only notable source. Methylmercury constitutes 80-
100% of the total mercury in fish. The main source in Norway is lean fish.  
The updated UB exposure assessments indicated mean and 95th percentile exposure in 2-
year-old at 0.50 and 1.1 µg/kg bw/week. In adults, the mean and 95th percentile 
exposures were 0.30 and 1.2 µg/kg bw/week, and in pregnant women the mean and 95th 
percentile exposures were 0.17 and 0.39 µg/kg bw/week, respectively. For mercury exposure 
from fish, the upper and lower bounds are quite similar. 
Dioxins and dl-PCBs 
Fatty fish is the major contributor, but consumption of cod liver oil may contribute in 
addition. In adults, cod liver oil contributes a smaller part, whereas cod liver oil constitutes a 
larger part in 2-year-olds. The updated exposure assessments from fish indicates mean 
exposure in 2-year-olds between 2.0 (LB) and 2.6 (UB) pg TEQ/kg bw/week and 95th 
percentile exposure between 7.3 (LB) and 9.4 (UB) pg TEQ/kg bw/week. In adults, the 
mean exposure was between 1.4 (LB) and 1.7 (UB) pg TEQ/kg bw/week and the the 95th 
percentile exposure was between 5.6 (LB) and 6.8 (UB) pg TEQ/kg bw/week. In pregnant 
women, the mean exposure was between 0.75 (LB) and 0.94 (UB) pg TEQ/kg bw/week and 
the 95th percentile exposure was between 2.2 (LB) and 2.7 (UB) pg TEQ/kg bw/week.  
Changes in nutrient intake and contaminant exposure since 2006: The updated 
nutrient calculations in the current opinion indicate no change in EPA+DPA+DPA 
contributed by fish consumption, a modest decline in the amount of vitamin D contributed by 
fish, and a substantial decline in iodine and selenium. There is no environmental or biological 
reason why iodine and selenium intake from fish should be decreased since 2006, as long as 
the fish consumption is unchanged. The observed differences are likely due to improved data 
on iodine and selenium concentrations in wild fish in 2014 and thus less uncertainty now 
than in the intake assessments in 2006. 
The main difference regarding mercury exposure from fish is that the database on mercury 
concentrations in fish has been substantially improved since the assessment in 2006, and 
this has reduced the uncertainties in the exposure estimates. Overall, the exposure estimates 
for mercury from fish in 2006 and 2014 are similar. 
Also for dioxins and dl-PCBs the database on concentrations in fish has improved 
substantially since the assessment in 2006, reducing the uncertainty in the exposure 
assessments. There is a decreasing trend of dioxins and dl-PCBs in the environment and 
therefore also in food. A decrease in exposure to dioxins and dl-PCBs from fish can be seen 
since 2006, as present exposure is estimated to be around 40% of the exposure calculated 
in 2006. The decrease is likely due to a combination of more data on levels of dioxins and dl-
PCBs in fish in 2014 than in 2006, and decreased levels of dioxins and dl-PCBs in the 
environment, as well as in farmed salmon. The reduced level of dioxins and dl-PCBs in 
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farmed fish is mainly due to decreased fish oil inclusion in fish feed today compared to 2006. 
In contrast to farmed fish, the available data for wild fish are not suitable to show time-
trends of contaminant levels e.g. regular sampling of the same species from the same area 
over a long period of time.   
ToR 4: Consider the benefits of eating fish with regard to the 
intake of nutrients and the risks associated with the intake of 
dioxins, dioxin-like PCBs and mercury. 
The present benefit-risk assessment is comprised of three elements, i.e. risk assessment, 
benefit assessment and benefit-risk comparison (Chapter 8).  
Fish consumption and association with health outcomes 
Since 2006 large prospective cohort and population studies have been conducted assessing 
fish consumption and associations with different health outcomes. VKM has summarized 
research on association between fish consumption and several health effects (cardiac 
disease, neurodevelopment and other outcomes related to the central nervous system, 
cancer, type-2 diabetes and other metabolic outcomes, asthma, allergy and other atopic 
outcomes, and pregnancy-related outcomes). A comprehensive summary of health effects 
associated with fish consumption is given in Chapter 4.8.  
VKM concludes that meta-analyses conducted since 2009 do not show association between 
fish consumption and cancer. Furthermore, the studies summarized have not revealed 
consistent associations between fish consumption and type-2 diabetes, although some 
Nordic studies indicate protective associations. None of the studies controlled for 
contaminant exposure from fish, and it is not known whether this would have affected the 
outcome.  
No meta-analyses reported association between fish consumption and adverse health 
effects. A few studies showing positive health effects of fish consumption reported a 
decrease in the positive health effects by contaminants in fish (negative confounding). 
Beneficial effects of fish consumption: VKM is of the opinion that according to 
epidemiological studies, the net effects of the present average fish consumption in Norway 
for adults including pregnant women is beneficial for specific cardiovascular diseases 
(particularly cardiac mortality, but also with regard to ischaemic stroke, non-fatal coronary 
heart disease events, congestive heart failure and atrial fibrillation) as well as for optimal 
neurodevelopment for foetuses and infants. VKM notes that the calculated benefits of fish 
consumption in relation to the health outcomes mentioned above refer to net effects 
combining beneficial, neutral, and adverse effects of nutrients and non-nutrients, including 
contaminants such as methylmercury, dioxins, dl-PCBs. VKM also notes that EPA and DHA 
play a role. However, the beneficial effects of fish intake are most likely mediated through a 
complex interplay among a wide range of nutrients commonly found in fish, thus fatty and/or 
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lean fish may be involved. VKM is of the opinion that adults including pregnant women with 
fish consumption less than one dinner serving per week may miss the beneficial effects on 
cardiovascular diseases and optimal neurodevelopment of foetus and infant. The health 
benefit of fish consumption is reported from 1-2 dinner servings per week and up to 3-4 
dinner servings per week. The health benefit of fish consumption is reported from 1-2 dinner 
servings per week and up to 3-4 dinner servings per week. For higher fish intake per week 
the limited number of consumers in epidemiological studies does not allow for drawing firm 
conclusions about the actual balance of risk and benefit. More knowledge is needed to reveal 
the beneficial mechanisms of fish consumption. 
Furthermore, for pregnancy-related outcomes, VKM notes that results from MoBa indicate 
that fish consumption during pregnancy, and in particular lean fish consumption is associated 
with increased birth weight and lower risk of preterm birth, however, the findings need to be 
confirmed in other cohorts. Regarding atopic diseases, VKM also notes that results from 
MoBa indicate a protective association between maternal fish consumption and/or early life 
fish consumption and atopic diseases. None of the studies controlled for contaminant 
exposure from fish and it is not known whether this would have affected the outcome. 
Benefit characterisation of nutrients in fish: VKM has estimated the contribution from 
fish to the recommended intakes of certain nutrients. Fish is the major source of 
EPA+DPA+DHA, but for vitamin D, iodine and selenium there are also other substantial 
sources. Fish is not a major dietary source of n-6 fatty acids, also not when the 
consequences of inclusion of plant oils in the feed for farmed Atlantic salmon have been 
taken into consideration in the intake assessments. Based on intake estimates in comparison 
with upper limits of nutrients, it is unlikely that fish consumption in Norway could lead to 
harmful high intake of vitamins, minerals or n-3 LCPUFAs for any age group. Therefore, in 
the present assessment of nutrients VKM focuses on the possible benefits of intake of 
nutrients from fish consumption in relation to recommended nutrient intakes. 
Taking the current levels of nutrients in fish, and the consumption of fish in different 
population groups in Norway into account, VKM concludes that the contribution of 
EPA+DHA from average fish consumption will reach the European recommended intake of 
EPA+DHA for adults and 2-year-olds. For pregnant women the average fish consumption is 
insufficient to meet the European recommendation of EPA and DHA for pregnant women, but 
sufficient to meet the national intake recommendation of DHA. With high fish consumption 
(95th percentile), all age groups will reach the recommended intake of EPA and DHA.  
For vitamin D, current average fish consumption contributes approximately to 1/5 of the 
recommended intakes for adults but less for pregnant women and 2-year-olds. Since there 
are few other dietary vitamin D sources, this supports the necessity for the current 
recommendation of vitamin D supplements in the population.  
Fish contributes with 30 to 50% (mean fish consumption in adult and pregnant) and up to 
90% (mean fish consumption in 2-year-olds) of the recommended iodine intakes for the 
different age groups. High fish consumption contributes with 48% of the recommended 
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selenium intake for 2-year-olds and less for adults and pregnant women. Low intakes of 
selenium and iodine from fish relative to the recommended values may be complemented 
by intake from other dietary sources.  
Risk characterisation of undesirable substances in fish: VKM has compared the 
dietary exposure to contaminants contributed by fish with the tolerable weekly intakes. A 
tolerable intake is the amount of a substance, or substance group, which can be consumed 
safely throughout a person's lifetime without appreciable risk of adverse health effects. 
Tolerable intakes are set by international risk assessment bodies, such as WHO or EFSA, and 
incorporate safety margins, in order to protect all parts of the population. 
VKM concludes that with the present mean concentration of mercury in fish on the 
Norwegian market and the present fish consumption in Norway, the methylmercury exposure 
from fish is below the tolerable weekly intake (TWI) of 1.3 µg/kg bw/week for more than 
95% of the population of 2-year-olds, adults and pregnant women. This exposure represents 
a negligible risk and is of no concern. 
With the present mean level of dioxins and dl-PCBs in fish on the Norwegian market and 
the present fish consumption in Norway, high fish consumption (the 95th percentile) 
contributes with up to 50%, 19%, 67% of the TWI of 14 pg TEQ/kg bw/week for adults, 
pregnant women and 2-year-olds respectively. Daily consumption of cod liver oil or fish oil 
(which is common in all population groups) in amounts as suggested on the product will in 
addition contribute with 0.8 to 16% of the TWI, depending on the body weight. With the 
present TWI and taking into consideration that fish and fish products are significant sources 
to dioxins and dl-PCBs in the Norwegian diet, VKM concludes that the exposure from fish to 
dioxins and dl-PCBs represents negligible risk and is of no concern. 
Scenarios: VKM has made various scenarios to foresee how possible changes in fish 
consumption pattern and amounts will affect the exposure from fish to tolerable weekly 
intakes of mercury, dioxins and dl-PCBs. Fish is the only source for methylmercury exposure 
from foods, whereas exposure to dioxins and dl-PCBs also comes from other foods than fish. 
Based on these scenarios, where only exposure to dioxins and dl-PCBs from fish were taken 
into consideration, VKM is of the opinion that fish consumption in line with the food-based 
dietary guideline of 300-450 g fish, hereof 200 g fatty fish per week, does not lead to 
exposures to dioxins and dl-PCBs or methylmercury from either fatty or lean fish exceeding 
the respective TWIs, and is therefore, from a contaminant exposure perspective, of no 
concern. 
However, since there are other food sources in the Norwegian diet that contribute to 
exposure to these contaminants, VKM performed a simple model estimate of weekly intake 
of dioxins and dl-PCBs in adults from various amounts of farmed salmon and other foods.  
Based on this scenario, VKM is of the opinion that there is negligible risk associated with 
eating farmed Atlantic salmon with the present mean concentrations of dioxins and dl-PCBs. 
The TWI is not exceeded when consuming amounts equivalent to 1400 g farmed salmon 
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weekly for adults (representing 9 weekly dinner servings). Neither is the TWI exceeded when 
exposures to dioxins and dl-PCBs from other foods and cod liver oil are taken into 
consideration. In comparison, an adult can consume about 800 g mackerel weekly 
(representing 5 weekly dinner servings) with current mean concentration of dioxins and dl-
PCBs without exceeding TWI. From a contaminant exposure perspective consumption of 
farmed salmon is of no concern. This also applies for commercially available wild caught fish 
like mackerel. 
VKM is of the opinion that the present exposure to residues of veterinary medicinal products 
including residues of antibiotics in farmed fish in the Norwegian diet is of no concern 
since the levels are very low and often not detectable even with sensitive analytical methods.  
For new contaminants in fish feed like the pesticide endosulfan, polyaromatic 
hydrocarbon (PAHs) and mycotoxins, VKM is of the opinion that the concentrations in 
farmed fish in the Norwegian diet are likely not a food safety issue since the concentrations 
are very low and often not detectable even with sensitive analytical methods. 
Regarding the environmental contaminants brominated flame retardants, VKM refers to 
the conclusions in a risk assessments from EFSA in 2011 that the health risk associated with 
the current exposure to these compounds is low. The amount of fluorinated compounds 
such as PFOS and PFOA in the Norwegian diet is much lower than what is tolerable 
according to an EFSA assessment in 2008. 
Benefit-risk comparison 
From a benefit assessment perspective, VKM is of the opinion that the average fish 
consumption in Norway for adults should give substantial benefit (positive health effects) 
with regard to specific cardiovascular disease. Pregnant women, who eat little or no fish, 
may miss the beneficial effects of fish consumption on neurodevelopmental outcomes in 
foetuses and infants. 
From a nutrient benefit assessment perspective, VKM is of the opinion that for the 
different age groups, increase in both lean and fatty fish consumption will improve the role 
of fish as a source of important nutrients (EPA+DPA+DHA, vitamin D, iodine and selenium) 
relative to recommended intakes. Increased consumption of fatty fish will increase the intake 
of EPA+DPA+DHA and vitamin D while an increase in the consumption of lean fish will 
increase the intake of iodine. Generally, an increase of marine fish consumption will increase 
the intake of selenium. 
From a risk perspective it is the opinion of VKM that with the present concentrations of 
dioxins and dl-PCBs, and mercury, the exposure to these compounds is below the tolerable 
intakes when fish is consumed in accordance with the dietary advice of 300-450 g fish per 
week (representing 2-3 dinner servings, hereof 200 g fatty fish), and is therefore of no 
concern. This also apply if the fish consumed in adults consist of 1400 g farmed Atlantic 
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salmon (representing 9 dinner servings) or 800 g mackerel weekly (representing 5 dinner 
servings). 
Following a comprehensive assessment of the scientific literature on the positive health 
effects of fish consumption and the contribution from fish to intake of beneficial compounds 
as well as exposure to hazardous contaminants in Norway, VKM concludes that the benefits 
clearly outweighs the negligible risk presented by current levels of contaminants and other 
known undesirable substances in fish. Furthermore, in Norway, adults including pregnant 
women with fish consumption less than one serving per week may miss the beneficial effects 
on cardiovascular diseases and optimal neurodevelopment in foetuses and infants. In 
contrast to the conclusion in 2006, VKM concludes that there is no reason for specific dietary 
limitations on fatty fish consumption for pregnant women. 
The health benefit of fish consumption is reported from 1-2 dinner servings per week and up 
to 3-4 dinner servings per week. For higher fish intake per week, the limited number of 
consumers in epidemiological studies does not allow for drawing firm conclusions about the 
actual balance of risk and benefit. More knowledge is needed to reveal the beneficial 
mechanisms of fish consumption. 
ToR 5: Does this change the conclusions from the report in 
2006? 
Fish consumption and dietary guidelines 
Existing dietary guidelines: In 2006, the Norwegian recommendation for fish 
consumption merelywas to eat more fish both for dinner and as bread spreads. In 2014, 
based on the VKM assessment in 2006 (VKM, 2006) and the report “Dietary advice to 
promote public health and prevent chronic diseases in Norway” (Norwegian National Council 
for Nutrition, 2011), these recommendations were altered and made quantitative by the 
Norwegian Directorate of Health (2014). The Norwegian Directorate for Health now (per 
2014) recommends fish as dinner meal 2-3 times per week for all age groups. Fish is also 
recommended as bread spread. This represents totally 300-450 g fish per week for adults, 
and less for children. For adults, at least 200 g should be fatty fish such as salmon, trout, 
mackerel or herring. Six portions of bread spreads represents approximately one dinner 
portion. A clarification was given for young females and pregnant women. They should, over 
time, avoid eating more than two meals of fatty fish per week, including fish like salmon, 
trout, mackerel and herring. The Norwegian health authorities also recommend a daily 
supplement of vitamin D to infants from 4 weeks of age, and if this supplement is taken as 
cod liver oil it will in addition ensure an adequate supply of n-3 LCPUFAs (Chapter 1). 
Current fish consumption: Fish consumption of 2-year-olds, adults (18-70 year of age) 
and pregnant women have been calculated from the food consumption surveys 
Småbarnskost 2007 (n=1674), Norkost 3 (n=1787) and MoBa (n=83 848), respectively. 
According to these estimates adults eat on average 364 g/week (equivalent to 2-3 fish 
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dinner servings per week given a portion size of 150 g), pregnant women eat 217 g/week 
(equivalent to 1-2 dinner servings per week given a portion size of 150 g), while 2-year-olds 
eat 112 g/week (equivalent to 1-2 dinner servings per week given a portion size of 75 g) 
(see Chapters 3 and 8 for details). 
Comparison of fish consumption and food based dietary guidelines: VKM concludes 
that of the different population groups, only adults (18-70 years of age) with an average or 
higher fish consumption reach the food based dietary guidelines for total fish consumption. 
Both the mean total and fatty fish consumption of children (2-year-olds) and pregnant 
women as well as the mean fatty fish consumption of adults are lower than recommended. A 
larger proportion of the pregnant women compared to other adults have fish consumption 
less than the recommendations.   
Comparison of conclusions in 2006 and 2014: In 2006, exposure to dioxins and dl-
PCBs exceeded the tolerable intake for approximately 15% of the population. In the present 
benefit-risk assessment VKM concludes that for all population groups studied (2-year-olds, 
pregnant women and adults), the exposure to dioxins, dl-PCBs and mercury is below the 
tolerable intakes with the present fish consumption. This would be the case also if fish is 
consumed in accordance with the dietary advice of 300-450 g fish hereof 200 g fatty fish per 
week (representing 2-3 dinner servings). Furthermore, based on scenarios VKM is of the 
opinion that this also apply if the fish consumed in adults consist of 1400 g farmed Atlantic 
salmon (representing 9 dinner servings) or 800 g mackerel weekly (representing 5 dinner 
servings). VKM is of the opinion that from a contaminant exposure perspective consumption 
of farmed salmon is of no concern. This also applies for commercially available wild caught 
fish like mackerel. In the 2006 report, it was concluded based on the levels of contaminants 
in farmed salmon, “Over a long period of time, eating more than 2 meals of fatty fish per 
week at current levels of dioxins and PCBs may result in the tolerable intake (TWI) for 
dioxins and dioxin-like PCBs being moderately exceeded. This is especially important with 
respect to fertile women”. In contrast to the cited conclusion of 2006, VKM concludes in this 
report that there is no reason for specific dietary limitations on fatty fish consumption for 
pregnant women. 
Health effect of fish consumption  
Beneficial health effects of fish consumption: In the present VKM report, literature 
addressing fish consumption and effects on specific health outcomes that was considered 
relevant for the benefit-risk evaluation has been reviewed. This includes systematic reviews 
and meta-analyses, assessments prepared by international scientific bodies as well as some 
single cohort or population-based studies published after 2006. It appears that of the 
assessed health endpoints, there are more studies and more evidence related to fish 
consumption and cardiovascular endpoints and neurodevelopment, than for the other 
assessed endpoints (cancer, type-2 diabetes and other metabolic outcomes, asthma, allergy, 
and other atopic diseases, pregnancy-related outcomes, neurodevelopment, and cognitive 
decline, including Alzheimers disease). VKM concludes that documentation of the benefits of 
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fish consumption in relation to cardiovascular diseases and mortality as well as 
neurodevelopment of foetus and infant has been strengthened since 2006. VKM notes that 
the benefits of fish consumption refer to net effects combining beneficial, neutral, and 
adverse effects of nutrients and non-nutrients (including contaminants such as 
methylmercury, dioxins and dl-PCBs) in fish. VKM also notes that EPA and DHA from fish play 
a role, however, the beneficial effects of fish consumption most likely are mediated through 
a complex interplay among a wide range of nutrients commonly found in fish, thus fatty 
and/or lean fish may be involved. 
ToR 6: On the basis of updated knowledge, please comment if 
other substances, like pesticide and drug residues, which are 
not listed, could affect the conclusions with regard to the 
impact on public health? 
All feed ingredients may contribute with undesirable substances. Replacing fish oil and fish 
meal with alternative ingredients decreases the levels of marine contaminants, however, the 
new ingredients may contribute with similar and/or other types of contaminants. 
For new contaminants in fish feed like the pesticide endosulfan, polycyclic aromatic 
hydrocarbons (PAH) and mycotoxins, VKM is of the opinion that the reported concentrations 
in farmed fish in the Norwegian diet is not likely a food safety issue since the concentrations 
are very low and often not detectable even with sensitive analytical methods.  
With regard to the synthetic antioxidants (ethoxyquin, butylhydroksyanisol (BHA) and 
butylhydroksytoluen (BHT)) and the pesticide endosulfan, the calculated exposures from a 
300 g portion of farmed fish fillets are reported to be below their respective acceptable daily 
intakes (ADIs) and therefore of no concern.  
The concentrations of brominated flame retardants and perfluorated organic compounds in 
fish feed and fish on the Norwegian market are generally low, and considered to be of no 
concern from a human health perspective by VKM. 
VKM is of the opinion that the present exposure to residues of veterinary medicinal products 
including residues of antibiotics in farmed fish in the Norwegian diet is of no concern since 
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11 Data gaps 
No essential data gaps have been identified for conducting this benefit-risk assessment of 
fish and fish products in the Norwegian diet. However, during preparation of the present 
report, it is revealed that future benefit-risk assessment of fish consumption will profit from 
enlargement of data on nutrient composition and content in wild and farmed fish and in 
commercial available fish based products. In order to show time-trends of both nutrients and 
contaminant levels in wild caught fish, regular sampling of the same species from the same 
area over a long period of time is of importance. For farmed fish, changes in fish feed recipe 
should be followed by continuing scientific research and monitoring to reveal its impact on 
fish as food. In order to follow changing trends in food consumption in the Norwegian 
population, regular conduction of national dietary surveys in all age groups is important. 
Some of the abovementioned areas are detailed below: 
 There is a lack of data on nutrients and contaminants in commercial products containing 
fish like fish cakes and bread spreads, ready to eat meals (fish soup and fish au gratin). 
Knowledge of concentrations of nutrients and contaminants in these products will refine 
the intake and exposure calculations.  
 There are no available samples suitable to show time-trend of contaminant levels in wild 
fish, such as regular sampling of the same species, e.g. cod liver and fillet, from the 
same area over a long period of time. Such data is only available for farmed fish. 
 Data from the national food dietary surveys among children and adolescents (i.e. 4-, 9-, 
and 13-year-olds), conducted in 2000 and 2001, were considered too old to be used in 
this opinion. It is of importance that the national dietary surveys in all age groups are 
conducted regularly to follow the changing trends in food consumption, at least each 5th-
10th year. 
 The relevance and challenges of a two times 24h-recall dietary method as used in 
Norkost 3 for use in intake/exposure assessment should be further clearified 
 More knowlegde is needed to reveal the beneficial mechanisms of fish consumption.  
 There is a need for studies assessing health effects of fish consumption that control for 
potential effects of concomitant contaminants exposure.  
 Changes in fish feed recipe and the subsequent impact on fish as food needs to be 
followed  
o Plant ingredients used in fish feed may introduce new contaminants such as 
PAHs, mycotoxins, and new pesticides. More knowledge are needed on the 
concentrations in fish feed and transfer from feed to fish fillet of new 
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contaminants as well as for the brominated flame retardants and perfluorated 
compounds.  
o Future new feed ingredients, including GM-oils and protein sources, for farmed 
fish feed introduce contaminants as well as nutrients. When future new 
ingredients are introduced, knowledge on nutrient and contaminant composition, 
content, impact on fish health and if they affect the eatable portion and its 
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Appendix I 
Fish species and percentage raw fish used for each fish product 
in calculations of fish consumption for 2-year-olds, pregnant 
women and adults 
Fish consumption from national dietary surveys among 2-year-olds (Småbarnskost 2007) and 
adults (Norkost 3) as well as information about fish consumption reported during the time 
period 2002-2008 by pregnant women in Norwegian Mother and Child Cohort Study (MoBa), 
are described in Chapter 3. The fish consumption is presented as raw fish to match the 
concentration data of nutrients and contaminants analysed in raw fish. Details regarding 
percentages of raw fish in various fish products, and for the fish species used for each fish 
product, are presented below in Tables AI-1, AI-2 and AI-3. 
Table AI-1 Type of fish and percentage of raw fish in fish products used in calculations in the 
Småbarnkost 2007 study for fish consumption in 2-year-olds 
Fish/fish product Percent of raw fish in the 
product’s recipe (%) 
Fish species used for 
consumption calculations 
Cod, saithe, other white 
fish (as dinner) 
100 Atlantic cod 
Trout, salmon, mackerel, 
herring (as dinner) 
100 Atlantic salmon (farmed) 
Fish balls, fish pudding 55 Atlantic cod 
Fish au gratin 50 Atlantic cod 
Fish burgers 60 Atlantic cod 
Fish fingers 60 Atlantic cod 
Jarred baby food with fish 10 Atlantic cod 
Mackerel in tomato-sauce 60 Mackerel (North East Atlantic) 
Caviar 46 Atlantic cod roe 
Table AI-2 Type of fish and percentage of raw fish in fish products, used in calculations for in the 
Norkost 3 study for fish consumption in adults 
Fish/fish product Percent of raw fish in the 
product’s recipe (%)  
Fish species used for 
consumption calculations 
Salmon, trout 100 Atlantic salmon (farmed) 
Farmed trout 100 Atlantic salmon (farmed) 
“Klippfisk” 200 Atlantic cod 
“Bokna fish” 111 Atlantic cod 
“Lutefisk” 61 Atlantic cod 
Fish pudding* 55 Atlantic cod 
Fish balls* 55 Atlantic cod 
Fish cakes* 60 Atlantic cod 
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Fish/fish product Percent of raw fish in the 
product’s recipe (%)  
Fish species used for 
consumption calculations 
Salmon cakes 83 Atlantic salmon (farmed) 
Fried breaded saithe 70 Saithe 
Fried breaded cod 60 Atlantic cod 
Fried breaded plaice 70 Plaice 
Mackerel in tomato sauce 60 Mackerel (North East Atlantic) 
Sushi 33 Atlantic salmon (farmed) 
Fish au gratin* 50 Atlantic cod 
Crab sticks* 72 Atlantic cod 
Pickled herring 60 Herring (Norwegian spring 
spawning) 
Caviar 46 Atlantic cod roe 
Caviar light 68 Atlantic cod roe 
Caviar mix 27 Atlantic cod roe 
Fish soup 20 Atlantic salmon (farmed) 
* white fish is a common source of fish in many fish products in Norway, however, due to lack of data 
for white fish the nutrient content of cod is used in the calculations. 
 
Table AI-3 Type of fish and percentage of raw fish in fish products used in calculations for the 
MoBa study for fish consumption in pregnant women 
Fish /fish product Percent of raw fish in the 
product’s recipe (%) 
Fish species used for 
consumption calculations 
Cod, saithe 100 Atlantic cod 
Pike, perch 100 Pike 
Mackerel, herring 100 Mackerel (North East Atlantic) 
Salmon, trout 100 Atlantic salmon (farmed) 
Fish products like fish 
pudding, fish balls, fish 
burgers 
60 Atlantic cod 
Fish pate  50 Atlantic salmon (farmed), Atlantic 
cod 
Fried breaded fish 67 Atlantic salmon (farmed), Atlantic 
cod 
Pasta dish with fish 20 Atlantic cod 
Mackerel in tomato-sauce 60 Mackerel (North East Atlantic) 
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Appendix II  
List of fish species and fish based products named in English, 
Norwegian and Latin (if relevant) 
Table AII-1 Fish species and fish based products listed alphabetically in English, Norwegian and 
Latin  
English fish name Norwegian fish name Latin fish name 
Atlantic cod, all populations Torsk (alle typer) Gadus morhua 
Cod (costal) Kysttorsk - 
Cod (North Sea) Nordsjøtorsk - 
Cod (North East Atlantic) Nordøstatlantisk torsk - 
Atlantic halibut  Kveite Hippoglossus hippoglossus 
Atlantic salmon (wild)  Villaks Salmon salar 
Atlantic salmon (farmed) Oppdrettslaks Salmo salar 
Arctic char (farmed) Oppdrettsrøye Salvelinus alpinus 
Brown trout  Ferskvannsørret Salmo trutta 
Cod roe Torskerogn - 
Cod roe and liver pate Svolværpostei - 
Fish liver Fiskelever - 
Greenland halibut  Blåkveite Reinhardtius hipoglossoides 
Haddock  Hyse Melanogrammus aeglefinus 
Herring (North Sea herring)  Nordsjøsild Clupea harengus 
Herring, (Norwegian spring 
spawning)  Norsk vårgytende sild Clupea harengus 
Mackerel (North East Atlantic)  Nordøstatlantisk makrell Scomber scombrus 
Perch  Abbor Perca fluviatilis 
Pike  Gjedde Esox lucius 
Plaice  Rødspette Pleuronectes platessa 
Redfish  Uer Sebastes marinus 
Saithe  Sei Pollachius virens 
Sprat  Brisling (hel og fersk) Sprattus sprattus 
Mackerel in tomato sauce Makrell i tomat på boks - 
Trout (farmed) Oppdrettsørret Onocorhynchus mykiss 
Tuna (canned) Tunfisk på boks 




(Canned tuna is often based on 
Katsuwonus pelamis) 
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Appendix III 
Differences in dietary assessment methods used by VKM in 
2006 and 2014 - details 
In order to address changes in fish consumption since 2006, the methods behind the dietary 
surveys used then and now have been taken into consideration; see Chapter 3 in the main 
text. 
The method used for consumption recording in Småbarnskost 1999 and Småbarnskost 2007 
were similar (food frequency questionnaire; FFQ), and data from these two surveys can be 
compared even though the questions in the FFQs differ for some food groups (see Chapter 
3.3). However, for adults, the methods used in the Norwegian Fish and Game study (FFQ) 
and in Norkost 3 (24-hour recalls), respectively, are not similar, and data from these two 
surveys cannot be directly compared. However, both studies were nation-wide and 
participants were invited by arbitrary selection from the population. The Norwegian Mother 
and Child Cohort Study (MoBa) is a prospective population-based pregnancy cohort study 
which among other issues addresses the dietary habits during the first 4-5 months of 
pregnancy.  
Details of changes in the methods used for dietary assessment in 2006 and 2014 are 
outlined in Table AIII-1. 
Table AIII-1 Changes in the dietary assessment methods used in the 2006 and the present benefit-
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Appendix IV 
Search terms for fish consumption and health outcomes 
This Appendix refers to Chapter 4 “Health effects associated with fish consumption – 
epidemiological studies” in the main text. 
The search was performed 11. April 2014. For the main search (Table AIV-1), fish 
consumption was combined with one or several health outcomes, language was English or 
Scandinavian, human studies only was included and publication date was from 2009 until 
day of searching. The number of hits was 2460 including duplicates. The main search was 
then restricted to only Nordic studies only (Table AIV-2, 163 hits) and to reviews (Table AIV-
3, 444 hits).  
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Appendix V 
Search terms for supplementary n-3 fatty acids (EPA and/or 
DHA) and health outcomes 
In the main text Chapter 4 addresses “Health effects associated with fish consumption –
epidemiological studies”. Thus, the main literature search (Appendix IV) aimed to retrieve 
studies addressing fish consumption and health outcomes. However, in addition a secondary 
search was conducted aiming to identify whether new scientific evidence would imply a 
change in the previously established beneficial effects of supplementary EPA and/or DHA in 
prevention of cardiovascular diseases. The same search strategy as in the VKM report of 
2011 which evaluated negative and positive health effects of n-3 fatty acids as constituents 
of food supplements and fortified foods was used, but the search period was limited from 




Metaanalyser, systematic reviews:  
1. Eicosapentaenoic Acid/ 
2. eicosapentaenoic acid*.mp. 
3. Docosahexaenoic Acids/ 
4. Docosahexaenoic Acid*.mp. 
5. Fatty Acids, Omega-3/ 
6. omega-3 fatty acid*.mp. 
7. Fish Oils/ 
8. fish oil*.mp. 
9. fish liver oil*.mp. 
10. Cod Liver Oil/ 
11. cod liver oil*.mp. 
12. cod oil*.mp. 
13. alpha-Linolenic Acid/ 
14. alpha linolenic acid*.mp. 
15. or/1-14 
16. ae.xs. 
17. adverse effect*.mp. 
18. adverse event*.mp. 
19. Risk Assessment/ 
20. risk factor*.mp. 
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24. Dose-Response Relationship, Drug/ 
25. Dose-Response.mp. 
26. or/16-25 
27. 15 and 26 
28. Oxidative Stress/ 
29. oxidative stress.mp. 
30. stress oxidative.mp. 
31. Lipid Peroxides/ 
32. Lipid Peroxidation/ 







40. Thiobarbituric Acid Reactive Substances/ 
41. Thiobarbituric Acid*.mp. 
42. or/28-41 
43. 15 and 27 
44. 15 and 42 
45. or/43-44 
46. Meta-Analysis/ 
47. Meta-Analysis as Topic/ 
48. meta analy*.mp. 
49. metaanaly*.mp. 
50. (systematic adj (review*1 or overview*1)).mp. 
51. exp "Review Literature as Topic"/ 
52. or/46-51 
53. 45 and 52 
54. limit 53 to yr="2000 -Current" 
EMBASE 
VKM_Fish_Oils_3_EMBASE  
Metaanalyser, systematisc reviews: 
1. eicosapentaenoic acid/ 
2. eicosapentaenoic acid*.mp. 
3. docosahexaenoic acid/ 
4. docosahexaenoic acid*.mp. 
5. omega 3 fatty acid/ 
6. omega 3 fatty acid*.mp. 
7. fish oil/ 
8. fish oil*.mp. 
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9. fish liver oil*.mp. 
10. cod liver oil/ 
11. cod liver oil*.mp. 
12. cod oil*.mp. 
13. linolenic acid/ 
14. alpha-linolenic acid*.mp. 
15. or/1-14 
16. adverse effect*.mp. 
17. adverse event*.mp. 
18. risk assessment/ 
19. risk assessment.mp. 
20. risk factor*.mp. 
21. toxicity testing/ 
22. toxicity.mp. 
23. toxic.mp. 
24. dose response/ 
25. dose response.mp. 
26. or/16-24 
27. oxidative stress/ 
28. oxidative stress.mp. 
29. stress oxidative.mp. 
30. lipid peroxide/ 
31. lipid peroxidation/ 






38. thiobarbituric acid/ 
39. thiobarbituric acid*.mp. 
40. thiobarbiturate*.mp. 
41. or/27-40 
42. 15 and 26 
43. 15 and 41 
44. or/42-43 
45. meta analysis/ 
46. meta analy*.mp. 
47. metaanaly*.mp. 
48. (systematic adj (review*1 or overview*1)).mp. 
49. or/45-48 
50. 44 and 49 
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53. editorial*.pt. 
54. or/51-53 
55. 50 not 54 
56. limit 55 to yr="2000 -Current" 
57. (animal* not (animal* and human*)).mp. 
58. 56 not 57 
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Appendix VI 
Description of sampling, methods for chemical analyses and 
quality assurance of nutrients and contaminants in fish  
This appendix provides detailed information about the background for the tables in Chapter 6 
Nutrients and contaminants in fish on the Norwegian market.  
The content of this appendix is as follows: 
AVI-1 Description of collection of farmed and wild fish for analyses of nutrients 
and contaminants 
 Farmed Atlantic salmon and trout – sampling for analyses of contaminants 
 Base line studies – sampling for analyses of contaminants 
o Herring – Norwegian spring spawning (NVG herring). Data used for calculating 
exposure and nutrient intake in the current report 
o Herring – North Sea. Data not used to calculate exposure or nutrient intake in the 
current report 
o Mackerel 
o Atlantic cod 
o Saithe 
o Greenland halibut 
 Atlantic halibut – sampling for analyses of contaminants 
 Wild Atlantic salmon – sampling for analyses of contaminants 
 Samples of other species, fish oils and canned fish for analyses contaminants  
 Sampling of farmed and wild fish for analyses of nutrients 
AVI-2  Methods for chemical analyses and quality assurance of nutrients and 
contaminants in fish 
 Nutrients 
 Contaminants: Description of the limit of detection (LOD) and the limit of quantification 
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AVI-1  Description of collection of farmed and wild fish for analyses of nutrients 
and contaminants 
 Farmed Atlantic salmon and trout – sampling for analyses of contaminants 
The samples of farmed Atlantic salmon and trout analysed and data used for this report is 
based on market-size fish (3-5 kg) sampled at processing plants (Hannisdal et al., 2014) as 
part of the annual surveillance project of farmed fish. In this program, residues of 
therapeutic agents, illegal substances, and other substances in Norwegian farmed fish are 
measured in accordance with the Directive 96/23/EC "On measures to monitor certain 
substances and residues thereof in live animal and animal products”. The Norwegian Food 
Safety Authority (NFSA) is responsible for the enforcement, planning, and sampling, 
following up this directive in Norway, while NIFES is responsible for the analysis. The scope 
of sampling is based on total production (minimum 1 sample per 100 tonnes produced), and 
is randomised with regards to season and region in the whole of coastal Norway, and the 
sample identification is blinded for the analysts. Samples of fish muscle were transported to 
NIFES in a frozen state. On arrival at NIFES, the Norwegian quality cut (NQC) was obtained 
from the fish (Johnsen et al., 2011). Pooled sample of five fish from the same cage/farm 
were homogenised before analyses.  
 
Figure AVI-1  Illustration of Norwegian Quality Cut (NQC) for Atlantic salmon and Rainbow trout. 
Upper left picture show the area which is sampled between the posterior part of the back fin and 
anterior part of the gut. Upper right picture show how the sample is divided into two fillet parts. 
Lower left picture show the part of the fillet that is included in the NQC sample for further chemical 
analyses. Lower right picture show the material that is not included in the NQC sample. Source: 
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 Base line studies – sampling for analyses of contaminants 
The majority of wild fish species analysed for contaminants and used for calculations in this 
report are from comprehensive baseline studies performed by NIFES. The general goal of the 
baseline studies is to reflect commercial fisheries in Norwegian waters, while also trying to 
cover the widest possible part of the distribution area of the species as well as all seasons 
and the relevant size range of the fish. The number of samples from different areas was 
selected in collaboration with researchers from the Institute of Marine Research based on 
fisheries statistics and geographic distribution area of the species. Fish were caught mainly 
using the reference fleet, which are commercial fishing vessels assisting IMR with sampling 
of fish either as part of their commercial fishing or as special assignments. These are the 
same vessels which are used for IMR fish population estimates. If nothing else is stated, 
determinations of Hg, dioxins and PCBs were performed on fish fillets without skin but with 
the sub-cutaneous fat scraped off the skin and included in the sample. 
o Herring – Norwegian Spring Spawning (NVG herring). Data used for 
calculating exposure and nutrient intake in the current report 
Norwegian spring spawning herring (NSS herring) migrate in large schools in different areas 
at different times of the year.  
Samples of NSS herring were taken during the spawning season from January to February 
along the Norwegian coast (63-68°N, 200 fish) and after spawning in April-June (225 fish) 
and in August-October (375 fish) in the Norwegian Sea (65-73°N, from outside the 
Norwegian coast and as far west as Iceland). No samples were collected during wintering in 
West Fjord or off the coast of northern Norway.  
Data for age, size, gender and fat contents from the final report are shown in Table AV-1 
below. Fish of all sizes were sampled from the catches.  
Fish age and size were very important factors for concentrations of both Hg and organic 
pollutants in NSS herring, where concentrations increased with increasing size and age. For 
organic pollutants the time of year was of great significance since the highest concentrations 
were measured in herring from January-February, before spawning, and the lowest in spring, 
after spawning. January-February and October are important commercial fishing seasons for 
NSS herring, while in March-April much less is being caught. Hence, not all the samples in 
the project are equally representative of the commercially available herring for consumption.  
Table AV-1  Information about the 800 sampled and analysed NVG herring  
NVG herring n Mean Std Minimum Maximum 
Weight (g) 800 276 89 76 536 
Length (cm) 800 31.4 2.6 23 38 
Age (years) 727 6.2 2.5 3 16 
Sex (%) 660 50.5 ♂  + 49.5 ♀  No data No data No data 
Lipid content (g/100g) 800 11.8 6.3 1.3 27 
Source: All data are described and reported by Frantzen et al. (2009) 
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o Herring – North Sea. Data not used to calculate exposure or nutrient 
intake in the current report. 
The samples for the baseline study were mainly derived from commercial catches. The size 
of the fish varied widely from catch to catch, but they were all appropriate for different 
markets. The samples were collected to cover the entire area of distribution of North Sea 
herring for all seasons, and for instance some of the samples were taken around the English 
Channel in December and February. These samples were particularly high in dioxins and are 
not representative of the commercially available North Sea herring. These are part of what 
we have defined as the southern component (we have provided data both on all samples 
from the open sea and separated into a northern and a southern component). In the 
northern part two samples were included which were caught as by-catch in the mackerel 
fishery, with particular old and shed herring particularly high in cadmium. These are also 
probably less relevant for the market. Hence, North Sea herring data were not used for 
exposure and nutrient intake calculations. North Sea herring data are, however, included in 
the tables to show the variation in herring nutrient and contaminant concentrations. 
All data are described and reported by Duinker et al. (2013). 
o Mackerel 
Sample material was selected in collaboration with the Institute of Marine Research based on 
catch statistics and the geographic distribution of the species at the time the baseline study 
was conducted. Since then, the mackerel migration patterns changed and mackerel is now 
being fished to a greater extent in the Norwegian Sea. 
Most samples were collected in autumn, during the period from August to November. 
Samples from three positions were collected in the spring, in March, April and June. Most 
samples were collected in the North Sea, particularly during the period from October to 
November. In September, samples were also taken from two locations in the Skagerrak and 
four positions in the Norwegian Sea off northern Norway. The samples collected in March 
and April, were taken west of Scotland. Analyses were performed on fish fillets without skin. 
For overview, see Table AVI-2. 
Table AVI-2  Information about the analysed mackerel 
Mackerel Samples type n Mean Std Minimum Maximum 
Age (years) All fish 1170 4.3 2.5 0 15 
 Fish analysed for metals 831a 4.1 2.6 0 15 
 Fish analysed for POPs 803a 4.6 2.5 1 15 
Lenght (cm) All fish 1191 33.4 4.6 18 44 
 Fish analysed for metals 845 32.7 4.9 19 43 
 Fish analysed for POPs 818 33.8 4.5 20 44 
Weight (g) All fish 1191 352 146 35 774 
 Fish analysed for metals 845 325 146 49 773 
 Fish analysed for POPs 818 367 141 51 774 
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Mackerel Samples type n Mean Std Minimum Maximum 
Fillet lipid (g/100g) All fish 1166 21.5 8.9 1.2 41 
 Fish analysed for metals 845 19.2 8.8 1.2 39 
 Fish analysed for POPs 818 22.0 9.3 1.2 41 
Sex (%) All fish 787 51.2 - - - 
 Fish analysed for metals 468 50.0 - - - 
 Fish analysed for POPs 764 51.3 - - - 
aNot possible to decide age for all the fish 
Source: All data are described and reported by Frantzen et al. (2010) 
o Atlantic cod 
Samples of Atlantic cod were collected at 84 positions in the species' entire Norwegian 
distribution area from the north east Barents Sea in the north to the North Sea in the south, 
based on catch statistics. The samples included both 804 ocean caught cod from 33 positions 
in the Barents Sea (Northeast arctic cod), 585 ocean caught cod from 24 positions in the 
North Sea (North Sea cod) and 675 coastal and fjord cod from 27 different positions mainly 
in the fjords. The data in this report is divided into three cod stocks to differentiate between 
the three populations; Northeast arctic cod, which has the lowest concentrations of 
contaminants and is the most representative with respect to consumption, North Sea cod 
which has intermediate concentrations, and the coastal and fjord cod which has the highest 
levels of contaminants. To calculate contaminant exposure and nutrient intake, mean 
concentrations of the three populations were used. 
Although Atlantic cod were collected from all quarters of the year the numbers of fish caught 
during the different seasons reflect the main fishing seasons for each fishing area. 
For overview, see Table AVI-3. 
Table AVI-3  Information about the analysed Atlantic cod sampled from three different sea 
areas. Data are given as mean±std with minimum and maximum values given in brackets. 
Samples North-East arctic Coast/fjord North Sea 
Number of fish 804 675 585 
Age (year) 5.9±1.5 (3-13) 5.2±2.0 (2-12) 3.9±1.3 (2-8) 
Length (cm) 65±13 (37-110) 60±12 (33-103) 63±16 (29-100) 
Weight (kg) 2.5±1.6 (0.5-14.3) 2.7±1.7 (0.3-14.2) 3.2±2.5 (0.3-11.2) 
Liver weight (g) 102±93 (8-630) 105±135 (2-1106) 149±178 (1-1095) 
Dry matter (g/100g) 192±35 (178-228) 191±12 (134-222) 194±95 (164-235) 
Liver lipids (g/100g) 51±13 (6-84) 47±15 (8-84) 51±13 (5-71) 
Source: All data are described and reported by Julshamn et al. (2013a); Julshamn et al. (2013b); 
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o Saithe 
Two baseline studies for saithe have been performed, one for Northeast Arctic saithe from 
the Norwegian Sea and the Barents Sea and another for saithe in the North Sea. The data 
used in this report are all data combined representing the range of commercially available 
saithe.  
In the two baseline studies saithe were sampled from a total of 41 positions from the entire 
area of distribution from the northeast Barents Sea in the North to the North Sea in the 
south. The samples included 485 fish from 15 positions in the Barents Sea (Northeast Arctic 
saithe), 471 fish from 19 positions in the Norwegian Sea (Northeast Arctic saithe) and 664 
fish from 27 positions in the North Sea (North Sea saithe). In all the regions fish were 
gathered from both coastal and fjord areas and from the open sea. Commercially, Northeast 
Arctic saithe are more important than saithe from the North Sea. To reflect this, more fish 
were collected from the Norwegian Sea and the Barents Sea than from the North Sea.  
The concentration of mercury in the fillet and organic contaminants in the liver of saithe 
were highest in saithe from the North Sea and lowest in saithe from the Barents Sea. 
However, concentrations also increased with increasing fish age and size.  
For overview, see Table AVI-4.  
Table AVI-4  Information about the analysed saithe sampled from two different sea areas. Data are 
given as mean±std with minimum and maximum values given in brackets. 
Parameters Saithe, Northeast arctic Saithe, North sea Saithe, all 
 n mean ± std 
(min-max) 
n mean ± std 
(min-max) 
n mean ± std 
(min-max) 
Age (years) 856 5.4 ± 2.2  
(2-18) 
663 5.2 ± 1.6 
(2-12) 
1519 5.3 ± 1.9 
(2-18) 
Lenght (cm) 956 52 ± 12 
(33-100) 
664 49 ± 9 
(35-82) 
1620 51 ± 11 
(33-100) 
Weight (g) 956 1.8 ±1.3 
(0.50-9.0) 
664 1.5 ± 1.0 
(0.32-5.1) 
1620 1.7 ±1.2 
(0.32-9.0) 
Liver weight 902 116 ± 113 
(8.8-1000) 
639 79 ± 96 
(4.7 -505) 
1541 100 ± 108 
(4.7-1000) 
Liver lipid (g/100g) 951 60 ± 11 
(4.1-86) 
580 50 ± 18 
(4.8-87) 
1552 56 ± 15 
(3.7-87) 
Source: All data are described and reported by Nilsen et al. (2013a); Nilsen et al. (2012). 
o Greenland halibut 
Samples were collected of Greenland halibut from a total of 27 positions from the entire area 
of distribution along the Norwegian continental shelf edge from about 63°N to 77°N (west of 
Svalbard) and in the Barents Sea off the coast of eastern Finnmark. Most samples were 
collected in an area from Lofoten to Tromsøflaket (454 fish from 10 positions) which is the 
main area for commercial fishing of Greenland halibut. In addition, 342 fish from seven 
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locations in the area south of Lofoten, 300 fish from six positions in the area west of Bear 
Island and Svalbard and 192 fish from four locations off the coast of eastern Finnmark, were 
collected. For overview, see Table AVI-5. 
The amount of samples in different quarters of the year reflected the Greenland halibut 
commercial fishery. Samples were collected during the first, second and third quarter of the 
year, but not during the fourth quarter since hardly any Greenland halibut fishing is done 
during this period.  
The most pronounced variations in the concentration of mercury and persistent organic 
pollutants in Greenland halibut were due to geographical area with concentrations of 
mercury and persistent organic pollutants being lowest in fish caught off eastern Finnmark. 
The highest levels of POPs were found in Greenland halibut from the area south of Lofoten, 
and consequently, some of these fishing areas were closed for commercial fishing by the 
Norwegian Directorate of fisheries due to increased risk of exceeding upper limits for 
contaminants. Data on contaminant levels from this area from the follow up of base line 
studies after 2010 have not been included in this report (but are available at 
www.nifes.no/sjomatdata), as these are not representative for commercially available 
Greenland halibut.  
The concentration of mercury increased with increasing fish age and size and decreased with 
increasing fat content of the fillet. There was, however, no correlation found between the 
concentration of organic contaminants and Greenland halibut age, size or fat content.  
Table AVI-5 Information about the analysed Greenland halibut 
Parameter n Mean Std Minimum Maximum 
Length (cm) 1288 66 7 41 90 
Weight (g) 1288 3075 1146 665 8795 
Fillet lipids (g/100 g) 1288 11 3.3 1.1 23 
Age (years) 716 17.8 3.1 7 28 
Sex distribution (%) 1288 12 ♂+ 88 ♀ No data No data No data 
Source: All data are described and reported by Nilsen et al. (2010).  
 Atlantic halibut – sampling for analyses of contaminants 
The samples of Atlantic halibut reported here are not from a complete baseline study, but 
collected from separate smaller surveys from 2006 to 2010, where a total of 90 fish were 
analysed. In the different studies, different parts of the fish fillet were sampled and 
analysed, but the majority of the fish were analysed as B-section and I-section and then 
combining the two to give a mean content of Hg and POPs (Figure AV-2). The I-section 
contains more fat and hence more POPs, whereas the B-section is leaner with less POPs. The 
halibut collected in 2006 were not divided into I-section and B-section, but analysed as 
whole fillets. The 20 halibut from 2007 were caught in the Norwegian Sea in September 
2007, and had a weight range from 47.6 to 80 kg. The second study included 22 halibut 
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caught in the period from February 2008 to May 2010, all caught north of 69°N. Here, fish 
weight ranged from 1.7 to 70.5 kg (Table AVI-6). Since fat contents and contaminant 
concentrations increase with increasing halibut size (Figure AVI-3) it is important to have a 
range of sizes represented in the data material, as is the case in the data used for this report 
with halibut weight ranging from 1.7 kg to 70.5 kg. 
Table AVI-6 Sampling position, length (cm) and weight (kg) of individual Atlantic halibut sampled 
in North Norway during 2008-2010 
Sampling site  Sampling date Length (cm) Weight (kg) 
70°25’N 19°28’E  22.02.08 58 1.7 
70°25’N 19°28’E  22.02.08 63 2.0 
70°41’N 21°43’E  20.02.08 67 2.6 
Hammerfest havn  01.05.09 64 3.2 
69°24’N 15°52’E   27.02.08 70 3.4 
70°45’N 28°08’E  24.04.08 74 3.6 
69°24’N 15°52’E  27.02.08 76 4.3 
70°59’N 23°29’E  06.05.10 78 5.3 
70°59’N 23°29’E  06.05.09 90 7.2 
70°40’N 23°41’E  06.06.09 88 8.0 
71°05’N 27°17’E  25.08.08 93 8.1 
71°05’N 27°17’E  25.08.08 91 8.3 
69°52’N15°57’E  04.09.08 117 18.3 
70°00’N 18°15’E  07.04.08 123 19.5 
72°07’N 17°40’E  21.01.09 144 41.5 
Vesterålen  04.09.08 Unknown 45.0 
Troms  20.09.08 Unknown 53.5 
Nordland  19.09.08 Unknown 53.7 
Vesterålen/Troms  09.08.08 Unknown 60.3 
Vesterålen  04.09.08 Unknown 70.5 
 
  
Figure AVI-2 Different cuts from Atlantic halibut. The two cuts referred to in the description of 
sampling are highlighted by a blue circle (B-cut) and red circle (I-cut, which runs along one of the fins 
of the halibut). Source: Nortvedt and Tuene (1998) 
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Figure AVI-3 Weight (kg) of Atlantic halibut (I-cut) at the x-axis and dioxins and dl-PCBs (ng 
TEQ/kg ww) in fillet at the y-axis. Increased halibut size is followed by increased content of body fat 
and increased concentration of dioxins and dioxin-like PCBs. Source: Julshamn et al. (2007);Julshamn 
et al. (2011) 
 Wild Atlantic salmon – sampling for analyses of contaminants 
The sample materials were provided by a project led by the Institute of Marine Research. 
Wild Atlantic salmon were caught by local fishermen in six areas in northern Norway based 
on the known local geographic distribution range of the species. Between 22 and 167 fish 
were collected per site (total 422 wild salmon), and the average fish length and weight 
ranged from 62 to 77 cm and from 2.5 to 5.1 kg. There were significant differences in the 
size of individual fish and the weight ranged from 1.1 to 18.4 kg. The data used in this 
report are analysis 20 Atlantic salmon fillets from five different localities (only 18 fish from 
one locality). Wild Atlantic salmon of comparable size as farmed Atlantic salmon of 
approximately 2.5-5 kg were selected for analyses. Data are described by Lundebye et al. 
(manuscript in prep.; pers. comm.). 
 Samples of other species, fish oils and canned fish for analyses contaminants  
Samples of commercially relevant size of different fish being relevant for small scale 
commercial fisheries and consumption was sampled by NIFES in surveillance programs and 
analysed for selected contaminants. In this report, data is on consumption size relevant 
redfish (n=13), wolffish (n=10), plaice (n=25), haddock (n=7) and sprat (n=14) 
(www.nifes.no/sjomatdata). A selection of canned tuna (n=6) and cod roe and liver pate 
(Svolværpostei, one pooled sample based on five cans) and various fish oils for human 
consumption sampled over the years from 2006 to 2013 was analysed by NIFES.  
Data for contaminants are described and reported in annual reports to the NFSA, «Miljøgifter 
i fisk og fiskevarer», available at www.nifes.no and www.mattilsynet.no.  
 
  
y = 0,1318x + 1,2276 
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 Sampling of farmed and wild fish for analyses of nutrients 
Nutrients analyses were performed on a selected and limited number of fish from the annual 
surveillance program of farmed Atlantic salmon (Hannisdal et al., 2014), and from the 
baseline studies for NVG herring, north sea herring, Greenland halibut, Atlantic cod, saithe 
and mackerel described above. If nothing else is stated, analyses were performed on fillets 
without skin of fish selected to be relevant size for consumption (www.nifes.no/sjomatdata). 
Nutrients of wild Atlantic salmon were analysed in fish sampled by two IMR projects, one of 
wild Atlantic salmon in Sørfjorden (“Vossolaks”; n=27) and another of wild Atlantic salmon 
off the Finnmark coast as described above (Lundebye et al., manuscript in prep.; pers. 
comm.; n=97). 
Atlantic halibut collected for nutrient analyses were sampled from two ocean areas 
(Norskehavet and Nordsjøen) and are not from the same sample batches described above 
for contaminant analyses. For these fish, only the leaner part of the fillet (A and B cuts, see 
Figure AV-1) were sampled and analysed, explaining the relative low lipid content (2.3%) 
compared to what reported in “Matvaretabellen” (6.1%). The fish size varied from 0.5 kg to 
40kg, which cover relevant consumer sized halibut. 
Wolffish and plaice of relevant consumer sizes were sampled random from commercial 
fishing sites but not as part of a larger base line study and analysed by NIFES.  
Fish oils analysed for nutrients were a selection of oils from the material described above as 
part of the annual surveillance project by NIFES for the NFSA «Miljøgifter i fisk og fiskevarer» 
available at www.nifes.no and www.mattilsynet.no. 
AVI-2 Methods for chemical analyses and quality assurance of nutrients and 
contaminants in fish 
The NIFES laboratory routines and data reported in this chapter are based on analytical 
methods which are accredited in accordance with the standard ISO 17025. The analytical 
methods for the contaminants and their Limit of detection (LOD) and Limit of quantification 
(LOQ) are described for each set of data in all reports where the data were reported by 
Duinker et al. (2013); Frantzen et al. (2009); Frantzen et al. (2010); Hannisdal et al. (2014); 
Julshamn et al. (2010); Julshamn et al. (2007); Julshamn et al. (2013d); Nilsen et al. 
(2013a); Nilsen et al. (2010); Nilsen et al. (2012).The limit of detection (LOD) is the lowest 
level at which the method is able to detect the substance, while the limit of quantification 
(LOQ) is the lowest level for a reliable (Duinker et al., 2013) quantitative measurement. For 
all methods, a quality control sample (QCS) with a known composition and concentration of 
target analyte, is included in each series. The QCS results are checked to be within pre-
defined limits before the results are approved. The methods are regularly verified by 
participation in inter laboratory proficiency tests, or by analysing certified reference material 
(CRM), where such exist. Since analytical methodology is constantly improving, sensitivity 
and accuracy may increase resulting in decreased LOQ and LOD over time for quantification 
of contaminants and nutrients. 
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 Nutrients 
For chemical analyses of nutrient, the methodological principle and limits of quantifications 
(LOQs) are given in Table AVI-7.  
Table AVI-7 Method principle, limit of quantification for the main methodology used for analyses of 
farmed and wild fish species and fish oils. All methods are accredited according to ISO standards. 
Parameter Method principle Limit of quantification (LOQ) 
Total lipids Ethyl acetate 0.1 g/100g 
Fatty acids GC-FID 0.001 g/100g 
Vitamin D3 HPLC-UV 1 μg/100g 
B12 Microbiology 0.1 μg/100g 
Selenium ICP-MS 1 μg/100g 
Iodine ICP-MS 4 μg/100g 
 Contaminants: Description of the limit of detection (LOD) and the limit of 
quantification (LOQ) for dioxins and dioxin-like PCBs (dl-PCBs) 
For the analyses of dioxins and dioxin-like PCBs NIFES methodology is accredited according 
to ISO-standards and validated for using variable limit of detection (LOD) and limit of 
quantification (LOQ). LOD and LOQ are used to identify the lowest concentrations of an 
analyte (i.e. the congeners of dioxin and dl-PCB); the method can measure with accurate 
and reliable results. In this report the reported sum dioxins and dl-PCBs upper bound (UB) 
and lower bound (LB) values are based on variable LOQs determined for each congener in 
each sample (totally 29 congeners are included in sum dioxins and dl-PCBs). When 
determining low levels of organic pollutants in food and biological samples, the level of 
“noise” will increase relative to the “signal” as the concentration of the pollutant decreases. 
The noise will eventually be the limiting factor for the analytical method:  Using a S/N ratio 
acquired close to the LOQ level, we define: LOD= 3 * S/N and LOQ = 10 * S/N. When using 
a variable LOQ and LOD, the S/N ratio is determined for each analyte in each sample:  In 
contrast, for a fixed LOD and LOQ the S/N ratio for each analyte is determined in a separate 
validation experiment. 
Variable vs fixed LOD and LOQ; A theoretical basis for a fixed LOQ is that analysed samples 
is assumed to have similar analytical properties to the samples included in the validation 
experiment. 
A variable LOQ may be applied in chromatographic analytical methods if sophisticated 
detector and soft-ware are used. Its theoretical basis is then that the instrumental signal 
(peak area) for each analyte contains a noise corresponding to the noise found immediately 
around the signal (peak area) of the analyte.  
Procedure for variable LOD and LOQ: Each analyte’s S/N ratio is automatically calculated 
from its surrounding noise, using standard deviation or optionally the mean peak area of the 
nearby chromatographic noise. Alternatively, the analyst may override this option and select 
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graphically a "typical peak area" in the surrounding noise. LOD is then 3 * S/N and LOQ is 10 
* S/N. Analyst intervention provides a more reliable LOD and LOQ, but is time consuming. 
A variable LOQ is the limit of quantification achieved in the current sample. By using the S/N 
ratios from the current sample a lower LOQ value is often achieved, which is preferred when 
analysing contaminants where the goal is to quantify as low concentrations as possible.  
Hannisdal et al. (2014) report the range of LOQ for each of the 29 dioxins and dl-PCB 
congeners for the farmed fish data used in this report. The range of LOQ of the congeners of 
dioxins and dl-PCBs data of wild fish used in this report is reported by Julshamn et al. 
(2010), Julshamn et al. (2007), Julshamn et al. (2013d), Nilsen et al. (2013a), Nilsen et al. 
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Appendix VII 
Concentrations of nutrients and contaminants in fish used in the exposure 
estimates 
In Chapter 6 of the main document, concentrations of nutrients and contaminants in fish and 
fish products on the Norwegian market are given in Tables 6.1-1, 6.2-1 and 6.3-1. However, 
choices have been made regarding which fish/fish products (presented in Chapter 6) to 
include in the calculations of nutrient intake and of contaminant exposure (presented in 
Chapter 7). Based on the reported fish consumed in one or several of the surveys (Chapter 
3), data on nutrient and contaminant content had both to be available, and representative 
for fish on the Norwegian market. For example, Norwegian Spring Spawning herring (NVG 
herring) was used for the calculations since this herring population dominates the consumer 
market over the North Sea herring. For Atlantic cod, data on three populations are available 
(Chapter 6, Appendix V), i.e. coastal cod, North Sea cod and North East Atlantic cod. It is not 
possible to conclude that one population dominates the Norwegian consumer market over 
the others, and the contaminant and nutrient profile differ in the three. Hence, a mean 
nutrient and contaminant concentrations of the three cod populations were used to best 
represent the intake and exposure for consumers. Mackerel sampled in the North Atlantic 
was analysed for nutrients and contaminants. There are also available mackerel nutrient data 
of fish sampled in the North Sea (Chapter 6). These were not used for the calculations due 
to lacking contaminant data from the same population and very high mean fat content at 32 
g/100 g fillet.  
Nutrient and contaminant concentration data in farmed Atlantic salmon used for the 
calculations is the most recent analysed fish, i.e. sampled during 2013 and analyses finalised 
in 2014. Contaminant data on farmed trout from 2013 show very similar concentrations 
(Chapter 6), although analysed in far less samples compared to farmed salmon. Further, 
nutrient concentrations were not available for farmed trout from 2012 or 2013. Based on the 
very similar contaminant concentrations in farmed trout and salmon (Chapter 6) and similar 
changes in contaminant concentrations over time as observed in farmed salmon (Chapter 5), 
nutrient and contaminant concentrations in farmed salmon was used for the calculations for 
trout. 
Concentrations of contaminants and nutrients of both wild halibut and wild Atlantic cod were 
used for the exposure and intake calculations, respectively. This was done since volumes of 
farmed cod and farmed halibut in Norway today is very low and negligible in the context of 
this report. 
Nutrient and contaminant data of Atlantic cod roe was used to calculate the concentrations 
in caviar by using the percentage of roe in caviar. In surveys where intake data of fresh 
water fish was recorded, nutrient and contaminant concentrations of Perch were used for 
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exposure calculations. For consumers reporting eating fish liver, concentrations in cod liver 
was used for exposure and intake calculations. 
The nutrient and contaminant concentrations for the fish species used for the intake and 
exposure calculations from fish can be found in tables: 
 Table AVII-1 Content of nutrients in fish fillet and fish products used in intake 
calculations in the main text 
 Table AVII-2 Concentrations of mercury (Hg) in fish and fish products used in exposure 
estimates in the main text 
 Table AVII-3 Concentrations of dioxins (PCDD), furans (PCDF), and dioxin-like PCBs 
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Table AVII-1 Concentrations of nutrients in fish fillet and fish products used in intake calculations in the main text   





















Lean fish (≤ 5% fat)a          
Atlantic cod, all populationsb,ABC 51 2006/07/11 1.1 273 282 22 1.4d 323 24 
Saithec,B 40 2006/11 1.4 439 458 27 1.4 160 30 
Haddockd,A - - 0.6 No datae No data
e No datae 0.7 No datae 28 
PlaiceBC 15-
20 
2007 2.6 623 709 74 6.5 14 34 
Redfishd,B - - 2.8 No data
e No datae No datae No datae No datae 50 
WolffishB 3 2011 0.9 223 250 121 1.8d 124 29 
Tuna, canned d,BC - - 1 No data
e No datae No datae 1.6 8 200 
Fatty fish (> 5% fat)a           
Atlantic halibutf,B 53 2005 2.3 612 709 80 12.0 18 No datae 
Herring (Norwegian spring 
spawning)g,BC 
30  9.9 1655 2213 170 14.5 2 58 
Mackerel (North East 
Atlantic)ABC 
10 2010 23.3 4456 6738 605 2.8 17 52 
Atlantic salmon (wild) (Finnmark 
coast)B 
99 2012 8.0 1765 2126 193 11.2h 14h 46h 
Atlantic salmon (farmed)i,ABC 90 2013 15.0 1311 2303 2296 7.5 4 12 
Freshwater fish          
Perchd,C - - 1.3 No data
e No datae No datae 0.8 18 28 
Sandwich spreads from fish          
Cod roe and liver patej,ABC 
- 2014 32.6 
5500 
(EPA+DHA) 
6600 No datae 39.1d 234d 60d 
Cod roe j,ABC 5 2014 6.4 300 (EPA+DHA) 700 No datae 12.1d 104d 9d 
Cod liver k,BC 41 2006/07 58.8 11296 13477 1323 89.4 379 80 
aLean fish=fish with fat content below 2%, medium fatty fish=fish with 2-5% fat and fatty fish=fish with <5% fat, bMean of cod harvested in the Norwegian 
Sea 2006 (10 samples), Northern Sea 2011 (10 samples) and Barents Sea 2006 (20 samples) and 2007 (11 samples). For vitamin D, 42 samples were 
analysed, cMean of saithe harvested in the North Sea 2006, Barents Sea 2006 and 2011, Haltenbank 2006 (10 samples per harvesting), dValues according to 
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the Norwegian Food Composition Table, 2014, ezero is used in the calculations due to no data, fMean of 53 samples of halibut harvested in Norwegian Sea 
and North Sea in 2005, gMean of Norwegian spring-spawning herring from the Norwegian Sea in 2005 and 2010, and the North Sea 2005 (10 samples per 
harvest), but for iodine, 10 samples were analysed, hValues from wild Atlantic salmon, fillet (Sørfjorden, Vossolaks), n=27, iMean of 90 samples farmed 
salmon harvested in 2013, except for analysis of vitamin D where 70 samples were analysed, jValues from the food industry, 2014, kMean content in cod liver 
from cods harvested in the Barents Sea in 2006 (21 samples) and 2007 (10 samples) and in the Norwegian Sea in 2006 (10 samples). 
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Table AVII-2  Concentrations of methylmercury (Hg) in fish fillet and fish products used in 
exposure estimates in the main text   
Food item Year n Mean mg Hg/kg wet weight  
   Lower bound Upper bound 
Lean fish (≤ 5% fat)a     
Atlantic cod, all populationsABC 2009-2011 2109 0.075 0.075 
SaitheB 2010-2012 1620 0.051 0.051 
Haddock b,B 2003 25 0.08b 0.08 
PlaiceBC 2007 156 0.07 0.07 
RedfishB 2007 178 0.13 0.13 
WolffishB 2003 10 0.021 0.025 
Tuna, cannedBC 2006 6 0.10 0.10 
Fatty fish (> 5% fat)a     
Atlantic halibut B 2006-2010 88 0.26 0.26 
Herring (Norwegian spring 
spawning)BC 
2006-2007 800 0.039 0.039 
Mackerel (Northeast Atlantic)ABC 2007-2009 845 0.039 0.039 
Atlantic salmon (wild)B 2012 98 0.036 0.036 
Atlantic salmon (farmed)ABC 2013 132c 0.014 0.014 
Freshwater fish      
Perchd,C 1965-2008 >5000 0.328 0.328 
Sandwich spreads from fish     
Cod roe and liver patee,ABC 2014 9 0 f 0.011 
Cod roee,BC 2014 unknown 0 f 0.011 
Cod liverBC 2009-2011 1908 0.042 0.045 
aLean fish=fish with fat content below 2%, medium fatty fish=fish with 2-5% fat and fatty fish=fish 
with <5% fat, bOld values from the Seafood database, NIFES, and no data on lower bound exists, 
thus, for calculating purposes upper bound value are used as a conservative lower bound value, 
cPooled samples of five fish each, dValues from Jenssen et al. (2012), eData from the food industry, 
fzero is used due to values under limit of quantification (LOQ). 
A Values used in Småbarnskost 2007 (2-year-olds), B Values used in Norkost 3 (adults; 18-70 years of 
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Table AVII-3  Concentrations of dioxins and dioxin-like PCBs used in exposure estimates in 
the main text  
Food item Year n Sum dioxinsa and dl-PCBb  
pg 2005-TE/g wet weight 
   Lower bound Upper bound 
Lean fish (≤ 5% fat)c     
Atlantic cod (all populations)ABC 2007-2010 136 0.035 0.056 
SaitheB 2006 41 0.072 0.097 
HaddockB 2003 7 0.045 0.054 
Flatfish, plaiceBC  2007 25 0.33 0.34 
RedfishB 2004 24 0.60 0.61 
WolffishB 2003 10 0.49 0.49 
Tuna, cannedBC - - No datad No datad 
Fatty fish (> 5% fat)c     
Atlantic halibutB 2006-2010 90 4.3 4.4 
Herring (Norwegian spring 
spawning)BC 
2006-2007 799 0.56 0.63 
Mackerel (Northeast Atlantic)ABC 2007-2009 791 0.63 0.87 
Atlantic salmon (wild)B  2012 92 0.82 0.96 
Atlantic salmon (farmed)ABC 2013 102e 0.4 0.5 
Freshwater fish     
Perchf,C - - No datad No datad 
Sandwich spreads from fish     
Cod roe and liver pate g,ABC 2014 9 4.3h 4.3 
Cod roef,BC 2005 4 0.321 0.321i 
Cod liverBC 2009-2011 528 20.9 21.7 
aDioxins - PCDD/PCDF - polychlorinated dibenzo-para-dioxins (PCDD) and polychlorinated dibenzo 
furans (PCDF), bdl-PCB = dioxin-like PCB (non-ortho and mono-ortho substituted PCBs),c Lean 
fish=fish with fat content below 2%, medium fatty fish=fish with 2-5% fat and fatty fish=fish with 
<5% fat, d zero is used in the calculations due to no occurrence data, ePooled samples of five fish 
each, fData from Kvalem et al. (2009), gData from the food industry, hNo data on lower bound, for 
calculating purposes upper bound value are also used as a conservative lower bound value, i No data 
on upper bound, for calculating purposes lower bound value are used. 
A Values used in Småbarnskost 2007 (2-year-olds), B Values used in Norkost 3 (adults; 18-70 years of 
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Concentrations of nutrients and contaminants in fish oil/cod liver oil used in the 
exposure estimates 
For intake estimates of nutrients and exposure calculations from fish oil and cod liver oil, 
respectively, data for fish oil and cod liver oil were combined, and a weighed mean based on 
data from Tables 6.1-2 and 6.3-2 were calculated. Data for sum dioxins and dl-PCBs without 
lower bound were excluded since both lower and upper bounds were calculated. Overview of 
the data used can be found in tables below: 
Table AVII-4 Concentrations of nutrients in fish oil/cod liver oil used in intake calculations in the 
main text 
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Table AVII-5 Concentrations of dioxin and dl-PCB in fish oil/cod liver oil used in exposure estimates 
in the main text 
Supplement Year n Sum dioxins and dl-PCBs 
pg 2005-TEQ/g 
   Lower bound Upper bound 
Cod liver/fish oil 2011-2014 27 0.27 0.95 
 
